Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FGFBP1,Fibroblast growth factor-binding protein 1,39909,0.107361500434135,0.0028455354738191,0.10178425090545,0.112938749962821,1.49613900003248e-298
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PLA2G7,Platelet-activating factor acetylhydrolase,39854,0.0916411525716953,0.00273338634474232,0.0862837153360004,0.0969985898073903,3.20084999525754e-238
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MFGE8,Lactadherin,39854,-0.120139530503163,0.00394938743511861,-0.127880329875995,-0.11239873113033,1.22563716980361e-197
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IGSF9,Protein turtle homolog A,37433,-0.221084156217836,0.00742294202027269,-0.235633122577571,-0.206535189858102,7.03560916135349e-189
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GCG,Pro-glucagon,39473,-0.312622673362994,0.011123734999589,-0.334425193962188,-0.290820152763799,1.40876215570851e-169
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MAMDC4,Apical endosomal glycoprotein,37364,-0.134002911441403,0.00504643621384356,-0.143893926420537,-0.12411189646227,1.73116427460279e-151
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,C9,Complement component C9,37441,0.123889182086595,0.00480794997541814,0.114465600134776,0.133312764038415,5.43789140525774e-143
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRAP1,Proline-rich acidic protein 1,37433,-0.0926464446247498,0.00365256230430268,-0.0998054667411831,-0.0854874225083166,1.0248412707982e-138
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRSS8,Prostasin,39801,-0.085586713866962,0.00366007921065333,-0.0927604691198426,-0.0784129586140815,6.21722015637188e-119
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PYY,Peptide YY,37017,-0.196614032100236,0.00842024234286834,-0.213117707092258,-0.180110357108214,3.41887550107197e-118
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL17RB,Interleukin-17 receptor B,39640,0.114013361209333,0.0049168376399656,0.104376359435,0.123650362983665,5.35003134632606e-117
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IGFBP1,Insulin-like growth factor-binding protein 1,40013,0.256292884072954,0.0112369793794813,0.23426840448917,0.278317363656737,2.34305296272786e-113
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TMPRSS15,Enteropeptidase,39784,-0.179403378813657,0.00815605079974894,-0.195389238381165,-0.163417519246149,1.16225479616596e-105
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,OXT,Oxytocin-neurophysin 1,40005,-0.272551702725432,0.0126824162782079,-0.29740923863072,-0.247694166820145,4.95114553967493e-101
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CES1,Liver carboxylesterase 1,39850,-0.155707363183064,0.00728807923481097,-0.169991998483294,-0.141422727882835,7.0651125591247e-100
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,APOF,Apolipoprotein F,37441,0.0487998777235636,0.00236693182612513,0.0441606913443584,0.0534390641027689,5.06404977030169e-93
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLC39A5,Zinc transporter ZIP5,39862,-0.0975385298473034,0.0048477489618495,-0.107040117812528,-0.0880369418820784,6.14627803529252e-89
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FGF21,Fibroblast growth factor 21,40007,-0.21799453930393,0.0109372278962898,-0.239431505980658,-0.196557572627202,2.43435787300927e-87
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PON3,Serum paraoxonase/lactonase 3,39927,0.051222868558234,0.0025835423550194,0.0461591255423959,0.056286611574072,1.89230411578476e-86
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CA14,Carbonic anhydrase 14,40026,0.0610516097730567,0.00322493387744587,0.0547307393732628,0.0673724801728506,4.52476168980416e-79
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MET,Hepatocyte growth factor receptor,39875,0.0335773636692872,0.00179505362727604,0.0300590585598262,0.0370956687787482,2.96950771794654e-77
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GIP,Gastric inhibitory polypeptide,37039,-0.0733469091506481,0.00399757848697489,-0.0811821629851188,-0.0655116553161773,2.88057959974544e-74
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CPM,Carboxypeptidase M,39951,-0.0578078962450193,0.00316434212672967,-0.0640100068134095,-0.0516057856766291,8.20584161086293e-74
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ACY1,Aminoacylase-1,39864,-0.103173703160521,0.00566996887044744,-0.114286842146598,-0.0920605641744444,3.00902403860033e-73
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NRP1,Neuropilin-1,39945,0.046212310753282,0.00254673116932096,0.0412207176614129,0.051203903845151,7.39011609910526e-73
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FGFBP3,Fibroblast growth factor-binding protein 3,37384,0.0606253084609888,0.00336034473139919,0.0540390327874464,0.0672115841345312,6.41160604511122e-72
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,39927,0.0632026213077157,0.00353519820742942,0.0562736328211541,0.0701316097942774,8.47008069048429e-71
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NPY,Pro-neuropeptide Y,40026,-0.108788151856774,0.006093315874367,-0.120731050970533,-0.0968452527430143,1.28844706892856e-70
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,INHBC,Inhibin beta C chain,39854,-0.0677928309181291,0.00381116444069092,-0.0752627132218833,-0.0603229486143749,4.14597050997665e-70
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IGFBP2,Insulin-like growth factor-binding protein 2,40008,0.0976110056173335,0.00571974712232058,0.0864003012575851,0.108821709977082,9.88116242006572e-65
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PPY,Pancreatic prohormone,39822,-0.154669524871125,0.00922469952863488,-0.172749935947249,-0.136589113795001,1.46148351160096e-62
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TFPI,Tissue factor pathway inhibitor,39839,0.0469547813435293,0.00289503261880094,0.0412805174106794,0.0526290452763791,1.08752484935224e-58
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ANGPTL7,Angiopoietin-related protein 7,40026,-0.0547189410509126,0.00343355098315957,-0.0614487009779053,-0.0479891811239198,9.55688197136716e-57
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NRP2,Neuropilin-2,39854,0.0413985015090999,0.00262744099356727,0.0362487171617081,0.0465482858564918,1.62799084949132e-55
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SHBG,Sex hormone-binding globulin,37441,0.0738819219094293,0.00474288159350452,0.0645858739861604,0.0831779698326981,3.05167070034616e-54
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MEP1A,Meprin A subunit alpha,37378,-0.102064275485677,0.00658467916943032,-0.11497024665776,-0.0891583043135933,1.00097430606854e-53
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CKB,Creatine kinase B-type,37433,0.0826847743904907,0.00535101784805924,0.0721967794082946,0.0931727693726868,2.07788545410768e-53
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AGRP,Agouti-related protein,40054,-0.0754667187089211,0.00492998385074341,-0.0851294870563782,-0.065803950361464,1.58398891944061e-52
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IGFBPL1,Insulin-like growth factor-binding protein-like 1,39864,-0.0461411690025648,0.00302923641951207,-0.0520784723848084,-0.0402038656203211,5.02732130548147e-52
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CHI3L1,Chitinase-3-like protein 1,39541,-0.104903254811113,0.00693971723039543,-0.118505100582688,-0.0913014090395376,2.90215621831644e-51
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FURIN,Furin,39909,-0.046688788365344,0.00312417053745106,-0.0528121626187481,-0.0405654141119399,3.68473477520624e-50
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTPRS,Receptor-type tyrosine-protein phosphatase S,40048,0.0333941236481694,0.0022544712940812,0.0289753599117703,0.0378128873845686,2.56219884986004e-49
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LPL,Lipoprotein lipase,39864,0.0641650107989879,0.00435806845405048,0.055623196629049,0.0727068249689269,9.52365851910875e-49
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ASGR1,Asialoglycoprotein receptor 1,39745,-0.0394464278649854,0.00268192397563556,-0.0447029988572311,-0.0341898568727397,1.19192352482811e-48
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GHR,Growth hormone receptor,37120,-0.0383495487717814,0.00265450970655745,-0.043552387796634,-0.0331467097469288,5.95355143026505e-47
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CTSD,Cathepsin D,38717,-0.0521780004012682,0.00363181415414168,-0.0592963561433859,-0.0450596446591505,1.70977971592507e-46
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AFM,Afamin,37449,-0.0250628038674422,0.00174860988776099,-0.0284900792474537,-0.0216355284874306,2.95841672189121e-46
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,C4BPB,C4b-binding protein beta chain,39909,0.051941896551934,0.00366155092838279,0.0447652567323038,0.0591185363715643,2.11118750190884e-45
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SERPINF1,Pigment epithelium-derived factor,37250,-0.0333681509914529,0.00235634123073383,-0.0379865798036912,-0.0287497221792146,3.38367757927803e-45
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFSF10,Tumor necrosis factor ligand superfamily member 10,40054,0.0336155182101473,0.00239811727867377,0.0289152083439467,0.0383158280763479,2.21501954663628e-44
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ACE2,Angiotensin-converting enzyme 2,39581,-0.064434770325477,0.0046092526638874,-0.0734689055466963,-0.0554006351042576,3.82454646642835e-44
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LPA,Apolipoprotein(a),37182,0.22201150637043,0.0162152907727012,0.190229536455936,0.253793476284925,2.20905634434578e-42
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GH1,Somatotropin,39842,0.226946520870876,0.0166600660861279,0.194292791342066,0.259600250399687,5.07358568146626e-42
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CTSF,Cathepsin F,39909,-0.0505825860039842,0.00373579083769439,-0.0579047360458652,-0.0432604359621032,1.53528704852688e-41
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MME,Neprilysin,39784,-0.0983605902090823,0.00726859736340138,-0.112607041041349,-0.0841141393768156,1.71051038937094e-41
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FTCD,Formimidoyltransferase-cyclodeaminase,37364,-0.105255976702255,0.00778243912628571,-0.120509557389775,-0.0900023960147353,2.07655328257668e-41
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DSG2,Desmoglein-2,39854,0.0331897375452032,0.00246340746504236,0.0283614589137202,0.0380180161766863,3.7759813007573e-41
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SELE,E-selectin,40048,-0.0615858091643057,0.00460221450477468,-0.0706061495936641,-0.0525654687349473,1.27038188571674e-40
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GUSB,Beta-glucuronidase,39915,-0.0725463669052864,0.00542325765008242,-0.0831759518994479,-0.0619167819111248,1.36113173196785e-40
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GPR37,Prosaposin receptor GPR37,39581,-0.078322583991916,0.00594498955529047,-0.0899747635202853,-0.0666704044635466,1.98909484989603e-39
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCG2,Secretogranin-2,39945,-0.037447596782088,0.00287380096746402,-0.0430802466783175,-0.0318149468858585,1.2842402213196e-38
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MVK,Mevalonate kinase,39583,-0.0950823487787289,0.00732033917660102,-0.109430213564867,-0.0807344839925909,2.23189923348095e-38
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VWA1,von Willebrand factor A domain-containing protein 1,40007,-0.0511236789000501,0.0039446221635617,-0.058855138340631,-0.0433922194594692,3.18466340118031e-38
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KIT,Mast/stem cell growth factor receptor Kit,39904,0.0344083655291157,0.00265743433494548,0.0291997942326226,0.0396169368256089,3.74659252449016e-38
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NHLRC3,NHL repeat-containing protein 3,36834,-0.0381262830403612,0.0029479904074034,-0.0439043442388718,-0.0323482218418505,5.03668741724645e-38
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KLK14,Kallikrein-14,40026,0.0538508526108403,0.00417055090530572,0.0456765728364411,0.0620251323852395,5.92022210785717e-38
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LGALS4,Galectin-4,39858,-0.0628143024809217,0.00487345206514274,-0.0723662685286014,-0.0532623364332419,7.99997397064611e-38
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CFHR4,Complement factor H-related protein 4,37405,0.0856167648181848,0.00664135455745189,0.0725997098855791,0.0986338197507905,8.38776381187454e-38
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FGA,Fibrinogen alpha chain,37145,0.0366162757429428,0.00284227591232835,0.0310454149547792,0.0421871365311064,9.47339021871031e-38
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MUC13,Mucin-13,39485,-0.0602718371857806,0.00468874632090334,-0.0694617799747511,-0.05108189439681,1.25761087034982e-37
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,F7,Coagulation factor VII,39895,-0.035498447939423,0.00276538052596576,-0.0409185937703159,-0.0300783021085301,1.56249676066712e-37
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GSTA1,Glutathione S-transferase A1,39837,-0.100543952564495,0.0078427764084409,-0.11591579432504,-0.0851721108039512,1.93918003013274e-37
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LAG3,Lymphocyte activation gene 3 protein,39784,0.0478845143203373,0.00375648209711871,0.0405218094099847,0.05524721923069,4.90423785853902e-37
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,UPB1,Beta-ureidopropionase,37433,-0.108417963813177,0.0085047290665673,-0.125087232783649,-0.0917486948427051,5.2157252654427e-37
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ALPI,Intestinal-type alkaline phosphatase,37052,-0.141598072747793,0.011158455829098,-0.163468646172825,-0.119727499322761,1.10396797296014e-36
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HJV,Hemojuvelin,37408,-0.051605156368197,0.00409640235987714,-0.0596341049935562,-0.0435762077428378,3.46869797947058e-36
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTH,Parathyroid hormone,37035,-0.0930483588947733,0.00739957095604014,-0.107551517968612,-0.0785451998209346,4.67764831739768e-36
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,39581,-0.0973426629555116,0.00781764547524433,-0.11266524808699,-0.0820200778240327,2.01220704175041e-35
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NFASC,Neurofascin,40054,-0.0311961744880469,0.00256117928401603,-0.0362160858847183,-0.0261762630913755,5.5673932747146e-34
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BCAN,Brevican core protein,39745,0.0374474381753586,0.00307572347049211,0.031419020173194,0.0434758561775231,5.97193481148255e-34
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CRELD1,Protein disulfide isomerase CRELD1,37120,-0.0416783844490881,0.00343959861332819,-0.0484199977312113,-0.0349367711669648,1.28866178263139e-33
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EPHA1,Ephrin type-A receptor 1,39900,-0.0372849523335638,0.00308693014530761,-0.0433353354183667,-0.0312345692487609,1.92052165332355e-33
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GSTA3,Glutathione S-transferase A3,39473,-0.085237159269446,0.00707182750633115,-0.099097941181855,-0.0713763773570369,2.62683973777532e-33
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CPA2,Carboxypeptidase A2,39929,-0.0712534878751702,0.00595564751295481,-0.0829265570005617,-0.0595804187497788,7.56210433558038e-33
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PSRC1,Proline/serine-rich coiled-coil protein 1,39473,-0.0651978438046309,0.00547586752649532,-0.0759305441565618,-0.0544651434527001,1.51612534265918e-32
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,F9,Coagulation factor IX,39904,-0.019912349795413,0.00168173870437896,-0.0232085576559958,-0.0166161419348302,3.2885938523859e-32
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NCAN,Neurocan core protein,40005,0.0400653387284405,0.0033923670921308,0.0334162992278641,0.0467143782290168,4.6717240451225e-32
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VPS37A,Vacuolar protein sorting-associated protein 37A,39784,-0.0866321973564571,0.00734763910122871,-0.101033569994865,-0.0722308247180488,5.93477003882854e-32
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,39927,0.0469519344770937,0.00398245954307091,0.0391463137726747,0.0547575551815127,5.9745857954427e-32
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MTSS1,Protein MTSS 1,37378,-0.11905370885859,0.0101918495747261,-0.139029734025053,-0.0990776836921267,2.24839014277082e-31
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PVR,Poliovirus receptor,40005,-0.0401435961554426,0.00343871468904884,-0.0468834769459783,-0.0334037153649069,2.31329433419687e-31
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADAMTSL2,ADAMTS-like protein 2,37433,-0.0340239925830872,0.00293340824136191,-0.0397734727361566,-0.0282745124300179,5.84884676071423e-31
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MXRA8,Matrix remodeling-associated protein 8,37120,0.0318322744076861,0.002782057326114,0.0263794420485026,0.0372851067668695,3.57272646640278e-30
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLEC4M,C-type lectin domain family 4 member M,37406,0.0510701450026019,0.0044695016768922,0.0423099217158932,0.0598303682893106,4.24107694295013e-30
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,OMD,Osteomodulin,39927,0.0458694026488303,0.00402231579567612,0.0379856636893051,0.0537531416083555,5.22521034036602e-30
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,UMOD,Uromodulin,40008,0.0555438676050792,0.0048761093614214,0.0459866932566933,0.0651010419534651,6.03117655739431e-30
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,APOA4,Apolipoprotein A-IV,37449,-0.0369761720182942,0.00327048279462801,-0.0433863182957651,-0.0305660257408233,1.65933669680144e-29
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LTA4H,Leukotriene A-4 hydrolase,40026,0.0612652244710126,0.00542327310473571,0.0506356091857306,0.0718948397562946,1.75668934770106e-29
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NCAM2,Neural cell adhesion molecule 2,39854,0.0275723605894374,0.00247099191485867,0.0227292164363144,0.0324155047425604,8.32193447494009e-29
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GRP,Gastrin-releasing peptide,37039,-0.053619061912198,0.00481495907654732,-0.0630563817022307,-0.0441817421221652,1.1258863380628e-28
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DEFB4A_DEFB4B,Beta-defensin 4A,39581,-0.148545735969692,0.0133850313309697,-0.174780397378392,-0.122311074560991,1.63893222328137e-28
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCL16,C-C motif chemokine 16,40048,-0.0535121698328389,0.00482593434583058,-0.0629710011506668,-0.0440533385150109,1.80728671600226e-28
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,INSL5,Insulin-like peptide INSL5,37378,-0.0990941916578381,0.00895140322932808,-0.116638941987321,-0.0815494413283551,2.31588326164756e-28
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADIPOQ,Adiponectin,37449,0.0674653740571687,0.00610920012992207,0.0554913418025214,0.079439406311816,3.1160874330321e-28
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FAM20A,Pseudokinase FAM20A,37433,-0.028791801138337,0.00261309609028442,-0.0339134694752945,-0.0236701328013795,4.1045987821524e-28
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ACAN,Aggrecan core protein,39726,0.0286079356367815,0.00260629983923344,0.023499587951884,0.0337162833216791,6.25109004982041e-28
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VASN,Vasorin,39638,0.0275856083704393,0.00253341888293867,0.0226201073598795,0.0325511093809991,1.63494193215222e-27
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CRIM1,Cysteine-rich motor neuron 1 protein,39927,0.0202314423520589,0.00186481174401421,0.0165764113337911,0.0238864733703268,2.50621827349035e-27
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LTBP2,Latent-transforming growth factor beta-binding protein 2,40048,0.0309074337252755,0.0028550108968197,0.0253116123675089,0.0365032550830421,3.22438757312756e-27
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LECT2,Leukocyte cell-derived chemotaxin-2,37433,-0.0646083940781354,0.00597183070869012,-0.0763131822671681,-0.0529036058891028,3.61708890044378e-27
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SELPLG,P-selectin glycoprotein ligand 1,39862,-0.0275410211113715,0.00257380668864732,-0.0325856822211203,-0.0224963600016228,1.24560570515469e-26
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCN1,CCN family member 1,39754,-0.0753925333513898,0.00706805881215077,-0.0892459286232054,-0.0615391380795743,1.79167801408283e-26
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CGREF1,Cell growth regulator with EF hand domain protein 1,39864,-0.0412571211803852,0.00387281113834654,-0.0488478310115444,-0.033666411349226,2.0695515756311e-26
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GGT1,Glutathione hydrolase 1 proenzyme,39822,-0.0485956388818199,0.00459693017944069,-0.0576056220335237,-0.0395856557301161,4.93443884434828e-26
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADGRG1,Adhesion G-protein coupled receptor G1,39784,-0.053203485268575,0.00503565042785724,-0.0630733601071752,-0.0433336104299748,5.25825006659143e-26
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ISM1,Isthmin-1,39862,-0.0388637504235754,0.00368985824408799,-0.0460958725819879,-0.031631628265163,7.42805172458481e-26
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CTSE,Cathepsin E,37120,-0.0514417282093779,0.00488933095370334,-0.0610248168786364,-0.0418586395401193,8.71492837532387e-26
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,37364,-0.0366223823454208,0.00348604861175867,-0.0434550376244678,-0.0297897270663738,1.02485058183796e-25
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NOTCH3,Neurogenic locus notch homolog protein 3,40048,0.032828327436346,0.00314631889299685,0.0266615424060722,0.0389951124666199,2.09044403246356e-25
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IFNGR2,Interferon gamma receptor 2,39745,-0.0500773233536846,0.00481613248116153,-0.0595169430167612,-0.040637703690608,3.05650998704426e-25
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GAST,Gastrin,37384,-0.11153440399436,0.0107375036177026,-0.132579911085057,-0.0904888969036626,3.52013398032073e-25
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AGR2,Anterior gradient protein 2 homolog,39360,-0.0963635565204868,0.00928473873919779,-0.114561644449314,-0.0781654685916591,3.7471064801299e-25
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GLA,Alpha-galactosidase A,37084,-0.0362213915930403,0.00349790925557044,-0.0430772937339584,-0.0293654894521223,4.9423620313264e-25
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ENO3,Beta-enolase,37039,-0.0574215619771937,0.00558323310043047,-0.0683646988540374,-0.0464784251003499,1.02479950586509e-24
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADGRD1,Adhesion G-protein coupled receptor D1,37120,-0.0369963644884178,0.00360056591210448,-0.0440534736761426,-0.029939255300693,1.12849225183988e-24
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL15,Interleukin-15,39862,-0.0308354432304552,0.00300480090954408,-0.0367248530131616,-0.0249460334477488,1.24528448218287e-24
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCL27,C-C motif chemokine 27,39864,-0.0588203086764199,0.00578283458176457,-0.0701546644566784,-0.0474859528961613,3.14824128400513e-24
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PLA2G1B,Phospholipase A2,40027,0.038429170999028,0.00378590582525617,0.0310087955815259,0.0458495464165301,3.890934033983e-24
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TTR,Transthyretin,37305,-0.0236503096955261,0.00233060877981942,-0.0282183029039721,-0.01908231648708,4.14382938575702e-24
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",39784,0.0401526428896152,0.00396568997491661,0.0323798905387787,0.0479253952404518,5.05968821405075e-24
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,40005,0.041649521047729,0.00412459147620998,0.0335653217543575,0.0497337203411006,6.64910604313443e-24
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MCAM,Cell surface glycoprotein MUC18,39927,0.0305576837607905,0.00302713257719647,0.0246245039094854,0.0364908636120956,6.87752249747271e-24
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADGRG2,Adhesion G-protein coupled receptor G2,39864,0.0249726603028936,0.00248324860914205,0.0201054930289752,0.0298398275768121,1.01202974999074e-23
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AMOT,Angiomotin,37120,-0.0384282598590564,0.00382505924034567,-0.0459253759701339,-0.0309311437479789,1.1572895265354e-23
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SERPINA3,Alpha-1-antichymotrypsin,37403,0.0134069064997618,0.00133730995851064,0.010785778981081,0.0160280340184427,1.42612115202918e-23
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL1R2,Interleukin-1 receptor type 2,39826,-0.0181929187388765,0.00181525543668109,-0.0217508193947715,-0.0146350180829816,1.42899727530977e-23
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTPRF,Receptor-type tyrosine-protein phosphatase F,40048,0.0265608214797475,0.00265046705092301,0.0213659060599384,0.0317557368995566,1.44101921243625e-23
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRCP,Lysosomal Pro-X carboxypeptidase,39944,-0.0288453917552512,0.0028789075890153,-0.0344880506297212,-0.0232027328807813,1.46623382433458e-23
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LRG1,Leucine-rich alpha-2-glycoprotein,37449,0.0234565381578885,0.00235067188391517,0.0188492212654147,0.0280638550503622,2.27462427675863e-23
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CTSZ,Cathepsin Z,39861,-0.0284390809540224,0.00287085075816509,-0.034065948440026,-0.0228122134680188,4.56099614636212e-23
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CES3,Carboxylesterase 3,39784,-0.0627994495406538,0.00637704596533263,-0.0752984596327057,-0.0503004394486018,8.14588045755829e-23
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KHK,Ketohexokinase,37039,-0.0589339626400005,0.00598927570463701,-0.0706729430210891,-0.047194982258912,9.07747996208222e-23
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HEPH,Hephaestin,37433,-0.0239151296801785,0.0024383245768085,-0.0286942458507231,-0.0191360135096338,1.23651951545979e-22
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCLY,Selenocysteine lyase,39980,-0.0445239767896567,0.0045550783598518,-0.0534519303749662,-0.0355960232043472,1.67169339503562e-22
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AGR3,Anterior gradient protein 3,39460,-0.0530074010670814,0.00546427166939432,-0.0637173735390943,-0.0422974285950685,3.45845557330706e-22
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CHL1,Neural cell adhesion molecule L1-like protein,39896,0.0279088562254824,0.00288623469962081,0.0222518362142256,0.0335658762367392,4.66151328341493e-22
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SERPINA5,Plasma serine protease inhibitor,37279,-0.0283765316622219,0.00294228482491156,-0.0341434099190486,-0.0226096534053952,6.11663691111557e-22
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,39910,0.0268182531150816,0.002784115435608,0.02136138686129,0.0322751193688733,6.6755469858002e-22
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SEMA4C,Semaphorin-4C,39784,0.0252137820550116,0.00262496647579833,0.0200688477624468,0.0303587163475763,8.69376697462675e-22
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MAN2B2,Epididymis-specific alpha-mannosidase,37433,-0.0523996428312701,0.00545604426455351,-0.063093489589795,-0.0417057960727452,9.02194098913575e-22
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DMP1,Dentin matrix acidic phosphoprotein 1,37039,0.0536629504520613,0.00560035834496171,0.0426862480959364,0.0646396528081863,1.11931952382511e-21
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD209,CD209 antigen,39881,0.034419048675072,0.00360018912014785,0.0273626779995822,0.0414754193505618,1.34019754027678e-21
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLITRK1,SLIT and NTRK-like protein 1,37052,0.0280488764566289,0.00295459084659612,0.0222578783973006,0.0338398745159573,2.61732453463257e-21
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CNTN3,Contactin-3,39854,-0.0286695651449067,0.00302321365931983,-0.0345950639171736,-0.0227440663726398,2.80636626673312e-21
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IDUA,Alpha-L-iduronidase,40026,-0.0402102704476752,0.0042496474998609,-0.0485395795474025,-0.0318809613479478,3.42680166783205e-21
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",39881,0.0290857956362319,0.00308140632986886,0.023046239229689,0.0351253520427749,4.26435872859283e-21
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,39425,-0.0760712874542125,0.00806173935105425,-0.0918722965822788,-0.0602702783261461,4.40539317757507e-21
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,POSTN,Periostin,37433,0.032395616889964,0.00343826063124879,0.0256566260527164,0.0391346077272117,5.12595449316769e-21
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,39784,0.0172576714798993,0.00183444256122534,0.0136621640598976,0.0208531788999009,5.75427605718099e-21
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,F10,Coagulation factor X,37441,-0.0228482512639482,0.00245346778091007,-0.0276570481145319,-0.0180394544133644,1.435859031804e-20
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",37039,-0.0493140785133966,0.00530848120369233,-0.0597187016726335,-0.0389094553541596,1.78708943113149e-20
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CNDP1,Beta-Ala-His dipeptidase,39927,-0.0391887826262022,0.0042199452663341,-0.047459875348217,-0.0309176899041873,1.79306061501614e-20
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RBP5,Retinol-binding protein 5,39784,-0.048022132661055,0.00518648939276971,-0.0581876518708836,-0.0378566134512263,2.31939238414872e-20
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AREG,Amphiregulin,39784,-0.0400013116521152,0.00433350497388812,-0.0484949814009359,-0.0315076419032945,3.01990050469059e-20
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,APLP1,Amyloid-like protein 1,39864,0.0437236766239028,0.00474103658889541,0.0344312449096678,0.0530161083381377,3.26046331291667e-20
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLUL1,Clusterin-like protein 1,39836,0.0385227648607097,0.00418465169600317,0.0303208475365435,0.046724682184876,3.80577634818227e-20
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GPD1,Glycerol-3-phosphate dehydrogenase,37364,-0.0446021106959201,0.00484644955530795,-0.0541011518243237,-0.0351030695675165,3.98367790856581e-20
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,39473,-0.0530570428559719,0.00578615211956663,-0.0643979010103225,-0.0417161847016213,5.32598886349069e-20
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,THBS2,Thrombospondin-2,39854,-0.0305775400619286,0.00333618650771205,-0.0371164656170443,-0.024038614506813,5.52341015601739e-20
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ANGPTL4,Angiopoietin-related protein 4,39904,0.0383822157401181,0.00418913351385936,0.0301715140529538,0.0465929174272825,5.68102257455168e-20
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NOTCH1,Neurogenic locus notch homolog protein 1,40048,0.0132975040460559,0.00145260531676573,0.010450397625195,0.0161446104669167,6.11440778288406e-20
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CHMP6,Charged multivesicular body protein 6,37433,-0.048105194206814,0.00525447446570722,-0.0584039641596001,-0.0378064242540278,6.19710081437742e-20
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ASPN,Asporin,37433,0.022881542088016,0.00249936862434106,0.0179827795843075,0.0277803045917245,6.20637884939561e-20
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD86,T-lymphocyte activation antigen CD86,37378,0.0247987430199886,0.00271105589955826,0.0194850734568544,0.0301124125831228,6.66346507897795e-20
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CTBS,Di-N-acetylchitobiase,37292,-0.0233633628406758,0.00255904580478322,-0.0283790926180509,-0.0183476330633007,7.83584844515287e-20
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CTSB,Cathepsin B,39843,0.0432652428762499,0.00475466887276373,0.0339460918856329,0.0525843938668668,1.01217888614169e-19
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,39909,-0.0292886568893189,0.00322751782857637,-0.0356145918333285,-0.0229627219453092,1.2700468668382e-19
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CPB1,Carboxypeptidase B,40048,-0.0483038436941591,0.00532364138492158,-0.0587381808086054,-0.0378695065797129,1.28297824225124e-19
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SEZ6L2,Seizure 6-like protein 2,39784,0.0201960559371224,0.00222600216021836,0.0158330917030944,0.0245590201711503,1.29309577061878e-19
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KRT18,"Keratin, type I cytoskeletal 18",39784,-0.0681451848648129,0.0075374113375058,-0.0829185110863243,-0.0533718586433015,1.72906851343729e-19
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CPE,Carboxypeptidase E,39902,0.0322172301014794,0.00357212570742458,0.0252158637149273,0.0392185964880316,2.10765256154414e-19
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,37449,0.0217754858229551,0.00241679587997374,0.0170385658982066,0.0265124057477037,2.33058963501464e-19
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SBSN,Suprabasin,37416,0.0282962065204442,0.00314250091944398,0.022136904718334,0.0344555083225544,2.4549769904954e-19
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TREH,Trehalase,37433,-0.0626717929933492,0.00697290540733796,-0.0763386875917316,-0.0490048983949668,2.84882791532877e-19
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD2AP,CD2-associated protein,39864,-0.0527050872964435,0.005865692987761,-0.064201845552455,-0.0412083290404319,2.86270973945462e-19
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDH1,Cadherin-1,39311,-0.0335677715165733,0.00373968949544024,-0.0408975629276362,-0.0262379801055105,3.12338429750183e-19
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NTRK3,NT-3 growth factor receptor,40005,0.0176336818194671,0.00197386982816806,0.0137648969562577,0.0215024666826765,4.56250373736522e-19
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BTD,Biotinidase,37449,-0.0169565915669642,0.00190048426680414,-0.0206815407299003,-0.0132316424040281,5.14678473961236e-19
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NCAM1,Neural cell adhesion molecule 1,39927,0.0247516749375463,0.00277653834052143,0.0193096597901243,0.0301936900849683,5.41379513461034e-19
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FAM3B,Protein FAM3B,39784,-0.0296215670405153,0.00332795538089693,-0.0361443595870733,-0.0230987744939573,6.13016966822837e-19
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,39784,-0.0359843206519435,0.00404462039043915,-0.0439117766172042,-0.0280568646866828,6.35370265507831e-19
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RTN4R,Reticulon-4 receptor,40026,-0.0272495325536496,0.00307014316931112,-0.0332670131654993,-0.0212320519417998,7.66869868704132e-19
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPOCK1,Testican-1,39745,0.0208515272621812,0.00235037704369892,0.0162447882565313,0.0254582662678311,7.96791977220386e-19
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CNTN1,Contactin-1,40048,0.0218825542199116,0.00247010354815798,0.0170411512655219,0.0267239571743012,8.90087017472391e-19
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SELL,L-selectin,37449,0.0185454522412362,0.00209293576459526,0.0144432981426295,0.0226476063398429,8.90594041186584e-19
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,F11R,Junctional adhesion molecule A,39854,-0.0462750567435965,0.00523964228165087,-0.0565447556156322,-0.0360053578715608,1.13600654340815e-18
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SNAPIN,SNARE-associated protein Snapin,37408,-0.0473392306573222,0.00536760660850525,-0.0578597396099925,-0.0368187217046519,1.28943646558892e-18
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,40005,-0.0426708460635351,0.00484248036955082,-0.0521621075878547,-0.0331795845392155,1.3551632181638e-18
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDH15,Cadherin-15,39969,-0.0436724197628256,0.00496355582785432,-0.0534009891854201,-0.0339438503402311,1.52333052599043e-18
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NPPC,C-type natriuretic peptide,39862,-0.0371838408577609,0.00423390565784388,-0.045482295947135,-0.0288853857683869,1.75981320560806e-18
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PLAU,Urokinase-type plasminogen activator,39854,0.0232555227578573,0.00264894809829529,0.0180635844851985,0.028447461030516,1.81113893642171e-18
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SMAD1,Mothers against decapentaplegic homolog 1,39473,-0.0672407304846949,0.00765915731394945,-0.0822526788200358,-0.052228782149354,1.81572381078619e-18
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDKN1A,Cyclin-dependent kinase inhibitor 1,39784,-0.0866426840294765,0.00987494457353278,-0.105997575393601,-0.0672877926653523,1.89653448808792e-18
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TF,Serotransferrin,37449,-0.0177090449333646,0.00202097658283769,-0.0216701590357265,-0.0137479308310027,2.131329523399e-18
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PLAT,Tissue-type plasminogen activator,39998,-0.0401440358107628,0.00459771109849304,-0.0491555495638091,-0.0311325220577164,2.76027160175565e-18
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,39745,-0.0255940856051633,0.00293522695869874,-0.0313471304442129,-0.0198410407661138,3.06341501888124e-18
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL1RN,Interleukin-1 receptor antagonist protein,39816,-0.0430478754375619,0.00495597640132511,-0.0527615891841591,-0.0333341616909647,4.11101980771995e-18
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EGFR,Epidermal growth factor receptor,40048,0.0129007380163861,0.00148691279350317,0.00998638894111988,0.0158150870916523,4.47585555847192e-18
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CA5A,"Carbonic anhydrase 5A, mitochondrial",39581,-0.0731315072910647,0.00845136767047349,-0.0896961879251928,-0.0565668266569367,5.48513539927647e-18
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,OPTC,Opticin,39784,0.0353537800309054,0.00408985208004573,0.0273376699540157,0.043369890107795,5.92336649796383e-18
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,S100A14,Protein S100-A14,37408,-0.0408589108795408,0.00473023753342313,-0.0501301764450502,-0.0315876453140315,6.36475951706045e-18
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VMO1,Vitelline membrane outer layer protein 1 homolog,39784,-0.0532327505555868,0.00616642609363313,-0.0653189456991077,-0.0411465554120659,6.5528081418934e-18
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KLB,Beta-klotho,39485,0.058989154404151,0.0068358044589517,0.0455909776646057,0.0723873311436964,6.751459856255e-18
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TCTN3,Tectonic-3,37433,-0.0235254450569552,0.00273328858583823,-0.0288826906851981,-0.0181681994287122,8.31609847009746e-18
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTS,6-pyruvoyl tetrahydrobiopterin synthase,39415,-0.043541100862502,0.00506649283137595,-0.0534714268119988,-0.0336107749130051,9.19330231463447e-18
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CXADR,Coxsackievirus and adenovirus receptor,39862,-0.0401301794216266,0.00469611548517228,-0.0493345657725643,-0.0309257930706889,1.39501828177658e-17
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD200,OX-2 membrane glycoprotein,39862,0.0202993687733825,0.00238377740076699,0.0156271650678792,0.0249715724788858,1.80232223087911e-17
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,37384,-0.0686188606518507,0.00805736093652322,-0.0844112880874362,-0.0528264332162652,1.81983037511132e-17
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ESM1,Endothelial cell-specific molecule 1,39858,0.0268097274656293,0.0031580562685428,0.0206199371792854,0.0329995177519732,2.25886284191581e-17
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFSF12,Tumor necrosis factor ligand superfamily member 12,40054,0.0226353181247446,0.00267178684005633,0.0173986159182342,0.027872020331255,2.61745852720453e-17
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTGR1,Prostaglandin reductase 1,37433,-0.062390456086621,0.00738153143781659,-0.0768582577047415,-0.0479226544685005,3.14656539007436e-17
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NOTCH2,Neurogenic locus notch homolog protein 2,37433,0.0169340989968715,0.00201353524803677,0.0129875699107195,0.0208806280830236,4.50095403688109e-17
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,37110,-0.036912662724923,0.00439520151295796,-0.0455272576903206,-0.0282980677595254,4.98290624113414e-17
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GLB1,Beta-galactosidase,39745,-0.0327589705917472,0.00390504506808777,-0.0404128589251993,-0.0251050822582952,5.31604829043808e-17
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CTSO,Cathepsin O,40054,-0.0232533384827411,0.0027745187332764,-0.0286913951999628,-0.0178152817655193,5.67259967250459e-17
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SEZ6L,Seizure 6-like protein,39909,0.020908061632695,0.00249629162358731,0.0160153300504638,0.0258007932149261,5.94116701670828e-17
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SERPINA4,Kallistatin,37237,-0.0180858530221964,0.00216505241939197,-0.0223293557642047,-0.0138423502801882,7.27231465902768e-17
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RARRES2,Retinoic acid receptor responder protein 2,39945,-0.0364017445989192,0.00437409728299816,-0.0449749752735956,-0.0278285139242428,9.32736710116489e-17
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADH1B,All-trans-retinol dehydrogenase,37120,-0.0584420721838151,0.00702553611951892,-0.0722121229780721,-0.044672021389558,9.77042060910885e-17
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADM,Pro-adrenomedullin,40026,-0.0202865861065361,0.00243961215123118,-0.0250682259229493,-0.015504946290123,9.85691364538489e-17
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CREG1,Protein CREG1,39656,-0.0289005385422546,0.00348863819448366,-0.0357382694034425,-0.0220628076810666,1.2836792997618e-16
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,39854,0.0275660056803573,0.00334451321624722,0.0210107597765127,0.0341212515842018,1.82129501188997e-16
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,37017,-0.0428564173531042,0.00520904684443691,-0.0530661491682005,-0.0326466855380078,2.09359743290421e-16
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD300LG,CMRF35-like molecule 9,39854,0.0276855471955742,0.0033939051525337,0.0210334930966081,0.0343376012945403,3.67437981905541e-16
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GFAP,Glial fibrillary acidic protein,39449,0.0329173275048158,0.00405225323704788,0.024974911160202,0.0408597438494297,4.87752172009224e-16
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HAO1,Hydroxyacid oxidase 1,40026,-0.0970542302430001,0.0119516210276876,-0.120479407457268,-0.0736290530287324,4.97102259020015e-16
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SORD,Sorbitol dehydrogenase,39959,-0.0515377451593095,0.00635071345880713,-0.0639851435385715,-0.0390903467800475,5.19439807030794e-16
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,37120,-0.036604052081209,0.00454040850324152,-0.0455032527475624,-0.0277048514148556,8.15605820387208e-16
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FGFBP2,Fibroblast growth factor-binding protein 2,37433,-0.0369789466834962,0.00459693907595025,-0.0459889472723587,-0.0279689460946337,9.39282271998137e-16
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CFHR5,Complement factor H-related protein 5,37263,0.0307502962662434,0.00382405425154008,0.0232551499332249,0.038245442599262,9.63208967688278e-16
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FOLR2,Folate receptor beta,40005,0.0214285613891204,0.00266997751978779,0.0161954054503363,0.0266617173279045,1.07801280949337e-15
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MYH9,Myosin-9,37433,-0.0821154441871648,0.0103138949705261,-0.102330678329396,-0.0619002100449337,1.83206916222495e-15
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CA4,Carbonic anhydrase 4,40048,0.0172721478576628,0.00217210943916208,0.0130148133569051,0.0215294823584204,1.95899388374255e-15
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EPO,Erythropoietin,39862,-0.0566530778087272,0.007154986295059,-0.0706768509470429,-0.0426293046704116,2.57134953619656e-15
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CPA1,Carboxypeptidase A1,40048,-0.0433001285652729,0.0054854884309541,-0.0540516858899429,-0.0325485712406028,3.12336817419224e-15
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ALDH1A1,Retinal dehydrogenase 1,39854,-0.0384347299557104,0.00487031979683175,-0.0479805567575006,-0.0288889031539202,3.17485255647017e-15
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GSN,Gelsolin,37379,0.0136021680844104,0.00172746397000729,0.0102163387031962,0.0169879974656247,3.69343585202565e-15
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRSS2,Trypsin-2,39927,-0.0374465531752426,0.00475971247251028,-0.0467755896213627,-0.0281175167291225,3.85009507660628e-15
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,37120,-0.0157588719645633,0.00200429955065327,-0.0196872990838437,-0.0118304448452829,4.05410590532387e-15
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LBP,Lipopolysaccharide-binding protein,39927,0.0421957848789943,0.00536886316924428,0.0316728130672755,0.0527187566907131,4.10462682971313e-15
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,39745,-0.0391061057499315,0.00500646009206569,-0.0489187675303802,-0.0292934439694827,6.02032630438806e-15
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TFPI2,Tissue factor pathway inhibitor 2,39860,0.0290329621605957,0.00371833536779276,0.0217450248397219,0.0363208994814695,6.16578318700007e-15
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VNN1,Pantetheinase,37441,-0.0522729507687628,0.00671120105310826,-0.065426904832855,-0.0391189967046706,7.24724606698732e-15
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MOG,Myelin-oligodendrocyte glycoprotein,40026,0.0227441090955905,0.00294693342651278,0.0169681195796255,0.0285200986115556,1.25153118330283e-14
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,39980,0.0243027319127345,0.00314941755812184,0.0181298734988157,0.0304755903266533,1.2646170829315e-14
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DNAJB1,DnaJ homolog subfamily B member 1,39784,-0.0620296670330878,0.00805107829638431,-0.0778097804940011,-0.0462495535721746,1.39047113672826e-14
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ERBB2,Receptor tyrosine-protein kinase erbB-2,39909,-0.0178505244573412,0.00232534167088875,-0.0224081941322832,-0.0132928547823993,1.72850335877471e-14
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",39784,-0.0693964558631621,0.00905410811133583,-0.0871425077613803,-0.0516504039649439,1.89643058185102e-14
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HHEX,Hematopoietically-expressed homeobox protein HHEX,37384,-0.0541902902446451,0.00710416876081895,-0.0681144610158502,-0.0402661194734399,2.5440365066735e-14
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FGFR2,Fibroblast growth factor receptor 2,39909,-0.0152410012565487,0.00199995811471878,-0.0191609191613976,-0.0113210833516999,2.66438733637267e-14
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,39862,0.0273700360305116,0.00359853593985146,0.0203169055884027,0.0344231664726204,2.98654658640367e-14
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,40026,-0.0238809064211203,0.00314166903023504,-0.030038577720381,-0.0177232351218596,3.09108814495565e-14
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HEG1,Protein HEG homolog 1,37120,-0.0190923557495753,0.00251375720240783,-0.0240193198662947,-0.014165391632856,3.27996086564373e-14
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EPCAM,Epithelial cell adhesion molecule,39863,-0.0669479812142608,0.00882203760498914,-0.0842391749200395,-0.0496567875084821,3.40823438598502e-14
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FGF23,Fibroblast growth factor 23,40004,-0.041024647433978,0.00541441417366898,-0.0516368992143692,-0.0304123956535868,3.72961335534555e-14
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IGSF3,Immunoglobulin superfamily member 3,39784,-0.0247568147513246,0.00328629133528549,-0.0311979457684842,-0.0183156837341651,5.21015347645021e-14
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ERP44,Endoplasmic reticulum resident protein 44,39754,-0.0180585784348362,0.00241143095385842,-0.0227849831043987,-0.0133321737652737,7.31840075775752e-14
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLPS,Colipase,39832,0.0478559604446503,0.00641364264481602,0.0352852208608109,0.0604267000284897,8.9880505043537e-14
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AGT,Angiotensinogen,37441,-0.0154592110775769,0.00207724531888285,-0.0195306119025873,-0.0113878102525665,1.04994851894157e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LAMP2,Lysosome-associated membrane glycoprotein 2,39379,-0.0132961795906585,0.00178808678821706,-0.016800829695564,-0.00979152948575311,1.09214603541762e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CTRL,Chymotrypsin-like protease CTRL-1,37384,0.0453265200050392,0.0060969221459761,0.033376552598926,0.0572764874111523,1.1141445612902e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,39784,-0.0269519174882559,0.00363037799011458,-0.0340674583488805,-0.0198363766276313,1.19379383398117e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PODXL2,Podocalyxin-like protein 2,39909,0.0188270226875136,0.00254838819636907,0.0138321818226302,0.023821863552397,1.56596850086728e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FAM3C,Protein FAM3C,39842,-0.0197956727573306,0.00268353862727637,-0.0250554084667923,-0.0145359370478689,1.70216151311606e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPARCL1,SPARC-like protein 1,39867,0.0186145770320132,0.00252608012619305,0.0136634599846748,0.0235656940793515,1.80356225828302e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLEC11A,C-type lectin domain family 11 member A,39818,0.0321933249355359,0.00438450197893881,0.0235997010568159,0.040786948814256,2.19707346627233e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,B4GAT1,"Beta-1,4-glucuronyltransferase 1",39854,0.0165417940388847,0.00225918497933614,0.0121137914793859,0.0209697965983835,2.55891827331069e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CHRDL1,Chordin-like protein 1,39904,0.0207500631671519,0.00284340003165425,0.0151769991051096,0.0263231272291942,3.06602383905665e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,37052,-0.0302883347413817,0.00415129845697179,-0.0384248797170464,-0.022151789765717,3.13125868037627e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GASK1A,Golgi-associated kinase 1A,37017,-0.0289829196200498,0.00397334889216912,-0.0367706834487013,-0.0211951557913983,3.17324709296888e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SMAD2,Mothers against decapentaplegic homolog 2,37364,-0.0467121845639362,0.00642699777863397,-0.0593091002100588,-0.0341152689178136,3.84546786112611e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IGSF8,Immunoglobulin superfamily member 8,39864,-0.0202832911660639,0.00279809903744152,-0.0257675652794493,-0.0147990170526785,4.39187020129376e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SERPINE1,Plasminogen activator inhibitor 1,40048,-0.0454431700913744,0.0062773645255254,-0.0577468045614042,-0.0331395356213446,4.71565926822246e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MARCO,Macrophage receptor MARCO,39864,0.0175185908644963,0.00243056017959092,0.0127546929124981,0.0222824888164945,5.94734936845749e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AP3S2,AP-3 complex subunit sigma-2,37384,-0.0314244164046354,0.00436136531023064,-0.0399726924126874,-0.0228761403965833,6.10370484291659e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NCS1,Neuronal calcium sensor 1,40026,-0.0187525891066854,0.00260678941100577,-0.0238618963522567,-0.0136432818611141,6.57998110863428e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IKBKG,NF-kappa-B essential modulator,39862,-0.0613982038583806,0.00854227436599634,-0.0781410616157334,-0.0446553461010277,6.88660573159237e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DPT,Dermatopontin,40048,0.0178668875126802,0.00248709476393043,0.0129921817753766,0.0227415932499839,7.07322717397769e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LRP1,Prolow-density lipoprotein receptor-related protein 1,39784,0.0176563291597926,0.00245792061214999,0.0128388047599786,0.0224738535596066,7.0987466637849e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CNTN5,Contactin-5,39893,0.023940141381305,0.00333411423683224,0.0174052774771138,0.0304750052854962,7.25793722113489e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,COL3A1,Collagen alpha-1(III) chain,37433,-0.015397440117873,0.00215339600201568,-0.0196180962818237,-0.0111767839539223,9.1013989510551e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TSPAN8,Tetraspanin-8,37378,-0.0647421077856951,0.00907430372897853,-0.082527743094493,-0.0469564724768972,1.01964141343472e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LEP,Leptin,39864,-0.0446084186832097,0.006281022296137,-0.0569192223836382,-0.0322976149827812,1.28050322093031e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ARSA,Arylsulfatase A,39854,-0.0295084128681376,0.00416853952144544,-0.0376787503301707,-0.0213380754061045,1.51410272262887e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ZBTB16,Zinc finger and BTB domain-containing protein 16,39473,-0.0464519431960493,0.00658429464521001,-0.059357160700661,-0.0335467256914377,1.79903543043381e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ELN,Elastin,37433,-0.0219683847485598,0.00311574613358702,-0.0280752471703904,-0.0158615223267293,1.86544747762798e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ACHE,Acetylcholinesterase,37120,-0.021319736331821,0.00303277446485311,-0.0272639742829331,-0.0153754983807089,2.16981998487009e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,40005,0.0289315503436867,0.00412595260551303,0.0208446832368812,0.0370184174504923,2.44089496683293e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AMBP,Protein AMBP,39999,-0.0125581732349899,0.00179176095084934,-0.0160700246986546,-0.00904632177132519,2.49804494290379e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,UNC5D,Netrin receptor UNC5D,37052,0.0172559540911762,0.00246539988720902,0.0124237703122465,0.0220881378701059,2.69772463902559e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CHAD,Chondroadherin,37120,0.0326782997851461,0.00467514945508662,0.0235150068531763,0.0418415927171159,2.88469898947844e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BACH1,Transcription regulator protein BACH1,39862,-0.0479898889165465,0.00687394269885823,-0.0614628166063087,-0.0345169612267844,3.0369237901197e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ALCAM,CD166 antigen,40048,0.0125431285930117,0.00180107664562471,0.00901301836758729,0.0160732388184362,3.42881779115372e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",39862,-0.0633227127111329,0.00909666557578159,-0.0811521772396648,-0.0454932481826009,3.5076422064666e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CX3CL1,Fractalkine,39745,0.0213778777687174,0.00307490493978443,0.01535106408674,0.0274046914506949,3.73186046713922e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DKK3,Dickkopf-related protein 3,40048,0.0184452878970969,0.00266559547171348,0.0132207207725385,0.0236698550216554,4.69360844241653e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,APOA2,Apolipoprotein A-II,37441,0.0304764530322427,0.00441371315780108,0.0218255752429525,0.0391273308215328,5.24544343193789e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,C19orf12,Protein C19orf12,39485,-0.0416547258746906,0.00603392182054961,-0.0534812126429679,-0.0298282391064134,5.27177721899226e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TRIM5,Tripartite motif-containing protein 5,39862,-0.0551278624360026,0.00800386353926021,-0.0708154349729526,-0.0394402898990526,5.88308562092049e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SARG,Specifically androgen-regulated gene protein,37386,-0.0699691527534766,0.0101598491479864,-0.0898824570835301,-0.0500558484234232,5.95687452413624e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD93,Complement component C1q receptor,39234,0.0196414676059662,0.00285502281555692,0.0140456228874747,0.0252373123244578,6.23296318567967e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CHRDL2,Chordin-like protein 2,39864,-0.0358995399458854,0.00522099339520531,-0.0461326870004878,-0.025666392891283,6.38336907604854e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDH5,Cadherin-5,40048,0.0194438403503803,0.00282986537598112,0.0138973042134573,0.0249903764873033,6.61038172698997e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDH17,Cadherin-17,39864,-0.0422155197078489,0.00615708320037592,-0.0542834027805857,-0.0301476366351121,7.31914302996834e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD248,Endosialin,37433,0.0250071559883248,0.00367436106976076,0.0178054082915937,0.0322089036850559,1.04669570953876e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,YES1,Tyrosine-protein kinase Yes,39784,-0.0717184826023796,0.0105775131943021,-0.0924504084632118,-0.0509865567415475,1.24160469140138e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DPEP2,Dipeptidase 2,39784,0.018253478707819,0.00269850700358583,0.0129644049807907,0.0235425524348472,1.38630898718924e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SIT1,Signaling threshold-regulating transmembrane adapter 1,39583,-0.0343620800842379,0.00508306329699183,-0.0443248841463419,-0.0243992760221339,1.4273597228175e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CYTL1,Cytokine-like protein 1,37433,0.0143299698868397,0.00211986914764176,0.0101750263574618,0.0184849134162176,1.43790532201332e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SORT1,Sortilin,39842,-0.0233116904761255,0.00345726408688464,-0.0300879280864194,-0.0165354528658316,1.60668840724683e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SERPIND1,Heparin cofactor 2,37420,-0.0176010337666144,0.00261062343496259,-0.022717855699141,-0.0124842118340877,1.62452163499647e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MTSS2,Protein MTSS 2,37364,-0.0620208968358203,0.00924496713381518,-0.080141032418098,-0.0439007612535425,2.04311536336508e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL10RB,Interleukin-10 receptor subunit beta,39927,-0.0174171985705999,0.00259954596132932,-0.0225123086548054,-0.0123220884863944,2.15206868600606e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DCTN1,Dynactin subunit 1,40026,-0.0403207011776047,0.00603002638222582,-0.0521395528867673,-0.0285018494684421,2.35808641573314e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ICAM4,Intercellular adhesion molecule 4,39862,0.0323979635915889,0.00486302041309498,0.0228664435819227,0.041929483601255,2.78731652894337e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IGF2R,Cation-independent mannose-6-phosphate receptor,39854,-0.0144801260806412,0.00217725266077374,-0.0187475412957577,-0.0102127108655247,3.01275520341433e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PBLD,Phenazine biosynthesis-like domain-containing protein,39485,-0.0318146173970085,0.00479247051017076,-0.0412078595969432,-0.0224213751970738,3.27421761304034e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,YOD1,Ubiquitin thioesterase OTU1,37017,-0.0377308877676325,0.00569544028414421,-0.0488939507245552,-0.0265678248107099,3.61360069496127e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SRP14,Signal recognition particle 14 kDa protein,39784,-0.0366677657761756,0.00553589061823495,-0.0475181113879161,-0.0258174201644351,3.61675664477026e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TJAP1,Tight junction-associated protein 1,39909,-0.0508892782355313,0.00770462186743885,-0.0659903370957115,-0.0357882193753512,4.09918002305146e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TXLNA,Alpha-taxilin,39745,-0.0545338776895912,0.00826722136578565,-0.0707376315665311,-0.0383301238126514,4.3457503852114e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDHR2,Cadherin-related family member 2,39784,-0.044618523524743,0.00676922765710438,-0.0578862097326676,-0.0313508373168184,4.49457901938223e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PLA2G15,Phospholipase A2 group XV,39909,-0.0161654432312304,0.00245475828952251,-0.0209767694786945,-0.0113541169837663,4.67905869662398e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MBL2,Mannose-binding protein C,37253,0.0654390164820311,0.00995965882675058,0.0459180851815999,0.0849599477824622,5.20330433129847e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCL2,C-C motif chemokine 2,39716,-0.0314419061275763,0.00478940942468309,-0.0408291485999552,-0.0220546636551974,5.3691040485525e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DPP4,Dipeptidyl peptidase 4,39571,0.0182460710607675,0.00277994698093526,0.0127973749781343,0.0236947671434006,5.42195047155879e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HGF,Hepatocyte growth factor,40054,-0.0206641109942968,0.00315069242276208,-0.0268394681429105,-0.0144887538456832,5.5962192763003e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NME3,Nucleoside diphosphate kinase 3,39881,0.0144758852026326,0.00221078800682678,0.0101427407092521,0.0188090296960131,6.01505397896219e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NOMO1,Nodal modulator 1,39854,-0.0143990280723326,0.00219974322461079,-0.0187105247925697,-0.0100875313520954,6.09876074871046e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DDC,Aromatic-L-amino-acid decarboxylase,39842,-0.0294510891701751,0.00450843075110613,-0.0382876134423431,-0.020614564898007,6.66574176393989e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GPA33,Cell surface A33 antigen,39784,-0.0796019061074141,0.0121857919693164,-0.103486058367274,-0.0557177538475539,6.67063868029609e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DIPK2B,Divergent protein kinase domain 2B,37120,0.0171557059827865,0.00263070728024889,0.0119995197134987,0.0223118922520743,7.22138215752225e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCL23,C-C motif chemokine 23,39927,-0.024791129370921,0.00381551347644,-0.0322695357847434,-0.0173127229570987,8.40919982048879e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DLL1,Delta-like protein 1,39909,0.0171225924489952,0.00263615433886843,0.0119557299448131,0.0222894549531773,8.53089894106536e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDH2,Cadherin-2,39864,-0.02112941067677,0.00325323646962239,-0.0275057541572299,-0.0147530671963101,8.55439126799203e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,39679,-0.0279512694658498,0.00430717868025743,-0.0363933396791543,-0.0195091992525452,8.87046943453267e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NXPH3,Neurexophilin-3,37052,0.0178553835268388,0.00275406985169328,0.01245740661752,0.0232533604361576,9.29502343673345e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SUSD2,Sushi domain-containing protein 2,39854,0.0168870914203001,0.00261255910105893,0.0117664755822246,0.0220077072583756,1.05052332739619e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,39973,-0.0617802184076171,0.00956245673673242,-0.0805226336116126,-0.0430378032036215,1.07203673719902e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,39581,0.0128236519506692,0.00199236343340733,0.0089186196211908,0.0167286842801475,1.25881443414739e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BOC,Brother of CDO,39581,0.0139785868257354,0.00217402678237856,0.00971749433227337,0.0182396793191973,1.31445265350864e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FYB1,FYN-binding protein 1,39832,-0.0546443398760432,0.00850639917261602,-0.0713168822543706,-0.0379717974977158,1.36573960815017e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,39745,-0.0441079363159168,0.00686774280928547,-0.0575687122221164,-0.0306471604097173,1.37881505265722e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TGFB1,Transforming growth factor beta-1 proprotein,40036,-0.0228767825389894,0.00356982795912723,-0.0298736453388788,-0.0158799197391,1.51149522077743e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",40048,0.0171839379757892,0.00268726366957266,0.0119169011834268,0.0224509747681516,1.65393487311943e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PLA2G10,Group 10 secretory phospholipase A2,39745,-0.0349160492662034,0.00547249650100206,-0.0456421424081675,-0.0241899561242394,1.81659377063746e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AKR7L,Aflatoxin B1 aldehyde reductase member 4,37052,-0.0417515372714832,0.00654376085786406,-0.0545773085528968,-0.0289257659900697,1.82577488662043e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",39784,-0.0260679162591827,0.0040874047969194,-0.0340792296611447,-0.0180566028572206,1.8481836797241e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,37017,-0.0404764975987401,0.00634896277570875,-0.0529204646391292,-0.0280325305583509,1.88712272679429e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTPRB,Receptor-type tyrosine-protein phosphatase beta,37433,-0.0173150353415571,0.00271662355414653,-0.0226396175076843,-0.0119904531754299,1.90444514583477e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPP1,Osteopontin,40008,0.0266004060925801,0.00417670146645189,0.0184140712183344,0.0347867409668258,1.95714070508574e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ERMAP,Erythroid membrane-associated protein,37052,-0.0263042512438094,0.00412967656744384,-0.0343984173159993,-0.0182100851716195,1.9585399152585e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,APOD,Apolipoprotein D,36777,0.0255585994601417,0.004015722966762,0.0176877824452882,0.0334294164749952,2.02375204544414e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PDCD1,Programmed cell death protein 1,39994,0.0241192845799232,0.00379971020727093,0.0166718525736722,0.0315667165861742,2.24445255012693e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CEP85,Centrosomal protein of 85 kDa,39473,-0.0376049764616881,0.00592809511273999,-0.0492240428826584,-0.0259859100407177,2.30759640483024e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AXL,Tyrosine-protein kinase receptor UFO,39927,0.0160179216420757,0.00252874969278113,0.0110615722442247,0.0209742710399267,2.44721577735748e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FCN1,Ficolin-1,37426,-0.0329885231529926,0.00521630954277412,-0.0432124898568299,-0.0227645564491553,2.62680354972452e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLEC1B,C-type lectin domain family 1 member B,40005,-0.0564346856428092,0.00892791052320703,-0.073933390268295,-0.0389359810173234,2.66432504853814e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,THOP1,Thimet oligopeptidase,39794,-0.0178322621000447,0.00282307168859769,-0.0233654826096962,-0.0122990415903932,2.74441289928674e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRG2,Bone marrow proteoglycan,37433,0.0296721831255778,0.00469791577073975,0.0204642682149278,0.0388800980362277,2.76734079848373e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EEF1D,Elongation factor 1-delta,37433,-0.0534706984527228,0.00846814379165926,-0.0700682602843749,-0.0368731366210706,2.79776949824774e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,40048,0.0160282520608857,0.00254176599666666,0.011046390707419,0.0210101134143524,2.93855022587945e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,APOE,Apolipoprotein E,37449,-0.0423598196367413,0.00672210075689697,-0.0555351371202594,-0.0291845021532233,3.03730534208422e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BECN1,Beclin-1,37039,-0.0353428896751962,0.00561110274914078,-0.0463406510635122,-0.0243451282868803,3.09607052152432e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ANGPTL1,Angiopoietin-related protein 1,39613,-0.017074428747345,0.00271266205978228,-0.0223912463845183,-0.0117576111101718,3.16868902698987e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD70,CD70 antigen,39862,0.0246541958007187,0.0039186579757724,0.0169736261682048,0.0323347654332326,3.2260679181261e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCG3,Secretogranin-3,39881,0.0188413107962331,0.00300766682913288,0.0129462838111326,0.0247363377813335,3.83748105513154e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LAMP1,Lysosome-associated membrane glycoprotein 1,37093,-0.0164088012749424,0.00262061595274405,-0.0215452085423208,-0.0112723940075641,3.93257223086031e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SNAP29,Synaptosomal-associated protein 29,39909,-0.0528698345838886,0.00847082440405953,-0.0694726504158453,-0.036267018751932,4.44550569153707e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GFER,FAD-linked sulfhydryl oxidase ALR,39473,-0.0374592112482526,0.00601760827638251,-0.0492537234699623,-0.0256646990265429,4.94069634602866e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BANK1,B-cell scaffold protein with ankyrin repeats,39862,-0.0613056129845013,0.00986001669169481,-0.0806312457002231,-0.0419799802687795,5.17348406416343e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KIAA0319,Dyslexia-associated protein KIAA0319,37384,0.0174428140601018,0.00280800983289136,0.0119391147876347,0.0229465133325689,5.39136597739437e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KRT5,"Keratin, type II cytoskeletal 5",39485,-0.0291450218292346,0.00469404020307273,-0.0383453406272572,-0.0199447030312121,5.46907291072481e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ICAM3,Intercellular adhesion molecule 3,40048,0.014584535002952,0.00235076893774841,0.00997702788496511,0.0191920421209389,5.63284132602241e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADA2,Adenosine deaminase 2,39778,0.0236724871811144,0.00382577376313604,0.0161739706053678,0.031171003756861,6.25683645937538e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TANK,TRAF family member-associated NF-kappa-B activator,39583,-0.0406827980647338,0.00658023147002668,-0.0535800517459861,-0.0277855443834815,6.46202556961624e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MANSC1,MANSC domain-containing protein 1,39909,0.0154979944192386,0.00250721509672267,0.0105838528296622,0.020412136008815,6.50884892220916e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDC27,Cell division cycle protein 27 homolog,39473,-0.0351778611038682,0.00569261771718707,-0.0463353918295548,-0.0240203303781815,6.58769951879027e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",39909,-0.0197981199860684,0.00320784159748768,-0.0260854895171443,-0.0135107504549926,6.91437925714231e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GPRC5C,G-protein coupled receptor family C group 5 member C,37364,-0.0326128372598814,0.00529059438256551,-0.0429824022497098,-0.022243272270053,7.28087536992783e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ABCA2,ATP-binding cassette sub-family A member 2,37017,-0.0210044153301253,0.00341408222381945,-0.0276960164888115,-0.0143128141714392,7.85883935584117e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,COL9A1,Collagen alpha-1(IX) chain,39862,0.0249259167313731,0.00405525390530667,0.0169776190769721,0.0328742143857742,8.10516076389044e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CXCL12,Stromal cell-derived factor 1,39583,0.0226937670341122,0.00370265278603332,0.0154365675734869,0.0299509664947375,9.05113769248858e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CNST,Consortin,39864,-0.061371125308732,0.0100161859322729,-0.0810028497359869,-0.041739400881477,9.15357114738128e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ITGA11,Integrin alpha-11,39862,0.0193245550266013,0.00315428945258101,0.0131421476995425,0.0255069623536601,9.19720439217945e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNR,Tenascin-R,39745,0.0237894950669555,0.00388975323034721,0.016165578735475,0.031413411398436,9.82376767835365e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCL15,C-C motif chemokine 15,40048,-0.0245567639783139,0.00402260151149918,-0.0324410629408523,-0.0166724650157755,1.05345044892025e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VCAN,Versican core protein,40005,0.0166844855874824,0.00274098909889284,0.0113121469536524,0.0220568242213123,1.1762450190197e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LRP11,Low-density lipoprotein receptor-related protein 11,39864,-0.0196211621916988,0.00322814677158382,-0.0259483298640031,-0.0132939945193946,1.24334059721567e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ITGB1,Integrin beta-1,39858,0.0122124161944686,0.00201550941869609,0.00826201773382428,0.0161628146551129,1.39848357574127e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ARF6,ADP-ribosylation factor 6,37378,-0.059660822107378,0.00985849641913192,-0.0789834750888765,-0.0403381691258794,1.47100182625311e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EGLN1,Egl nine homolog 1,39862,-0.0298964094794082,0.00494881672341176,-0.0395960902572952,-0.0201967287015212,1.56434577410121e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NFKB1,Nuclear factor NF-kappa-B p105 subunit,37017,-0.0419143635016752,0.0069534891595762,-0.0555432022544446,-0.0282855247489059,1.70634859468252e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TAX1BP1,Tax1-binding protein 1,37384,-0.0351790578167983,0.00584961961123092,-0.0466443122548109,-0.0237138033787857,1.85776145877644e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RBKS,Ribokinase,39500,-0.0276026802080933,0.00459531195147926,-0.0366094916329927,-0.018595868783194,1.93527533074738e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,37433,0.014376278942041,0.00239616486269761,0.00967979581115372,0.0190727620729284,2.02709300177145e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DNER,Delta and Notch-like epidermal growth factor-related receptor,39817,0.0141262926240755,0.0023548348040882,0.00951081640806261,0.0187417688400884,2.03016891879766e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NECTIN2,Nectin-2,39842,-0.0156611844176186,0.00261619728796289,-0.0207889311020259,-0.0105334377332113,2.19341129029327e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LSP1,Lymphocyte-specific protein 1,39862,-0.0224039295799686,0.00375007194798157,-0.0297540705980125,-0.0150537885619247,2.36026446756685e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FEN1,Flap endonuclease 1,39473,-0.0345309631165113,0.00579056353620754,-0.0458804676474781,-0.0231814585855446,2.52500980243672e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KYNU,Kynureninase,40054,-0.0251420211639621,0.0042187660649007,-0.0334108026511675,-0.0168732396767568,2.58151666797863e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MFAP5,Microfibrillar-associated protein 5,40048,-0.0222268179293112,0.00373519713325053,-0.0295478043104823,-0.0149058315481402,2.72603094373115e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SUOX,"Sulfite oxidase, mitochondrial",37408,-0.0346275677704076,0.0058190193460658,-0.0460328456886966,-0.0232222898521186,2.73495466623987e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",39583,-0.0329913896634208,0.00555130337411885,-0.0438719442766937,-0.0221108350501478,2.8576890098692e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PSME1,Proteasome activator complex subunit 1,39734,-0.0203543083648189,0.00342546380526152,-0.0270682174231315,-0.0136403993065063,2.87351700494955e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",37433,-0.041654027262898,0.00702256143615705,-0.0554182476777658,-0.0278898068480302,3.07561867178949e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ERBB4,Receptor tyrosine-protein kinase erbB-4,39909,0.0130886136420724,0.00220934633902427,0.00875829481758486,0.01741893246656,3.20233836303564e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LCAT,Phosphatidylcholine-sterol acyltransferase,37441,-0.0119707917237937,0.00202759437735073,-0.0159448767034011,-0.00799670674418625,3.63398967448384e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,37364,-0.0264792198537817,0.00448746319451116,-0.0352746477150235,-0.0176837919925398,3.7061234013058e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CTRC,Chymotrypsin-C,39852,0.0338215287207471,0.00573284473967219,0.0225851530309896,0.0450579044105046,3.71724338730392e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNC,Tenascin,39927,0.0257513400539233,0.00436733419383819,0.0171913650340005,0.0343113150738462,3.79075642057376e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SFRP4,Secreted frizzled-related protein 4,37120,-0.0227046044535239,0.00385260943354715,-0.0302557189432763,-0.0151534899637715,3.87738677257862e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AXIN1,Axin-1,39862,-0.0521438746810474,0.00885170287908743,-0.0694932123240588,-0.0347945370380361,3.91967764899826e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SEMA3F,Semaphorin-3F,39864,-0.0139348965425847,0.0023668679661357,-0.0185739577562107,-0.00929583532895872,3.99965431325976e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HEXIM1,Protein HEXIM1,39862,-0.0444894732610732,0.00757239210351132,-0.0593313617839554,-0.0296475847381911,4.30662072120851e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD22,B-cell receptor CD22,40054,0.0218543628399554,0.00372175384878702,0.0145597252963328,0.0291490003835779,4.38834856363145e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,37362,-0.0445866544159403,0.00760200647124714,-0.0594865870995847,-0.0296867217322959,4.59319488583704e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RFC4,Replication factor C subunit 4,37364,-0.0116223264632486,0.00198213787059106,-0.0155073166896071,-0.00773733623689014,4.63717045233101e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,OMG,Oligodendrocyte-myelin glycoprotein,39784,0.0353204915021528,0.00602645661183324,0.0235086365429597,0.047132346461346,4.69444785162132e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,37408,0.0139463612951615,0.0023799075121061,0.00928174257143358,0.0186109800188895,4.7350069331486e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FBLN2,Fibulin-2,37433,0.0164367021703064,0.00280491377305175,0.010939071175125,0.0219343331654878,4.73697986570219e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",37039,-0.037968201636675,0.00649081834567257,-0.0506902055941933,-0.0252461976791568,5.04678111230703e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ASAH2,Neutral ceramidase,39745,-0.0283982152399259,0.004856832024548,-0.03791760600804,-0.0188788244718118,5.10137202837606e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PLXNA4,Plexin-A4,39862,-0.0440098031548247,0.00753261766922239,-0.0587737337865006,-0.0292458725231489,5.24014636954046e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,39745,-0.0381427038845639,0.00654519695031352,-0.0509712899071784,-0.0253141178619494,5.73235977081973e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,39877,0.0265771652919579,0.00456750103979026,0.017624863253969,0.0355294673299468,6.0419740767326e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NPTXR,Neuronal pentraxin receptor,39864,0.0183238350201134,0.00315362961891393,0.0121427209670421,0.0245049490731847,6.35095837296678e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TCN2,Transcobalamin-2,40008,0.0156962910780454,0.00271489664664458,0.010375093650622,0.0210174885054688,7.5385339674813e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",39754,-0.0401006294963143,0.00694393985090117,-0.0537107516040805,-0.026490507388548,7.84321398624764e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD4,T-cell surface glycoprotein CD4,39835,-0.0154473741707983,0.00267815545779953,-0.0206965588680854,-0.0101981894735113,8.17423231884558e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,37384,-0.0219969806381196,0.00382065267307749,-0.0294854598773515,-0.0145085013988877,8.72807255578252e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MEGF9,Multiple epidermal growth factor-like domains protein 9,39998,-0.0112842567217415,0.00196576993127458,-0.0151371657870397,-0.00743134765644329,9.61641906710206e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TMPRSS5,Transmembrane protease serine 5,39663,0.0202425771225619,0.00352742470199737,0.0133288247066471,0.0271563295384768,9.71960246940885e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SNAP23,Synaptosomal-associated protein 23,39864,-0.0462397317616123,0.00806638042366397,-0.0620498373919936,-0.0304296261312309,1.00802633850779e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MERTK,Tyrosine-protein kinase Mer,40054,0.0134793845924586,0.00235164705690666,0.00887015636092157,0.0180886128239957,1.01084835267096e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IGFBP3,Insulin-like growth factor-binding protein 3,39927,-0.0146812571259975,0.00256869421356418,-0.0197158977845833,-0.00964661646741168,1.11351576701321e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CTSC,Dipeptidyl peptidase 1,39852,-0.0226625238448999,0.00396981638170292,-0.0304433639530376,-0.0148816837367622,1.15856409636933e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MMP1,Interstitial collagenase,39310,-0.0486444372037016,0.00852406103020439,-0.0653515968229022,-0.031937277584501,1.17286103200032e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DCXR,L-xylulose reductase,39909,-0.0285188689460308,0.00500049988739934,-0.0383198487253335,-0.018717889166728,1.19647076292761e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NFKBIE,NF-kappa-B inhibitor epsilon,39473,-0.0261002580758286,0.00457759759403741,-0.0350723493601419,-0.0171281667915152,1.20737802313528e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PXN,Paxillin,39485,-0.027387969086709,0.00480672856411953,-0.0368091570723833,-0.0179667811010347,1.23522229774778e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NELL1,Protein kinase C-binding protein NELL1,39909,0.0214751454695581,0.00379036815546887,0.0140460238848391,0.0289042670542771,1.48925528388355e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCGB1A1,Uteroglobin,39899,0.0287375772295723,0.00507653142909728,0.0187875756285416,0.0386875788306029,1.5318648912141e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NOS3,"Nitric oxide synthase, endothelial",39485,-0.0268485113410116,0.00474601907285274,-0.036150708723803,-0.0175463139582202,1.56687388619294e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IGFBP4,Insulin-like growth factor-binding protein 4,39581,-0.0207822627428368,0.0036805364721017,-0.0279961142281561,-0.0135684112575174,1.6654875687135e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CXCL6,C-X-C motif chemokine 6,40054,-0.0402053103669533,0.00712182917491353,-0.0541640955497838,-0.0262465251841228,1.67597330686499e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LBR,Delta(14)-sterol reductase LBR,40005,-0.0349435550208615,0.00619306557931238,-0.0470819635563138,-0.0228051464854093,1.70542567342941e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,COL15A1,Collagen alpha-1(XV) chain,37433,0.0130763586524693,0.00231823417881266,0.00853261966199652,0.0176200976429422,1.7278766544239e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FSTL3,Follistatin-related protein 3,39799,-0.0156990732203895,0.00278352077521237,-0.0211547739398057,-0.0102433725009733,1.72931230738349e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SERPING1,Plasma protease C1 inhibitor,37420,0.00983611893767052,0.00174457789825787,0.0064167462570851,0.0132554916182559,1.75359059257985e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PSIP1,PC4 and SFRS1-interacting protein,39862,-0.0330287099389855,0.00586353047952641,-0.0445212296788573,-0.0215361901991138,1.80180674025291e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,39837,-0.0320352494423008,0.00569539211942945,-0.0431982179963825,-0.0208722808882191,1.88872176100122e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ROBO2,Roundabout homolog 2,40005,0.0118039665476554,0.00210835073269842,0.00767159911156646,0.0159363339837442,2.19515742798282e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VEGFA,Vascular endothelial growth factor A,39989,-0.0295850257933741,0.00528729621830057,-0.0399481263812433,-0.019221925205505,2.2357429356058e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LAT2,Linker for activation of T-cells family member 2,39784,-0.0645840205426278,0.0115569058735385,-0.0872355560547632,-0.0419324850304924,2.32996524276471e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KRT8,"Keratin, type II cytoskeletal 8",36987,-0.0338082121120993,0.00605079816003422,-0.0456677765057663,-0.0219486477184322,2.35085185493581e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PDCD6,Programmed cell death protein 6,39864,0.0360612376801646,0.00646320711319552,0.0233933517383014,0.0487291236220278,2.45169870521732e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GPKOW,G-patch domain and KOW motifs-containing protein,39485,-0.0141101778872288,0.00252981117939322,-0.0190686077988395,-0.00915174797561806,2.47957828796046e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,39994,-0.0156093927837731,0.00279923141014915,-0.0210958863476654,-0.0101228992198808,2.4960937490551e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SDCCAG8,Serologically defined colon cancer antigen 8,37364,-0.0591810114922976,0.0106164999714434,-0.0799893514363267,-0.0383726715482685,2.53090751207206e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,37433,0.0167168574677278,0.00300698179486381,0.0108231731497947,0.0226105417856608,2.75893186751032e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD1C,T-cell surface glycoprotein CD1c,39909,0.0120358876062543,0.00217738123376827,0.00776822038806846,0.0163035548244401,3.29532065259246e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TIE1,Tyrosine-protein kinase receptor Tie-1,40048,0.0210808570606499,0.00381378099382065,0.0136058463127614,0.0285558678085384,3.29754050411187e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FABP2,"Fatty acid-binding protein, intestinal",39864,0.039827341497998,0.00721914368435749,0.0256778198766574,0.0539768631193387,3.50369630509716e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BMPER,BMP-binding endothelial regulator protein,37120,-0.0114947795596152,0.00208575216722131,-0.015582853807369,-0.00740670531186146,3.63263620559896e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPINK4,Serine protease inhibitor Kazal-type 4,39862,-0.0316554512599635,0.00575974924992283,-0.0429445597898123,-0.0203663427301147,3.94490525480069e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PLTP,Phospholipid transfer protein,39972,0.0183103721934299,0.00333285122347053,0.0117779837954276,0.0248427605914321,3.99097354981059e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,39473,-0.0344283111709563,0.00627610197917036,-0.0467294710501302,-0.0221271512917824,4.18428788072206e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,39864,-0.0321901787534327,0.0058944838778475,-0.0437433671540138,-0.0206369903528516,4.80332335456751e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SKAP1,Src kinase-associated phosphoprotein 1,39709,-0.0364480983056832,0.00667671834581518,-0.049534466263481,-0.0233617303478855,4.86064138172085e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ARHGEF12,Rho guanine nucleotide exchange factor 12,39862,-0.0525517154609714,0.00963954605109988,-0.0714452257211271,-0.0336582052008156,5.06351545133885e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NCF2,Neutrophil cytosol factor 2,39839,-0.0419966401185378,0.0077035532159024,-0.0570956044217065,-0.0268976758153691,5.06606927619617e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PECAM1,Platelet endothelial cell adhesion molecule,39854,-0.0151505841930868,0.00278494475410587,-0.0206090759111343,-0.00969209247503931,5.40106327375518e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SMNDC1,Survival of motor neuron-related-splicing factor 30,37378,-0.0299850688248544,0.00553088940315618,-0.0408256120550405,-0.0191445255946683,6.01551890255839e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADGRE1,Adhesion G protein-coupled receptor E1,37378,0.0268838571493712,0.0049747632036116,0.0171333212702924,0.0366343930284499,6.62584298661108e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ANPEP,Aminopeptidase N,39887,0.0139575886776393,0.0025917235317072,0.00887781055549316,0.0190373667997854,7.32836110020388e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TINAGL1,Tubulointerstitial nephritis antigen-like,39840,0.0111046255258343,0.00206361264700035,0.00705994473771358,0.0151493063139549,7.5051271201642e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,39465,-0.0294369772200308,0.00547802495467168,-0.0401739061311873,-0.0187000483088743,7.82671531571047e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FCRL1,Fc receptor-like protein 1,39864,0.0218487427052387,0.00407130282924275,0.0138689891599229,0.0298284962505545,8.13863374616369e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MYBPC1,"Myosin-binding protein C, slow-type",37433,-0.0339972623724718,0.00633870858149926,-0.0464211311922103,-0.0215733935527332,8.29921749986017e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IDS,Iduronate 2-sulfatase,40054,0.00447898416168938,0.000835791816738079,0.00284083220088275,0.00611713612249602,8.48425761496088e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TRIM40,E3 ubiquitin ligase TRIM40,37035,-0.0362910985613106,0.00677225009004704,-0.0495647087378028,-0.0230174883848184,8.51897239697643e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CEMIP2,Cell surface hyaluronidase,37052,-0.0158840631739125,0.00296944514851303,-0.021704175664998,-0.010063950682827,8.98347161346372e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NFX1,Transcriptional repressor NF-X1,37017,-0.0334463276897709,0.00625475718558803,-0.0457056517735234,-0.0211870036060183,9.07476713062837e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DCTN2,Dynactin subunit 2,39784,-0.0470459463421395,0.00880377829999762,-0.0643013518101349,-0.0297905408741442,9.2252571737484e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AMN,Protein amnionless,39583,-0.0236357880206708,0.00442890262834365,-0.0323164371722243,-0.0149551388691172,9.59586923541302e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNIP1,TNFAIP3-interacting protein 1,37384,-0.0436145776036026,0.0081782219206527,-0.0596438925680818,-0.0275852626391233,9.81503138140704e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NUMB,Protein numb homolog,37052,-0.0417569984924738,0.00784801328627747,-0.0571391045335776,-0.02637489245137,1.050539768859e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,OSMR,Oncostatin-M-specific receptor subunit beta,39945,0.00997105329331442,0.00187523380446229,0.00629559503656833,0.0136465115500605,1.06765665388663e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TPK1,Thiamin pyrophosphokinase 1,37433,0.0136144629207097,0.00256096268257647,0.00859497606285979,0.0186339497785595,1.07664426553175e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SERPINA9,Serpin A9,39711,-0.0358613101961533,0.00674964354070869,-0.0490906115359423,-0.0226320088563643,1.09252724269867e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,37378,0.0346117087571406,0.0065253757940831,0.0218219722007377,0.0474014453135435,1.14970747356151e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FUOM,Fucose mutarotase,37120,-0.0312354458346874,0.00589564478348487,-0.0427909096103178,-0.0196799820590571,1.18916255497354e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SDC1,Syndecan-1,39864,0.0195060659789611,0.00368500351748913,0.0122834590846823,0.0267286728732398,1.21671364380119e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FGR,Tyrosine-protein kinase Fgr,39485,-0.0276363752299544,0.00524397640082592,-0.0379145689755732,-0.0173581814843356,1.38148009375296e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,39583,0.020376734500455,0.00387012321491489,0.0127912929992219,0.0279621760016882,1.41927146905979e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL1RAP,Interleukin-1 receptor accessory protein,39854,0.0209269799184753,0.00397529090550857,0.0131354097436785,0.0287185500932721,1.42571705108185e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADD1,Alpha-adducin,37120,-0.033704618281544,0.00640451542616383,-0.0462574685168251,-0.0211517680462629,1.44220281917671e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCL13,C-C motif chemokine 13,40020,-0.0335322410865432,0.00638293969525496,-0.0460428028892429,-0.0210216792838435,1.51198135305962e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GDF15,Growth/differentiation factor 15,40048,-0.0206732238154068,0.00393726106215877,-0.028390255497238,-0.0129561921335756,1.53470333826316e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PLEKHO1,Pleckstrin homology domain-containing family O member 1,37384,-0.0337173004091976,0.00643675254699786,-0.0463333354013135,-0.0211012654170818,1.6454216606325e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,REG4,Regenerating islet-derived protein 4,39881,-0.0228372677415297,0.00436201076709952,-0.0313868088450448,-0.0142877266380147,1.66625568443518e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ITGBL1,Integrin beta-like protein 1,37433,-0.0173369485743252,0.00331119931460881,-0.0238268992309585,-0.0108469979176919,1.66677476649436e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,39927,-0.0201417083918034,0.00384969984848347,-0.027687120094831,-0.0125962966887758,1.69773713810406e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCL25,C-C motif chemokine 25,40054,-0.0241826925909868,0.00462650345654187,-0.0332506393658089,-0.0151147458161647,1.74430292376872e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VCAM1,Vascular cell adhesion protein 1,39904,0.0129379431818755,0.0024756978308351,0.00808557543343872,0.0177903109303123,1.75406531041971e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CGA,Glycoprotein hormones alpha chain,39854,0.0427749600460613,0.00820480144036686,0.0266935492229422,0.0588563708691803,1.87712482498835e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SAA4,Serum amyloid A-4 protein,37449,-0.0159268004538048,0.00306063992442011,-0.0219256547056682,-0.00992794620194139,1.98151658455965e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CRTAC1,Cartilage acidic protein 1,40048,0.0145415908330914,0.00279513822568453,0.00906311991074975,0.0200200617554331,1.9906811535324e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VSIG2,V-set and immunoglobulin domain-containing protein 2,37364,-0.0257040048182909,0.0049500151070359,-0.0354060344280813,-0.0160019752085006,2.10263613643698e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SULT2A1,Bile salt sulfotransferase,39862,-0.026882608059739,0.00518268765319058,-0.0370406758599926,-0.0167245402594855,2.16313998199257e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",37039,0.0124420272369178,0.00241044692946901,0.00771755125515853,0.0171665032186771,2.48264495918527e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MLN,Promotilin,39862,-0.0426474124949357,0.00826535272751986,-0.0588475038408746,-0.0264473211489967,2.50193334206995e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,37120,0.0185930443600324,0.00361079198554347,0.0115158920683672,0.0256701966516976,2.65208131207581e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BCAM,Basal cell adhesion molecule,39854,0.0112308778171414,0.00218389662763356,0.00695044042697966,0.0155113152073032,2.74179787040501e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ENTR1,Endosome-associated-trafficking regulator 1,37039,-0.0285549434346026,0.00555395193980795,-0.0394406892366262,-0.017669197632579,2.76643969512987e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,OSM,Oncostatin-M,39781,-0.0340580308510523,0.00663262880440865,-0.0470579833076933,-0.0210580783944114,2.85588898968272e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TRAF2,TNF receptor-associated factor 2,39862,-0.0338496498396786,0.00659212885204192,-0.0467702223896808,-0.0209290772896765,2.85667864188617e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DAAM1,Disheveled-associated activator of morphogenesis 1,37120,-0.0393435870674712,0.00767473973096418,-0.054386076940161,-0.0243010971947814,2.99533499929358e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,WIF1,Wnt inhibitory factor 1,40026,0.01591453934041,0.00310970164926353,0.00981952410785347,0.0220095545729665,3.12818009518199e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCL11,Eotaxin,40054,-0.0181225619571659,0.0035412454579205,-0.0250634030546901,-0.0111817208596418,3.13041826162833e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EZR,Ezrin,40005,-0.0114033387064531,0.00222845476524779,-0.0157711100463387,-0.00703556736656741,3.13743602691932e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PNLIPRP1,Inactive pancreatic lipase-related protein 1,37384,-0.0366984925062401,0.00717352947589991,-0.0507586102790039,-0.0226383747334763,3.16656018907552e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FLI1,Friend leukemia integration 1 transcription factor,39473,-0.0522570435112486,0.010226197700617,-0.0723003910044579,-0.0322136960180393,3.25762108266476e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,A1BG,Alpha-1B-glycoprotein,37449,-0.00809162399155791,0.00158431399678197,-0.0111968794252506,-0.00498636855786526,3.31155515627024e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MYL3,Myosin light chain 3,37039,-0.0344293170576714,0.00675375933028622,-0.0476666853450324,-0.0211919487703104,3.4838547339519e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PLIN1,Perilipin-1,39485,-0.0164085666728787,0.00321904072513599,-0.0227178864941452,-0.0100992468516121,3.48468905364872e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LEPR,Leptin receptor,39864,0.0145871429914456,0.00286708900234552,0.00896764854684837,0.0202066374360428,3.66361901665221e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ART3,Ecto-ADP-ribosyltransferase 3,39927,0.015579172343342,0.00306429021652718,0.00957316351894875,0.0215851811677353,3.73515552273175e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,37165,-0.0204044119786521,0.00402162063855193,-0.0282867884302139,-0.0125220355270904,3.9545606717412e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KAZN,Kazrin,37378,-0.0489661815068942,0.00965616544426981,-0.067892265777663,-0.0300400972361254,4.01019854041063e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,40005,0.0125802392760376,0.00248532515966559,0.00770900196309308,0.0174514765889822,4.19865246973228e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TOP2B,DNA topoisomerase 2-beta,37052,-0.0373480920044022,0.00738079110224359,-0.0518144425647997,-0.0228817414440048,4.2450800394211e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,39975,-0.0269599421529811,0.00533770125762524,-0.0374218366179266,-0.0164980476880356,4.44647362000862e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SH2D1A,SH2 domain-containing protein 1A,39862,-0.026459881111672,0.00524910808319926,-0.0367481329547425,-0.0161716292686014,4.68568295696078e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AZI2,5-azacytidine-induced protein 2,37408,-0.0259266500035788,0.0051436919958576,-0.0360082863154597,-0.0158450136916979,4.7036939408383e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CSPG4,Chondroitin sulfate proteoglycan 4,37433,0.01535161444232,0.00304602120921624,0.00938141287225618,0.0213218160123838,4.71793071386899e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FIS1,Mitochondrial fission 1 protein,39851,-0.0364911828202821,0.00726042702685586,-0.0507216197929196,-0.0222607458476446,5.06124742542451e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IMMT,MICOS complex subunit MIC60,37364,-0.0204376683606405,0.00407185682968066,-0.0284185077468146,-0.0124568289744664,5.25340777172385e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,REN,Renin,39864,-0.0306698466943446,0.00611530099779105,-0.042655836650015,-0.0186838567386741,5.35276300276564e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ANGPT1,Angiopoietin-1,39790,-0.0392419665347325,0.00783894684016221,-0.0546063023414504,-0.0238776307280145,5.61586768837393e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SEMA3G,Semaphorin-3G,37120,0.0203473617649123,0.00406735214398292,0.0123753515627058,0.0283193719671188,5.72845029424302e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,UBAC1,Ubiquitin-associated domain-containing protein 1,39784,-0.0159596115430104,0.00319251910740363,-0.0222169489935216,-0.00970227409249932,5.82208608163568e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD36,Platelet glycoprotein 4,37052,-0.0211912605868104,0.00424102463545447,-0.0295036688723012,-0.0128788523013197,5.90572328503047e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,APOM,Apolipoprotein M,39904,0.012348396028286,0.00247159418168597,0.00750407143218152,0.0171927206243905,5.91087407597105e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",37354,-0.0505048842739282,0.0101203997167818,-0.0703408677188205,-0.0306689008290358,6.10039484180484e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PON1,Serum paraoxonase/arylesterase 1,37441,0.0118359557076618,0.00237255821917226,0.00718574159808413,0.0164861698172394,6.15419938798481e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CR1,Complement receptor type 1,37416,0.0164463459986221,0.00330542154436718,0.00996771977166243,0.0229249722255818,6.58546807675396e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LDLRAP1,Low density lipoprotein receptor adapter protein 1,37408,-0.0450716916792065,0.00906765517973955,-0.062844295831496,-0.027299087526917,6.75615900122924e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ARHGEF10,Rho guanine nucleotide exchange factor 10,37408,-0.043193798966087,0.00869011356937001,-0.0602264215620522,-0.0261611763701218,6.76130126741719e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,39745,-0.024604722579023,0.00495612735842268,-0.0343187322015315,-0.0148907129565146,6.9590286292827e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,S100A4,Protein S100-A4,39909,-0.0261593983483949,0.00527664010338856,-0.0365016129510365,-0.0158171837457534,7.21027536935482e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ABO,Histo-blood group ABO system transferase,37441,0.0659480822496942,0.0133058253342115,0.0398686645946397,0.0920274999047488,7.27027036694767e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PAK4,Serine/threonine-protein kinase PAK 4,39485,-0.0283327807333562,0.00572268561234093,-0.0395492445335444,-0.017116316933168,7.46189132857194e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LDLR,Low-density lipoprotein receptor,39878,-0.0241330745813662,0.00487669378021312,-0.0336913943905839,-0.0145747547721485,7.54868876631231e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BCR,Breakpoint cluster region protein,39862,-0.042069200885292,0.00852942799942846,-0.0587868797641718,-0.0253515220064122,8.21069156314993e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LYPD8,Ly6/PLAUR domain-containing protein 8,39473,-0.0240425162461355,0.00487483215424733,-0.0335971872684603,-0.0144878452238108,8.2242347279414e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BRAP,BRCA1-associated protein,37245,-0.0503253980248281,0.0102165161471359,-0.0703497696732144,-0.0303010263764418,8.49819635070242e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SHMT1,"Serine hydroxymethyltransferase, cytosolic",39904,-0.0397487643267249,0.00807064698824266,-0.0555672324236805,-0.0239302962297693,8.51552199869327e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL22RA1,Interleukin-22 receptor subunit alpha-1,39583,-0.0196735705699623,0.00400206741063663,-0.0275176226948101,-0.0118295184451145,8.92884732129464e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ANG,Angiogenin,39839,-0.0153812914778652,0.00313383325895453,-0.0215236046654161,-0.00923897829031431,9.28509309216306e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,OCLN,Occludin,37408,-0.0195205786876603,0.00398213188365083,-0.0273255571796159,-0.0117156001957047,9.59439109474668e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NAA80,N-alpha-acetyltransferase 80,37035,-0.0551954502302033,0.0112600941568836,-0.0772652347776952,-0.0331256656827113,9.60621363023272e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TDRKH,Tudor and KH domain-containing protein,39485,-0.0388714728310619,0.00793174574741853,-0.0544176944960022,-0.0233252511661216,9.64305255189789e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CNTN4,Contactin-4,39854,0.01083714739879,0.00221361301400301,0.00649846589134413,0.0151758289062359,9.89205238504206e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,S100P,Protein S100-P,39581,-0.0239433831980742,0.00489173012897332,-0.0335311742508619,-0.0143555921452865,9.94495436821728e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FETUB,Fetuin-B,39904,-0.01526800968327,0.00312378610806185,-0.0213906304550712,-0.00914538891146876,1.03026655944864e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SMOC1,SPARC-related modular calcium-binding protein 1,40026,-0.014799831241742,0.00303347578099592,-0.020745443772494,-0.00885421871099001,1.07729867983354e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IRAK1,Interleukin-1 receptor-associated kinase 1,39583,-0.0318878204837409,0.00654292290249538,-0.0447119493726318,-0.0190636915948499,1.10631551293146e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",39473,-0.0374922511422819,0.00770914877572667,-0.0526021827427062,-0.0223823195418577,1.16542596545001e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCPEP1,Retinoid-inducible serine carboxypeptidase,36991,-0.022962244496703,0.0047211432771822,-0.0322156853199801,-0.0137088036734259,1.16544729326301e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DNAJC6,Putative tyrosine-protein phosphatase auxilin,37039,-0.0382709820063933,0.00787319983156038,-0.0537024536762516,-0.0228395103365349,1.18189092661448e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CTHRC1,Collagen triple helix repeat-containing protein 1,37433,-0.0121117080206396,0.00249222117620716,-0.0169964615260057,-0.0072269545152736,1.18815280961742e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLSTN3,Calsyntenin-3,37384,0.0136212872388535,0.00280430537617389,0.00812484870155268,0.0191177257761543,1.20343882755043e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BIN2,Bridging integrator 2,39854,-0.0404150403272801,0.00832146239248529,-0.0567251066165513,-0.0241049740380089,1.20472920632544e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NELL2,Protein kinase C-binding protein NELL2,39927,0.0126570498700276,0.00261344588523515,0.00753469593496673,0.0177794038050885,1.29051643372496e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NFE2,Transcription factor NF-E2 45 kDa subunit,37039,-0.0334514501178311,0.00691532936626373,-0.047005495675708,-0.0198974045599542,1.3311036784505e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CFI,Complement factor I,37449,-0.00895419256530501,0.00185203690534558,-0.0125841848997823,-0.00532420023082768,1.34751390593029e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IPCEF1,Interactor protein for cytohesin exchange factors 1,39716,-0.0401211791585085,0.00830612643436381,-0.0564011869698616,-0.0238411713471554,1.37592969284237e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,37165,-0.0508673162877392,0.0105373659415707,-0.0715205535332178,-0.0302140790422606,1.39915394846737e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,F12,Coagulation factor XII,37449,-0.0185519721226312,0.00384542149265241,-0.0260889982482299,-0.0110149459970325,1.41927396711123e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ABL1,Tyrosine-protein kinase ABL1,39784,-0.0305891460177824,0.00634820571441333,-0.0430316292180325,-0.0181466628175323,1.45937816659228e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ATG4A,Cysteine protease ATG4A,39473,-0.0263194919639115,0.00546594127339498,-0.0370327368597656,-0.0156062470680573,1.48445650539563e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ITGAV,Integrin alpha-V,40026,0.00738390344105863,0.00153488537635625,0.00437552810340038,0.0103922787787169,1.51744110487648e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,STC1,Stanniocalcin-1,40005,-0.0186748045056923,0.0038887884031061,-0.0262968297757802,-0.0110527792356043,1.58326243661235e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TARBP2,RISC-loading complex subunit TARBP2,39485,-0.0355466810516955,0.00740372251724474,-0.0500579771854951,-0.0210353849178958,1.59186023148522e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,REG3A,Regenerating islet-derived protein 3-alpha,40048,0.0261412734512154,0.00544994530547879,0.015459380652477,0.0368231662499538,1.62808759832044e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FSHB,Follitropin subunit beta,37039,0.0290914470677616,0.00606956360499693,0.0171951024019677,0.0409877917335556,1.66095202526756e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FCER2,Low affinity immunoglobulin epsilon Fc receptor,39854,0.0212060572958135,0.00443204996996528,0.0125192393546816,0.0298928752369455,1.72766322772533e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RNF41,E3 ubiquitin-protein ligase NRDP1,39473,-0.0298511739801417,0.00624412400011003,-0.0420896570203574,-0.0176126909399261,1.76293834818899e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CEBPB,CCAAT/enhancer-binding protein beta,39581,-0.0165660189285608,0.00346930654759031,-0.0233658597618379,-0.00976617809528382,1.81306062081236e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AP1G2,AP-1 complex subunit gamma-like 2,37364,-0.0354158899784396,0.00741843344951338,-0.0499560195394858,-0.0208757604173934,1.82461612467013e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SUSD5,Sushi domain-containing protein 5,37060,0.0149809365912169,0.00314556672650563,0.00881562580726587,0.0211462473751679,1.93189068208664e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCN4,CCN family member 4,40026,-0.0176770172351301,0.00371792121486882,-0.024964142816273,-0.0103898916539872,2.00609945974868e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SYT1,Synaptotagmin-1,37384,0.016305637937371,0.00343392874802458,0.00957513759124278,0.0230361382834992,2.07144362719912e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ANGPT2,Angiopoietin-2,40026,-0.016753236514592,0.00353528649524588,-0.0236823980452739,-0.00982407498391008,2.16750375628907e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,C8B,Complement component C8 beta chain,37449,0.0133105500500371,0.00281203163153444,0.00779896805222962,0.0188221320478446,2.22985569150829e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SERPINA1,Alpha-1-antitrypsin,37243,0.00354643745180472,0.000749373994680793,0.00207766442223036,0.00501521048137907,2.24004141220987e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MASP1,Mannan-binding lectin serine protease 1,39709,-0.0103254520808219,0.00218352519543403,-0.0146051614638726,-0.00604574269777124,2.27796343194187e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ITGB2,Integrin beta-2,39727,0.0125976848483775,0.00266548454919148,0.0073733351319622,0.0178220345647928,2.30693120708341e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LGALS8,Galectin-8,40005,-0.0267887955255033,0.00567434645490236,-0.037910514577112,-0.0156670764738947,2.36616778075334e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,39864,0.0134270779845658,0.00285135927328186,0.0078384138089334,0.0190157421601983,2.51011908579071e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDA,Cytidine deaminase,37418,-0.020267584358935,0.00430798271819475,-0.0287112304865968,-0.0118239382312733,2.56803101841943e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MNDA,Myeloid cell nuclear differentiation antigen,39837,-0.0425221211928443,0.00904046693518389,-0.0602414363858048,-0.0248028059998839,2.57838942941827e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RGMB,RGM domain family member B,40005,0.0111180163113203,0.00236442754993928,0.00648373831343933,0.0157522943092013,2.594990242716e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLC51B,Organic solute transporter subunit beta,37017,-0.0330498222667806,0.00704366982902137,-0.0468554151316625,-0.0192442294018988,2.73097061316212e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLMAP,Sarcolemmal membrane-associated protein,37378,-0.0364339680017092,0.00776746379309842,-0.0516581970361822,-0.0212097389672363,2.75088773386356e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CALCA,Calcitonin,39709,-0.0264954395019434,0.00565280729386971,-0.037574941797928,-0.0154159372059588,2.79369375928651e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,S100G,Protein S100-G,37408,0.0195020699675538,0.00416755291867981,0.0113336662469414,0.0276704736881663,2.90356864063025e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,37302,-0.0131742746173965,0.00282283260862149,-0.0187070265302946,-0.00764152270449838,3.08519528767843e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,39581,-0.0244996164394636,0.00526326711340211,-0.0348156199817318,-0.0141836128971955,3.26896141496857e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MMP10,Stromelysin-2,39853,0.0253741108165544,0.00545184875697497,0.0146884872528835,0.0360597343802254,3.27817369937461e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FLT1,Vascular endothelial growth factor receptor 1,39751,0.00999514055219989,0.00214771993272081,0.0057856094840671,0.0142046716203327,3.28443795117231e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LCP1,Plastin-2,37433,0.0202429471885553,0.00435170346414133,0.0117136083988383,0.0287722859782723,3.32270869651403e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RBP2,Retinol-binding protein 2,39784,0.0329928838195579,0.00709571032767307,0.0190852915773187,0.0469004760617972,3.35096970064181e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",39805,-0.028267869656665,0.00608570167439717,-0.0401958449384834,-0.0163398943748465,3.42851750145995e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RNASET2,Ribonuclease T2,39970,-0.0109820317899698,0.00236658111355854,-0.0156205307725445,-0.00634353280739508,3.50367938550788e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SSNA1,Sjoegren syndrome nuclear autoantigen 1,37378,-0.0217059265900215,0.00468477223740382,-0.0308880801753329,-0.01252377300471,3.63253450036926e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,37378,-0.0126668249157377,0.00273425112903107,-0.0180259571286386,-0.00730769270283685,3.64385949634017e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,39904,-0.0329101681720709,0.00712632372693998,-0.0468777626768732,-0.0189425736672685,3.90251972783263e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,STAB2,Stabilin-2,37433,-0.0119931445584538,0.00259950774377537,-0.0170881797362535,-0.00689810938065405,3.99333004832665e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GSTP1,Glutathione S-transferase P,39389,0.0297500636609476,0.00645058690636837,0.0171069133244655,0.0423932139974296,4.02009057928262e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KLRB1,Killer cell lectin-like receptor subfamily B member 1,40054,-0.0154413195246624,0.00335079629673193,-0.022008880266257,-0.00887375878306785,4.0916280117676e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPINT1,Kunitz-type protease inhibitor 1,39790,0.0110835309113813,0.00241009670882576,0.00635974136208279,0.0158073204606798,4.28219802674651e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BCHE,Cholinesterase,37204,-0.011751565748831,0.00255990639433343,-0.0167689822817245,-0.00673414921593749,4.45958569603964e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SGSH,N-sulphoglucosamine sulphohydrolase,37261,-0.0235314130959654,0.00512957639134234,-0.0335853828229964,-0.0134774433689344,4.52871047952551e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPINT2,Kunitz-type protease inhibitor 2,39927,-0.0174462102258915,0.00381400422534905,-0.0249216585075757,-0.00997076194420737,4.81499890254884e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,39709,-0.0475005080612468,0.0103867549233897,-0.0678585477110906,-0.027142468411403,4.84011681099643e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCN2,CCN family member 2,39876,-0.0248105748759434,0.00542998091641074,-0.0354533374721084,-0.0141678122797783,4.93285188437415e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SKAP2,Src kinase-associated phosphoprotein 2,39927,-0.0440254182302819,0.00966009848547517,-0.0629592112618132,-0.0250916251987505,5.21598872328409e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SIGLEC5,Sialic acid-binding Ig-like lectin 5,39854,0.050091588479754,0.0110053393180256,0.0285211234164239,0.0716620535430841,5.36389063026754e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AHSP,Alpha-hemoglobin-stabilizing protein,39832,-0.0359232225813041,0.00791271979965921,-0.0514321533886361,-0.0204142917739721,5.66829409493129e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCAMP3,Secretory carrier-associated membrane protein 3,39784,-0.0355600515964995,0.00784875791228349,-0.0509436171045751,-0.0201764860884239,5.92271610375825e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CTRB1,Chymotrypsinogen B,39854,-0.0224182833599432,0.00495859528558551,-0.0321371301196909,-0.0126994366001956,6.19619979356352e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",37039,-0.0155975777437492,0.00345168772498417,-0.0223628856847182,-0.00883226980278022,6.2724321438309e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CRISP3,Cysteine-rich secretory protein 3,37321,0.0112523979974477,0.0024932594127119,0.00636560954853236,0.016139186446363,6.44199645075043e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LATS1,Serine/threonine-protein kinase LATS1,37052,-0.036049470753506,0.00798846534723856,-0.0517068628340936,-0.0203920786729185,6.45638594548011e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PQBP1,Polyglutamine-binding protein 1,39473,-0.0228813309733969,0.00508038473191818,-0.0328388850479565,-0.0129237768988372,6.72144167053159e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PIGR,Polymeric immunoglobulin receptor,39673,-0.0151820551194634,0.00337159705792908,-0.0217903853530044,-0.00857372488592241,6.75031084826768e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL22,Interleukin-22,37364,-0.0273280583190884,0.00607321380254143,-0.0392315573720696,-0.0154245592661072,6.85956260001363e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL18R1,Interleukin-18 receptor 1,40054,-0.0135821145197718,0.00302129037683172,-0.0195038436583619,-0.00766038538118158,6.98985624423189e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GFRAL,GDNF family receptor alpha-like,36938,0.0259179045017743,0.00577620831189253,0.014596536210465,0.0372392727930837,7.28459811347396e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,37433,-0.0317781710191915,0.00708823314506795,-0.0456711079835247,-0.0178852340548583,7.41244454896486e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLEC4C,C-type lectin domain family 4 member C,39862,0.0190830103680246,0.00426923053047511,0.0107153185282934,0.0274507022077558,7.879562630105e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTPRR,Receptor-type tyrosine-protein phosphatase R,37384,0.0147585135160672,0.00331056686812705,0.00826980245453815,0.0212472245775962,8.33928945920855e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DKK1,Dickkopf-related protein 1,40005,-0.0246813630566466,0.00553822790686552,-0.035536289754103,-0.0138264363591902,8.38515252561701e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,USP25,Ubiquitin carboxyl-terminal hydrolase 25,37364,-0.0300941768683995,0.0067525400592571,-0.0433291553845434,-0.0168591983522556,8.38933768143675e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLU,Clusterin,37449,0.0131541152182454,0.00295528905685002,0.00736174866681932,0.0189464817696714,8.61349932874277e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AZU1,Azurocidin,39340,-0.0315873270322889,0.00711794732282658,-0.045538503785029,-0.0176361502795488,9.15524242487393e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,39958,0.0141743420290385,0.00319612163090659,0.00790994363246157,0.0204387404256154,9.27437558673158e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FOXO1,Forkhead box protein O1,39862,-0.0353414255757941,0.00797980239895211,-0.0509818382777402,-0.019701012873848,9.53606121309479e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TADA3,Transcriptional adapter 3,37364,-0.0162823257285255,0.00367715714168586,-0.0234895537262298,-0.00907509773082122,9.58730584711973e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,37052,-0.014861675191548,0.00336215793337717,-0.0214515047409672,-0.0082718456421287,9.93608913295119e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,39473,-0.0243085545170817,0.00550286846992497,-0.0350941767181346,-0.0135229323160287,1.0055185757409e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HMBS,Porphobilinogen deaminase,40026,-0.0176041456964203,0.0039883457834799,-0.0254213034320409,-0.00978698796079967,1.02184109392982e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CHGB,Secretogranin-1,39948,0.0161420896673991,0.00365908404733357,0.00897028493462531,0.0233138944001729,1.03318480072644e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PGF,Placenta growth factor,40054,-0.0105204437938612,0.00238781033069319,-0.0152005520420198,-0.0058403355457025,1.06024014126102e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AGXT,Serine--pyruvate aminotransferase,39864,-0.031796601237787,0.00722541376953354,-0.0459584122260727,-0.0176347902495013,1.08619360487764e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ELOA,Elongin-A,39784,-0.0208567048126003,0.0047458413051024,-0.030158553770601,-0.0115548558545996,1.11626339778563e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,POF1B,Protein POF1B,37052,-0.0184226640419513,0.00419628121817723,-0.0266473752295787,-0.010197952854324,1.14108732107923e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTP4A3,Protein tyrosine phosphatase type IVA 3,37052,-0.0210084709717055,0.00479683902042211,-0.0304102754517328,-0.0116066664916782,1.19786961224327e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",37408,-0.0169300770404092,0.00386875992401298,-0.0245128464914746,-0.00934730758934373,1.21726069864911e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SIAE,Sialate O-acetylesterase,39871,-0.0191562854860427,0.00438200536327904,-0.0277450159980696,-0.0105675549740158,1.24128362728582e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLC,Galectin-10,39837,0.0269889600481049,0.00618037373546558,0.0148754275265923,0.0391024925696174,1.26825892165604e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ATXN3,Ataxin-3,37384,-0.02481099628558,0.00568709090961523,-0.0359576944684259,-0.0136642981027342,1.29426543869306e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DPEP1,Dipeptidase 1,39709,0.0191457337334242,0.00439331128891793,0.0105348436071451,0.0277566238597034,1.32125802922169e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KLKB1,Plasma kallikrein,37183,-0.0100891463753488,0.00231952955846341,-0.0146354243099371,-0.00554286844076056,1.37367439357633e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DTNB,Dystrobrevin beta,37344,-0.0177394980171427,0.00407888164012631,-0.0257341060317903,-0.00974489000249517,1.37695758716206e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,C2,Complement C2,39904,0.00953411036508256,0.00219461358614977,0.00523266773622902,0.0138355529939361,1.40563837567182e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CKAP4,Cytoskeleton-associated protein 4,39987,0.010241756498836,0.00235822809196572,0.00561962943858319,0.0148638835590888,1.41415562629061e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RABGAP1L,Rab GTPase-activating protein 1-like,39583,-0.0240448303365442,0.00553666587057643,-0.034896695442874,-0.0131929652302144,1.4153569534798e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GGH,Gamma-glutamyl hydrolase,39569,0.0136274520364334,0.00314800612434348,0.00745736003272015,0.0197975440401466,1.50772804512386e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,39745,0.0154716635106648,0.00357461774105462,0.0084654127381978,0.0224779142831319,1.51251747904985e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EPPK1,Epiplakin,37039,-0.0299273435170174,0.00692186748267222,-0.043494203783055,-0.0163604832509799,1.5463531437054e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TRIM24,Transcription intermediary factor 1-alpha,37131,-0.0262069172262123,0.00606295988842519,-0.0380903186075256,-0.0143235158448989,1.55421563095646e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SERPINA7,Thyroxine-binding globulin,37449,0.00742391990461163,0.00172024756987508,0.00405223466765646,0.0107956051415668,1.60287498120454e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PAXX,Protein PAXX,37120,-0.0184143458967858,0.0042688430984791,-0.0267812783698049,-0.0100474134237668,1.61734350052333e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FUS,RNA-binding protein FUS,39451,-0.015659231729398,0.00364602856384042,-0.0228054477145252,-0.00851301574427079,1.75850407243842e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,INHBB,Inhibin beta B chain,37120,0.0197333039175177,0.00459473721563395,0.0107276189748752,0.0287389888601603,1.7612503192393e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD14,Monocyte differentiation antigen CD14,39560,0.0163319272926295,0.00380619284565794,0.00887178931513999,0.0237920652701191,1.79029646160044e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NIT1,Deaminated glutathione amidase,37039,-0.0187375659496778,0.0043723966911464,-0.0273074634643248,-0.0101676684350309,1.83687461567975e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SERPINA12,Serpin A12,39401,-0.0469979330876402,0.0109719824650561,-0.0685030187191503,-0.0254928474561302,1.85123444170348e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LRRC25,Leucine-rich repeat-containing protein 25,39784,0.0154224188223451,0.00360357259607858,0.0083594165340311,0.0224854211106591,1.88189979473332e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CEP43,Centrosomal protein 43,39472,-0.0277911836233637,0.00649960748534111,-0.0405304142946322,-0.0150519529520951,1.9156202198288e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CNTNAP2,Contactin-associated protein-like 2,39862,0.0162558718221369,0.00380296924710972,0.00880205209780182,0.0237096915464719,1.92657407343023e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD34,Hematopoietic progenitor cell antigen CD34,39941,0.00952974894520896,0.00222957005679178,0.00515979163389706,0.0138997062565209,1.92882567271104e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLEC7A,C-type lectin domain family 7 member A,40054,0.0226652872751525,0.00531390045943221,0.0122500423746654,0.0330805321756397,2.00781817750219e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,OGA,Protein O-GlcNAcase,37378,-0.0281272159238742,0.00660261155805522,-0.0410683345776624,-0.0151860972700859,2.05797444757076e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TSNAX,Translin-associated protein X,37017,-0.0155286167752417,0.003646213691274,-0.0226751956101387,-0.00838203794034465,2.06923681468563e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL32,Interleukin-32,39862,0.0169168601475896,0.00397475084464225,0.00912634849209075,0.0247073718030884,2.09226182370948e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VEGFD,Vascular endothelial growth factor D,40020,0.0140221292345824,0.00329712516980839,0.00755976390175794,0.0204844945674068,2.12267694954706e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,39900,-0.0254049119839487,0.00597449279599387,-0.0371149178640967,-0.0136949061038007,2.12851239672288e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",37378,0.0405959522169458,0.00958332481078944,0.0218126355877985,0.0593792688460931,2.28938486616205e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RABEP1,Rab GTPase-binding effector protein 1,37120,-0.0306397413060717,0.00723818213668175,-0.0448265782939679,-0.0164529043181754,2.32073469111799e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SIGLEC7,Sialic acid-binding Ig-like lectin 7,39864,-0.0110227692702088,0.00260500396627174,-0.0161285770441014,-0.00591696149631614,2.33552062100818e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,37378,-0.04248277741451,0.0100396213872378,-0.0621604353334961,-0.0228051194955239,2.33656574295659e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KITLG,Kit ligand,39864,0.0145201927312075,0.00343870379032016,0.00778033330217998,0.021260052160235,2.42858593464559e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LACRT,Extracellular glycoprotein lacritin,37335,-0.0189013135968384,0.00447713468324041,-0.0276764975759896,-0.0101261296176872,2.44009831121857e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GP1BA,Platelet glycoprotein Ib alpha chain,39813,0.0127442168024349,0.00302442246816842,0.00681634876482485,0.0186720848400451,2.52525123690173e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CBLIF,Cobalamin binding intrinsic factor,39842,-0.0267945014231789,0.00636681219793581,-0.0392734533311331,-0.0143155495152247,2.58516358610101e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RAPGEF2,Rap guanine nucleotide exchange factor 2,37165,-0.0209914983288227,0.00498865605176936,-0.0307692641902906,-0.0112137324673547,2.59507038689017e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PNLIP,Pancreatic triacylglycerol lipase,37441,-0.0238983325346706,0.00568182592174232,-0.0350347113412856,-0.0127619537280557,2.61481157216494e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,39473,-0.0383425645716408,0.00913747490644365,-0.0562520153882703,-0.0204331137550112,2.72945410788047e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,COMMD9,COMM domain-containing protein 9,37364,-0.0152706876477657,0.00364207876430643,-0.0224091620258063,-0.00813221326972513,2.77228429125005e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ASGR2,Asialoglycoprotein receptor 2,37441,0.00984712593381136,0.00235029097433662,0.00524055562411158,0.0144536962435111,2.8103006325748e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SDC4,Syndecan-4,39864,0.0176253917148685,0.00421006528764717,0.00937366375108008,0.025877119678657,2.84817268613675e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD72,B-cell differentiation antigen CD72,37120,0.0161286849876319,0.00385585009884836,0.00857121879388915,0.0236861511813747,2.89649365257862e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SH2B3,SH2B adapter protein 3,39473,-0.0382289681301856,0.00915331103910782,-0.0561694577668369,-0.0202884784935343,2.97612824640912e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLEC4G,C-type lectin domain family 4 member G,39862,0.0128664490831885,0.0030809616075624,0.00682776433236623,0.0189051338340108,2.98100851640873e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HBEGF,Proheparin-binding EGF-like growth factor,39980,-0.0280688575926797,0.00672213550332079,-0.0412442431791884,-0.0148934720061709,2.9878128671597e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPINK1,Serine protease inhibitor Kazal-type 1,39854,-0.0155280207924234,0.0037232111335751,-0.0228255146142306,-0.00823052697061622,3.05401726749947e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EDN1,Endothelin-1,37039,-0.010860676089672,0.00260563229116871,-0.0159677153803627,-0.00575363679898136,3.09038001597883e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DNMBP,Dynamin-binding protein,39745,-0.0239791692450937,0.0057533423265901,-0.0352557202052103,-0.0127026182849771,3.09090519361041e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FBP1,"Fructose-1,6-bisphosphatase 1",39864,-0.0281032760597995,0.00674716164706941,-0.0413277128880556,-0.0148788392315435,3.12711103768227e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PALM2,Paralemmin-2,37384,-0.0145864068240456,0.00350845782836456,-0.0214629841676402,-0.00770982948045109,3.23734939294643e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AOC3,Membrane primary amine oxidase,39927,0.0115961186004069,0.0027896600199041,0.00612838496139489,0.017063852239419,3.24378477381001e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD300E,CMRF35-like molecule 2,39987,0.0148264469985294,0.00356933269171823,0.00783055492276165,0.0218223390742971,3.28621272225128e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CPQ,Carboxypeptidase Q,37426,-0.0145397110860144,0.00350055604577163,-0.0214008009357268,-0.00767862123630198,3.29370321798074e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EHBP1,EH domain-binding protein 1,37433,-0.0289403605495008,0.00697179081656272,-0.0426050705499638,-0.0152756505490379,3.32951247425397e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VPS53,Vacuolar protein sorting-associated protein 53 homolog,39784,-0.0295798509512605,0.00712786132890314,-0.0435504591559107,-0.0156092427466103,3.34361365205344e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,39485,-0.0248475657521857,0.00598999078030156,-0.0365879476815767,-0.0131071838227946,3.36899433147482e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,STAT5B,Signal transducer and activator of transcription 5B,39784,-0.0530032193460709,0.0127824480288069,-0.0780568174825325,-0.0279496212096093,3.39252497570076e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CMIP,C-Maf-inducing protein,37364,-0.0318921526210056,0.00769802267167596,-0.0469802770574905,-0.0168040281845207,3.45027259276137e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",39854,-0.017894489472907,0.00431991470586046,-0.0263615222963935,-0.00942745664942048,3.45569417471959e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLC4A1,Band 3 anion transport protein,37433,-0.0179144150595577,0.00432476510668561,-0.0263909546686614,-0.00943787545045387,3.45943122150953e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PPP1R9B,Neurabin-2,40054,-0.036260364465939,0.00879197362112499,-0.053492632763344,-0.019028096168534,3.73788433092075e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ATP6V1G1,V-type proton ATPase subunit G 1,37039,-0.0278211361674688,0.00674568147746299,-0.0410426718632963,-0.0145996004716414,3.74163999013056e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DNLZ,DNL-type zinc finger protein,36987,0.0343455364266528,0.00834538507946977,0.0179885816708921,0.0507024911824136,3.8868024276105e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,37039,0.00799471951243659,0.00194282410262029,0.00418678427130083,0.0118026547535724,3.8953579098049e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ATG16L1,Autophagy-related protein 16-1,37378,-0.0327792704474995,0.00797484323913433,-0.0484099631962028,-0.0171485776987962,3.9741952081021e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ERBB3,Receptor tyrosine-protein kinase erbB-3,39805,-0.00735988165101743,0.00179085235267224,-0.010869952262255,-0.00384981103977984,3.98139465466538e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NBN,Nibrin,39583,-0.0196353878654055,0.00478933831290238,-0.0290224909586941,-0.0102482847721168,4.15563288056558e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LRRC38,Leucine-rich repeat-containing protein 38,37035,-0.0184377213089194,0.0044988209579397,-0.0272554103864812,-0.00962003223135757,4.18607299932686e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,39909,-0.0359996803674595,0.00878953104530806,-0.0532271612162633,-0.0187721995186557,4.22876227191902e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GUK1,Guanylate kinase,37017,0.0157696900956816,0.00385101563839457,0.00822169944442824,0.0233176807469349,4.24797294442879e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TPP1,Tripeptidyl-peptidase 1,39763,-0.0176933738084462,0.0043213427873809,-0.0261632056717127,-0.00922354194517961,4.25326549696847e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MAPK9,Mitogen-activated protein kinase 9,39862,-0.0165033408272846,0.00403178519918012,-0.0244056398176776,-0.00860104183689156,4.27348272172626e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SYTL4,Synaptotagmin-like protein 4,37433,-0.0274517483709216,0.00671071547697478,-0.0406047507057922,-0.0142987460360511,4.32493963184201e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",37408,-0.0305025113422323,0.00745734956859244,-0.0451189164966735,-0.0158861061877911,4.33378151925263e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RAB27B,Ras-related protein Rab-27B,37433,-0.0310576939744775,0.00761735954359432,-0.0459877186799224,-0.0161276692690326,4.58361180799036e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD99L2,CD99 antigen-like protein 2,39854,-0.00910758596544285,0.00223569597497251,-0.013489550076389,-0.00472562185449673,4.6492382657696e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GOLGA3,Golgin subfamily A member 3,37408,-0.0293576124764646,0.00720832544090206,-0.0434859303406326,-0.0152292946122965,4.67282253816722e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,39784,0.0144458373277039,0.00354722728199694,0.00749327185498994,0.021398402800418,4.67500778655034e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,39581,0.0120221213775339,0.00296335125068236,0.00621395292619645,0.0178302898288713,4.99611602934544e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IFNGR1,Interferon gamma receptor 1,39927,0.00759628309320811,0.00187405593281401,0.00392313346489264,0.0112694327215236,5.07180573171942e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CFP,Properdin,37449,0.00870470995567431,0.00214786637160421,0.00449489186733005,0.0129145280440186,5.09064607494926e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IQGAP2,Ras GTPase-activating-like protein IQGAP2,39784,-0.0205717822445807,0.00508125475130923,-0.0305310415571468,-0.0106125229320146,5.17767200533991e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FRZB,Secreted frizzled-related protein 3,39691,0.0098979245155295,0.00244514194878858,0.00510544629590389,0.0146904027351551,5.19037109329825e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DDHD2,Phospholipase DDHD2,37408,-0.0250553067951587,0.0061922746565238,-0.0371921651219454,-0.0129184484683721,5.23401085836886e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL1RL2,Interleukin-1 receptor-like 2,39583,0.0149282295977238,0.00369333643127436,0.0076892901924261,0.0221671690030216,5.3264081479273e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MRC1,Macrophage mannose receptor 1,37441,0.0103239442363782,0.00255479363317099,0.00531654871536305,0.0153313397573933,5.35148731307387e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,39473,-0.0319955552260821,0.00792424228064675,-0.0475270700961497,-0.0164640403560145,5.42401900358036e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,37408,-0.0246388020323977,0.00610312865520255,-0.0366009341965947,-0.0126766698682008,5.44189974481237e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SELP,P-selectin,39927,-0.0214611451034166,0.00532587071086684,-0.0318998516967157,-0.0110224385101176,5.61284012972074e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KLK4,Kallikrein-4,40026,0.0225048803808439,0.00558539183646376,0.011557512381375,0.0334522483803129,5.62136530727711e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD207,C-type lectin domain family 4 member K,39492,-0.0140774326546284,0.00349468228685703,-0.0209270099368682,-0.00722785537238865,5.64606841895971e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RASSF2,Ras association domain-containing protein 2,39473,-0.020589111603668,0.00511747389582673,-0.0306193604394884,-0.0105588627678477,5.76596962407438e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GNLY,Granulysin,39854,0.0189939982523722,0.00472794931638715,0.00972721759225342,0.0282607789124911,5.91163613353101e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EIF4B,Eukaryotic translation initiation factor 4B,39745,-0.0216008701819606,0.00538436227126075,-0.0321542202336316,-0.0110475201302895,6.05389845958825e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,YTHDF3,YTH domain-containing family protein 3,39583,-0.0316351508894404,0.00792585000723156,-0.0471698169036142,-0.0161004848752665,6.59855737434689e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CRTAM,Cytotoxic and regulatory T-cell molecule,39745,0.0183013968704771,0.00458640177071047,0.00931204939988455,0.0272907443410696,6.62690201752258e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,COMT,Catechol O-methyltransferase,39399,-0.0315934388740158,0.00791740626598949,-0.0471115551553552,-0.0160753225926764,6.62709367541062e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PLA2G2A,"Phospholipase A2, membrane associated",39822,0.020186029642312,0.00506194400384098,0.0102646193947837,0.0301074398898403,6.69854708881288e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PDCD5,Programmed cell death protein 5,40005,-0.021442307640998,0.00537754819033157,-0.0319823020940479,-0.0109023131879482,6.71022253118634e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCT5,T-complex protein 1 subunit epsilon,39473,-0.0165829489196859,0.00415990405822249,-0.024736360873802,-0.00842953696556985,6.73948850183467e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SERPINI1,Neuroserpin,37084,0.0113986997803608,0.00286019483857096,0.00579271789676174,0.0170046816639599,6.77601044676278e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BTN3A2,Butyrophilin subfamily 3 member A2,39862,-0.0136001940888626,0.00341420882784699,-0.0202920433914427,-0.00690834478628251,6.82340381299137e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRTG,Protogenin,40026,-0.00919889159012127,0.00231096818686392,-0.0137283892363746,-0.00466939394386798,6.90605277408419e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CILP,Cartilage intermediate layer protein 1,37433,-0.0197806117220134,0.00498505787284891,-0.0295513251527972,-0.0100098982912295,7.28571170441422e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,39745,-0.0163516803380995,0.00412185930651172,-0.0244305245788624,-0.00827283609733649,7.30828206096634e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,36842,-0.0120997783247746,0.00305433091059809,-0.0180862669095469,-0.00611328974000237,7.48736966756176e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TAFA5,Chemokine-like protein TAFA-5,39784,0.0125125785876435,0.00316092451113502,0.00631716654581886,0.0187079906294681,7.5743614907157e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PALM,Paralemmin-1,37295,0.0104346838889771,0.00263683014364218,0.00526649680743841,0.0156028709705158,7.61969089539693e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,37052,-0.0133900055232889,0.00338508180906611,-0.0200247658690585,-0.0067552451775193,7.67443479783811e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MYOC,Myocilin,39854,0.0168392714898506,0.00426285752212203,0.00848407074649144,0.0251944722332098,7.84107913549492e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PDLIM7,PDZ and LIM domain protein 7,39927,-0.046136088192117,0.0117245269129243,-0.0691161609414485,-0.0231560154427854,8.35446199239728e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TREML2,Trem-like transcript 2 protein,39854,0.0120939621382685,0.00307474206798863,0.00606746768501082,0.0181204565915263,8.41322104782839e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CES2,Cocaine esterase,39784,-0.0197699504566022,0.0050281170989561,-0.0296250599705562,-0.00991484094264828,8.46411541257386e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LARP1,La-related protein 1,37364,-0.0233882827666131,0.00595038443235959,-0.0350510362540379,-0.0117255292791883,8.51744978554908e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,APOBR,Apolipoprotein B receptor,37039,0.0155086220284996,0.00394603142484951,0.00777440043579453,0.0232428436212046,8.53151941261494e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",37408,0.0157950314414585,0.00402023731912822,0.00791536629596719,0.0236746965869498,8.57658481904554e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCGN,Secretagogin,39583,-0.0156953798538714,0.00400563331626274,-0.0235464211537464,-0.00784433855399647,8.95431840668849e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,WASF1,Wiskott-Aldrich syndrome protein family member 1,39581,-0.0342432325279993,0.00874755544655918,-0.0513884412032553,-0.0170980238527433,9.09338844584122e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GRN,Progranulin,39783,0.00896313059493765,0.00228996809895761,0.00447479312098074,0.0134514680688946,9.11252179977329e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NINJ1,Ninjurin-1,39473,0.0205129223619016,0.00524212475348924,0.0102383578450627,0.0307874868787405,9.15077817653362e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DTYMK,Thymidylate kinase,37433,-0.0249342742629436,0.0063750603474115,-0.0374293925438702,-0.0124391559820171,9.22776705756823e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD226,CD226 antigen,37052,-0.0151927141852244,0.00389023771461543,-0.0228175801058706,-0.00756784826457816,9.45605045636062e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,37039,-0.027876238507082,0.007138482238152,-0.0418676636938599,-0.0138848133203041,9.46696946335765e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PDGFA,Platelet-derived growth factor subunit A,40048,-0.0260100811624928,0.00667172615812441,-0.0390866644324167,-0.012933497892569,9.71592644705114e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLIC5,Chloride intracellular channel protein 5,37035,0.0116413350509591,0.00298751968826417,0.00578579646196132,0.0174968736399569,9.80127014672636e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CSF2RB,Cytokine receptor common subunit beta,37052,0.0156592691253581,0.00402245551589111,0.0077752563142115,0.0235432819365046,9.95149314391382e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DLK1,Protein delta homolog 1,40048,-0.0201614334803462,0.00517980117971236,-0.0303138437925825,-0.01000902316811,9.96889560693715e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD163,Scavenger receptor cysteine-rich type 1 protein M130,39927,0.0153582739435488,0.00394648052927739,0.00762317210616508,0.0230933757809324,9.99715387925768e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CASP10,Caspase-10,39485,-0.0258396797824797,0.00664768208733568,-0.0388691366736576,-0.0128102228913018,0.000101901263382939
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BPIFB1,BPI fold-containing family B member 1,39782,0.0228501316261203,0.00588316386411563,0.0113191304524537,0.034381132799787,0.000103172819725644
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RAB33A,Ras-related protein Rab-33A,37017,-0.0242243743812402,0.00624453769176337,-0.0364636682570964,-0.011985080505384,0.000105271980894847
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ERBIN,Erbin,39784,-0.0369719677168673,0.00954232279850639,-0.0556749204019398,-0.0182690150317948,0.000107260749589618
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DPP7,Dipeptidyl peptidase 2,39750,-0.021619347300629,0.0055829180457909,-0.0325618666703791,-0.0106768279308788,0.000108196116965529
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,39784,-0.0100679256300321,0.00260189520217559,-0.0151676402262963,-0.00496821103376793,0.000109512007616851
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,OPLAH,5-oxoprolinase,37039,-0.024895548734309,0.00643701846729386,-0.037512104930205,-0.012278992538413,0.000110458733906165
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GLO1,Lactoylglutathione lyase,39581,-0.0207659010844381,0.0053740789684172,-0.0312990958625359,-0.0102327063063404,0.000111953874377579
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PF4,Platelet factor 4,37381,-0.0346016725459563,0.00895870878532581,-0.0521607417651949,-0.0170426033267178,0.000112824877996005
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLEC4A,C-type lectin domain family 4 member A,39862,0.0124247743865848,0.00322568271690304,0.00610243626145486,0.0187471125117148,0.00011769643249646
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GFRA2,GDNF family receptor alpha-2,39784,0.00743678521283266,0.00193373097186991,0.00364667250796763,0.0112268979176977,0.000120616791310541
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,37017,0.00925463504177611,0.00240922692340336,0.00453255027190553,0.0139767198116467,0.000122943930151358
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,COMMD1,COMM domain-containing protein 1,37039,-0.0220956745405652,0.005752905627064,-0.0333713695696106,-0.0108199795115198,0.00012321575363339
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DSC2,Desmocollin-2,39669,0.0118549184018019,0.00308679800486654,0.00580479431226354,0.0179050424913404,0.000123251572119805
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BRK1,Protein BRICK1,39485,0.0158861504269818,0.00414038561745044,0.00777099461677893,0.0240013062371847,0.000125099021155981
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SRPK2,SRSF protein kinase 2,39862,-0.0298554415431111,0.00780569848340521,-0.0451546105705853,-0.0145562725156369,0.000131360991182198
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ROBO1,Roundabout homolog 1,39881,0.00838178266156834,0.0021918407259242,0.0040857748387569,0.0126777904843798,0.000131756519468739
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AMPD3,AMP deaminase 3,37384,-0.0250730280213631,0.00656672303230771,-0.0379438051646862,-0.01220225087804,0.000135031693200872
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDC42BPB,Serine/threonine-protein kinase MRCK beta,37378,-0.0362437360593216,0.00949923307349362,-0.0548622328833691,-0.0176252392352741,0.000136546829055551
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRELP,Prolargin,39858,0.00785312268788135,0.00205904210708812,0.00381740015798864,0.0118888452177741,0.000137266312001675
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,COL5A1,Collagen alpha-1(V) chain,37120,-0.0139862807416959,0.00367417265486655,-0.0211876591452343,-0.00678490233815746,0.000141497113670047
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",37408,0.0322393816910312,0.0084702243484938,0.0156377419679834,0.0488410214140791,0.000141738612851752
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,40036,0.0126840768597593,0.00333775899608172,0.0061420692274391,0.0192260844920794,0.000145122279543627
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GIT1,ARF GTPase-activating protein GIT1,37052,-0.0344158568865116,0.00906308543414281,-0.0521795043374315,-0.0166522094355917,0.000146896946853349
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CRIP2,Cysteine-rich protein 2,39745,-0.0126264610422861,0.0033297615242783,-0.0191527936298715,-0.0061001284547006,0.000149991075539836
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CXCL13,C-X-C motif chemokine 13,40005,-0.0206762796098842,0.00545744491426763,-0.0313728716418488,-0.00997968757791966,0.000152025630535764
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DPY30,Protein dpy-30 homolog,39975,-0.0208324369689064,0.00549887930720925,-0.0316102404110366,-0.0100546335267763,0.000152118118273012
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EDA2R,Tumor necrosis factor receptor superfamily member 27,40026,0.0124873736599748,0.00329813066288191,0.0060230375607262,0.0189517097592233,0.000153523331905291
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,XG,Glycoprotein Xg,39981,0.0105505477051419,0.00279416038003357,0.00507399336027609,0.0160271020500077,0.000159985368002048
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,OPHN1,Oligophrenin-1,37384,-0.0377115094841263,0.0100191710895362,-0.0573490848196174,-0.0180739341486353,0.000167967579585835
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AKR1B10,Aldo-keto reductase family 1 member B10,37035,-0.0213386569908846,0.00567137915398724,-0.0324545601326995,-0.0102227538490696,0.00016894139519225
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EBI3_IL27,Interleukin-27,40007,0.0107412162731734,0.00285741050346334,0.00514069168638529,0.0163417408599616,0.000171144613391111
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",37022,-0.0278059980852869,0.00740801039282351,-0.042325698455221,-0.0132862977153528,0.000175129399715775
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLA2,Src-like-adapter 2,37408,-0.0366463836134401,0.0097812572088603,-0.0558176477428063,-0.0174751194840739,0.000179996589488747
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SERPINH1,Serpin H1,37165,-0.0447234939353222,0.011948673278291,-0.0681428935607726,-0.0213040943098718,0.00018262525670101
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NSFL1C,NSFL1 cofactor p47,40005,-0.0225418941788164,0.00602807939376682,-0.0343569297905993,-0.0107268585670334,0.000185037040978307
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ANK2,Ankyrin-2,37017,0.0246745923969393,0.00660291925114869,0.0117328706646879,0.0376163141291908,0.000187074926093037
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EFCAB14,EF-hand calcium-binding domain-containing protein 14,37378,-0.00897754637082725,0.00240443317839392,-0.0136902354004793,-0.00426485734117517,0.000189425852857903
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD40,Tumor necrosis factor receptor superfamily member 5,39855,-0.0174480253585922,0.00467840380222305,-0.0266176968109494,-0.00827835390623505,0.000192535894361579
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,39745,-0.0327184923263418,0.00877727279529696,-0.0499219470051238,-0.0155150376475597,0.000193953766081337
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LIPF,Gastric triacylglycerol lipase,37039,-0.020692349858836,0.0055554458790677,-0.0315810237818087,-0.00980367593586336,0.000196366061401425
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ZNRD2,Protein ZNRD2,37378,-0.0234450928029941,0.00630064601074644,-0.0357943589840571,-0.0110958266219311,0.000199190741611374
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MAVS,Mitochondrial antiviral-signaling protein,39473,-0.0319352040963206,0.0085996438359727,-0.0487905060148271,-0.0150799021778141,0.000205083769003693
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PPBP,Platelet basic protein,37367,-0.0292685010541394,0.00788525328529821,-0.0447235974933239,-0.0138134046149549,0.000206615424925278
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FABP1,"Fatty acid-binding protein, liver",39858,-0.0322596748264705,0.00869320486902545,-0.0492983563697604,-0.0152209932831806,0.00020721763946316
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",37039,0.0315331445529453,0.00849712485262907,0.0148787798417924,0.0481875092640983,0.000207261157487988
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EVPL,Envoplakin,37165,0.0113642030855863,0.00306260717288914,0.0053614930267236,0.017366913144449,0.000207585984221156
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NECTIN4,Nectin-4,39909,0.0101121089713134,0.00273108590202391,0.00475918060334657,0.0154650373392803,0.000214118840207123
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD69,Early activation antigen CD69,39781,-0.0301205182675786,0.00815338022632343,-0.0461011435111725,-0.0141398930239847,0.00022128631940823
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,37017,0.00692439543747354,0.00187490264380088,0.00324958625562381,0.0105992046193233,0.000222343617178913
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VSNL1,Visinin-like protein 1,37384,-0.0129232571790259,0.00350476254430513,-0.0197925917658639,-0.00605392259218782,0.000227495824920176
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ITM2A,Integral membrane protein 2A,39862,0.0202123597018595,0.00548687983440915,0.00945807522641756,0.0309666441773014,0.000230574015415012
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CRISP2,Cysteine-rich secretory protein 2,40026,0.0191418349645773,0.00520348516663758,0.00894300403796767,0.029340665891187,0.000235226449285437
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,REEP4,Receptor expression-enhancing protein 4,37408,-0.0212850763833192,0.00578879136992138,-0.0326311074683651,-0.00993904529827327,0.000236954912723698
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,WNT9A,Protein Wnt-9a,39583,0.0096104792764546,0.00261421664581563,0.00448661465065598,0.0147343439022532,0.000237487566195805
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,METAP2,Methionine aminopeptidase 2,40007,-0.0196422529669723,0.00536014701104077,-0.0301481411086122,-0.00913636482533237,0.00024861671770052
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FARSA,Phenylalanine--tRNA ligase alpha subunit,37035,-0.0234161282346969,0.00639445309382488,-0.0359492562985936,-0.0108830001708001,0.000251288560463745
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPARC,SPARC,39909,-0.0239708565269441,0.00654881292779377,-0.0368065298654199,-0.0111351831884683,0.000252692524963191
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,UROS,Uroporphyrinogen-III synthase,37035,-0.0233604280674562,0.0063874712135718,-0.0358798716460569,-0.0108409844888555,0.000255952439791962
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,37378,0.00723785595266094,0.00198232416878959,0.00335250058183334,0.0111232113234885,0.000262005861593394
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DCN,Decorin,39581,0.00736211612711767,0.0020185025371394,0.00340585115432444,0.0113183810999109,0.000265850378778538
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,37408,-0.0360998450436699,0.00990100184759172,-0.0555058086649497,-0.0166938814223901,0.000267268293057367
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PDGFB,Platelet-derived growth factor subunit B,39927,-0.0289098562131962,0.00795207696557815,-0.0444959270657294,-0.013323785360663,0.000278297558619983
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD74,HLA class II histocompatibility antigen gamma chain,40005,-0.0113992281841615,0.00314164597962512,-0.0175568543042268,-0.00524160206409628,0.000286034884566125
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AKT1S1,Proline-rich AKT1 substrate 1,39485,-0.0227154514692745,0.00626325298940876,-0.0349914273285157,-0.0104394756100334,0.000287889051829839
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MSMB,Beta-microseminoprotein,39776,0.022592308531689,0.00623100614227604,0.010379536492828,0.0348050805705501,0.000288980586433828
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CEP20,Centrosomal protein 20,39473,-0.0248721446079261,0.00686266199754282,-0.03832296212311,-0.0114213270927422,0.000290698609082058
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EREG,Proepiregulin,39709,-0.0268357095670091,0.00740544463540153,-0.0413503810523961,-0.0123210380816221,0.000291235596006011
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CRNN,Cornulin,39393,0.0217400843475813,0.0059993480203886,0.00998136222761966,0.033498806467543,0.000291298942828625
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LY75,Lymphocyte antigen 75,39862,0.0129966110388614,0.00358714877841618,0.00596579943316569,0.0200274226445571,0.00029199053014043
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RNF149,E3 ubiquitin-protein ligase RNF149,37039,-0.00988765778274665,0.00273330926388395,-0.0152449439399592,-0.00453037162553412,0.000298611561184541
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD5L,CD5 antigen-like,37376,0.0156897987237326,0.00433809749876644,0.00718712762615033,0.0241924698213148,0.000299415760566092
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLEC1A,C-type lectin domain family 1 member A,39581,0.0107110670414325,0.0029755231134735,0.00487904173902442,0.0165430923438406,0.000319532809890585
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MIA,Melanoma-derived growth regulatory protein,39909,0.0120643914547824,0.00335794645059792,0.00548281641161051,0.0186459664979544,0.000328136666043817
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,37052,-0.0109000359357586,0.00303642506840608,-0.0168514290698345,-0.00494864280168268,0.000332183976713314
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPTLC1,Serine palmitoyltransferase 1,37384,-0.0118992504196538,0.00331661798951285,-0.018399821679099,-0.00539867916020862,0.000334700849191809
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLEC4D,C-type lectin domain family 4 member D,39862,-0.0201650755543807,0.00562474058249164,-0.0311895670960643,-0.00914058401269706,0.000337993659721624
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DENR,Density-regulated protein,37052,-0.0192169927162652,0.00536511962995596,-0.0297326271909789,-0.00870135824155152,0.000342412215077896
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,39784,-0.0100143787042678,0.00279668820095845,-0.0154958875781464,-0.00453286983038926,0.000343564714007559
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AKR1C4,Aldo-keto reductase family 1 member C4,39581,-0.0175588564399364,0.00490382064862019,-0.027170344911232,-0.00794736796864084,0.000343776324052883
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VWF,von Willebrand factor,40048,0.0242760782828842,0.00678735615129404,0.0109728602263479,0.0375792963394205,0.000349024539740117
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PROS1,Vitamin K-dependent protein S,37449,-0.00812808053658991,0.00227306769693209,-0.0125832932225768,-0.003672867850603,0.000350343935047542
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KEL,Kell blood group glycoprotein,39485,-0.0117972314263779,0.00330036013523932,-0.018265937291447,-0.00532852556130883,0.00035191716700753
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",37384,-0.012729829094986,0.00356531582297574,-0.0197178481080185,-0.00574181008195357,0.000357586392718918
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,40054,-0.0330148028707717,0.00924860758168265,-0.0511420737308697,-0.0148875320106737,0.000358417273489752
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VIT,Vitrin,37433,-0.0121909533247121,0.00341648285405585,-0.0188872597186616,-0.00549464693076264,0.000360576999348297
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CSF2,Granulocyte-macrophage colony-stimulating factor,37017,-0.0116401957562935,0.00326300934954942,-0.0180356940814104,-0.00524469743117664,0.000361933667596793
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TSC22D1,TSC22 domain family protein 1,37408,-0.0224179062214081,0.0062914686687391,-0.0347491848121367,-0.0100866276306795,0.000367587835536571
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LGALS1,Galectin-1,39864,0.0110661624811184,0.00311091107273269,0.00496877677856231,0.0171635481836745,0.000375898365266155
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,39883,0.00779929719623058,0.00219518018358361,0.00349674403640669,0.0121018503560545,0.000382076600014364
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",39759,-0.0344640507673994,0.00970067675916931,-0.0534773772153712,-0.0154507243194275,0.000382334640515495
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,37039,0.011504858199486,0.00323828496785369,0.00515781966249279,0.0178518967364792,0.000382539906610005
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LAT,Linker for activation of T-cells family member 1,40054,-0.0250188011126445,0.00704245143933085,-0.0388220059337329,-0.011215596291556,0.000382571817493271
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HLA_DRA,,39795,0.0116911968160393,0.00329241353176387,0.00523806629378211,0.0181443273382965,0.000384949636770912
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD160,CD160 antigen,40054,0.0147754680842957,0.00416436364958357,0.00661331533111195,0.0229376208374795,0.000389157652843665
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LMNB1,Lamin-B1,37344,0.0190688936702873,0.00537615850825909,0.00853162299409946,0.0296061643464751,0.000391060912051525
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD59,CD59 glycoprotein,39169,0.00696037765167889,0.00196389025584434,0.00311115275022399,0.0108096025531338,0.000395012118531903
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,39581,-0.0158723386616812,0.00448071043816295,-0.0246545311204805,-0.00709014620288178,0.000397695859186121
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LPP,Lipoma-preferred partner,37017,-0.0220869482467551,0.00624298118088771,-0.034323191361295,-0.0098507051322152,0.000404735506115969
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DYNLT1,Dynein light chain Tctex-type 1,37035,-0.0262857472450493,0.00744543746850113,-0.0408788046833115,-0.0116926898067871,0.00041626890840248
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ING1,Inhibitor of growth protein 1,39449,-0.0147791352596257,0.00418639812736916,-0.0229844755892692,-0.00657379492998211,0.000416325576339388
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL2RA,Interleukin-2 receptor subunit alpha,39728,0.0128489545004851,0.00364463128679281,0.00570547717837118,0.019992431822599,0.000423960321867424
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADAMTSL4,ADAMTS-like protein 4,37039,-0.00789786841772395,0.00224600833392023,-0.0123000447522076,-0.0034956920832403,0.000438908535320673
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SERPINE2,Glia-derived nexin,37433,-0.0210869631846505,0.00599802252942006,-0.0328430873423139,-0.00933083902698721,0.000440105414501734
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CARHSP1,Calcium-regulated heat-stable protein 1,39485,-0.0165235429212656,0.00470364008427636,-0.0257426774864473,-0.00730440835608394,0.000444451565589929
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DOK2,Docking protein 2,39864,-0.0399836559280779,0.0113851721091083,-0.0622985932619303,-0.0176687185942256,0.000446130649686968
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCL5,C-C motif chemokine 5,39927,-0.0329102004321708,0.00937424199093386,-0.0512837147344012,-0.0145366861299405,0.00044814438694004
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EGF,Pro-epidermal growth factor,39804,-0.0337619177462883,0.00962634513823092,-0.0526295542172209,-0.0148942812753557,0.000454023679406066
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLITRK6,SLIT and NTRK-like protein 6,39581,0.0108218135626994,0.00308592833687093,0.00477339402243233,0.0168702331029664,0.000454750521152297
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PGA4,Pepsin A-4,37441,-0.020234686396878,0.00577211589049328,-0.0315480335422449,-0.00892133925151121,0.000457061333799061
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,WASHC3,WASH complex subunit 3,37384,-0.0245614109019249,0.00703437814582235,-0.0383487920677367,-0.0107740297361131,0.000481623461699007
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SUSD4,Sushi domain-containing protein 4,37364,0.013525894356448,0.00387411537729829,0.00593262821694337,0.0211191604959526,0.000482120652811414
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GTPBP2,GTP-binding protein 2,37035,-0.0263323195890337,0.00754409196187811,-0.0411187398343148,-0.0115458993437527,0.000483774676237953
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,APP,Amyloid-beta precursor protein,39825,-0.0215608010614042,0.00617800104279582,-0.033669683105284,-0.00945191901752437,0.000484447451258106
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DPP6,Dipeptidyl aminopeptidase-like protein 6,39784,0.0107150281750638,0.00307377154897253,0.00469043593907762,0.0167396204110499,0.000491704727230196
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MMP12,Macrophage metalloelastase,39896,0.0162514754988735,0.00466226770854295,0.00711343079012937,0.0253895202076177,0.000492080993308842
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,STAMBP,STAM-binding protein,39709,-0.0208178772936035,0.0059733814873176,-0.032525705008746,-0.00911004957846098,0.000493268976500339
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SFRP1,Secreted frizzled-related protein 1,39685,0.0137290571866024,0.00394437166100059,0.00599808873104128,0.0214600256421636,0.000501508477945981
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD63,CD63 antigen,39716,-0.0165802645038235,0.00477588608242453,-0.0259410012253756,-0.00721952778227141,0.000518623830158955
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FGL1,Fibrinogen-like protein 1,37441,0.0199382687532395,0.00574767695670776,0.00867282191809227,0.0312037155883867,0.000524162746087015
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ZHX2,Zinc fingers and homeoboxes protein 2,37384,-0.0100190106485494,0.002889955135257,-0.0156833227136531,-0.00435469858344566,0.000528252361747971
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",37039,0.0225289209857069,0.00651136322475315,0.00976664906519072,0.0352911929062231,0.000542007224005853
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFSF8,Tumor necrosis factor ligand superfamily member 8,37433,0.0114235073586928,0.00330198601327951,0.00495161477266495,0.0178953999447206,0.00054266654862442
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ANKRD54,Ankyrin repeat domain-containing protein 54,39473,-0.0181152730970604,0.00524800456019787,-0.0284013620350483,-0.0078291841590726,0.000558251563947813
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VWC2L,von Willebrand factor C domain-containing protein 2-like,37408,0.0152311340993697,0.0044174144576767,0.00657300176232334,0.023889266436416,0.000566522978679711
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,USP8,Ubiquitin carboxyl-terminal hydrolase 8,39581,-0.0309781673165017,0.00901199450582593,-0.0486416765479205,-0.0133146580850829,0.000588766665222213
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TFF1,Trefoil factor 1,39785,-0.0239833479973962,0.00698021148149541,-0.0376645625011272,-0.0103021334936652,0.000592083448987816
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MENT,Protein MENT,37120,0.00708496121031095,0.00206464209708633,0.00303826270002173,0.0111316597206002,0.000601931610430381
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNF,Tumor necrosis factor,39551,0.0120988521190795,0.00352933105878964,0.00518136324385179,0.0190163409943072,0.000609412522058864
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HDGFL2,Hepatoma-derived growth factor-related protein 2,37384,-0.0199235222957752,0.00581308991622781,-0.0313171785315817,-0.00852986605996869,0.000611306408801078
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL6R,Interleukin-6 receptor subunit alpha,39801,0.0107096206333743,0.0031256156064727,0.00458341404468779,0.0168358272220608,0.000613173756720425
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TOP1,DNA topoisomerase 1,37378,-0.0361472521897682,0.0105547737254361,-0.0568346086916229,-0.0154598956879134,0.000617237988943759
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,COL18A1,Collagen alpha-1(XVIII) chain,39889,-0.00717909363681227,0.00209686209443569,-0.0112889433419062,-0.00306924393171833,0.000619220437494349
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ITGAM,Integrin alpha-M,39854,0.0100107352393228,0.00292678420398315,0.00427423819951587,0.0157472322791298,0.000626882650546712
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CENPF,Centromere protein F,37165,-0.0171671666303568,0.0050208840258314,-0.0270080993209863,-0.00732623393972724,0.000630049843986248
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRSS22,Brain-specific serine protease 4,37052,-0.0106650722054654,0.00312191250373483,-0.0167840207127857,-0.00454612369814519,0.000636934599089237
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,COL1A1,Collagen alpha-1(I) chain,40048,0.0078475256030832,0.00229973242326289,0.00334005005348793,0.0123550011526785,0.000645594642841653
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TIMP1,Metalloproteinase inhibitor 1,39694,-0.00874370465765582,0.00256282213600869,-0.0137668360442329,-0.00372057327107878,0.000647089731601199
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DOK1,Docking protein 1,37384,-0.0433654307582737,0.0127351094480998,-0.0683262452765494,-0.018404616239998,0.000663108740269414
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FABP6,Gastrotropin,39560,0.0171091463029359,0.00502488272077611,0.00726037617021475,0.0269579164356571,0.000663576159159266
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HTRA2,"Serine protease HTRA2, mitochondrial",39909,-0.019442353806999,0.00571237474745293,-0.0306386083120067,-0.00824609930199125,0.000666787800781467
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KRT19,"Keratin, type I cytoskeletal 19",39838,-0.0206358645815601,0.00607039531760924,-0.0325338394040742,-0.00873788975904594,0.000676922830892746
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GIGYF2,GRB10-interacting GYF protein 2,37408,-0.0241424722518057,0.00711170988244202,-0.0380814236213921,-0.0102035208822194,0.000688884699239296
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DPP10,Inactive dipeptidyl peptidase 10,39862,0.0109162359281535,0.00321617174675826,0.00461253930450734,0.0172199325517997,0.000690037862173844
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MTIF3,"Translation initiation factor IF-3, mitochondrial",37378,0.0275700511931627,0.00812473847596262,0.011645563780276,0.0434945386060494,0.000692424455895776
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,37378,-0.0443315382116794,0.0130713902065319,-0.069951463016482,-0.0187116134068768,0.00069711839123602
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SIL1,Nucleotide exchange factor SIL1,37039,-0.0104999804135037,0.0030966517582018,-0.0165694178595792,-0.00443054296742816,0.000699055592081727
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AKAP12,A-kinase anchor protein 12,37120,0.00663812222219678,0.00195862456234679,0.00279921807999708,0.0104770263643965,0.000703073204835203
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BGN,Biglycan,39444,0.0375302520348166,0.0110795339688375,0.015814365455895,0.0592461386137381,0.000707459781687587
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,39581,-0.0171700065839888,0.00506976740531777,-0.0271067506984117,-0.007233262469566,0.000709004942972151
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,WDR46,WD repeat-containing protein 46,37364,-0.0113019508680486,0.00334819587239993,-0.0178644147779524,-0.00473948695814469,0.000738799921890377
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SUGP1,SURP and G-patch domain-containing protein 1,37378,-0.0125668713210804,0.0037235587306777,-0.0198650464332087,-0.00526869620895211,0.000740333709207342
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NTRK2,BDNF/NT-3 growth factors receptor,39864,0.00799867308890122,0.00237105047025377,0.00335141416720382,0.0126459320105986,0.000744025376685502
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CPXM2,Inactive carboxypeptidase-like protein X2,37433,-0.00751431345902222,0.00222914807536641,-0.0118834436867404,-0.00314518323130405,0.000751224219608856
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NPTX2,Neuronal pentraxin-2,37433,0.0105296829497135,0.00312630335296078,0.00440212837791038,0.0166572375215166,0.000759002581351164
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BCL2L15,Bcl-2-like protein 15,37052,-0.0176728466108506,0.00524746816890652,-0.0279578842219074,-0.00738780899979382,0.00075964992286463
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PLSCR3,Phospholipid scramblase 3,37369,-0.0185713202161431,0.00552137258100745,-0.0293932104749177,-0.00774942995736849,0.000771654302835806
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLC16A1,Monocarboxylate transporter 1,39485,-0.0181273765321627,0.00539585783074386,-0.0287032578804207,-0.00755149518390477,0.000782708277184437
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,40054,-0.0113187157095922,0.00336969702436408,-0.0179233218773458,-0.00471410954183863,0.000784136196019223
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,COCH,Cochlin,37433,-0.0142216731166426,0.00424673650035178,-0.0225452766573321,-0.00589806957595307,0.000813692777546074
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,POLR2A,DNA-directed RNA polymerase II subunit RPB1,37052,0.00925067150513527,0.00276294589711309,0.00383529754679362,0.0146660454634769,0.000815897251985551
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PSMG3,Proteasome assembly chaperone 3,39862,-0.015435742411413,0.00461221086836958,-0.0244756757134173,-0.00639580910940861,0.000819643619491198
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,JAM3,Junctional adhesion molecule C,37120,-0.0157180632320243,0.00470149095109272,-0.024932985496166,-0.00650314096788256,0.000830449995373248
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FLT3,Receptor-type tyrosine-protein kinase FLT3,39473,0.00945941526389014,0.00283014069576636,0.00391233950018807,0.0150064910275922,0.000832573375222471
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PCBP2,Poly(rC)-binding protein 2,37408,-0.0224705705673312,0.0067320406978397,-0.035665370335097,-0.00927577079956542,0.000846554291864453
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AARSD1,Alanyl-tRNA editing protein Aarsd1,39784,-0.0169006210256688,0.00506971037074486,-0.0268372533523287,-0.00696398869900884,0.000859110738774022
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LGALS9,Galectin-9,39855,0.00973889971526732,0.00292402770774309,0.00400780540809086,0.0154699940224438,0.000868409369162012
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LGALS3BP,Galectin-3-binding protein,37449,-0.00930676679835842,0.00279631737398835,-0.0147875488513756,-0.00382598474534126,0.000876341853629165
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SMTN,Smoothelin,37338,-0.0297333834275669,0.00893817735778999,-0.0472522110488353,-0.0122145558062986,0.000881601609410479
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VEGFC,Vascular endothelial growth factor C,39909,-0.0171623696846739,0.00516006513543009,-0.0272760973501168,-0.00704864201923089,0.000883000226919815
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,THBD,Thrombomodulin,39864,0.00839294081325096,0.00252363663450845,0.0034466130096144,0.0133392686168875,0.0008838481717783
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SNCG,Gamma-synuclein,39745,-0.0200254944718979,0.00602769969620566,-0.031839785876461,-0.00821120306733481,0.000894978579500316
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PAGR1,PAXIP1-associated glutamate-rich protein 1,37039,-0.0134133028029049,0.00403769385019432,-0.0213271827492857,-0.005499422856524,0.000896111707693998
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PSAPL1,Proactivator polypeptide-like 1,37378,0.0153224294507038,0.00461265845134669,0.00628161888606428,0.0243632400153433,0.000896689282070609
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VPS28,Vacuolar protein sorting-associated protein 28 homolog,37165,-0.0207434892679072,0.00624673730893814,-0.0329870943934259,-0.0084998841423884,0.000900362546474876
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,37364,-0.0110273069058919,0.0033270819956077,-0.017548387617283,-0.00450622619450081,0.000920791853224553
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GM2A,Ganglioside GM2 activator,37174,0.0110999131669753,0.0033511115960983,0.00453173443862263,0.017668091895328,0.000927761561214892
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL13RA2,Interleukin-13 receptor subunit alpha-2,36987,0.00884093682331595,0.00267617530519705,0.00359563322512974,0.0140862404215022,0.000957169848635659
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LCN2,Neutrophil gelatinase-associated lipocalin,39368,0.0111854575580699,0.0033894906921806,0.00454205580139591,0.0178288593147439,0.000968888151466841
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDNF,Cerebral dopamine neurotrophic factor,39784,0.0096654534658689,0.00293214628200666,0.00391844675313585,0.015412460178602,0.000981554628357431
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LY9,T-lymphocyte surface antigen Ly-9,39695,0.00867395348575058,0.0026348351145263,0.00350967666127902,0.0138382303102221,0.00099685113717468
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,37120,-0.0178219541370558,0.00542013566955409,-0.0284454200493818,-0.00719848822472974,0.00101128158262356
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FGF2,Fibroblast growth factor 2,39862,-0.020331571352648,0.00618912531559281,-0.0324622569712099,-0.00820088573408611,0.0010218428956867
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD83,CD83 antigen,39862,0.00999801699249323,0.00304616091661492,0.00402754159592799,0.0159684923890585,0.00103232281711373
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EVI5,Ecotropic viral integration site 5 protein homolog,37052,-0.02774043846587,0.0084572568202674,-0.0443166618335941,-0.0111642150981459,0.00104048501276158
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FLT3LG,Fms-related tyrosine kinase 3 ligand,40054,-0.0101423761533564,0.00309334761530704,-0.0162053374793582,-0.00407941482735464,0.00104480342464943
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MGLL,Monoglyceride lipase,39904,-0.0266016873040573,0.00811371945816514,-0.042504577442061,-0.0106987971660536,0.00104543276210544
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ENO1,Alpha-enolase,39826,0.024019593291121,0.00733020552385165,0.00965239046437177,0.0383867961178702,0.00105216006485605
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FMNL1,Formin-like protein 1,39485,-0.0185712330356396,0.00566958065741717,-0.0296836111241773,-0.00745885494710197,0.00105670395920024
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MSTN,Growth/differentiation factor 8,39581,-0.0157727253829019,0.00481734777590388,-0.0252147270236735,-0.00633072374213028,0.00106208878043075
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CRLF1,Cytokine receptor-like factor 1,39927,-0.00792453875734597,0.0024223378094736,-0.0126723208639142,-0.00317675665077771,0.00107225912208921
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,37433,-0.0194367475120869,0.00594299019608807,-0.0310850082964196,-0.00778848672775433,0.00107612503033575
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TFF2,Trefoil factor 2,39904,-0.0173098796128958,0.00529513271894772,-0.0276883397420333,-0.00693141948375822,0.00108148960088675
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SEPTIN9,Septin-9,39784,0.00859872121871422,0.00263137416362443,0.00344122785801035,0.0137562145794181,0.00108628644426883
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CBS,Cystathionine beta-synthase,37039,-0.015456980439966,0.00473171736594342,-0.0247311464772151,-0.00618281440271687,0.00109096905620473
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CSF1R,Macrophage colony-stimulating factor 1 receptor,37441,0.0119638369979214,0.00366316148397267,0.00478404048933501,0.0191436335065079,0.00109353729589087
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FAM13A,Protein FAM13A,37378,-0.0204989383837955,0.00628659526875952,-0.0328206651105642,-0.00817721165702687,0.00111397860296538
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ACVRL1,Serine/threonine-protein kinase receptor R3,39716,0.00702480104469516,0.00215445689049366,0.00280206553932759,0.0112475365500627,0.00111415177895648
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRRT3,Proline-rich transmembrane protein 3,37039,0.0109681346963971,0.00336427426202944,0.00437415714281936,0.0175621122499747,0.00111624655006011
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RALY,RNA-binding protein Raly,37364,-0.0147300622105625,0.00451892342137379,-0.0235871521164551,-0.00587297230466987,0.00111829923068557
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IFT20,Intraflagellar transport protein 20 homolog,37035,-0.013225850558682,0.00406129754180646,-0.0211859937406226,-0.00526570737674129,0.00113057020125671
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LRRN1,Leucine-rich repeat neuronal protein 1,39583,0.0118356460435259,0.00363461736990813,0.00471179599850591,0.0189594960885458,0.00113086974794035
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BMP10,Bone morphogenetic protein 10,37120,0.00854023168256481,0.00262619402180871,0.00339289139981974,0.0136875719653099,0.00114905642656106
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KCTD5,BTB/POZ domain-containing protein KCTD5,37161,-0.013193827731043,0.00405741869535329,-0.0211463683739355,-0.00524128708815057,0.00114970895763949
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HSPB6,Heat shock protein beta-6,40026,-0.0113022099479408,0.0034804070800906,-0.0181238078249183,-0.00448061207096318,0.00116709552174015
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EFNA1,Ephrin-A1,39822,0.00793385678977811,0.00244450151087645,0.00314263382846026,0.012725079751096,0.00117447811851413
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AAMDC,Mth938 domain-containing protein,37039,-0.0160875176898977,0.00496105779470307,-0.0258111909675158,-0.00636384441227971,0.00118672568918913
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FNDC1,Fibronectin type III domain-containing protein 1,37384,-0.0138326477667492,0.00427250231779525,-0.0222067523096279,-0.00545854322387055,0.00120830773848558
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ATRN,"Attractin, Isoform 2",37449,-0.00489034708423994,0.00151170057506785,-0.00785328021137293,-0.00192741395710695,0.00121934847743087
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SNU13,NHP2-like protein 1,37017,-0.0186020207395595,0.00575540551210568,-0.0298826155432866,-0.00732142593583233,0.00123188477457203
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,STIP1,Stress-induced-phosphoprotein 1,39822,-0.0194074861255827,0.00600863941002158,-0.031184419369225,-0.00763055288194039,0.0012407103978525
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,39808,0.0175622330955086,0.00544368041032469,0.00689261949127225,0.028231846699745,0.00125712306768509
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPINK2,Serine protease inhibitor Kazal-type 2,37120,0.0109150851601654,0.00338767414714633,0.00427524383175862,0.0175549264885722,0.00127606650116734
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,QDPR,Dihydropteridine reductase,39786,-0.0129975015114168,0.00403630946795921,-0.0209086680686168,-0.00508633495421671,0.0012838281808416
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FABP3,"Fatty acid-binding protein, heart",37433,-0.0146723390773865,0.00455719493575803,-0.0236044411514723,-0.00574023700330079,0.00128672134863891
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NCK2,Cytoplasmic protein NCK2,39927,-0.0316842675837469,0.00986145815286226,-0.0510127255633569,-0.0123558096041369,0.00131643091008885
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ATXN2L,Ataxin-2-like protein,37408,-0.0143290137451654,0.00445991775857281,-0.0230704525519681,-0.00558757493836267,0.00131735662017414
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LAMB1,Laminin subunit beta-1,37039,-0.00905921870458828,0.00282226057404477,-0.014590849429716,-0.00352758797946052,0.00133092016497317
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GCC1,GRIP and coiled-coil domain-containing protein 1,37384,-0.0323128187723507,0.0100696073921569,-0.0520492492609783,-0.0125763882837232,0.00133533580124656
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RSPO1,R-spondin-1,39745,0.0104855679476681,0.00327308604495956,0.00407031929954741,0.0169008165957889,0.00136001767688939
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SEZ6,Seizure protein 6 homolog,37035,0.00927446540485975,0.00289748002675967,0.00359540455241079,0.0149535262573087,0.00137336931328062
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SEL1L,Protein sel-1 homolog 1,37039,-0.00930192737062271,0.00290678063238655,-0.0149992174101004,-0.00360463733114506,0.00137715465766611
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PKLR,Pyruvate kinase PKLR,39877,-0.0189573286980028,0.00593903007623538,-0.0305978276474241,-0.00731682974858142,0.00141568732282697
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",37039,0.0230314314928659,0.00722258754636566,0.00887515990198924,0.0371877030837426,0.00143195732968179
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCT,Secretin,37035,-0.0131276865848075,0.00411734869520645,-0.0211976900274122,-0.00505768314220291,0.00143405164826833
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,40048,0.00797377486600685,0.00250275654327257,0.00306837204119261,0.0128791776908211,0.001445298013869
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CA2,Carbonic anhydrase 2,39817,-0.0200686310269432,0.00629912046341465,-0.0324149071352359,-0.0077223549186505,0.00144561345710507
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PDGFRB,Platelet-derived growth factor receptor beta,40048,0.0102972434856528,0.00323929985575279,0.00394821576837729,0.0166462712029282,0.00148139594162729
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TGM2,Protein-glutamine gamma-glutamyltransferase 2,39831,-0.021434324650723,0.00675437837450232,-0.0346729062647476,-0.00819574303669848,0.00150951869363518
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IMPACT,Protein IMPACT,37384,-0.0162930207678266,0.00513825405941431,-0.0263639987242787,-0.00622204281137457,0.00152293287969189
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ERI1,3'-5' exoribonuclease 1,37165,-0.00986491397654453,0.0031156046786336,-0.0159714991466664,-0.00375832880642267,0.00154744172550507
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NMI,N-myc-interactor,37307,0.0211853635682939,0.00669357142467226,0.00806596357593632,0.0343047635606516,0.00155411955821148
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AP3B1,AP-3 complex subunit beta-1,37378,-0.0224903931026699,0.00711910651127335,-0.0364438418647657,-0.00853694434057413,0.00158573384153535
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,39678,0.00934142564571792,0.00295866341433156,0.00354244535362805,0.0151404059378078,0.00159529548359044
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SIGLEC1,Sialoadhesin,39927,0.0122369740717242,0.00387833505476849,0.00463543736437797,0.0198385107790704,0.00160676678438482
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MATN3,Matrilin-3,39716,0.0091707730631466,0.00290700940629473,0.00347303462680894,0.0148685114994843,0.00160957555298595
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RBPMS2,RNA-binding protein with multiple splicing 2,37039,-0.0301022286408193,0.00956329430646677,-0.0488462854814941,-0.0113581718001444,0.00164936368459654
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HGFAC,Hepatocyte growth factor activator,37314,0.00826682405143785,0.00262777718544308,0.00311638076796943,0.0134172673349063,0.00165915903059426
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,37017,0.0106941240610793,0.00340999090374315,0.00401054188974276,0.0173777062324159,0.0017157914735058
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CRKL,Crk-like protein,39877,-0.0311733985188653,0.00994501455435265,-0.0506656270453965,-0.0116811699923341,0.00172413839547464
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,37408,-0.0172229065394873,0.0055063953150208,-0.0280154413569281,-0.00643037172204653,0.00176492759674169
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ALPP,"Alkaline phosphatase, placental type",39784,-0.030674614424419,0.0098086964449445,-0.0498996594565102,-0.0114495693923278,0.00176745063976638
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GLYR1,Putative oxidoreductase GLYR1,37364,-0.0172778959826964,0.00553831337321487,-0.0281329901941975,-0.00642280177119524,0.00181414271094812
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KIRREL1,Kin of IRRE-like protein 1,36987,0.0174287369980259,0.00559810621811842,0.00645644881051382,0.028401025185538,0.00185388403774297
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CRELD2,Protein disulfide isomerase CRELD2,39904,-0.0150123105306676,0.00483438695443373,-0.0244877089613577,-0.00553691209997752,0.00190405456591173
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ASS1,Argininosuccinate synthase,37017,-0.0230823966007713,0.0074335904707723,-0.037652233923485,-0.00851255927805755,0.00190587990451381
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,39862,-0.0291755256120888,0.00941997383029642,-0.0476386743194698,-0.0107123769047078,0.00195697200257361
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCARF2,Scavenger receptor class F member 2,40005,0.00808371790686525,0.00261112155724451,0.002965919654666,0.0132015161590645,0.00196565974946947
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NCR1,Natural cytotoxicity triggering receptor 1,39831,0.0101921683349084,0.00329380901433437,0.00373630266681304,0.0166480340030038,0.00197591363767906
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NTF4,Neurotrophin-4,39473,0.0114310388351773,0.00369446587862259,0.00418988571307699,0.0186721919572776,0.00197761129878025
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TLR1,Toll-like receptor 1,37052,0.00747850129978903,0.00242086386760922,0.00273360811927496,0.0122233944803031,0.00201122267227281
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,C1GALT1C1,C1GALT1-specific chaperone 1,37017,0.00939121779414002,0.00304131350129677,0.00343024333159836,0.0153521922566817,0.00202007903219186
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CFC1,Cryptic protein,39473,-0.0133860493109483,0.00433687577066455,-0.0218863258214509,-0.00488577280044583,0.00202838138173603
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TFF3,Trefoil factor 3,39835,-0.013877234234934,0.00449818120811798,-0.0226936694028452,-0.00506079906702278,0.00203847244111517
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BIRC2,Baculoviral IAP repeat-containing protein 2,39473,-0.0182748871346823,0.00592440014924535,-0.0298867114272032,-0.00666306284216145,0.00204126260150154
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,OTUD7B,OTU domain-containing protein 7B,37408,-0.0183484815952482,0.00595488891088791,-0.0300200638605885,-0.00667689932990791,0.0020654914032294
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KLK6,Kallikrein-6,39885,0.00845832879882752,0.00274546461153514,0.00307721816021865,0.0138394394374364,0.00206769382495537
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FOXO3,Forkhead box protein O3,39473,-0.027951954172313,0.00907397459121962,-0.0457369443711034,-0.0101669639735225,0.00207045083596085
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SFTPA2,Pulmonary surfactant-associated protein A2,39473,0.0141032835808893,0.00457838985912682,0.00512963945700069,0.0230769277047778,0.00207080320128251
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EPHB6,Ephrin type-B receptor 6,39709,0.00863378982051241,0.00280520068566985,0.00313559647659951,0.0141319831644253,0.00208904962427714
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GMPR,GMP reductase 1,40054,-0.0141534177566844,0.00460701530191396,-0.0231831677484358,-0.00512366776493306,0.00212879298365877
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,37165,0.0102296390934538,0.00333053044543502,0.00370179942040115,0.0167574787665064,0.00213434285894194
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRG3,Proteoglycan 3,37433,0.014230935818358,0.00463328665813716,0.00514969396840915,0.0233121776683068,0.00213439002519696
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,C1RL,Complement C1r subcomponent-like protein,37428,0.0054673769752028,0.00178450672413119,0.00196974379590568,0.00896501015449993,0.00218971357074804
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FABP4,"Fatty acid-binding protein, adipocyte",40048,-0.0138137823206818,0.00450941290400426,-0.0226522316125301,-0.00497533302883345,0.00219254152059277
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CSF3,Granulocyte colony-stimulating factor,39583,0.0136509875923616,0.00445833310638323,0.00491265470385049,0.0223893204808728,0.0022030533869471
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,36987,0.0160426862896493,0.00524277613195064,0.00576684507102609,0.0263185275082726,0.00221813033190998
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SOD3,Extracellular superoxide dismutase,37441,0.0172866164527701,0.00565225000179781,0.00620820644924643,0.0283650264562938,0.00222985059565271
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTX3,Pentraxin-related protein PTX3,39862,0.0141088363252207,0.00461491051997069,0.00506361170607814,0.0231540609443633,0.00223762347217519
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DDX1,ATP-dependent RNA helicase DDX1,37378,-0.0141667011382404,0.00463666183965869,-0.0232545583439714,-0.00507884393250937,0.00225223651393804
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL20,Interleukin-20,39583,0.013852336679903,0.00453892557462606,0.00495604255363594,0.0227486308061701,0.00227778888638778
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,37039,-0.0102147282650677,0.00334986715895649,-0.0167804678966224,-0.00364898863351302,0.00229835349587129
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PPCDC,Phosphopantothenoylcysteine decarboxylase,40005,-0.0133529977383657,0.0043815171295995,-0.0219407713123808,-0.00476522416435073,0.00231069532646399
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MTPN,Myotrophin,39581,0.00917623853792527,0.00301400199912038,0.00326879461964933,0.0150836824562012,0.00233424658290734
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EGFL7,Epidermal growth factor-like protein 7,39473,-0.0111469531840413,0.00366285175241599,-0.0183261426187767,-0.00396776374930601,0.00234431243238676
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,REG1B,Lithostathine-1-beta,40048,-0.0153362745720534,0.00504760795230417,-0.0252295861585695,-0.00544296298553718,0.00238276254391049
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL2RB,Interleukin-2 receptor subunit beta,39583,0.0102521409653959,0.00337456192367898,0.00363799959498506,0.0168662823358067,0.00238492638690213
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RYR1,Ryanodine receptor 1,37017,0.0095553907846463,0.00314683052464878,0.00338760295633469,0.0157231786129579,0.00239800435907199
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TSPAN1,Tetraspanin-1,39581,-0.0113595084742477,0.00375023419190458,-0.0187099674903806,-0.00400904945811469,0.0024575225935331
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MITD1,MIT domain-containing protein 1,39745,-0.0272841503723361,0.00901842598763088,-0.0449602653080926,-0.00960803543657957,0.00248719427649927
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PARP1,Poly [ADP-ribose] polymerase 1,39862,-0.0153742896138253,0.00508249844052774,-0.0253359865572597,-0.00541259267039097,0.00249071075927065
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",37039,0.00911029842390798,0.00301237581822683,0.0032060418201834,0.0150145550276326,0.00249697116755613
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GET3,ATPase GET3,37433,-0.0157292902234165,0.00520310863367276,-0.0259273831454151,-0.00553119730141784,0.00250702766991663
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,37378,-0.00829784029335645,0.0027474573630369,-0.0136828567249088,-0.00291282386180411,0.00253088848300808
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TYRO3,Tyrosine-protein kinase receptor TYRO3,39864,0.00788606984343175,0.00261378337314486,0.00276305443206782,0.0130090852547957,0.00255598912691928
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL16,Pro-interleukin-16,40054,-0.0115368182028316,0.00382387865072088,-0.0190316203582445,-0.00404201604741868,0.00255647373283675
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,XIAP,E3 ubiquitin-protein ligase XIAP,37052,-0.0164084443475789,0.00543849730148575,-0.027067899058491,-0.00574898963666685,0.0025569930020185
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,39473,-0.0126778313701837,0.00421063327525114,-0.0209306725896759,-0.00442499015069142,0.00260883798332709
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MFAP4,Microfibril-associated glycoprotein 4,37120,-0.00890693388188377,0.00295856808804922,-0.0147057273344602,-0.00310814042930731,0.00261260889140512
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GLRX,Glutaredoxin-1,39767,-0.0156329936445007,0.0052089592204242,-0.0258425537165322,-0.00542343357246931,0.00269357799825236
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RILP,Rab-interacting lysosomal protein,39980,-0.0165336004885611,0.00550991081467364,-0.0273330256853215,-0.00573417529180078,0.00269769977971545
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PDGFRA,Platelet-derived growth factor receptor alpha,39864,0.00781485585246223,0.0026045185969758,0.00270999940238967,0.0129197123025348,0.0026995262411083
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GALNT7,N-acetylgalactosaminyltransferase 7,39784,-0.00577081367478222,0.00192377455347796,-0.00954141179959903,-0.00200021554996542,0.00270632542425877
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DAND5,DAN domain family member 5,37052,0.0149244740141307,0.00498193847869183,0.00515987459589475,0.0246890734323667,0.00274309741657283
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TBC1D5,TBC1 domain family member 5,39862,-0.021668999526016,0.00723525225407688,-0.0358500939440067,-0.00748790510802537,0.00274937080806447
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TP53I3,Quinone oxidoreductase PIG3,36870,-0.0149041306822826,0.00497663606382725,-0.024658337367384,-0.00514992399718119,0.0027512329827253
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PKN3,Serine/threonine-protein kinase N3,37165,-0.0211724420500041,0.00707429442600587,-0.0350380591249756,-0.00730682497503255,0.0027687492790345
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MMP9,Matrix metalloproteinase-9,39839,-0.0168122866010908,0.00562240927353351,-0.0278322087772165,-0.00579236442496517,0.00279193789523638
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,37384,-0.0171514859194796,0.00574297726130849,-0.0284077213516443,-0.00589525048731501,0.00282682913260799
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,37052,-0.0132590459054147,0.00444992769315056,-0.0219809041839898,-0.00453718762683955,0.00289141977211842
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD82,CD82 antigen,37165,0.0116701372925281,0.00392189554409926,0.00398322202609356,0.0193570525589626,0.0029290626600709
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FXN,"Frataxin, mitochondrial",40026,0.0202760068570235,0.0068154994947851,0.00691762784724468,0.0336343858668023,0.00293436175650737
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DRAXIN,Draxin,39745,0.0115902856344809,0.00390136314061333,0.00394361387887881,0.0192369573900831,0.00297440818958476
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTPRC,Receptor-type tyrosine-protein phosphatase C,37433,0.00614176078566717,0.00206819121982689,0.00208810599480647,0.0101954155765279,0.00298680960306734
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KLHL41,Kelch-like protein 41,37408,-0.0140868346251783,0.00474365029907013,-0.0233843892113557,-0.00478928003900082,0.00298691598138631
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DGKA,Diacylglycerol kinase alpha,37052,-0.0150882522748,0.00508494037084267,-0.0250547354016516,-0.00512176914794834,0.00301022755365154
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FOXJ3,Forkhead box protein J3,37052,-0.0123562708996253,0.00416482206313697,-0.0205193221433738,-0.00419321965587686,0.00301438154802954
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,OBP2B,Odorant-binding protein 2b,39697,0.0173372406612044,0.00584409462913722,0.00588281518809548,0.0287916661343134,0.00301536960981408
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,OGFR,Opioid growth factor receptor,39784,-0.00900629677070092,0.00303626788879558,-0.0149573818327403,-0.00305521170866159,0.00301913427556592
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,37364,-0.029745287811407,0.0100287948896081,-0.0494017257950388,-0.0100888498277753,0.00302239998363372
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RRM2,Ribonucleoside-diphosphate reductase subunit M2,39473,-0.0139978892164545,0.00472306795531182,-0.0232551024088657,-0.00474067602404334,0.00304395436722077
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AP2B1,AP-2 complex subunit beta,37035,-0.013559349537056,0.00457614655303977,-0.0225285967810139,-0.004590102293098,0.00305151807762431
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,UROD,Uroporphyrinogen decarboxylase,37120,-0.0190964810822125,0.00644516552952388,-0.0317290055200793,-0.00646395664434569,0.0030528122878955
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AMY2A,Pancreatic alpha-amylase,39242,0.0129496320377016,0.00437302567146624,0.00437850172162781,0.0215207623537755,0.00306858851638622
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DUSP13,Dual specificity protein phosphatase 13 isoform A,37364,0.0115323725132128,0.00390227766617532,0.00388390828750922,0.0191808367389165,0.00312912078572292
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",37433,-0.00820770623818529,0.00278108913502594,-0.0136586409428361,-0.00275677153353444,0.0031702550985025
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TLR4,Toll-like receptor 4,37052,0.00754598073970338,0.00255800698043415,0.00253228705805244,0.0125596744213543,0.00318388375046205
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RAB11FIP3,Rab11 family-interacting protein 3,37433,-0.0295059426386036,0.0100033552890695,-0.0491125190051798,-0.00989936627202741,0.00318723763881884
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,S100A16,Protein S100-A16,39452,-0.0170475570340257,0.00578027611094851,-0.0283768982114848,-0.00571821585656662,0.00319005219401625
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,YJU2,Splicing factor YJU2,37364,-0.00889106379896095,0.00301492111136851,-0.0148003091772432,-0.00298181842067866,0.0031932927080132
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL3,Interleukin-3,36958,0.0162991781807666,0.00552873167941704,0.0054628640891092,0.027135492272424,0.00320312089683697
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PDLIM5,PDZ and LIM domain protein 5,37408,-0.0327462883448594,0.011114954643999,-0.0545315994470974,-0.0109609772426214,0.00322307305868577
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DAG1,Dystroglycan,39927,-0.0132730896643425,0.0045065375711257,-0.0221059033037489,-0.00444027602493612,0.00323107801366176
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TPSG1,Tryptase gamma,37052,0.00735081317470408,0.00249603520753966,0.00245858416792634,0.0122430421814818,0.00323522817619228
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ATP6AP2,Renin receptor,39473,-0.0111026399064589,0.00378569289112234,-0.0185225979730586,-0.00368268183985908,0.00336419706528877
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,C1QL2,Complement C1q-like protein 2,37052,0.0114168474847401,0.0038944053117107,0.00378381307378715,0.0190498818956931,0.0033779727013801
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLC12A2,Solute carrier family 12 member 2,37017,0.00758419173941487,0.00258984895557516,0.00250808778648756,0.0126602956923422,0.00341262537850033
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,39581,-0.00996004648461734,0.00340258384538724,-0.0166291108215763,-0.00329098214765835,0.00342517906680347
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LTBP3,Latent-transforming growth factor beta-binding protein 3,39473,0.0149507091890327,0.00510932036934963,0.00493644126510739,0.024964977112958,0.00343664447421437
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SEMA4D,Semaphorin-4D,40005,0.00812994357873657,0.00277890150458559,0.00268329662974882,0.0135765905277243,0.00344275579160337
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLEC3B,Tetranectin,37134,0.00574563103051268,0.00196396483470233,0.00189625995449611,0.00959500210652926,0.0034445629710683
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,COL4A1,Collagen alpha-1(IV) chain,39864,0.0105961675585884,0.00362612403997995,0.00348896444022772,0.0177033706769491,0.00348082783122404
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SERPINI2,Serpin I2,37378,-0.0155221307339216,0.00531170340009302,-0.0259330693981039,-0.00511119206973932,0.00348086844916759
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,OLFM4,Olfactomedin-4,36650,-0.033397170723561,0.0114313141679568,-0.0558025464927563,-0.0109917949543657,0.00348902042049302
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LPO,Lactoperoxidase,39340,-0.0162228209911348,0.00555599082765333,-0.0271125630133353,-0.00533307896893424,0.0035067220015007
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AMY2B,Alpha-amylase 2B,38828,0.0130480558209859,0.00447266675745103,0.00428162897638188,0.0218144826655899,0.00353614730248974
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,JUN,Transcription factor AP-1,39583,0.0140532542077001,0.00482553939088931,0.00459519700155704,0.0235113114138431,0.00359321509806608
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AIF1L,Allograft inflammatory factor 1-like,37039,0.0158307044523234,0.0054403811071678,0.00516755748227456,0.0264938514223723,0.00362204651923848
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ANXA2,Annexin A2,36875,-0.0188017464690268,0.00646639457986958,-0.0314758798455712,-0.00612761309248243,0.00364818650885673
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NXPE4,NXPE family member 4,37017,0.00944298799062223,0.00324923777402022,0.00307448195354259,0.0158114940277019,0.00366438549732822
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DYNLT3,Dynein light chain Tctex-type 3,37364,-0.0117471449246472,0.00406174571484653,-0.0197081665257464,-0.00378612332354803,0.00383236004588476
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NUDT5,ADP-sugar pyrophosphatase,39854,-0.0138079931718846,0.00478951529189085,-0.0231954431439907,-0.00442054319977857,0.00394479229359934
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RAB10,Ras-related protein Rab-10,37433,-0.0143304886788809,0.0049740729872639,-0.0240796717339181,-0.00458130562384363,0.00396989914205277
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCN4B,Sodium channel subunit beta-4,37039,-0.0110728530378371,0.00384586826651844,-0.0186107548402133,-0.003534951235461,0.00399383359187156
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPINK6,Serine protease inhibitor Kazal-type 6,40026,-0.0144418264175982,0.00501902460286379,-0.0242791146392112,-0.00460453819598512,0.00401470340157612
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",37408,-0.0206753820341715,0.0071917163018296,-0.0347711459857575,-0.00657961808258551,0.00404799671957629
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CNTN2,Contactin-2,40026,0.0118234595255534,0.00411427072484716,0.00375948890485295,0.0198874301462538,0.00406135356876763
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL17D,Interleukin-17D,39583,0.00904800845235769,0.00314972979767577,0.00287453804891318,0.0152214788558022,0.00407615135580153
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CANT1,Soluble calcium-activated nucleotidase 1,39812,-0.00529720433081212,0.00184945035911529,-0.0089221270346781,-0.00167228162694615,0.00418603273806322
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,39745,-0.0103118923419213,0.00360131040444029,-0.0173704607346243,-0.00325332394921837,0.00419706405789689
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",39784,0.00903512492047608,0.00315642926878046,0.00284852355366637,0.0152217262872858,0.00420926157012079
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MYL4,Myosin light chain 4,37039,-0.0137766637306819,0.00481679381858138,-0.0232175796151014,-0.00433574784626244,0.00424130756497538
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RAP1A,Ras-related protein Rap-1A,37052,0.0180215261683975,0.00630932451715,0.00565525011478345,0.0303878022220115,0.00429236102794002
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MEGF10,Multiple epidermal growth factor-like domains protein 10,39858,0.0106282106469448,0.00372380604361524,0.00332955080145896,0.0179268704924307,0.0043210881111699
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ARSB,Arylsulfatase B,39784,-0.0146451598727631,0.00513333013634336,-0.024706486939996,-0.00458383280553006,0.00433705683136302
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",37017,0.0132860689103833,0.00466240787955773,0.00414774946645018,0.0224243883543165,0.0043840114963562
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HAVCR1,Hepatitis A virus cellular receptor 1,39999,-0.0158636785508291,0.00556845073358155,-0.026777841988649,-0.00494951511300927,0.00439331146558419
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DNAJA2,DnaJ homolog subfamily A member 2,40005,-0.0217376306584844,0.00764252690262245,-0.0367169833876244,-0.00675827792934435,0.00445652245702487
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MANSC4,MANSC domain-containing protein 4,37017,0.0164536115127352,0.00579194976184154,0.0051013899795258,0.0278058330459447,0.00450735193559644
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TTF2,Transcription termination factor 2,37035,-0.0130314191207379,0.00458821738454908,-0.0220243251944541,-0.00403851304702172,0.00451554554274923
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KLF4,Krueppel-like factor 4,36987,-0.0103963479198466,0.0036670094982267,-0.0175836865363709,-0.00320900930332221,0.00458809837630477
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PACS2,Phosphofurin acidic cluster sorting protein 2,37017,-0.0164734737460254,0.00581182893729556,-0.0278646584631247,-0.00508228902892613,0.00459712239432081
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NUDT16,U8 snoRNA-decapping enzyme,37362,0.0232054872074139,0.00819322153530188,0.00714677299822224,0.0392642014166056,0.00462859549558261
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,39583,-0.0109978285286246,0.00388965231257185,-0.0186215470612655,-0.00337410999598382,0.00469784444595499
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RTKN2,Rhotekin-2,37017,0.0136584049186131,0.00483201516907837,0.00418765518721952,0.0231291546500067,0.00471089796879821
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DSG4,Desmoglein-4,39721,0.0128854282252084,0.00456338930345503,0.00394118519043648,0.0218296712599802,0.00475389190417959
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ICA1,Islet cell autoantigen 1,39583,-0.0210408883741753,0.0074593150819232,-0.0356611459347448,-0.00642063081360584,0.0047971027208234
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HPSE,Heparanase,37302,-0.0246272387340875,0.00873310047782291,-0.0417441156706204,-0.00751036179755463,0.00480957375756621
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SMPD1,Sphingomyelin phosphodiesterase,39908,-0.0128220841895902,0.00454993381903658,-0.0217399544749019,-0.00390421390427854,0.00483706325879804
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CPVL,Probable serine carboxypeptidase CPVL,39986,0.0105226577501098,0.00373484517265128,0.00320236121171334,0.0178429542885064,0.00484688193456568
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KLK13,Kallikrein-13,39486,-0.0110503943372549,0.00392405747153061,-0.0187415469814549,-0.0033592416930549,0.00486769865459688
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DKKL1,Dickkopf-like protein 1,39784,-0.0220062756939109,0.00781930698578847,-0.0373321173860563,-0.00668043400176551,0.00489357561634439
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PAMR1,Inactive serine protease PAMR1,39854,0.00723554163696688,0.00257182938233796,0.00219475604758448,0.0122763272263493,0.00490829827900751
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MCEMP1,Mast cell-expressed membrane protein 1,37052,-0.0235194872846558,0.00836991339608864,-0.0399245175409895,-0.00711445702832201,0.00496138838857601
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,37165,-0.0277659992893631,0.00988773898202395,-0.0471459676941301,-0.00838603088459616,0.00499035772228198
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PSMC3,26S proteasome regulatory subunit 6A,36958,0.00779520988830005,0.00277990128919177,0.00234660336148418,0.0132438164151159,0.00505265200069519
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PADI4,Protein-arginine deiminase type-4,39452,-0.0183338873983914,0.0065407670353851,-0.0311537907877462,-0.00551398400903662,0.00506893558612728
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,COL2A1,Collagen alpha-1(II) chain,37039,-0.0208890209820678,0.00746720742056083,-0.035524747526367,-0.0062532944377686,0.00515849703852983
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NXPH1,Neurexophilin-1,39485,0.00974594490784303,0.00349287898832615,0.00289990209072378,0.0165919877249623,0.00527340111268591
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,40030,0.00688288412334343,0.00246839915241762,0.0020448217846049,0.011720946462082,0.00530309814988276
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MICALL2,MICAL-like protein 2,37035,-0.0176544582026072,0.00634417293919287,-0.0300890371634252,-0.00521987924178917,0.00539715156732137
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RANBP2,E3 SUMO-protein ligase RanBP2,36987,0.00872752847329746,0.0031386478871272,0.00257577861452815,0.0148792783320668,0.00543249668285761
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCRIB,Protein scribble homolog,37039,-0.0232832265783535,0.00837680528460514,-0.0397017649361795,-0.00686468822052741,0.00545218757849735
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MYH4,Myosin-4,37017,0.0123405763426756,0.00444288571658022,0.0036325203381784,0.0210486323471728,0.00548388780540704
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MAMDC2,MAM domain-containing protein 2,37433,0.00852691421099295,0.00307077226108551,0.00250820057926535,0.0145456278427206,0.00549725547784309
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RABEPK,Rab9 effector protein with kelch motifs,39473,-0.0154791168034437,0.00558472185977429,-0.0264251716486013,-0.00453306195828611,0.00558321704007847
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EHD3,EH domain-containing protein 3,37039,-0.0302319164668574,0.0109135571906308,-0.0516224885604938,-0.00884134437322105,0.00561132417659906
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PSME2,Proteasome activator complex subunit 2,39662,-0.00928505624644117,0.00335560948412198,-0.0158620508353202,-0.0027080616575621,0.00566361453212766
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRDX1,Peroxiredoxin-1,39430,0.0232467010625995,0.00840707501840038,0.00676883402653473,0.0397245680986642,0.00569661451350508
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DFFA,DNA fragmentation factor subunit alpha,40054,-0.0173950342826164,0.00629483559760853,-0.0297329120539291,-0.00505715651130366,0.00572704000075064
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SEMA7A,Semaphorin-7A,39998,0.00691034051106993,0.00250191686153174,0.00200658346246773,0.0118140975596721,0.00575102104126984
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,OTOA,Otoancorin,36987,0.0135821191376112,0.00492463199635727,0.00392984042475092,0.0232343978504714,0.00582372245986735
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",39581,-0.0227193423474168,0.00823849464592487,-0.0388667918534296,-0.00657189284140411,0.0058275813514063
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TGFBR2,TGF-beta receptor type-2,39909,-0.0076080668319712,0.00276767792451176,-0.0130327155640143,-0.00218341809992815,0.00598626798831873
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PSG1,Pregnancy-specific beta-1-glycoprotein 1,39745,0.0281629229250245,0.0102564886605813,0.00806020515028514,0.0482656406997639,0.00604196804516342
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NADK,NAD kinase,39864,-0.0135771608291532,0.00495527040743613,-0.023289490827728,-0.00386483083057835,0.0061517845057187
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NPL,N-acetylneuraminate lyase,37433,-0.0111927108046371,0.0040875788385132,-0.019204365328123,-0.00318105628115124,0.00618523194689331
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRR4,Proline-rich protein 4,37027,0.0177455573874745,0.00648312189780172,0.00503863846778309,0.0304524763071658,0.00620490475921166
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DDT,D-dopachrome decarboxylase,37433,-0.0101919391841718,0.00372469281052353,-0.0174923370927979,-0.00289154127554565,0.00622119943855914
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,37408,0.00933863288618348,0.00341367242264308,0.00264783493780306,0.0160294308345639,0.00623371403153139
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TBC1D17,TBC1 domain family member 17,39485,-0.011183167402321,0.00409105838990522,-0.0192016418465353,-0.00316469295810679,0.00627235821579526
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BMP6,Bone morphogenetic protein 6,39564,-0.0106076843607876,0.00388434666913923,-0.0182210038323005,-0.00299436488927476,0.00632359679328152
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SMS,Spermine synthase,36987,-0.016268814290478,0.00596330870141537,-0.0279568993452522,-0.00458072923570392,0.00637749224722064
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,F3,Tissue factor,39927,0.00686230185707571,0.00252151764547552,0.0019201272719437,0.0118044764422077,0.0065057052314626
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ALDH2,"Aldehyde dehydrogenase, mitochondrial",37364,-0.0128642956554384,0.00473405036826217,-0.0221430343772323,-0.00358555693364456,0.00658814596535727
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CPXM1,Probable carboxypeptidase X1,39909,-0.0171189237577982,0.00630604323450989,-0.0294787684974376,-0.00475907901815884,0.006640965478381
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD79B,B-cell antigen receptor complex-associated protein beta chain,40054,0.0105387427403784,0.00388711972676699,0.00291998807591506,0.0181574974048417,0.00671117101140302
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SERPINB9,Serpin B9,39745,-0.0084097840013554,0.00310234509346371,-0.0144903803845443,-0.00232918761816653,0.00671966761343989
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SEC31A,Protein transport protein Sec31A,37039,-0.0193726072544598,0.00715165738755455,-0.0333898557340667,-0.00535535877485289,0.00676086189969304
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PODXL,Podocalyxin,39784,0.003780465513328,0.00139717129935939,0.00104200976658358,0.00651892126007241,0.00682127021120297
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KCNC4,Potassium voltage-gated channel subfamily C member 4,36987,0.0141011149077113,0.00521246607873507,0.00388468139339059,0.0243175484220321,0.00683374986610605
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LXN,Latexin,39678,0.0167695102947785,0.00619972577324455,0.00461804777921921,0.0289209728103379,0.00684023442759486
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RRAS,Ras-related protein R-Ras,37035,-0.0331926644237664,0.0122837804441593,-0.0572688740943188,-0.00911645475321411,0.00689801061565918
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GORASP2,Golgi reassembly-stacking protein 2,37378,-0.0118870791151096,0.00439976136846125,-0.0205106113972937,-0.00326354683292559,0.00690605246208378
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IRAK4,Interleukin-1 receptor-associated kinase 4,39862,-0.0262870327479189,0.00973022256010008,-0.0453582689657151,-0.00721579653012274,0.00690823426423455
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLEC10A,C-type lectin domain family 10 member A,39745,0.00902617248136957,0.00334263637821508,0.00247460518006802,0.0155777397826711,0.0069347166708903
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FSTL1,Follistatin-related protein 1,37039,-0.00574325640312079,0.00212761188561112,-0.00991337569891859,-0.001573137107323,0.00695551142725038
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RNF43,E3 ubiquitin-protein ligase RNF43,37165,-0.0147847187617959,0.00548350371217435,-0.0255323860376576,-0.00403705148593415,0.00702200915627126
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NPR1,Atrial natriuretic peptide receptor 1,37017,0.0104066835122857,0.00386042714473007,0.00284024630861476,0.0179731207159566,0.00703230960053907
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,OSCAR,Osteoclast-associated immunoglobulin-like receptor,39881,0.00828806478055913,0.00307479124001266,0.00226147395013432,0.0143146556109839,0.00703588446966441
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CSF3R,Granulocyte colony-stimulating factor receptor,37052,0.00781749313691942,0.00290644899643279,0.00212085310391115,0.0135141331699277,0.00716049712081723
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RTBDN,Retbindin,39784,0.00732080417338202,0.00272355711337783,0.00198263223116147,0.0126589761156026,0.00719654166837642
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GRPEL1,"GrpE protein homolog 1, mitochondrial",39784,-0.0153066134521278,0.00569832997122857,-0.0264753401957358,-0.0041378867085198,0.0072353913887195
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TREM2,Triggering receptor expressed on myeloid cells 2,39858,-0.0128686351705662,0.00479503841320293,-0.0222669104604439,-0.00347035988068844,0.00728786763531186
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RARRES1,Retinoic acid receptor responder protein 1,39473,-0.00844645412439682,0.00314756689440424,-0.0146156852374291,-0.00227722301136451,0.00729356586044571
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SNX18,Sorting nexin-18,37378,-0.0112464055128382,0.00419467067609239,-0.0194679600379793,-0.00302485098769717,0.00734657724976797
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MARS1,"Methionine--tRNA ligase, cytoplasmic",37084,-0.0214918605080124,0.008026207637039,-0.0372232274766089,-0.00576049353941598,0.00742188053196162
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SMOC2,SPARC-related modular calcium-binding protein 2,39927,-0.00942856772899279,0.00352402667499399,-0.016335660011981,-0.00252147544600456,0.00746913224678531
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLC39A14,Zinc transporter ZIP14,39485,0.0081190457243886,0.00303792791524631,0.00216470701050584,0.0140733844382714,0.00753529679322004
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,39745,-0.0194976672895149,0.00729755061053669,-0.0338008664861668,-0.00519446809286297,0.00755203478759963
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SRPX,Sushi repeat-containing protein SRPX,37433,0.00846236999428936,0.00317022774230787,0.00224872361936594,0.0146760163692128,0.00760941690313852
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FAM3D,Protein FAM3D,37378,-0.020662646269162,0.00774190208192051,-0.0358367743497262,-0.00548851818859783,0.0076182656065099
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTN,Pleiotrophin,39581,0.0124819449194789,0.00467995659276336,0.00330922999766276,0.0216546598412951,0.00765856695771763
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BLVRB,Flavin reductase,39854,-0.0159399530200346,0.0059832731704905,-0.0276671684341959,-0.00421273760587318,0.00772752722889654
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",37052,0.0087521357272478,0.00328642628987159,0.00231074019909948,0.0151935312553961,0.00775146216518562
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TFRC,Transferrin receptor protein 1,39914,0.00967040723932943,0.00363157565884063,0.00255251894800179,0.0167882955306571,0.00775550238987959
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VWC2,Brorin,39680,0.00951537777338107,0.00357392176942149,0.00251049110531495,0.0165202644414472,0.00776532143840385
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PALLD,Palladin,37052,0.0100622992353679,0.00377978091120475,0.00265392864940658,0.0174706698213292,0.00777401285707917
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PAEP,Glycodelin,39745,-0.0357591872231873,0.0134376937502789,-0.0620970669737339,-0.00942130747264075,0.00779617142486396
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,STC2,Stanniocalcin-2,39827,-0.00652780028587987,0.00245594492587607,-0.011341452340597,-0.00171414823116278,0.00786938234283368
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DBNL,Drebrin-like protein,39927,-0.0229515095162139,0.00863994864294574,-0.0398858088563875,-0.00601721017604022,0.00790483957822465
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,INSL3,Insulin-like 3,37384,0.0176741526534163,0.00672655614162599,0.00449010261582935,0.0308582026910032,0.00861071673121582
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GPC1,Glypican-1,40026,0.00707123992945139,0.0026923533284216,0.00179422740574506,0.0123482524531577,0.00863706300970879
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LRRC59,Leucine-rich repeat-containing protein 59,37433,-0.0113521624242572,0.00433952987321356,-0.0198576409757557,-0.0028466838727586,0.00890679195792691
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PAPPA,Pappalysin-1,39583,0.0115003186466583,0.00441067585138252,0.00285539397794857,0.0201452433153681,0.00913235757868783
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CTSL,Cathepsin L1,39864,0.00577927650741212,0.0022171105403803,0.00143373984826674,0.0101248131665575,0.00915120644900814
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RPL14,60S ribosomal protein L14,37039,-0.00978568929011709,0.00375586848913196,-0.0171471915288157,-0.00242418705141844,0.00918595171639459
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MOCS2,Molybdopterin synthase catalytic subunit,37120,-0.0164599588063513,0.00632395428555174,-0.0288549092060328,-0.00406500840666993,0.00925700464007281
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PNMA2,Paraneoplastic antigen Ma2,36987,-0.0104954475656191,0.00403636414652959,-0.0184067212928171,-0.00258417383842111,0.00932675249923214
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDCP1,CUB domain-containing protein 1,39745,-0.012014844475366,0.00462966630029639,-0.0210889904239469,-0.00294069852678505,0.00946267032316431
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SNRPB2,U2 small nuclear ribonucleoprotein B'',37384,-0.00973648309582971,0.00375476073518184,-0.0170958141367861,-0.00237715205487332,0.00952165749318163
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GNAS,Neuroendocrine secretory protein 55,37408,-0.0216811415463622,0.00838883751409243,-0.0381232630739834,-0.00523902001874103,0.00976174606630343
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ATP6V1G2,V-type proton ATPase subunit G 2,37017,-0.0236616955903947,0.00916640736462051,-0.0416278540250509,-0.00569553715573853,0.00985222524000606
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SIGLEC10,Sialic acid-binding Ig-like lectin 10,39862,0.00785651586881688,0.00304586844047807,0.00188661372547986,0.0138264180121539,0.00990602352061186
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD3E,T-cell surface glycoprotein CD3 epsilon chain,37165,0.0082118668621878,0.00318923355079657,0.00196096910262652,0.0144627646217491,0.0100384351136039
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFSF14,Tumor necrosis factor ligand superfamily member 14,39745,-0.013710295051857,0.00533388501026472,-0.0241647096719759,-0.00325588043173815,0.0101667173800905
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,XCL1,Lymphotactin,40026,-0.0130739005716248,0.00509239482528698,-0.0230549944291873,-0.00309280671406231,0.0102571658300089
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NUCB2,Nucleobindin-2,39991,-0.0089337018276952,0.00347983836060456,-0.0157541850144801,-0.00211321864091026,0.0102590606073233
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SEPTIN8,Septin-8,37353,-0.00759279258001043,0.0029579734575948,-0.0133904205568962,-0.00179516460312462,0.010272197749573
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CRYM,Ketimine reductase mu-crystallin,36987,-0.0183004655804215,0.00713108077906113,-0.0322773839073814,-0.00432354725346172,0.0102900911395579
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DLG4,Disks large homolog 4,37384,-0.0170712776462017,0.00665449314699941,-0.0301140842143206,-0.00402847107808289,0.0103170848982223
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SUSD1,Sushi domain-containing protein 1,39581,-0.0115934192101194,0.0045192824401574,-0.0204512127928279,-0.00273562562741092,0.0103171697553655
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PLG,Plasminogen,37158,-0.00537967551123275,0.00209988646558266,-0.00949545298377476,-0.00126389803869074,0.010421386899414
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDHR1,Cadherin-related family member 1,39485,-0.0101522796304634,0.00397297295886511,-0.017939306629839,-0.00236525263108777,0.0106179284252739
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNN,Tenascin-N,37433,0.0101738641787829,0.00398560105605727,0.00236208610891064,0.0179856422486551,0.0107013828084358
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HSPA1A,Heat shock 70 kDa protein 1A,39900,-0.0169353451506805,0.00663465221198517,-0.0299392634861714,-0.00393142681518958,0.0107026416390803
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PCDH12,Protocadherin-12,37408,-0.00598981550742291,0.00234861276042445,-0.0105930965178548,-0.00138653449699099,0.0107719798284672
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ACOT13,Acyl-coenzyme A thioesterase 13,37378,0.0269986310450465,0.0105958016366806,0.00623085983715255,0.0477664022529405,0.0108436643294493
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TG,Thyroglobulin,37364,0.0256931751741336,0.0100865836882001,0.0059234711452614,0.0454628792030058,0.0108681668451981
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCL14,C-C motif chemokine 14,39839,-0.00919056282042024,0.00361067677670878,-0.0162674893027695,-0.00211363633807103,0.0109250418860833
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KDR,Vascular endothelial growth factor receptor 2,39909,-0.00602127675882644,0.00237144246100407,-0.0106693039823944,-0.00137324953525846,0.0111238713423492
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DDX39A,ATP-dependent RNA helicase DDX39A,37052,0.0052970932277395,0.00209053091712757,0.00119965263016946,0.00939453382530953,0.0112931521647366
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RHOC,Rho-related GTP-binding protein RhoC,39668,-0.0277430786949571,0.0109511456282358,-0.0492073241262994,-0.00627883326361488,0.0113074075606446
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GLI2,Zinc finger protein GLI2,37052,0.00808594693530321,0.00319217382488418,0.00182928623853023,0.0143426076320762,0.0113188575290937
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BLMH,Bleomycin hydrolase,40048,0.00752968157039761,0.0029729979703152,0.00170260554857981,0.0133567575922154,0.0113284733147178
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TUBB3,Tubulin beta-3 chain,36987,0.00661284374674064,0.00261640835936326,0.00148468336238865,0.0117410041310926,0.0115010255978309
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EVI2B,Protein EVI2B,36958,0.00965840585477232,0.00382493454229932,0.00216153415186566,0.017155277557679,0.0115776925119551
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HAVCR2,Hepatitis A virus cellular receptor 2,39854,0.00787923161961574,0.00312162132625423,0.00176085382015746,0.013997609419074,0.0116096484993536
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FST,Follistatin,39904,0.0120560683281079,0.00477649200908476,0.00269414399030182,0.0214179926659141,0.011610962284474
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,UXS1,UDP-glucuronic acid decarboxylase 1,39473,-0.0122525427400951,0.00485630515646261,-0.0217709008467618,-0.00273418463342842,0.0116451094451432
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SELENOP,Selenoprotein P,37449,0.00519156971573051,0.00206230027363328,0.00114946117940929,0.00923367825205173,0.0118349166632347
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KLK8,Kallikrein-8,39312,-0.00812365760153151,0.00322745473074877,-0.0144494688737991,-0.00179784632926392,0.0118443153231993
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ENOPH1,Enolase-phosphatase E1,37364,0.013011606271609,0.00518000548831394,0.00285879551451365,0.0231644170287043,0.0120202049758695
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,39473,-0.0101431748744448,0.00404068243098399,-0.0180629124391734,-0.00222343730971616,0.0120741623909699
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,STAT2,Signal transducer and activator of transcription 2,37052,-0.0183520405070112,0.00731313277226092,-0.0326857807406426,-0.00401830027337976,0.0121033508943198
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CELA2A,Chymotrypsin-like elastase family member 2A,37433,-0.0138085596061833,0.00550400136839247,-0.0245964022882326,-0.00302071692413408,0.0121250117084614
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SFTPA1,Pulmonary surfactant-associated protein A1,39473,0.0134751039234982,0.00537146274277048,0.0029470369476681,0.0240031708993284,0.0121295047776135
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FGF19,Fibroblast growth factor 19,39927,-0.0178199445827438,0.00710513727900772,-0.0317460136495989,-0.00389387551588866,0.0121501843868183
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DSCAM,Down syndrome cell adhesion molecule,37408,0.00820244436726638,0.00327302402862117,0.00178731727116889,0.0146175714633639,0.0122195918485635
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CPPED1,Serine/threonine-protein phosphatase CPPED1,40005,-0.015250093289941,0.00608644125302549,-0.0271795181458709,-0.00332066843401103,0.0122346790063023
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MRPL52,"39S ribosomal protein L52, mitochondrial",36938,0.00587376045781831,0.00234644386691752,0.00127473047865997,0.0104727904369767,0.0123175831065994
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPAG1,Sperm-associated antigen 1,37408,-0.013551212911499,0.00541452988454554,-0.0241636914852082,-0.0029387343377897,0.0123349487247537
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,39862,-0.00856155032812126,0.00343212005609792,-0.0152885056380732,-0.00183459501816933,0.0126221641105669
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TSPAN15,Tetraspanin-15,37017,0.0114509333540955,0.00459116071681288,0.00245225834914227,0.0204496083590488,0.0126389468471972
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DTX3,Probable E3 ubiquitin-protein ligase DTX3,39784,0.00540311354884288,0.00216674341102494,0.00115629646323399,0.00964993063445176,0.0126535537871466
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BPIFA2,BPI fold-containing family A member 2,36589,-0.0251472327144276,0.0100896181010523,-0.0449228841924902,-0.00537158123636498,0.012701386844742
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NLGN2,Neuroligin-2,36987,0.0108987432050921,0.00438145449924622,0.00231109238656951,0.0194863940236147,0.0128777937191868
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MPHOSPH8,M-phase phosphoprotein 8,39581,-0.0175314778644888,0.00705528057203645,-0.0313598277856803,-0.00370312794329739,0.0129700795578585
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MSLN,Mesothelin,39762,0.0121131002951054,0.00487725785266851,0.00255367490387514,0.0216725256863357,0.0130168330744129
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BAG4,BAG family molecular chaperone regulator 4,37052,-0.0114701417879932,0.00463440219795788,-0.0205535700959906,-0.00238671347999576,0.0133361174043471
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",39862,-0.0101040750126994,0.00408404427028572,-0.0181088017824595,-0.00209934824293943,0.0133698947356435
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FCRL2,Fc receptor-like protein 2,39986,0.0106370290548806,0.00430051597944528,0.00220801773516789,0.0190660403745934,0.0133924917542861
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PLIN3,Perilipin-3,39864,-0.00985881243425035,0.00398604915828839,-0.0176714687844956,-0.00204615608400509,0.0133963737182707
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PPME1,Protein phosphatase methylesterase 1,39784,-0.0137446471940882,0.00556316969538953,-0.0246484597970517,-0.00284083459112472,0.0134971534737967
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,37408,-0.0154174857694243,0.00624479977208265,-0.0276572933227063,-0.00317767821614228,0.013566976016186
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,39927,0.00977558330863873,0.00396013654826789,0.00201371567403367,0.0175374509432438,0.0135785273287166
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NID2,Nidogen-2,39854,-0.0166489976775485,0.00674580176174972,-0.0298707691305779,-0.003427226224519,0.0135953963265644
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CREB3,Cyclic AMP-responsive element-binding protein 3,36958,0.0128579207187803,0.00521059591729527,0.00264515272088153,0.023070688716679,0.0136130556648426
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GAD2,Glutamate decarboxylase 2,37052,0.0106646268940985,0.00432296437327443,0.00219161672248061,0.0191376370657164,0.0136387551194335
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PCSK7,Proprotein convertase subtilisin/kexin type 7,37364,-0.0101571021079996,0.00411971748403073,-0.0182317483766998,-0.00208245583929935,0.0136951282699351
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,APOA1,Apolipoprotein A-I,37449,-0.00624990208220643,0.00253511826435143,-0.0112187338803352,-0.00128107028407762,0.0137009943670311
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,STEAP4,Metalloreductase STEAP4,36987,0.0172210117541893,0.00698560389220537,0.00352922812546677,0.0309127953829118,0.0137058276804712
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MYOM3,Myomesin-3,37120,-0.0214345717501299,0.00870119057665733,-0.0384889052803783,-0.00438023821988155,0.0137749730377049
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KIAA1549L,UPF0606 protein KIAA1549L,37165,0.00633466110625181,0.00257320245587163,0.00129118429274342,0.0113781379197602,0.0138374924219905
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CR2,Complement receptor type 2,39927,0.0103671277092417,0.00421138506936936,0.00211281297327777,0.0186214424452057,0.0138388105496623
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LTBR,Tumor necrosis factor receptor superfamily member 3,39782,0.00611706516770812,0.00248547240240056,0.00124553925900302,0.0109885910764132,0.0138606326101274
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TRIM21,E3 ubiquitin-protein ligase TRIM21,39862,-0.0171422295894399,0.00697584287777191,-0.0308148816298728,-0.00346957754900692,0.0140063615886313
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,F13B,Coagulation factor XIII B chain,37376,-0.00581520249455379,0.00236819892446082,-0.010456872386497,-0.00117353260261058,0.0140798856900897
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BID,BH3-interacting domain death agonist,39862,-0.0150692197105131,0.00613974754926859,-0.0271031249070796,-0.00303531451394672,0.0141236934656169
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RNASE4,Ribonuclease 4,37047,-0.0059124572595319,0.0024138017584484,-0.0106435087060908,-0.00118140581297304,0.0143208580423382
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCL21,C-C motif chemokine 21,39927,-0.00890100968798822,0.00363441276673609,-0.016024458710791,-0.00177756066518549,0.014332308458432
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RSPO3,R-spondin-3,40026,0.00611357495873386,0.00250198473850325,0.00120968487126749,0.0110174650462002,0.0145565879870795
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TBC1D23,TBC1 domain family member 23,39784,-0.0204267832736859,0.00836509352370557,-0.0368223665801488,-0.00403119996722298,0.0146206997469616
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TEF,Thyrotroph embryonic factor,37017,0.00962283172361531,0.00394381479249566,0.00189295473032381,0.0173527087169068,0.0147011590166159
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NRCAM,Neuronal cell adhesion molecule,39864,0.00624799378873519,0.00256980421139226,0.00121117753440637,0.011284810043064,0.0150551878157472
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,37052,-0.010216528883435,0.00420371770132724,-0.0184558155780364,-0.00197724218883361,0.0150972574244505
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,C1S,Complement C1s subcomponent,37449,0.00471883643079951,0.00194325396278508,0.000910058663740756,0.00852761419785826,0.0151819724558554
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HCG22,Protein PBMUCL2,37017,0.0122267893855025,0.00503838006301287,0.00235156446199724,0.0221020143090077,0.015248919475172
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DEFB103A_DEFB103B,Beta-defensin 103,36996,-0.00903919045966048,0.00373086982680267,-0.0163516953201937,-0.00172668559912725,0.0154143904637839
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD6,T-cell differentiation antigen CD6,40036,-0.0117797311814355,0.00486869549931234,-0.0213223743600877,-0.0022370880027833,0.015553495458964
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RANGAP1,Ran GTPase-activating protein 1,39473,0.011117405400998,0.00459976829542491,0.0021018595419652,0.0201329512600308,0.0156625959267976
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RWDD1,RWD domain-containing protein 1,40005,-0.0142898417749328,0.00592366226460096,-0.0259002198135507,-0.00267946373631496,0.0158619047188068
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PCNA,Proliferating cell nuclear antigen,36958,0.0142859904342223,0.00593021820649832,0.00266276274948563,0.025909218118959,0.0160093101050821
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ITGB7,Integrin beta-7,40026,0.0101639172192892,0.00422422536537257,0.00188443550315894,0.0184433989354194,0.0161349124481472
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,39842,0.00705298233195813,0.00293476006933728,0.00130085259605706,0.0128051120678592,0.0162610891251138
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,37120,-0.00618721557614379,0.00257719800379745,-0.0112385236635868,-0.0011359074887008,0.016375069731604
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL18,Interleukin-18,39792,-0.0101493436804914,0.00422799914096751,-0.0184362219967878,-0.00186246536419513,0.0163837513786871
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",39862,-0.0214798647408675,0.0089545953825834,-0.039030871690731,-0.00392885779100405,0.0164623683826551
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SMPD3,Sphingomyelin phosphodiesterase 3,37052,0.0133726710173733,0.00557869847281977,0.00243842201064659,0.0243069200241001,0.0165394557641744
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,WFDC1,WAP four-disulfide core domain protein 1,37119,-0.0116857294510546,0.00487985232334931,-0.0212502400048192,-0.0021212188972899,0.0166482566083263
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ARHGEF1,Rho guanine nucleotide exchange factor 1,37384,-0.0201420395707815,0.00841980670255693,-0.0366448607077931,-0.00363921843376994,0.0167603165643078
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NIT2,Omega-amidase NIT2,37373,-0.0167768055639768,0.00701348606028842,-0.0305232382421421,-0.00303037288581151,0.0167668637475404
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",39695,0.0089297363511349,0.00373661332533782,0.00160597423347277,0.016253498468797,0.0168694452101171
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TBCC,Tubulin-specific chaperone C,39745,-0.0180122770941291,0.00754458883159828,-0.0327996712040618,-0.00322488298419649,0.0169776461243121
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NFAT5,Nuclear factor of activated T-cells 5,37052,-0.0191369655833942,0.00801769244970347,-0.034851642784813,-0.00342228838197542,0.0170077938263501
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DMD,Dystrophin,37039,-0.0114613511884916,0.00480851261216385,-0.0208860359083327,-0.00203666646865046,0.017160427413055
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CIT,Citron Rho-interacting kinase,37035,-0.0100641034486901,0.00422418543904848,-0.0183435069092251,-0.00178469998815508,0.0172098332715244
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GZMA,Granzyme A,40054,-0.00747452967261437,0.00313984501294971,-0.0136286258979958,-0.00132043344723294,0.0172987365711262
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADGRB3,Adhesion G protein-coupled receptor B3,39716,0.00729210822026783,0.00306456724327062,0.00128555642345741,0.0132986600170783,0.0173483545520628
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SEMA6C,Semaphorin-6C,37052,0.00577426745437532,0.00242929297645271,0.00101285322052801,0.0105356816882226,0.0174714208547644
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,37018,0.00858502570658575,0.00361310785658923,0.00150333430767085,0.0156667171055006,0.0175119982557636
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,INSR,Insulin receptor,37052,0.00366883479686045,0.00154456232051524,0.000641492648650582,0.00669617694507031,0.0175477936666158
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GAMT,Guanidinoacetate N-methyltransferase,37017,0.00813514275650761,0.00342523736259482,0.00142167752582176,0.0148486079871935,0.0175603672402207
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,39927,-0.00937193040418988,0.00394947162652809,-0.0171128947921849,-0.00163096601619482,0.0176579671490778
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,UPK3A,Uroplakin-3a,36987,0.0105134053087864,0.00443583460997509,0.00181916947323519,0.0192076411443376,0.0177972782101154
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCGB3A2,Secretoglobin family 3A member 2,39904,0.0169731862758157,0.00716757451998193,0.00292474021665117,0.0310216323349803,0.0178938279073167
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GPHA2,Glycoprotein hormone alpha-2,37378,0.0102201838679316,0.00431597774334388,0.00176086749097761,0.0186795002448856,0.0178991015843812
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RNF5,E3 ubiquitin-protein ligase RNF5,37039,-0.0161642843094095,0.00682686449007644,-0.0295449387099593,-0.00278362990885967,0.01791114887532
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BDNF,Brain-derived neurotrophic factor,37433,-0.0181147800300305,0.00765510058383418,-0.0331187771743455,-0.00311078288571547,0.0179775713886109
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD55,Complement decay-accelerating factor,39311,0.00559310543250364,0.00236389089717624,0.000959879274038219,0.0102263315909691,0.0179908452852674
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DNM3,Dynamin-3,37408,-0.0120465698599173,0.00509646865175411,-0.0220356484173553,-0.00205749130247925,0.0181070401883525
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLC27A4,Long-chain fatty acid transport protein 4,39485,-0.0148691134968988,0.00629681051266416,-0.0272108621017206,-0.00252736489207711,0.0182196461621965
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPINK8,Serine protease inhibitor Kazal-type 8,37017,0.00818409801576259,0.00346990349047675,0.00138308717442815,0.014985108857097,0.0183587891451174
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,YY1,Transcriptional repressor protein YY1,37052,0.00605485288689801,0.00257647400454229,0.00100496383799511,0.0111047419358009,0.0187853421891462
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PROK1,Prokineticin-1,39862,0.0141280052276435,0.00601294886624262,0.00234262544980799,0.025913385005479,0.0188058432901055
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KYAT1,Kynurenine--oxoglutarate transaminase 1,39846,-0.0123248477812709,0.00525769532164079,-0.0226299306116868,-0.00201976495085494,0.0190824692610328
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCL24,C-C motif chemokine 24,39904,0.0179276594341408,0.00765926141649597,0.00291550705780867,0.0329398118104729,0.0192623250719742
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ZNF830,Zinc finger protein 830,37364,-0.0175042532228257,0.00748120605107864,-0.0321674170829398,-0.00284108936271152,0.0193104422331756
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LAMA4,Laminin subunit alpha-4,39927,0.00729993904029082,0.00312261987593901,0.00117960408345036,0.0134202739971313,0.0194118560829653
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",37120,-0.0227101827445043,0.00972312479442528,-0.0417675073415778,-0.00365285814743069,0.0195223537927448
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,STX16,Syntaxin-16,39473,-0.0126423203393617,0.0054149768390169,-0.0232556749438348,-0.00202896573488859,0.0195719583896068
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SH3GLB2,Endophilin-B2,37384,-0.0143205967815279,0.00614192536641492,-0.0263587704997011,-0.00228242306335461,0.019735636225804
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GGT5,Glutathione hydrolase 5 proenzyme,39745,-0.00494844368621892,0.00213171279913698,-0.00912660077252741,-0.000770286599910444,0.0202807474769296
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HTR1A,5-hydroxytryptamine receptor 1A,36987,0.0163655548421441,0.00705154361962763,0.00254452934767397,0.0301865803366143,0.0203103370998121
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DNM1,Dynamin-1,37378,0.0246664230705862,0.0106370106231549,0.00381788224920258,0.0455149638919698,0.0204139719170335
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,APOB,Apolipoprotein B-100,37441,0.00487630046807219,0.00210320342376197,0.000754021757498729,0.00899857917864566,0.0204363330542152
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,39881,-0.00574592335074225,0.00247890934167285,-0.010604585660421,-0.000887261041063456,0.0204659849164895
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD48,CD48 antigen,39904,0.00622725464896109,0.00268874047862339,0.000957323310859245,0.0114971859870629,0.0205681343714352
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,39862,-0.0130860906823327,0.005653823266249,-0.0241675842841808,-0.00200459708048471,0.0206498366410988
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,37378,-0.0139617824734089,0.00603968471093703,-0.0257995645068455,-0.00212400043997236,0.020810610698941
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PENK,Proenkephalin-A,37120,-0.0062574217409728,0.00270730000046354,-0.0115637297418813,-0.000951113740064266,0.020830745932306
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",37408,0.0150803973098636,0.0065266710322501,0.00228812208665342,0.0278726725330738,0.0208709945149343
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HBZ,Hemoglobin subunit zeta,37433,0.022631139063594,0.00979901529632194,0.00342506908280299,0.041837209044385,0.0209290147683131
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NT5C1A,Cytosolic 5'-nucleotidase 1A,37384,-0.0065574125887221,0.00284383626142923,-0.0121313316611234,-0.000983493516320815,0.0211349965973216
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NEXN,Nexilin,37441,-0.0147275418344107,0.00638904574650181,-0.0272500714975543,-0.00220501217126716,0.0211746386547443
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CTSV,Cathepsin L2,39963,-0.00873184067075482,0.00380181223000005,-0.0161833926415549,-0.00128028869995471,0.0216453809720175
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,37052,-0.0122344995656137,0.00532873389428247,-0.0226788179984074,-0.00179018113282007,0.0216944211701623
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,37433,0.00845194619353605,0.00368229991588366,0.00123463835840408,0.015669254028668,0.0217316886309387
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DDX4,Probable ATP-dependent RNA helicase DDX4,37052,0.0117385220841102,0.00511520957520872,0.00171271131670111,0.0217643328515193,0.0217586541846803
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TGFBR1,TGF-beta receptor type-1,37052,0.00463389154953174,0.00202071455809689,0.000673291015661836,0.00859449208340164,0.021852462469274
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MMP8,Neutrophil collagenase,39981,-0.0152413224918415,0.00665112822767542,-0.0282775338180853,-0.00220511116559769,0.0219450682744665
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FRMD4B,FERM domain-containing protein 4B,37017,-0.0149501762646957,0.00654275442687503,-0.0277739749413708,-0.0021263775880207,0.0223288255928495
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,39900,-0.0107593565869897,0.00471427706023699,-0.0199993396250542,-0.00151937354892523,0.0224851413437996
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,37120,-0.00893595424593704,0.00391714712701246,-0.0166135626148814,-0.00125834587699262,0.0225500085387268
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ITPA,Inosine triphosphate pyrophosphatase,37017,-0.0143767725754044,0.00630534061025919,-0.0267352401715125,-0.00201830497929643,0.0226180096038449
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SERPINA6,Corticosteroid-binding globulin,37449,0.003714309325,0.00163164453594674,0.000516286034544391,0.00691233261545561,0.0228363272369697
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCN5,CCN family member 5,39854,0.00812982792751617,0.00357190655686013,0.00112889107607032,0.015130764778962,0.0228563443784198
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,37433,-0.0149749832249763,0.00660356048754864,-0.0279179617805716,-0.00203200466938094,0.0233623242225052
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SOST,Sclerostin,39842,-0.00804661801037785,0.00355132362326025,-0.0150072123119679,-0.00108602370878776,0.0234764499960048
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NT5C3A,Cytosolic 5'-nucleotidase 3A,39825,0.0185687320277769,0.00820903658611607,0.00247902031898936,0.0346584437365644,0.0237116089540592
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IGBP1,Immunoglobulin-binding protein 1,37408,-0.0126537894782659,0.00560402595412087,-0.0236376803483428,-0.00166989860818902,0.023962628556076
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SORBS1,Sorbin and SH3 domain-containing protein 1,37408,-0.00793535150015125,0.00351685273622181,-0.014828382863146,-0.0010423201371565,0.0240627976487574
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TXNDC15,Thioredoxin domain-containing protein 15,39909,0.0056798225416012,0.00252119555214417,0.000738279259398621,0.0106213658238038,0.0242833795582679
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,37408,-0.0066518312251501,0.00295843161506658,-0.0124503571906806,-0.000853305259619614,0.0245646864633847
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NPC2,NPC intracellular cholesterol transporter 2,37264,-0.00620426932742086,0.0027597530390885,-0.0116133852840343,-0.000795153370807405,0.0245844149631773
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PPIE,Peptidyl-prolyl cis-trans isomerase E,37165,0.0130616367755501,0.00581532414389114,0.00166360145352344,0.0244596720975767,0.0247157355698133
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TXNL1,Thioredoxin-like protein 1,36967,-0.0203849471240414,0.00909173636131703,-0.0382047503922228,-0.00256514385586003,0.0249689711965795
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD99,CD99 antigen,39854,0.00398208163977899,0.00177682649136427,0.000499501716705008,0.00746466156285296,0.0250319571790341
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SORCS2,VPS10 domain-containing receptor SorCS2,39473,-0.00711763141244945,0.00317743267498788,-0.0133453994554257,-0.000889863369473207,0.0251012124920793
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RBFOX3,RNA binding protein fox-1 homolog 3,37408,-0.0076841511732871,0.00343482694530861,-0.014416411986092,-0.000951890360482234,0.0252941042248164
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SERPINC1,Antithrombin-III,37420,0.00302181598332911,0.00135147961275055,0.000372915942338026,0.00567071602432019,0.0253724554237913
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GPI,Glucose-6-phosphate isomerase,37441,-0.00984311646133015,0.00440707451540898,-0.0184809825115317,-0.00120525041112855,0.0255334730996303
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,UNC79,Protein unc-79 homolog,36958,-0.0117040284914808,0.00524068233975197,-0.0219757658773947,-0.00143229110556692,0.0255458303303612
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL3RA,Interleukin-3 receptor subunit alpha,39583,-0.00635437901634434,0.00285104805031384,-0.0119424331949595,-0.000766324837729208,0.0258421546144093
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TP53,Cellular tumor antigen p53,39473,-0.00914027656422924,0.00410403212183068,-0.0171841795230174,-0.00109637360544111,0.0259517547476504
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SNAP25,Synaptosomal-associated protein 25,36987,0.00978732936000622,0.00439540760490749,0.00117233045438755,0.0184023282656249,0.0259830846638426
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PVALB,Parvalbumin alpha,39967,0.0235779666110591,0.010598893196692,0.0028041359455428,0.0443517972765754,0.0261240051001674
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TGOLN2,Trans-Golgi network integral membrane protein 2,37441,0.00511685424774974,0.00230162658372414,0.000605666143650422,0.00962804235184907,0.0262222830617925
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,COMP,Cartilage oligomeric matrix protein,39725,0.00690159137410352,0.0031084223159783,0.000809083634786053,0.012994099113421,0.0264133292936722
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BAG6,Large proline-rich protein BAG6,39581,-0.00761828174778846,0.00343507376618668,-0.0143510263295144,-0.000885537166062557,0.0265832056212765
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TALDO1,Transaldolase,37411,-0.00919607331282444,0.00414870767819598,-0.0173275403620885,-0.00106460626356032,0.0266661887172924
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LHB,Lutropin subunit beta,39473,0.0182124253802164,0.008220743627533,0.00209976787025175,0.0343250828901811,0.026745409887502
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDH6,Cadherin-6,39864,0.00781916700566711,0.00353102253901432,0.000898362829199045,0.0147399711821352,0.026813935021251
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CST5,Cystatin-D,39555,-0.0111446275332937,0.00503421126815936,-0.0210116816188861,-0.00127757344770138,0.0268583570992689
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NPTN,Neuroplastin,39473,0.0172490202563854,0.00780021863591111,0.00196059172999961,0.0325374487827712,0.0270259816504205
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD28,T-cell-specific surface glycoprotein CD28,39473,0.0072293942603843,0.00327205319760791,0.000816169993072808,0.0136426185276958,0.0271587442673879
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MIF,Macrophage migration inhibitory factor,39822,-0.0139785031295999,0.00632871382707818,-0.0263827822306732,-0.00157422402852669,0.0272066671598906
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,39473,-0.0134488785611529,0.00609901552839938,-0.0254029489968157,-0.00149480812549015,0.0274622982649381
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PDGFC,Platelet-derived growth factor C,39473,-0.00596495924723366,0.00271015719269575,-0.0112768673449173,-0.000653051149549992,0.0277531338903262
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CALCB,Calcitonin gene-related peptide 2,37384,0.00803817948939377,0.00365225588546465,0.000879757953883057,0.0151966010249045,0.0277613078847185
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ARHGAP25,Rho GTPase-activating protein 25,39473,-0.0122870898132518,0.00561024564502735,-0.0232831712775054,-0.00129100834899814,0.0285305512594764
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LYPD3,Ly6/PLAUR domain-containing protein 3,39790,0.00699508974746405,0.00319817859003995,0.000726659710985752,0.0132635197839424,0.0287416492890874
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,STK11,Serine/threonine-protein kinase STK11,39581,-0.0148379431319445,0.00681192555847809,-0.0281893172265616,-0.00148656903732745,0.0294036982598501
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CXCL5,C-X-C motif chemokine 5,39801,-0.0230248120514298,0.0105706595542663,-0.0437433047777917,-0.00230631932506783,0.0294071526637936
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,39842,-0.0229233910412356,0.0105267328390034,-0.0435557874056823,-0.00229099467678889,0.0294477313521459
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,39797,-0.0377695815605098,0.0173446237390457,-0.0717650440890393,-0.00377411903198029,0.0294507513462136
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,37017,0.0104846358609576,0.00481980489444866,0.00103781826783826,0.019931453454077,0.0296236105650728
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,37052,-0.0161622343636957,0.00745775825742241,-0.0307794405482436,-0.00154502817914781,0.0302396831271845
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,39473,-0.0157536282334052,0.00727143385448759,-0.0300056385882009,-0.00150161787860952,0.0302873767081061
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CETN2,Centrin-2,39485,-0.0136513918698252,0.00630278078260755,-0.026004842203736,-0.0012979415359144,0.0303314910995033
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD40LG,CD40 ligand,40054,-0.0156277153208922,0.00722487209093205,-0.029788464619119,-0.00146696602266536,0.0305523896916949
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PCYT2,Ethanolamine-phosphate cytidylyltransferase,37378,-0.0154025367034439,0.00712219942776489,-0.0293620475818631,-0.00144302582502472,0.0305886998035589
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GBA,Lysosomal acid glucosylceramidase,37035,0.0106193835343766,0.00491060124955337,0.000994605085252049,0.0202441619835012,0.0305943257638989
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DNAJB2,DnaJ homolog subfamily B member 2,37120,-0.0107057054878291,0.00495181990418546,-0.0204112725000326,-0.0010001384756256,0.0306380161412847
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GSR,"Glutathione reductase, mitochondrial",37399,0.00451943075655353,0.00209067019564429,0.000421717173090722,0.00861714434001633,0.0306577044206881
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LTB,Lymphotoxin-beta,37364,0.00683603386796799,0.00317201551621482,0.000618883456186947,0.013053184279749,0.031171056668844
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PMCH,Pro-MCH,37017,0.0165474636698581,0.0077069347003869,0.00144187165709975,0.0316530556826164,0.0318045297154136
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PGR,Progesterone receptor,37052,0.0209010526828619,0.00974779718913452,0.00179537019215824,0.0400067351735656,0.0320365138670189
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CPLX2,Complexin-2,36958,0.00594738006733816,0.00278259296587509,0.000493497854222993,0.0114012622804533,0.0325878525468028
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CRH,Corticoliberin,39451,-0.0172630846309695,0.00808137985688277,-0.0331025891504597,-0.00142358011147925,0.0326822628495529
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,39854,0.00689113368298384,0.00323151426417684,0.000557365725197234,0.0132249016407704,0.0329827421583425
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,39502,-0.0156366882211098,0.00733750774084708,-0.0300182033931701,-0.00125517304904953,0.0330995343299931
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MPI,Mannose-6-phosphate isomerase,39784,0.0170872451256663,0.00802145449407094,0.00136519431728722,0.0328092959340453,0.0331709782774247
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCGB2A2,Mammaglobin-A,37017,0.00619032026045053,0.00292087386413249,0.000465407486750858,0.0119152330341502,0.0340805523596237
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,C5,Complement C5,37449,0.00299227204273951,0.00141220202685702,0.000224356070099745,0.00576018801537927,0.0341195735912174
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GFRA1,GDNF family receptor alpha-1,40007,-0.00528800332416542,0.0024974255663695,-0.0101829574342496,-0.000393049214081195,0.0342427060490187
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TIMP4,Metalloproteinase inhibitor 4,39854,0.00770975445969184,0.00364165254239043,0.000572115476606599,0.0148473934427771,0.0342664794052704
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PDZD2,PDZ domain-containing protein 2,37017,-0.0118060942211318,0.00557912913332368,-0.0227411873224462,-0.000871001119817425,0.0343535234706122
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL20RA,Interleukin-20 receptor subunit alpha,39583,0.00896704320030124,0.00423786545614421,0.000660826906258589,0.0172732594943439,0.0343661047932738
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PLXNB2,Plexin-B2,39980,-0.00463863099779258,0.00219251214775413,-0.00893595480739067,-0.000341307188194493,0.0343882223527887
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SMAD5,Mothers against decapentaplegic homolog 5,39784,-0.0040246980274139,0.001904822725012,-0.00775815056843742,-0.000291245486390382,0.0346249320153602
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLGN,Calmegin,37035,-0.00859005379885208,0.00406949052291038,-0.0165662552237564,-0.00061385237394773,0.0348046363628211
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AGER,Advanced glycosylation end product-specific receptor,39813,0.00775690932922738,0.00367739909275628,0.000549207107425068,0.0149646115510297,0.0349302116215029
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MMP3,Stromelysin-1,39854,0.00931659609012168,0.00442507879971663,0.000643441642677071,0.0179897505375663,0.0352713626354087
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SMAD3,Mothers against decapentaplegic homolog 3,37364,-0.00996602108530326,0.00473796061620587,-0.0192524238930668,-0.000679618277539746,0.0354456778203795
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CELA3A,Chymotrypsin-like elastase family member 3A,40030,0.0108909814917918,0.00517884613687311,0.000740443063520528,0.0210415199200631,0.0354834095739331
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",37017,-0.00798101304339693,0.00379600446842096,-0.015421181801502,-0.000540844285291852,0.03553044125705
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LAMA1,Laminin subunit alpha-1,37017,0.0105963134054686,0.00504200648908703,0.000713980686857997,0.0204786461240792,0.0356067285742371
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MYO9B,Unconventional myosin-IXb,39583,-0.0129101725730662,0.00614633262884392,-0.0249569845256002,-0.000863360620532098,0.035703612574815
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HSPA2,Heat shock-related 70 kDa protein 2,37364,-0.00659331968298257,0.00314007120725957,-0.0127478592492113,-0.000438780116753811,0.0357706023800825
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DEFA1_DEFA1B,Neutrophil defensin 1,39533,0.00977768627795871,0.00466148208659143,0.000641181388239499,0.0189141911676779,0.0359609948941335
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BOLA2_BOLA2B,BolA-like protein 2,37039,-0.0106602115950475,0.00509350350692408,-0.0206434784686187,-0.000676944721476291,0.03637683767937
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MUCL3,Mucin-like protein 3,36958,0.00870823620452404,0.0041638948014004,0.000547002393779266,0.0168694700152688,0.036514306809847
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RNASE1,Ribonuclease pancreatic,37441,-0.00434590593883998,0.00207876164405651,-0.00842027876119074,-0.000271533116489225,0.0365804575031136
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NRN1,Neuritin,37408,-0.00678976021832808,0.00326804174351144,-0.0131951220356105,-0.000384398401045652,0.0377628418749001
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",39838,-0.0122196129989409,0.00588174217363709,-0.0237478276592696,-0.000691398338612243,0.0377667648010782
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,37364,-0.0161527256141737,0.00778136302958502,-0.0314041971521603,-0.000901254076187017,0.0379292821172921
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,39745,0.00541748898589175,0.00261190172329754,0.000298161608228567,0.0105368163635549,0.0380809888591972
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,THSD1,Thrombospondin type-1 domain-containing protein 1,36971,0.00664283528316462,0.00320346839400815,0.000364037230908647,0.0129216333354206,0.0381323780948829
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ERVV_1,,37017,0.00927607021782694,0.00447371033561614,0.000507597960019307,0.0180445424756346,0.0381486785676846
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CST1,Cystatin-SN,35636,-0.019471126659543,0.00939195618786183,-0.0378793607877522,-0.00106289253133387,0.0381781077643749
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,39583,-0.010764787948278,0.00519493702580785,-0.0209468645188614,-0.000582711377694599,0.0382659359686068
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TDP1,Tyrosyl-DNA phosphodiesterase 1,37364,-0.0132796286946219,0.00641232468417765,-0.0258477850756101,-0.000711472313633667,0.0383820582529219
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,M6PR,Cation-dependent mannose-6-phosphate receptor,37039,-0.00790879403529356,0.00382556118911221,-0.0154068939659535,-0.000410694104633619,0.0387201666979898
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CSPG5,Chondroitin sulfate proteoglycan 5,36987,0.00939174318055557,0.00454520804065648,0.000483135420868875,0.0183003509402423,0.0388201500680895
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MYDGF,Myeloid-derived growth factor,37433,-0.0194331659197121,0.00941156338513896,-0.0378798301545844,-0.000986501684839703,0.0389591683191488
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CFD,Complement factor D,37449,0.00349858258358972,0.001694613954729,0.00017713923232089,0.00682002593485855,0.0389863540741165
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LMNB2,Lamin-B2,37384,0.00523807010705742,0.00253819187272447,0.000263214036517455,0.0102129261775974,0.0390650712298442
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LY6D,Lymphocyte antigen 6D,39757,0.00692045198402649,0.00335610368713253,0.000342488757246726,0.0134984152108063,0.0392192359634104
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TACSTD2,Tumor-associated calcium signal transducer 2,38019,0.00586256097816068,0.00284612826643256,0.000284149575952852,0.0114409723803685,0.0394323397967469
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PDIA5,Protein disulfide-isomerase A5,36958,-0.011727892979698,0.00569768771310496,-0.0228953608973837,-0.000560425062012239,0.039575316473815
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FGF20,Fibroblast growth factor 20,37052,0.00820604453344838,0.00398810360897742,0.000389361459852645,0.0160227276070441,0.0396452015785438
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,37039,0.0101453903955905,0.00493257566340579,0.000477542095315116,0.0198132386958658,0.0397237653351388
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCL4,C-C motif chemokine 4,39878,-0.0118853222666304,0.00578672782106002,-0.023227308795908,-0.000543335737352716,0.0400022020652225
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CASP3,Caspase-3,40048,-0.0169626637058777,0.00826683690147665,-0.0331656640327719,-0.000759663378983456,0.0401961246454619
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNXB,Tenascin-X,39854,0.00489749483332736,0.00238698852902753,0.000218997316433406,0.00957599235022131,0.0402105729227416
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CAPS,Calcyphosin,37384,0.0165304804629374,0.00807387025195745,0.0007056947691008,0.032355266156774,0.0406376367752629
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ICAM1,Intercellular adhesion molecule 1,39818,0.00540577902866648,0.00264038737540164,0.000230619772879275,0.0105809382844537,0.0406407417068636
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BEX3,Protein BEX3,36958,0.008884746019779,0.00434172537071212,0.000374964293183242,0.0173945277463747,0.0407405939172117
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",37165,-0.00946552898378119,0.00463534503261377,-0.0185508052477042,-0.000380252719858209,0.0411679032178756
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,USP28,Ubiquitin carboxyl-terminal hydrolase 28,37384,-0.00682369113284909,0.00335116733925359,-0.0133919791177861,-0.000255403147912053,0.0417483958885023
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CRHBP,Corticotropin-releasing factor-binding protein,39858,-0.0052937689864533,0.00260384030663397,-0.0103972959874559,-0.000190241985450727,0.0420627269969131
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCND2,G1/S-specific cyclin-D2,37165,0.00694752163294882,0.00342422632911246,0.000236038027888396,0.0136590052380092,0.0424851103353717
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GDNF,Glial cell line-derived neurotrophic factor,39485,-0.00723424567455661,0.00356662482117148,-0.0142248303240527,-0.000243661025060508,0.0425448359049478
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DGCR6,Protein DGCR6,36987,-0.00816713550966579,0.00402875602440167,-0.0160634973174931,-0.000270773701838511,0.0426610818814123
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,STK24,Serine/threonine-protein kinase 24,39485,-0.0117143001556733,0.00579102653941081,-0.0230647121729185,-0.000363888138428147,0.0431069989298823
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HPCAL1,Hippocalcin-like protein 1,40054,0.0139311537871595,0.00688829059206413,0.00043010422671381,0.0274322033476052,0.0431473304287677
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NPTX1,Neuronal pentraxin-1,39854,0.00766295498333021,0.00379153745703547,0.000231541567540679,0.0150943683991197,0.0432893539830027
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GMPR2,GMP reductase 2,37120,-0.0125845483966419,0.00622864873918668,-0.0247926999254477,-0.000376396867835967,0.0433588745459952
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,36927,0.00987349929162871,0.004887886201321,0.000293242337039545,0.0194537562462179,0.0434044088133803
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MTDH,Protein LYRIC,37052,-0.0173532077358138,0.00859260803796609,-0.0341947194902274,-0.00051169598140029,0.04345019183069
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL36A,Interleukin-36 alpha,37052,0.0110041655318707,0.00546118594007035,0.000300241089332833,0.0217080899744086,0.0439272783497981
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",37017,0.0115649866051295,0.0057525944160435,0.000289901549684203,0.0228400716605747,0.0444097758012208
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CASC3,Protein CASC3,37035,-0.00784535415216162,0.00391136181927805,-0.0155116233179466,-0.000179084986376644,0.0448995094211595
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CA1,Carbonic anhydrase 1,39527,-0.0110483908976625,0.00550878129412801,-0.0218456022341534,-0.000251179561171589,0.0449165099201568
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TPR,Nucleoprotein TPR,37017,-0.00875676354079842,0.0043785122267212,-0.017338647505172,-0.000174879576424876,0.0455272184103511
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TOR1AIP1,Torsin-1A-interacting protein 1,37039,-0.0093687113724305,0.00468514140901684,-0.0185515885341035,-0.000185834210757491,0.0455569835766551
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DBH,Dopamine beta-hydroxylase,37426,0.0202012101120486,0.0101131252048658,0.000379484710511576,0.0400229355135855,0.0457882266027444
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,STXBP1,Syntaxin-binding protein 1,37408,0.0144941817969369,0.00726033627025625,0.000263922707234684,0.0287244408866392,0.0459156743380121
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,37017,-0.00512835444111032,0.00257048527233019,-0.0101665055748775,-9.02033073431523e-05,0.0460534425276334
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RNASE6,Ribonuclease K6,37382,-0.0051181664050072,0.00256612018868023,-0.0101477619748205,-8.85708351939423e-05,0.0461157926064011
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PDCD1LG2,Programmed cell death 1 ligand 2,39784,0.00569899733391904,0.00285862852254209,9.60854297365338e-05,0.0113019092381015,0.0462114553789281
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLAMF8,SLAM family member 8,39473,0.00962568387801442,0.00483449526847813,0.000150073151797294,0.0191012946042315,0.0464936515802517
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FUCA1,Tissue alpha-L-fucosidase,39924,-0.0148708998302981,0.00748583842097753,-0.029543143135414,-0.000198656525182101,0.0469906193477626
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SERPINB1,Leukocyte elastase inhibitor,39807,-0.0164988409004086,0.00830913991950015,-0.0327847551426288,-0.000212926658188266,0.0470920095132494
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,37441,0.00861357324839687,0.00434007790351784,0.000107020557501896,0.0171201259392918,0.0472025489448683
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,STX1B,Syntaxin-1B,37035,0.00785855150066155,0.00396128068874421,9.44413507229019e-05,0.0156226616506002,0.0472942746589688
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDC25A,M-phase inducer phosphatase 1,36958,0.00763615201310731,0.0038656971354809,5.93856275647574e-05,0.0152129183986499,0.0482480188873844
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RAB44,Ras-related protein Rab-44,37364,-0.00773766911325149,0.00392121699266394,-0.0154232544188728,-5.20838076301681e-05,0.0484837364310048
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCL22,C-C motif chemokine 22,39682,0.00921451938612472,0.0046768810338561,4.78325597667566e-05,0.0183812062124827,0.0488297193119213
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HMCN2,Hemicentin-2,37096,-0.0103870738109505,0.00527671709468762,-0.0207294393165382,-4.47083053627707e-05,0.0490345042554891
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,37017,0.0105456932670439,0.00535873905945741,4.2564710507325e-05,0.0210488218235804,0.049095559331786
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SDHB,Succinate dehydrogenase,37378,0.0128114795587562,0.00651091666806654,5.00828893457463e-05,0.0255728762281666,0.0491238821253103
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SUMF1,Formylglycine-generating enzyme,37052,0.0124822823659587,0.00634460700169011,4.68526426461308e-05,0.0249177120892713,0.0491598038245961
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ERCC1,DNA excision repair protein ERCC-1,36958,0.00600138732316187,0.00305076224115323,2.18933305015439e-05,0.0119808813158222,0.0491839569211506
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GIMAP7,GTPase IMAP family member 7,37120,0.0059604891588863,0.00303088574700166,1.99530947630538e-05,0.0119010252230096,0.0492520991369382
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL12RB2,Interleukin-12 receptor subunit beta-2,37052,0.0075931640449361,0.00386595155933544,1.58989886386452e-05,0.0151704291012336,0.0495380035997592
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,36987,0.0111700359154968,0.00569260920193419,1.25218797058322e-05,0.0223275499512878,0.0497603363476656
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,YAP1,Transcriptional coactivator YAP1,37384,0.00464190875031053,0.00236708095563404,2.43007726780618e-06,0.00928138742335326,0.0498964089866437
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CXCL17,C-X-C motif chemokine 17,40054,-0.00780890302952135,0.00398451274162598,-0.0156185480031083,7.41944065566456e-07,0.0500346838667863
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,39881,0.00578601275570431,0.00295360694097828,-3.05684861312723e-06,0.0115750823600217,0.0501342001765388
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TP53INP1,Tumor protein p53-inducible nuclear protein 1,39581,0.00578644257191492,0.00295670938242638,-8.70781764077296e-06,0.0115815929614706,0.0503586862872348
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,40026,0.00457817712375888,0.00233988529050407,-7.9980456290903e-06,0.00916435229314686,0.0504138393776602
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PI16,Peptidase inhibitor 16,37441,0.00433250257018427,0.00221587761350389,-1.06175522833572e-05,0.0086756226926519,0.0505789553550469
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TEX33,Testis-expressed protein 33,37165,0.00721873807189534,0.00369616545948886,-2.57462287028328e-05,0.0144632223724935,0.0508364600486588
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IKZF2,Zinc finger protein Helios,39473,0.0170414430047639,0.00873708143131512,-8.32366006136911e-05,0.0341661226101416,0.051137614946005
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PITHD1,PITH domain-containing protein 1,36927,0.0142977648894306,0.00733607722003577,-8.09464618395268e-05,0.0286764762407007,0.0513208578134173
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FCRL3,Fc receptor-like protein 3,39583,0.0094270857659159,0.00484738463402713,-7.37881167772684e-05,0.0189279596486091,0.0518195393933837
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MYOM2,Myomesin-2,37017,-0.00931417567608447,0.00479059788769427,-0.0187037475359652,7.53961837962856e-05,0.0518851940938788
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,39473,0.0229086363498773,0.011792438808934,-0.000204543715633356,0.046021816415388,0.0520758511297514
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,QPCT,Glutaminyl-peptide cyclotransferase,39858,0.00477593869712251,0.00245911807980534,-4.39327392959604e-05,0.00959581013354097,0.0521383169238836
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IFNL1,Interferon lambda-1,39485,0.00809795716250271,0.00417725739983885,-8.94673411814297e-05,0.0162853816661868,0.0525702089610858
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LAMTOR5,Ragulator complex protein LAMTOR5,37364,0.00743192293576322,0.00384201605992023,-9.84285416804221e-05,0.0149622744132069,0.0530871621534644
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,39745,-0.00523026950930533,0.00270758442725358,-0.0105371349867223,7.65959681116764e-05,0.0534130017064359
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SAMD9L,Sterile alpha motif domain-containing protein 9-like,39862,-0.0131253173125745,0.0067996041181142,-0.0264525413840783,0.000201906758929339,0.0535865711227497
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SH3BP1,SH3 domain-binding protein 1,37378,-0.00858471217804121,0.00445074284642087,-0.0173081681570261,0.000138743800943697,0.0537732760961843
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FGF5,Fibroblast growth factor 5,39583,0.00593867101710515,0.00307898822978189,-9.61459132673486e-05,0.0119734879474777,0.0537769615781354
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TSHB,Thyrotropin subunit beta,39864,0.0134048647319248,0.00695143360279042,-0.000219945129544419,0.027029674593394,0.0538280629493029
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GP5,Platelet glycoprotein V,37120,0.00648156057843528,0.00336171619693602,-0.00010740316755931,0.0130705243244299,0.0538700995597213
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VSTM2B,V-set and transmembrane domain-containing protein 2B,37165,0.00744350882874617,0.00386283461095627,-0.000127647008728116,0.0150146646662205,0.0540064961006922
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LETM1,Mitochondrial proton/calcium exchanger protein,37408,-0.00937467440686422,0.00486552441999232,-0.0189111022700492,0.000161753456320735,0.0540310372887835
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,39904,0.0160318118863136,0.00832834218402854,-0.000291738794382348,0.0323553625670095,0.0542507249031854
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HNMT,Histamine N-methyltransferase,39665,-0.00825867920966124,0.00429136457217085,-0.0166697537711161,0.000152395351793625,0.0543113865841186
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",36958,0.0101096163620979,0.00526617498920209,-0.000212086616738156,0.020431319340934,0.0549141359149349
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HS1BP3,HCLS1-binding protein 3,37039,-0.0163079376257768,0.0085042420093396,-0.0329762519640824,0.000360376712528858,0.0551803089355314
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SEPTIN7,Septin-7,37165,0.00915250275708442,0.00477640437992859,-0.000209249827575612,0.0185142553417445,0.0553622004338956
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CEND1,Cell cycle exit and neuronal differentiation protein 1,36987,0.0104598805859554,0.00545878064696446,-0.000239329482094904,0.0211590906540058,0.0553668124059712
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,39981,0.00498326833748181,0.00260376746478523,-0.000120115893497245,0.0100866525684609,0.0556546576540199
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,37433,0.00606094480343095,0.00316726496988867,-0.000146894537550846,0.0122687841444127,0.0556896094159729
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,39909,0.00805576815934649,0.00421656925292054,-0.000208707576377771,0.0163202438950707,0.0560862831988962
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL15RA,Interleukin-15 receptor subunit alpha,39583,0.0060805244438914,0.00318865187806478,-0.000169233237115566,0.0123302821248984,0.0565483260107772
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL20RB,Interleukin-20 receptor subunit beta,37052,0.00763733668809053,0.00400856084496679,-0.000219442568044376,0.0154941159442254,0.0567684547503672
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ANXA5,Annexin A5,39411,0.00535155818594554,0.00281379615121978,-0.000163482270445225,0.0108665986423363,0.0572027222141062
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CBLN1,Cerebellin-1,36987,0.0169834985597586,0.00893889360211614,-0.000536732900389029,0.0345037300199063,0.0574608738323246
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NAAA,N-acylethanolamine-hydrolyzing acid amidase,39670,0.0104127734962727,0.00548201545090155,-0.000331976787494281,0.0211575237800398,0.0575244933024052
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ASPSCR1,Tether containing UBX domain for GLUT4,37408,-0.0119509748703274,0.00629434065306868,-0.0242878825503421,0.000385932809687182,0.0576270335008094
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TWF2,Twinfilin-2,37433,-0.0148829949425372,0.00784630694575447,-0.030261756556216,0.000495766671141517,0.0578735304021361
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EGFLAM,Pikachurin,37378,-0.00538787384838561,0.00284278191296018,-0.0109597263977876,0.000183978701016349,0.0580763433018307
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TRIM58,E3 ubiquitin-protein ligase TRIM58,37364,-0.0150300155306466,0.0079331610991792,-0.0305790112850378,0.00051898022374464,0.058169289911877
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CSDE1,Cold shock domain-containing protein E1,37017,-0.021077249670556,0.0111434522610926,-0.0429184161022974,0.000763916761185465,0.0585866389902782
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NRGN,Neurogranin,37441,-0.0160951158240115,0.00851324849209113,-0.0327810828685101,0.000590851220487097,0.058699526725194
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VTCN1,V-set domain-containing T-cell activation inhibitor 1,39473,0.00567683330700394,0.00300301540336565,-0.000209076883592726,0.0115627434976006,0.0587259676556996
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ICAM2,Intercellular adhesion molecule 2,40048,-0.00549827095159186,0.00291005399466522,-0.0112019767811357,0.000205434877951975,0.0588554178395455
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CAPN3,Calpain-3,37364,-0.00659945810651469,0.00349484501730491,-0.0134493543404323,0.00025043812740293,0.0590016408051465
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TMED8,Protein TMED8,37378,-0.0180948590460536,0.009605551770825,-0.0369217405168706,0.000732022424763376,0.059614595946184
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,REST,RE1-silencing transcription factor,36958,0.00623303960852326,0.0033109730846752,-0.00025646763744014,0.0127225468544867,0.0597848666129488
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NEDD9,Enhancer of filamentation 1,37052,0.00582643565547182,0.00309959716273507,-0.000248774783488915,0.0119016460944325,0.0601655908330583
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DNAJB14,DnaJ homolog subfamily B member 14,37378,-0.011329765763849,0.00602907364370287,-0.0231467501055067,0.000487218577808575,0.0602402570474248
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,COL6A3,Collagen alpha-3(VI) chain,40048,-0.00558907426731945,0.002975059024134,-0.0114201899546221,0.000242041419983184,0.0603111898290581
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCL18,C-C motif chemokine 18,39711,0.0123176867428972,0.00655721791604039,-0.000534460372541956,0.0251698338583364,0.0603321174036067
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPON1,Spondin-1,39881,0.0055573791732165,0.00295847940923427,-0.000241240468882659,0.0113559988153157,0.0603366881230133
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,37165,0.0126504466197567,0.00673439167455742,-0.000548961062375867,0.0258498543018892,0.0603368394733789
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ATP5IF1,"ATPase inhibitor, mitochondrial",39927,-0.0191620530367145,0.0102222053541804,-0.039197575530908,0.000873469457479011,0.0608725434631276
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KIAA2013,Uncharacterized protein KIAA2013,37364,0.00996731127269415,0.00532121312774701,-0.000462266457689986,0.0203968890030783,0.0610723492806754
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TACC3,Transforming acidic coiled-coil-containing protein 3,39784,-0.0203551315379948,0.0108699417853886,-0.0416602174373565,0.000949954361366884,0.0611409521024386
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MTR,Methionine synthase,37017,0.0112127286698509,0.00598930900598359,-0.000526316981876917,0.0229517743215788,0.0612116265252133
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CRYZL1,Quinone oxidoreductase-like protein 1,37039,-0.0160582902256337,0.00858617572106683,-0.0328871946389246,0.000770614187657327,0.0614713382255803
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CALB2,Calretinin,39485,0.00507366786913408,0.00271459432589026,-0.000246937009610831,0.010394272747879,0.0616368403112386
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL4R,Interleukin-4 receptor subunit alpha,39862,-0.00620335232318787,0.0033195327682154,-0.0127096365488901,0.00030293190251432,0.0616768887102387
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ANXA1,Annexin A1,37068,-0.00757919073269415,0.00406342216239513,-0.0155434981709886,0.000385116705600311,0.0621722315231514
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CAT,Catalase,37248,-0.00914705353844803,0.00490453895925318,-0.0187599498985843,0.000465842821688192,0.0622007391389875
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NGRN,Neugrin,37384,-0.00369142012513289,0.00197966379557079,-0.00757156116445165,0.000188720914185868,0.0622492881047487
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NOS1,"Nitric oxide synthase, brain",39485,-0.00935318920499361,0.0050224377995155,-0.019197167292044,0.000490788882056767,0.0625822844335313
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DKK4,Dickkopf-related protein 4,39714,-0.00783216084592244,0.00420784646951854,-0.0160795399261788,0.000415218234333896,0.0627170901418502
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NECAP2,Adaptin ear-binding coat-associated protein 2,37017,-0.0112328020924858,0.00603994617424956,-0.0230710965940149,0.000605492409043342,0.0629429208198857
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RNASEH2A,Ribonuclease H2 subunit A,37408,-0.00851527363624099,0.00457875878032961,-0.017489640845687,0.000459093573205055,0.0629448200453934
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HBQ1,Hemoglobin subunit theta-1,40026,0.0103524348424236,0.00556912018761975,-0.000563040725311097,0.0212679104101583,0.063059540763728
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ATP6V1F,V-type proton ATPase subunit F,39449,-0.011437676412707,0.00615716436124755,-0.0235057185607522,0.000630365735338159,0.0632417290264532
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",39980,-0.0121877962437738,0.00656172087911797,-0.025048769166845,0.000673176679297446,0.0632712793098716
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TCN1,Transcobalamin-1,37231,0.00589881305673105,0.00317769335501428,-0.000329465919096938,0.012127092032559,0.0634300616540064
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,STX8,Syntaxin-8,39862,-0.00840246117544271,0.00452930115380446,-0.0172798914368994,0.000474969086014028,0.0635954525494023
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RGCC,Regulator of cell cycle RGCC,37408,-0.0130385387981453,0.00703356054514345,-0.0268243174666265,0.000747239870335828,0.0637951108161892
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL7R,Interleukin-7 receptor subunit alpha,39854,0.00895204786464113,0.00483216615597389,-0.0005189978010677,0.01842309353035,0.063958809484557
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FOSB,Protein fosB,39485,-0.00672409807882276,0.00363480012385717,-0.0138483063215828,0.000400110163937299,0.0643436067725136
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BLNK,B-cell linker protein,37052,0.00671369102959814,0.00363157974914315,-0.000404205278722442,0.0138315873379187,0.0645239207457982
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRKD2,Serine/threonine-protein kinase D2,37017,-0.00785321123106286,0.00425259650572966,-0.016188300382293,0.000481877920167278,0.0648150764540865
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,39583,0.00614898717982464,0.00333290562666991,-0.000383507848448376,0.0126814822080977,0.0650660974898179
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RICTOR,Rapamycin-insensitive companion of mTOR,37052,0.0081991809255231,0.0044456857292325,-0.0005143631037726,0.0169127249548188,0.0651617490853643
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PARD3,Partitioning defective 3 homolog,37165,-0.0126991873231787,0.00688570572070409,-0.0261951705357588,0.000796795889401273,0.0651641814561093
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TPRKB,EKC/KEOPS complex subunit TPRKB,36958,0.0112699463874471,0.00611268993707989,-0.000710925889229511,0.0232508186641237,0.0652499256318173
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,37120,0.0109968118009051,0.00597101611229703,-0.000706379779197082,0.0227000033810073,0.0655415734398498
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ANXA10,Annexin A10,39485,-0.0134157406144067,0.00729071039707962,-0.0277055329926827,0.000874051763869371,0.0657704097594774
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PPP1R2,Protein phosphatase inhibitor 2,39864,-0.0137854561189635,0.00749551708669064,-0.0284766696088771,0.000905757370950158,0.0659101519702186
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ECM1,Extracellular matrix protein 1,37102,0.00617687648286087,0.00336098274500411,-0.000410649697347185,0.0127644026630689,0.066111534245725
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DDI2,Protein DDI1 homolog 2,37120,-0.0128259758514859,0.00698211154166811,-0.0265109144731554,0.000858962770183614,0.0662357101302634
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CEP164,Centrosomal protein of 164 kDa,39583,-0.0103407903100827,0.0056299832430616,-0.0213755574664834,0.000693976846318049,0.066267811430278
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IDI2,Isopentenyl-diphosphate delta-isomerase 2,39485,-0.00800297740122369,0.00436118158619559,-0.016550893310167,0.000544938507719665,0.0665175808515176
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FASLG,Tumor necrosis factor ligand superfamily member 6,40054,0.00623345404097202,0.00340799167349666,-0.000446209639081424,0.0129131177210255,0.0674075586508055
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,REXO2,"Oligoribonuclease, mitochondrial",37017,0.00810993139809382,0.00444246862893444,-0.00059730711461769,0.0168171699108053,0.0679413140601013
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCL20,C-C motif chemokine 20,40054,0.0142595018180831,0.00782392825204073,-0.00107539755591673,0.0295944011920829,0.0683899793188914
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VASP,Vasodilator-stimulated phosphoprotein,37441,0.0123403157739295,0.00677531154030352,-0.000939294845065353,0.0256199263929244,0.0685733705340724
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,37017,0.00859258363410919,0.00472136273068263,-0.000661287318028772,0.0178464545862472,0.0687912818939409
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD8A,T-cell surface glycoprotein CD8 alpha chain,40005,-0.00795084472511587,0.00437229965701954,-0.0165205520528742,0.000618862602642429,0.0690126303785241
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GPC5,Glypican-5,39745,0.0094291938563119,0.00518891704874933,-0.000741083559236794,0.0195994712718606,0.0692084612516704
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPART,Spartin,37120,-0.0131784973883047,0.00725309593837687,-0.0273945654275233,0.00103757065091398,0.0692476561296162
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NAMPT,Nicotinamide phosphoribosyltransferase,39473,-0.00861964906593447,0.00474452143114332,-0.0179189110709754,0.000679612939106441,0.0692732831960684
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",37384,-0.0165096531590845,0.00909806795316733,-0.0343418663472925,0.00132256002912343,0.0696024926294035
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FDX2,"Ferredoxin-2, mitochondrial",37017,0.00948919382630009,0.00524015633745078,-0.000781512595103451,0.0197599002477036,0.070185196417638
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCL28,C-C motif chemokine 28,39811,-0.00999664157577507,0.00553244136464041,-0.0208402266504703,0.000846943498920141,0.0707946424600901
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,39858,0.00497872652327497,0.00275574345862426,-0.000422530655628587,0.0103799837021785,0.0708321058023476
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,37384,-0.00808740541886866,0.00448865202642682,-0.0168851633906652,0.000710352552927904,0.0716078287932382
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CEP350,Centrosome-associated protein 350,36958,0.00604741467126465,0.00335767647503324,-0.000533631219800507,0.0126284605623298,0.0717146374949326
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PLPBP,Pyridoxal phosphate homeostasis protein,39864,-0.0113801684500012,0.00631968578128901,-0.0237667525813276,0.0010064156813253,0.0717612550739096
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CHP1,Calcineurin B homologous protein 1,36987,0.0121465187649098,0.00674727871309542,-0.00107814751275727,0.0253711850425768,0.0718504308031309
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ESAM,Endothelial cell-selective adhesion molecule,40048,-0.0052216461336825,0.0029049953883043,-0.0109154370947589,0.000472144827393926,0.0722794437742282
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NPHS1,Nephrin,37052,0.00570017435427661,0.00317992432140849,-0.000532477315684027,0.0119328260242373,0.0730677606509136
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLEC12A,C-type lectin domain family 12 member A,37052,0.00334864486555262,0.00186944875584932,-0.000315474695912044,0.00701276442701729,0.0732765491200327
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,C9orf40,Uncharacterized protein C9orf40,37378,-0.0131624893676506,0.00735703116919879,-0.0275822704592803,0.00125729172397898,0.0736205482905098
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CEP170,Centrosomal protein of 170 kDa,37039,-0.0128108714481801,0.00716307763893933,-0.0268505036205012,0.00122876072414097,0.073724929730455
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RAB37,Ras-related protein Rab-37,39583,-0.0138567251536348,0.00774971400010418,-0.029046164593839,0.00133271428656937,0.0737903341518939
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GSTM4,Glutathione S-transferase Mu 4,37017,0.011906273899927,0.00665995549714194,-0.00114723887447125,0.0249597866743252,0.0738408494947988
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ITGAL,Integrin alpha-L,37052,0.00708955497209728,0.00396786358548212,-0.000687457655447665,0.0148665675996422,0.0740018890679031
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CSNK2A1,Casein kinase II subunit alpha,37408,0.00744400303941216,0.00417184185953597,-0.000732807005278332,0.0156208130841027,0.0743900763509016
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ARG2,"Arginase-2, mitochondrial",37364,0.00724617835705373,0.00407186676769258,-0.000734680507623726,0.0152270372217312,0.0751685852435499
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PCDH7,Protocadherin-7,37378,-0.00554128752495316,0.00311633059254811,-0.0116492954863475,0.000566720436441141,0.075402522520758
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLIP2,CAP-Gly domain-containing linker protein 2,39862,-0.0186768568979992,0.0105132994888896,-0.0392829238962228,0.00192921010022442,0.0756698445227414
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PAM,Peptidyl-glycine alpha-amidating monooxygenase,39952,0.00458491300125343,0.00258120329731792,-0.000474245461489695,0.00964407146399655,0.0757073781803033
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AMIGO2,Amphoterin-induced protein 2,39784,0.00370502754105937,0.00208769021023067,-0.000386845270992753,0.00779690035311149,0.0759662407667444
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MZT1,Mitotic-spindle organizing protein 1,39473,-0.00878440662514276,0.00495888374527152,-0.0185038187658749,0.000935005515589411,0.0765056709069765
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,WARS,"Tryptophan--tRNA ligase, cytoplasmic",39854,-0.00618337438562171,0.0034916713626543,-0.0130270502564241,0.000660301485180724,0.0765976335318542
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GBP6,Guanylate-binding protein 6,37017,0.00760173197489006,0.0042943939984396,-0.000815280262051556,0.0160187442118317,0.0767249054426021
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD5,T-cell surface glycoprotein CD5,39999,-0.00540153848137135,0.00305231471628331,-0.0113840753252866,0.000580998362543941,0.0768038111597426
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCL3,C-C motif chemokine 3,39862,-0.0103127327186751,0.00583059113315125,-0.0217406913396515,0.00111522590230135,0.0769582404927586
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,37433,-0.00654949592823247,0.00371236897587321,-0.013825739120944,0.000726747264479023,0.0777147018737522
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ATP1B4,Protein ATP1B4,36958,0.00685149797077376,0.0038853611068855,-0.000763809798721819,0.0144668057402693,0.0778540980678713
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPINK5,Serine protease inhibitor Kazal-type 5,39854,0.00543710143983307,0.00308755723763778,-0.000614510745936971,0.0114887136256031,0.0782622712879231
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NEFL,Neurofilament light polypeptide,39434,0.00710898617322519,0.00404748302386524,-0.000824080553550683,0.0150420529000011,0.079040333191097
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BCL2L1,Bcl-2-like protein 1,37384,-0.0163133773384747,0.00929038831433551,-0.0345225384345722,0.00189578375762293,0.0791210514010858
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",39583,0.0117872709417076,0.00672753030544068,-0.00139868845695617,0.0249732303403713,0.0797769990830207
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CHRM1,Muscarinic acetylcholine receptor M1,37035,0.00599429224715147,0.00342340869480314,-0.000715588794662682,0.0127041732889656,0.0799740304295407
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SATB1,DNA-binding protein SATB1,37408,-0.00487215202373453,0.0027846615768872,-0.0103300887144334,0.000585784666964392,0.0802032947946708
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",37433,0.00877848957270322,0.0050188904677207,-0.00105853574402935,0.0186155148894358,0.0802981191443007
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ARAF,Serine/threonine-protein kinase A-Raf,37165,-0.0108920119764491,0.00623005596496414,-0.0231029216677788,0.00131889771488065,0.0804350137147629
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,39862,0.0135551419441067,0.00775405584958671,-0.00164280752108322,0.0287530914092967,0.0804597073624471
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DARS1,"Aspartate--tRNA ligase, cytoplasmic",39709,-0.0118882926270173,0.00680949544435719,-0.0252349036979574,0.00145831844392279,0.0808580550128674
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,39745,-0.0153631801125009,0.0088089994222703,-0.0326288189801507,0.00190245875514886,0.0811727889479836
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,39864,-0.0135097016815973,0.00774627026261192,-0.0286923913963167,0.00167298803312204,0.0811736441043589
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FABP5,Fatty acid-binding protein 5,39968,-0.0110383894564379,0.00632937632394104,-0.0234439670513624,0.0013671881384865,0.0811793457287102
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",37035,-0.00781094524182262,0.00450117601720524,-0.0166332502355449,0.00101135975189964,0.0827089210945701
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MAP2,Microtubule-associated protein 2,37384,-0.00741188652593213,0.00427432630406565,-0.0157895660819008,0.000965793030036541,0.0829323733878749
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ITGB5,Integrin beta-5,39909,-0.00610085177345599,0.00352530960757644,-0.0130104586043058,0.000808755057393823,0.0835448359931169
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDC37,Hsp90 co-chaperone Cdc37,39909,-0.0134543578677378,0.0077777125978371,-0.0286986745594985,0.00178995882402297,0.0836744263327378
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LYN,Tyrosine-protein kinase Lyn,39784,-0.0135890581240287,0.00786573438199503,-0.0290058975127389,0.0018277812646816,0.0840744387479565
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLAMF1,Signaling lymphocytic activation molecule,39583,-0.00938366523006425,0.00544426012765369,-0.0200544150802655,0.00128708462013698,0.0848017790255979
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LEG1,Protein LEG1 homolog,36699,0.0112158142717581,0.00650780205445251,-0.00153947775496881,0.023971106298485,0.0848328431475879
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,JPT2,Jupiter microtubule associated homolog 2,37378,-0.014103312494256,0.00819327684156304,-0.0301621351037196,0.00195551011520751,0.0852142972265503
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VEGFB,Vascular endothelial growth factor B,37052,0.00452461306051655,0.00263202071743928,-0.000634147545664443,0.00968337366669755,0.0856261094353703
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PKD1,Polycystin-1,37433,-0.00417882533203998,0.00243462450137526,-0.00895068935473549,0.000593038690655534,0.0861089812887743
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HIF1A,Hypoxia-inducible factor 1-alpha,37052,0.0108904669884245,0.00634664743128426,-0.00154896197689268,0.0233298959537416,0.0861964806177703
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,37052,0.00962231505001499,0.00561125289370615,-0.00137574062164906,0.020620370721679,0.0864008576697066
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NCLN,Nicalin,39583,0.00840340619781893,0.00490093784840279,-0.00120243198505054,0.0180092443806884,0.0864286308813092
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NUB1,NEDD8 ultimate buster 1,39862,-0.0134064566717348,0.00782458457017549,-0.0287426424292787,0.00192972908580917,0.0866627280062494
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PDIA3,Protein disulfide-isomerase A3,37120,0.00403242262420725,0.00235415741445176,-0.000581725908118197,0.0086465711565327,0.0867553792091727
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TERF1,Telomeric repeat-binding factor 1,37052,0.00464405440441324,0.00271160091954063,-0.000670683397886395,0.00995879220671287,0.0867983372607705
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VWA5A,von Willebrand factor A domain-containing protein 5A,36958,-0.0129268705488065,0.0075529720592181,-0.027730695784874,0.00187695468726098,0.0870135303171178
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CST7,Cystatin-F,39878,-0.0146464529594874,0.00856660186990787,-0.0314369926245069,0.00214408670553202,0.0873378420678119
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DNAJC21,DnaJ homolog subfamily C member 21,37384,-0.00610048598436282,0.00356946397541982,-0.0130966353761857,0.000895663407460031,0.0874597756138522
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,39862,-0.0159812003869727,0.00935242360032607,-0.0343119506436117,0.00234954986966643,0.0875117743522442
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,37408,-0.0134008587978411,0.0078486658933735,-0.0287842439488532,0.00198252635317098,0.0877695383722316
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SOX2,Transcription factor SOX-2,37388,0.00376154425037834,0.00220418989839332,-0.000558667950472561,0.00808175645122924,0.087930028163386
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SFTPD,Pulmonary surfactant-associated protein D,39864,-0.0104307168586861,0.0061176753693909,-0.0224213605826923,0.00155992686532007,0.0882113821777514
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL17C,Interleukin-17C,39583,-0.0104981073101499,0.00617618168026695,-0.0226034234034731,0.00160720878317334,0.0891933976797059
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AGRN,Agrin,39927,-0.00514786689998932,0.0030287645043325,-0.011084245328481,0.000788511528502383,0.0892144386955936
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,37433,0.0212012944689452,0.0124776191252231,-0.00325483901649209,0.0456574279543826,0.0893146262922468
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IGLON5,IgLON family member 5,36958,0.014534782480468,0.00855551737718894,-0.0022340315788223,0.0313035965397583,0.0893658721698559
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PLB1,"Phospholipase B1, membrane-associated",37384,0.00943151718672924,0.00555472089989851,-0.00145573577707184,0.0203187701505303,0.089544321895991
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,36987,0.00511277612789279,0.00301252225126304,-0.000791767484582762,0.0110173197403683,0.0896873684545496
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,36958,-0.00905548874469124,0.00534313788444675,-0.0195280389982069,0.00141706150882439,0.0901393170071459
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCAR2,Cell cycle and apoptosis regulator protein 2,37384,-0.00903223426085328,0.00533278554452973,-0.0194844939281315,0.001420025406425,0.0903419317249381
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FGF6,Fibroblast growth factor 6,37052,0.00644109494866138,0.00380349080407893,-0.00101374702733333,0.0138959369246561,0.0903897803259458
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RPS10,40S ribosomal protein S10,37017,0.00675808688742412,0.00399193289907235,-0.00106610159475769,0.0145822753696059,0.0904913255264822
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,F11,Coagulation factor XI,37245,0.00491417284610218,0.00290591467293179,-0.000781419912844123,0.0106097656050485,0.0908422644934258
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ELOB,Elongin-B,37017,-0.00616039531754941,0.00365219525086848,-0.0133186980092516,0.000997907374152808,0.0916722442911576
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NGF,Beta-nerve growth factor,39745,0.00192089680346705,0.00114095429196243,-0.000315373608779312,0.00415716721571341,0.0922809938106426
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TSPAN7,Tetraspanin-7,36987,0.0147446370189573,0.0087596533187162,-0.00242428348572644,0.031913557523641,0.0923515758566018
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MEP1B,Meprin A subunit beta,39864,-0.0179906443257752,0.0106928660021471,-0.0389486616899836,0.00296737303843323,0.0924932933880667
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GLOD4,Glyoxalase domain-containing protein 4,39828,-0.00559273285865602,0.0033251950187437,-0.0121101150953937,0.000924649378081626,0.0926026911378889
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EP300,Histone acetyltransferase p300,37052,0.00461192622511247,0.00274655455461309,-0.000771320701929196,0.00999517315215413,0.0931430089691982
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,39485,-0.017586753311919,0.0104918178889103,-0.0381507163741831,0.00297720975034509,0.0937121592344796
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MYL6B,Myosin light chain 6B,37035,-0.0144419494797474,0.00861912294286888,-0.0313354304477704,0.00245153148827559,0.0938460499707847
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL1R1,Interleukin-1 receptor type 1,39822,-0.00349142122515444,0.00208539715169128,-0.00757879964246934,0.000595957192160464,0.0941062450771716
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",37017,0.0132199198638877,0.00790539107866092,-0.00227464665028767,0.0287144863780631,0.0944955796994407
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD46,Membrane cofactor protein,39773,0.00439958052406346,0.00263159099277799,-0.000758337821781408,0.00955749886990833,0.0945769288671079
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PSPN,Persephin,39862,-0.0146265815982841,0.00875085831975826,-0.0317782639050103,0.00252510070844212,0.0946532942091108
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SERPINF2,Alpha-2-antiplasmin,37220,0.00209135833221791,0.00125188861525492,-0.000362343353681725,0.00454506001811755,0.0948315234042225
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ESYT2,Extended synaptotagmin-2,37384,-0.012760931064262,0.00764462496744907,-0.0277443960004622,0.00222253387193814,0.0950873404066258
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SKIV2L,Helicase SKI2W,37017,0.00624595114877463,0.0037439320418345,-0.00109215565322099,0.0135840579507703,0.0952826687858016
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LAMP3,Lysosome-associated membrane glycoprotein 3,40036,0.00777253471096438,0.0046599787765359,-0.00136102369104599,0.0169060931129747,0.0953482840385773
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NPPB,Natriuretic peptides B,39581,-0.0196097353698511,0.0117657145109437,-0.0426705358113007,0.00345106507159851,0.0955970537847349
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PEAR1,Platelet endothelial aggregation receptor 1,40048,0.0035008709589509,0.00210374045874885,-0.000622460340196836,0.00762420225809864,0.0961083387626121
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRDX2,Peroxiredoxin-2,37245,-0.00938969012972321,0.0056435185638412,-0.020450986514852,0.00167160625540554,0.0961756733907558
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HCLS1,Hematopoietic lineage cell-specific protein,40054,-0.00865406955515264,0.00520333143419821,-0.0188525991661811,0.00154446005587585,0.0962960382173409
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,S100A13,Protein S100-A13,37052,0.00536329768088283,0.00322658928116432,-0.000960817310199229,0.0116874126719649,0.0964926503452204
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CASP7,Caspase-7,37384,-0.0130138174770963,0.00783111065200611,-0.0283627943550283,0.00233515940083565,0.0965740664398858
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MSR1,Macrophage scavenger receptor types I and II,40005,0.00704155579787798,0.00423977627104857,-0.00126840569337721,0.0153515172891332,0.0967666243662283
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GAL,Galanin peptides,39927,-0.00991671633796982,0.00597635034268649,-0.0216303630096353,0.00179693033369569,0.0970695403567947
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,37378,0.00507964648894711,0.00306594899225642,-0.000929613535875463,0.0110889065137697,0.0975842983190578
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCARF1,Scavenger receptor class F member 1,40048,-0.00658342126325861,0.00397515786904504,-0.0143747306865869,0.00120788816006968,0.0977126834066927
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,39873,0.00877222868023668,0.0053050156101727,-0.00162560191570181,0.0191700592761752,0.098233976712469
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TXK,Tyrosine-protein kinase TXK,37165,0.0114071748855549,0.00690688526033849,-0.00213032022470855,0.0249446699958183,0.0986467130624204
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SOX9,Transcription factor SOX-9,37035,0.00415695628900148,0.00251863996473809,-0.00077957804188517,0.00909349061988813,0.0988693342025272
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDH22,Cadherin-22,37165,0.00445016423234912,0.00269798571877303,-0.000837887776446019,0.00973821624114426,0.0990812334769691
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AFP,Alpha-fetoprotein,39695,0.0103364821677042,0.00627044858002266,-0.00195359704914024,0.0226265613845486,0.0992814696873137
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SAT2,Thialysine N-epsilon-acetyltransferase,37165,-0.0109216011057406,0.00662533910722184,-0.0239072657558954,0.0020640635444142,0.0992820898496266
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LTA,Lymphotoxin-alpha,39862,0.00604406710803121,0.00366703366348486,-0.00114331887239911,0.0132314530884615,0.0993277877919918
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ARHGAP5,Rho GTPase-activating protein 5,36958,-0.0112499394007137,0.00686597499682498,-0.0247072503944907,0.00220737159306322,0.101340257464009
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD244,Natural killer cell receptor 2B4,40054,0.00405737235916285,0.00248081039496375,-0.000805016014966087,0.0089197607332918,0.101963121805209
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,37017,0.0046713506176072,0.00285995392376995,-0.0009341590729819,0.0102768603081963,0.102416035657661
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EIF5A,Eukaryotic translation initiation factor 5A-1,39583,0.00457348742024665,0.00280208031147305,-0.000918589990240534,0.0100655648307338,0.102662501843628
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SF3B4,Splicing factor 3B subunit 4,39784,0.0110522861102374,0.00677739061526982,-0.0022313994956914,0.0243359717161663,0.102961102397635
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GIPC2,PDZ domain-containing protein GIPC2,37384,-0.00433668214090974,0.00266383169684348,-0.00955779226672295,0.000884427984903478,0.103551034220567
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CREBZF,CREB/ATF bZIP transcription factor,36958,0.00396330300697781,0.00243568832446561,-0.000810646108974781,0.0087372521229304,0.103722955916821
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EDF1,Endothelial differentiation-related factor 1,37408,-0.0103967753081187,0.00639548466142812,-0.0229319252445178,0.00213837462828043,0.104048866773659
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FAS,Tumor necrosis factor receptor superfamily member 6,39998,-0.00481297203662883,0.00296467262350012,-0.0106237303786891,0.0009977863054314,0.104514629105315
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ANKRA2,Ankyrin repeat family A protein 2,36958,0.00815135873635185,0.00504266238311511,-0.00173225953455376,0.0180349770072575,0.106014834606085
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MORC3,MORC family CW-type zinc finger protein 3,37384,-0.00419515854548614,0.00259658234668879,-0.00928445994499617,0.000894142854023902,0.106194143054025
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCDC28A,Coiled-coil domain-containing protein 28A,37035,-0.0044342604410575,0.00274564974745424,-0.0098157339460678,0.000947213063952806,0.10633179309149
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TP73,Tumor protein p73,37035,0.00520208818818942,0.00322699544965828,-0.0011228228931408,0.0115269992695196,0.10697432618323
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PLXNB3,Plexin-B3,39808,-0.00712610774422597,0.00442305799104035,-0.0157953014066651,0.00154308591821312,0.107171854026785
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTTG1,Securin,37165,0.00625534592615704,0.00388447524659765,-0.00135822555717436,0.0138689174094884,0.107346246901503
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADGRV1,Adhesion G-protein coupled receptor V1,36987,0.0103515929013197,0.00644510976892517,-0.00228082224577366,0.022984008048413,0.108272512718914
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GPNMB,Transmembrane glycoprotein NMB,39440,0.00421200889581384,0.00262476850962176,-0.000932537383044801,0.00935655517467248,0.108576514343585
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRSS27,Serine protease 27,39814,-0.00597352491155347,0.00372814956289535,-0.0132806980548283,0.00133364823172141,0.109114367274532
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KIF1C,Kinesin-like protein KIF1C,37017,-0.00544961285970282,0.00340293305602484,-0.0121193616495115,0.00122013593010585,0.109302222205576
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HARS1,"Histidine--tRNA ligase, cytoplasmic",39854,-0.0115361021117833,0.00720939389188775,-0.0256665141398833,0.00259430991631672,0.109585355073969
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,37120,0.0055761200410976,0.00348632615116165,-0.00125707921517923,0.0124093192973744,0.109749844887801
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SETMAR,Histone-lysine N-methyltransferase SETMAR,39695,0.00441583342705672,0.00276172115923001,-0.000997140045034105,0.00982880689914755,0.109853323124798
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,B4GALT1,"Beta-1,4-galactosyltransferase 1",39927,-0.00398692691908062,0.00249581382332564,-0.00887872201279888,0.000904868174637633,0.110186070164321
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PCSK9,Proprotein convertase subtilisin/kexin type 9,40048,-0.00581315702395778,0.00364413847516785,-0.0129556684352868,0.00132935438737121,0.110685363527016
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ANXA3,Annexin A3,39981,-0.0103281930281502,0.0064811948876735,-0.0230313350079903,0.00237494895168981,0.111053528884717
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,USO1,General vesicular transport factor p115,39784,-0.0132756234806962,0.00833810862439205,-0.0296183163845046,0.00306706942311223,0.111368056143121
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TEK,Angiopoietin-1 receptor,39909,0.0032028743496551,0.00201241413387438,-0.000741457352738681,0.00714720605204889,0.111503688616259
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TAGLN3,Transgelin-3,36958,0.0088229749898955,0.00554444850342666,-0.00204414407682075,0.0196900940566118,0.111562392292556
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",39862,0.0122810842005251,0.00772273838517552,-0.00285548303441889,0.0274176514354691,0.111798233591143
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GRAP2,GRB2-related adapter protein 2,39864,-0.0189524573388039,0.0119246794004639,-0.0423248289637131,0.00441991428610537,0.112001752194641
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,39745,0.0103336233662748,0.00650497906673613,-0.00241613560452797,0.0230833823370777,0.112177102935694
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AMFR,E3 ubiquitin-protein ligase AMFR,39485,-0.0095561912452283,0.00602060024230028,-0.0213565677201368,0.00224418522968025,0.112476513104769
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MDH1,"Malate dehydrogenase, cytoplasmic",37393,-0.00592369636696948,0.00373800537718401,-0.0132501869062501,0.00140279417231117,0.113053058509866
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD109,CD109 antigen,39854,0.00495921397485786,0.0031314356685181,-0.00117839993543762,0.0110968278851533,0.11328473485616
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PZP,Pregnancy zone protein,37449,0.00808041870586012,0.00510465048044596,-0.00192469623581395,0.0180855336475342,0.113455586424276
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,37035,0.00468330080441128,0.00296042551391739,-0.00111913320286681,0.0104857348116894,0.113680696382535
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ABRAXAS2,BRISC complex subunit Abraxas 2,37017,-0.00981281969784216,0.00620671883732831,-0.0219779886190056,0.00235234922332132,0.113902177887948
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GBP2,Guanylate-binding protein 2,39583,0.00870435916399718,0.0055124530006021,-0.00210004871718292,0.0195087670451773,0.114348023328487
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CMC1,COX assembly mitochondrial protein homolog,37433,-0.0132877538975712,0.00842057375607341,-0.0297920784594751,0.00321657066433265,0.114586498867549
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,37408,-0.00697987244160022,0.00442909150723754,-0.0156608917957858,0.00170114691258536,0.11506870592332
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NAGA,Alpha-N-acetylgalactosaminidase,37033,-0.00882529319309732,0.0056003312546262,-0.0198019424521647,0.00215135606597003,0.115083929270618
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CHMP1A,Charged multivesicular body protein 1a,39745,-0.0116111600627762,0.00739109370308155,-0.026097703720816,0.00287538359526367,0.116210364317237
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SART1,U4/U6.U5 tri-snRNP-associated protein 1,37017,-0.00521295565843398,0.00332879895583298,-0.0117374016118666,0.00131149029499867,0.117368693429574
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BCL2,Apoptosis regulator Bcl-2,37378,-0.00734623919162153,0.00469381166688851,-0.016546110058723,0.00185363167547994,0.117585141088096
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDK1,Cyclin-dependent kinase 1,36958,-0.00525583328736816,0.00335832624654679,-0.0118381527305999,0.00132648615586354,0.117603387198425
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LIFR,Leukemia inhibitory factor receptor,39862,-0.00354311715278793,0.00226541023579751,-0.00798332121495105,0.000897086909375187,0.117835731431195
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CALY,Neuron-specific vesicular protein calcyon,37017,0.00550827267911122,0.00352250288231006,-0.00139583297021651,0.0124123783284389,0.117903088977507
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,37089,0.00709629012252231,0.00455815844830612,-0.0018377004361577,0.0160302806812023,0.119534132581692
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HDDC2,5'-deoxynucleotidase HDDC2,37378,0.00624473133097036,0.00401149635596686,-0.00161780152672468,0.0141072641886654,0.119563068783957
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MAPKAPK2,MAP kinase-activated protein kinase 2,37165,-0.0106125355155257,0.00683428802334006,-0.0240077400412722,0.00278266901022086,0.120485858382274
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DCLRE1C,Protein artemis,36958,0.00444782006270184,0.00287900746551694,-0.00119503456971136,0.010090674695115,0.122391131306038
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NUDC,Nuclear migration protein nudC,40054,-0.00922377624180901,0.005977365566786,-0.0209394127527096,0.00249186026909154,0.122821856591718
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD300LF,CMRF35-like molecule 1,40026,0.00855282685146256,0.0055440357323886,-0.00231348318401911,0.0194191368869442,0.122921275818899
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ARMCX2,Armadillo repeat-containing X-linked protein 2,36987,0.00897594522418471,0.00581835552661104,-0.00242803160797292,0.0203799220563423,0.122929015341655
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,40048,0.00998388509822811,0.00648303176453811,-0.00272285716026658,0.0226906273567228,0.123579290802249
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,WASL,Neural Wiskott-Aldrich syndrome protein,37052,0.00857763538647469,0.00558284445871354,-0.00236473975260384,0.0195200105255532,0.124457565052494
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD300C,CMRF35-like molecule 6,40005,0.00473941652199382,0.00308635839862365,-0.00130984593930854,0.0107886789832962,0.124655746735891
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SRC,Proto-oncogene tyrosine-protein kinase Src,39883,-0.0170711837016866,0.0111490922307327,-0.0389234044739227,0.00478103707054943,0.125746501016369
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CASP1,Caspase-1,39485,-0.00951108821531324,0.00622017007527172,-0.0217026215628458,0.00268044513221934,0.12626682605296
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",37017,0.00616456815132818,0.00403836524680767,-0.00175062773241485,0.0140797640350712,0.126909205885404
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ARID4B,AT-rich interactive domain-containing protein 4B,39485,-0.00575095206851253,0.00377486884884816,-0.0131496950122549,0.00164779087522986,0.127657913313068
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCS,Copper chaperone for superoxide dismutase,39745,-0.00667433474694193,0.0043824902296674,-0.01526401559709,0.00191534610320618,0.127789907839526
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VAV3,Guanine nucleotide exchange factor VAV3,36987,-0.0140822515018069,0.00925377786183343,-0.0322196561110004,0.00405515310738664,0.128087287391383
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CADPS,Calcium-dependent secretion activator 1,37035,0.00613023024751043,0.00404011659940735,-0.00178839828732798,0.0140488587823488,0.129204874030524
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FUT8,"Alpha-(1,6)-fucosyltransferase",39745,-0.00810797026289312,0.00535621353035975,-0.0186061487823982,0.00239020825661198,0.130109057279487
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,36987,0.00677998627817705,0.00447951427810869,-0.00199986170691599,0.0155598342632701,0.130163097219716
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BSG,Basigin,40036,-0.00273324425543317,0.00180647447698828,-0.00627393423033019,0.000807445719463852,0.130292393687878
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TBCB,Tubulin-folding cofactor B,39745,-0.0142304182392465,0.00940583372299597,-0.0326658523363186,0.00420501585782558,0.130315978196975
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRND,Prion-like protein doppel,37384,0.00712368591438954,0.00471306971630319,-0.0021139307295647,0.0163613025583438,0.130690899505747
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PCDHB15,Protocadherin beta-15,37364,-0.00557400231340797,0.00368957959404704,-0.0128055783177402,0.00165757369092422,0.130877632682263
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,THAP12,52 kDa repressor of the inhibitor of the protein kinase,36927,-0.01230065544585,0.00814534980395142,-0.0282655410615947,0.00366423016989482,0.131030728837097
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NPDC1,Neural proliferation differentiation and control protein 1,39864,0.00413503400000408,0.00273868265726159,-0.00123278400822864,0.00950285200823679,0.13109827771281
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IFNW1,Interferon omega-1,37017,0.0049694239525111,0.00329323533674157,-0.00148531730750238,0.0114241652125246,0.13132808496035
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",37035,0.0108117172958598,0.00716771899564484,-0.00323701193560411,0.0248604465273237,0.131478660610782
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCP2,Non-specific lipid-transfer protein,39473,-0.0109208804581331,0.00724444241245001,-0.0251199875865352,0.00327822667026888,0.131706894698631
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD58,Lymphocyte function-associated antigen 3,39831,0.00243424021702399,0.00161727396976391,-0.00073561676371327,0.00560409719776124,0.132305244189172
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TP53BP1,TP53-binding protein 1,37052,0.0122630010124144,0.00816362704368856,-0.00373770799321514,0.028263710018044,0.133082036112336
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,JCHAIN,Immunoglobulin J chain,39583,0.00845519336618977,0.00562928202745075,-0.0025781994076137,0.0194885861399932,0.133116651361587
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",39485,0.00691253106405151,0.00460482827874263,-0.00211293236228404,0.0159379944903871,0.133337363311051
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLINT1,Clathrin interactor 1,36958,0.00681048385865564,0.00453792040579909,-0.00208384013671057,0.0157048078540218,0.133432947190048
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GCLM,Glutamate--cysteine ligase regulatory subunit,37017,-0.00616930119255483,0.00411189102711557,-0.0142286076057014,0.00189000522059169,0.133546154250986
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PILRB,Paired immunoglobulin-like type 2 receptor beta,39864,-0.00790579859763737,0.00527044553015429,-0.0182358718367398,0.00242427464146504,0.133627724534605
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PER3,Period circadian protein homolog 3,37052,-0.0163538036817032,0.0109085523348949,-0.0377345662580971,0.0050269588946908,0.133852768470436
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PLXDC2,Plexin domain-containing protein 2,37384,-0.00372789479904712,0.00248794586957903,-0.00860426870342201,0.00114847910532778,0.134057214520046
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",36958,0.00758086427352511,0.00507452279986321,-0.00236520041420679,0.017526928961257,0.135224061384861
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VIM,Vimentin,39581,-0.0162226013742856,0.0108860240203323,-0.037559208454137,0.00511400570556575,0.136185720908989
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BAMBI,BMP and activin membrane-bound inhibitor homolog,39473,0.00415458037980652,0.00278795123507628,-0.00130980404094298,0.00961896480055602,0.136194171727601
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,37378,0.0163915259559697,0.0110026203265683,-0.00517360988410426,0.0379566617960437,0.13630441179864
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,F2,Prothrombin,37449,0.00203039132285748,0.00136304800683365,-0.000641182770536469,0.00470196541625142,0.136353612645042
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DRG2,Developmentally-regulated GTP-binding protein 2,39784,-0.00782921431358853,0.00525740446008732,-0.0181337270553597,0.00247529842818262,0.136460143370256
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TST,Thiosulfate sulfurtransferase,39451,0.0105663799235757,0.00711676623725713,-0.00338248190144831,0.0245152417485996,0.137639168295894
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",37433,-0.0121159640494684,0.00816315975599162,-0.028115757171212,0.00388382907227514,0.13777251730061
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MORN4,MORN repeat-containing protein 4,36958,-0.0109693344173477,0.00739884143132209,-0.025471063622739,0.00353239478804358,0.138211526883871
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL17F,Interleukin-17F,39583,0.0106497929020176,0.00719683383095263,-0.00345600140664955,0.0247555872106848,0.138949698193768
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADA,Adenosine deaminase,40054,-0.00476756609252522,0.00322937620894897,-0.0110971434620652,0.00156201127701476,0.139879661069753
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,STX3,Syntaxin-3,37384,-0.00518794546728589,0.00352782315634056,-0.0121024788537134,0.00172658791914161,0.141428055169122
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCL17,C-C motif chemokine 17,39832,-0.0122914167475749,0.00837384143545574,-0.0287041459610681,0.00412131246591836,0.142168764968335
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LYZL2,Lysozyme-like protein 2,36958,-0.00490808464024331,0.00334432894427612,-0.0114629693710245,0.00164680009053788,0.142241187375519
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FKBPL,FK506-binding protein-like,37378,-0.0081046799417709,0.00552482255564725,-0.0189333321508395,0.0027239722672977,0.142410877266372
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CEBPA,CCAAT/enhancer-binding protein alpha,37052,0.00514010097953971,0.00351025536278612,-0.00173999953152109,0.0120202014906005,0.143133176421606
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FABP9,Fatty acid-binding protein 9,39862,0.00750353071905327,0.00513757034928102,-0.00256610716553754,0.0175731686036441,0.144166501847064
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DHPS,Deoxyhypusine synthase,37364,-0.00554785353010773,0.00380509517945969,-0.0130058400818487,0.00191013302163326,0.14486200480127
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FGF9,Fibroblast growth factor 9,36927,0.00547586100137314,0.00375844353584129,-0.00189068832887579,0.0128424103316221,0.145154454471987
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CIAPIN1,Anamorsin,39909,-0.00852987707677645,0.00586594108721882,-0.0200271216077253,0.00296736745417243,0.145928113829284
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HIP1R,Huntingtin-interacting protein 1-related protein,37361,-0.00565682719141917,0.00389023919970756,-0.013281696022846,0.00196804164000765,0.14593966499111
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,37408,-0.0105375677205571,0.0072481954221984,-0.024744030748066,0.00366889530695174,0.146019524223687
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MMP15,Matrix metalloproteinase-15,37433,0.00668596633609889,0.00460260477791519,-0.00233513902861487,0.0157070717008127,0.146344524906193
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RELB,Transcription factor RelB,37052,0.00661991070443332,0.00456507893075717,-0.00232764399985074,0.0155674654087174,0.147048927559013
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DSG3,Desmoglein-3,39960,-0.00448779177667788,0.00309551847742424,-0.0105550079924294,0.00157942443907363,0.147141970555126
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,39745,0.0137431839231463,0.00949290433551531,-0.00486290857446367,0.0323492764207563,0.147711677013829
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ECI2,Enoyl-CoA delta isomerase 2,37017,-0.00832198841241622,0.00575729986075805,-0.019606296139502,0.00296231931466955,0.14835050218326
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SERPINA11,Serpin A11,40048,0.00549346041581731,0.00380131943857457,-0.00195712568378885,0.0129440465154235,0.14843632334993
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPINT3,Kunitz-type protease inhibitor 3,37378,0.0195141419311717,0.0135187059125837,-0.00698252165749224,0.0460108055198357,0.148905136974048
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MED21,Mediator of RNA polymerase II transcription subunit 21,37017,0.00658960777877157,0.00456677945354815,-0.00236127995018281,0.015540495507726,0.149060005935636
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MSRA,Mitochondrial peptide methionine sulfoxide reductase,39909,-0.00972531298494365,0.00675220882472928,-0.022959642281413,0.00350901631152573,0.149797582985149
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,37035,-0.00692796820419629,0.00481267216220845,-0.0163608056421249,0.00250486923373227,0.150025219136777
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CASP2,Caspase-2,39862,-0.00912566632987688,0.00634630285117675,-0.0215644199181833,0.00331308725842955,0.150467790077024
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KIF20B,Kinesin-like protein KIF20B,36987,0.0100242055530775,0.00698164556989174,-0.00365981976391034,0.0237082308700653,0.15108476553569
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",37052,0.00611343711350159,0.00425936857237095,-0.00223492528834547,0.0144617995153487,0.151227649532331
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HPGDS,Hematopoietic prostaglandin D synthase,39473,0.00495471251781943,0.0034535037462617,-0.00181415482485351,0.0117235798604924,0.15139505293825
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",39449,0.00626268042554285,0.00436945741476084,-0.0023014561073884,0.0148268169584741,0.151796287907765
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,STX5,Syntaxin-5,37052,0.00541151142119557,0.00377923509535381,-0.00199578936569791,0.012818812208089,0.152194264231934
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PECR,Peroxisomal trans-2-enoyl-CoA reductase,37039,-0.0037185984000894,0.00259776773806937,-0.00881022316670537,0.00137302636652657,0.152322379281265
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NENF,Neudesin,37364,0.0145896148896277,0.0101939768707551,-0.00539057977705223,0.0345698095563076,0.152396179749711
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TTN,Titin,37017,-0.00908887913270606,0.00636123825564139,-0.0215569061137632,0.00337914784835106,0.153088090318524
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,39473,-0.00905976043170797,0.00634100749874178,-0.0214881351292419,0.00336861426582591,0.153094021876676
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,36958,-0.00899020330540878,0.00629728423232493,-0.0213328804007656,0.00335247378994809,0.153421702362782
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GABARAP,Gamma-aminobutyric acid receptor-associated protein,37364,0.00646065167295681,0.00453538959710014,-0.00242871193735945,0.0153500152832731,0.154325582577962
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BTLA,B- and T-lymphocyte attenuator,36958,0.0114507028671127,0.00804666834131468,-0.00432076708186405,0.0272221728160895,0.154749387242149
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RALB,Ras-related protein Ral-B,37052,0.003853204575114,0.00271468136635777,-0.00146757090294723,0.00917398005317524,0.15580757971204
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCNE1,G1/S-specific cyclin-E1,37052,0.0125844383469387,0.00887891303972945,-0.00481823121093104,0.0299871079048084,0.15640717100365
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CSF1,Macrophage colony-stimulating factor 1,39927,0.00344756138055229,0.00243246396100599,-0.00132006798301945,0.00821519074412404,0.156410996565816
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL13,Interleukin-13,39583,0.00642274309693969,0.00453216383877668,-0.0024602980270626,0.015305784220942,0.156459722062424
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCN3B,Sodium channel subunit beta-3,36987,0.005846010742023,0.00413474381260876,-0.00225808713069017,0.0139501086147362,0.157422333758597
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TPSD1,Tryptase delta,37408,-0.00479564031775369,0.00339578614401082,-0.0114513811600149,0.00186010052450751,0.157904416531189
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KLK10,Kallikrein-10,39852,0.00516250064307915,0.00366009006786146,-0.0020112758899293,0.0123362771760876,0.158416093422264
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CST3,Cystatin-C,39893,-0.00348087115053815,0.00246830700402629,-0.00831875287842968,0.00135701057735338,0.158492307937018
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLC44A4,Choline transporter-like protein 4,37035,0.00890713420519625,0.00632130494526104,-0.00348262348751538,0.0212968918979079,0.158839332113657
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CXCL8,Interleukin-8,39746,-0.00863664817428708,0.0061325551550646,-0.0206564562782137,0.00338315992963955,0.159053584436367
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLK,STE20-like serine/threonine-protein kinase,37165,0.0100572319698947,0.00714161765764291,-0.00394033863908539,0.0240548025788748,0.159078394065808
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,WFDC12,WAP four-disulfide core domain protein 12,39986,-0.00812971796423777,0.00577739185489729,-0.0194534059998364,0.00319397007136092,0.159399056345609
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RLN1,Prorelaxin H1,37408,-0.0105266798494322,0.00748758301865193,-0.02520234256599,0.00414898286712563,0.159781240992649
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SIGLEC8,Sialic acid-binding Ig-like lectin 8,37039,0.00598537800022822,0.00427017520662477,-0.00238416540475632,0.0143549214052128,0.161037256758358
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RNF168,E3 ubiquitin-protein ligase RNF168,37052,0.00538181830722565,0.00384579268635823,-0.00215593535803649,0.0129195719724878,0.161715331142012
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TXNDC9,Thioredoxin domain-containing protein 9,37384,-0.00697677890614565,0.00499003352460927,-0.0167572446143798,0.00280368680208851,0.162093149908731
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRR5,Proline-rich protein 5,37052,0.00616111028159335,0.00441828393009877,-0.00249872622140023,0.0148209467845869,0.16320290050439
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SNX15,Sorting nexin-15,37120,-0.00697585989057342,0.00500798414528575,-0.0167915088153335,0.00283978903418666,0.163658965011791
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,UNG,Uracil-DNA glycosylase,37364,0.00448280703258637,0.00322027416929769,-0.0018289303392371,0.0107945444044098,0.163927890122172
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ST13,Hsc70-interacting protein,37120,-0.0071370050986492,0.00513667183923136,-0.0172048819035427,0.00293087170624427,0.164727779493579
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,S100A12,Protein S100-A12,39611,-0.00963985518225297,0.00694499021416274,-0.0232520360020119,0.00397232563750599,0.165147524137562
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,THBS4,Thrombospondin-4,39888,-0.00576152126382568,0.00415193595766437,-0.0138993157408478,0.00237627321319648,0.165256531192969
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TBR1,T-box brain protein 1,37035,-0.00622900897617324,0.00449387164136923,-0.0150369973932569,0.00257897944091044,0.165736194040466
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RBM17,Splicing factor 45,37408,-0.00984540788132237,0.00711261455181161,-0.0237861324028731,0.00409531664022839,0.166314565172596
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,39881,-0.00376992092694479,0.00272513779243286,-0.00911119100011321,0.00157134914622362,0.166565428062234
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HSP90B1,Endoplasmin,39401,0.00866519502216246,0.00627308387981439,-0.00363004938227374,0.0209604394265987,0.167197570100286
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HEBP1,Heme-binding protein 1,39581,0.00689086689757316,0.0049914121174926,-0.00289230085271235,0.0166740346478587,0.1674386638689
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HTR1B,5-hydroxytryptamine receptor 1B,36987,0.0054961898902456,0.0039812069975667,-0.00230697582498512,0.0132993556054763,0.167445928197678
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ELAVL4,ELAV-like protein 4,36987,-0.0108345002491084,0.00785445560605488,-0.0262292332369759,0.0045602327387592,0.167792439079065
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL18RAP,Interleukin-18 receptor accessory protein,39635,0.0218265900478166,0.0159167764721855,-0.00937029183766697,0.0530234719333001,0.170302635762473
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CPB2,Carboxypeptidase B2,37420,0.00287159453200594,0.00209603720933007,-0.00123663839828099,0.00697982746229287,0.170706076374443
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFSF13,Tumor necrosis factor ligand superfamily member 13,39927,0.0033409241406086,0.00244086734444914,-0.0014431758545117,0.00812502413572891,0.171098241160352
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TYMP,Thymidine phosphorylase,39760,0.00859058131824716,0.00628563067355878,-0.00372925480192805,0.0209104174384224,0.171738189562084
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GZMB,Granzyme B,39862,0.00812858709171232,0.00595041763066551,-0.00353423146439207,0.0197914056478167,0.171941460835984
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CA7,Carbonic anhydrase 7,37165,0.00427831437657165,0.00313465698895402,-0.00186561332177823,0.0104222420749215,0.172325507519177
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,REG3G,Regenerating islet-derived protein 3-gamma,37364,-0.00495828069175962,0.00363291303551023,-0.0120787902413597,0.00216222885784043,0.172331650346086
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FHIT,Bis(5'-adenosyl)-triphosphatase,39485,-0.00942667334770981,0.00692354649614986,-0.0229968244801635,0.00414347778474392,0.173363287602732
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RETN,Resistin,39786,0.00516055257540161,0.00379037801453395,-0.00226858833308493,0.0125896934838881,0.173378917534728
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MAEA,E3 ubiquitin-protein transferase MAEA,39473,-0.0050658699818128,0.00372352888724807,-0.012363986600819,0.00223224663719342,0.173690634619783
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TRAF3,"TNF receptor-associated factor 3, Isoform 2",37052,-0.00453294439610514,0.00333254046186333,-0.0110647237013573,0.00199883490914699,0.173787714712206
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,36671,0.00616964849999614,0.00453871991447527,-0.00272624253237538,0.0150655395323677,0.174063849710214
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AMOTL2,Angiomotin-like protein 2,37329,-0.00610886064444857,0.0044941740379289,-0.0149174417587892,0.00269972046989208,0.174079243887981
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,COL24A1,Collagen alpha-1(XXIV) chain,37378,0.00696792248121246,0.0051387830631058,-0.00310409232247491,0.0170399372848998,0.175138371619915
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LIF,Leukemia inhibitory factor,39485,-0.00646989326472291,0.00477860648730502,-0.0158359619798408,0.00289617545039494,0.175778654989633
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,C7,Complement component C7,37145,0.00402367718428624,0.0029756283850045,-0.00180855445032258,0.00985590881889506,0.17633087015808
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CA6,Carbonic anhydrase 6,39813,-0.00797967100988378,0.00590141491465283,-0.0195464442426033,0.00358710222283577,0.176342555508243
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,36705,0.0137470725983371,0.01017420160145,-0.00619436254050488,0.033688507737179,0.176664886024275
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CORO1A,Coronin-1A,39516,-0.011229422397244,0.00831110820713037,-0.0275191944832196,0.00506034968873148,0.17667197773623
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TGFA,Protransforming growth factor alpha,39862,-0.0057420704456328,0.00426161925980907,-0.0140948441948586,0.00261070330359297,0.177873187766498
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,APCS,Serum amyloid P-component,37329,0.00435859907775286,0.00323510454164033,-0.00198220582386219,0.0106994039793679,0.177911995660041
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,USP47,Ubiquitin carboxyl-terminal hydrolase 47,37017,-0.0109040822717359,0.00810189416049023,-0.0267837948262968,0.00497563028282493,0.178368193682328
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ORM1,Alpha-1-acid glycoprotein 1,37385,-0.00248144319030901,0.00184530307651987,-0.00609823722028796,0.00113535083966994,0.178733455063164
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DDA1,DET1- and DDB1-associated protein 1,37017,0.00495226188346813,0.00369511749821086,-0.00229016841302514,0.0121946921799614,0.180197720998265
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ESPL1,Separin,36958,0.0066706637168874,0.00499161542102734,-0.00311290250832618,0.016454229942101,0.181450362880706
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AK1,Adenylate kinase isoenzyme 1,39864,-0.00775424662411957,0.00581405817257555,-0.0191498006423676,0.00364130739412851,0.182319075107126
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ASAH1,Acid ceramidase,37336,-0.00584918290290064,0.00438648096625257,-0.0144466855967557,0.00274831979095439,0.182404479597062
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",37378,-0.0182456462190628,0.013687600138117,-0.0450733424897722,0.00858205005164653,0.182552464809058
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LCN15,Lipocalin-15,37408,-0.00766834129296981,0.00575481659610162,-0.018947781821329,0.00361109923538936,0.182715603117065
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TGFBR3,Transforming growth factor beta receptor type 3,40048,0.00390734696159887,0.00293726526688994,-0.0018496929615054,0.00966438688470315,0.183449066441108
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,37378,-0.00590090183059382,0.00444396746586705,-0.0146110780636932,0.0028092744025056,0.184251600375116
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TXNDC5,Thioredoxin domain-containing protein 5,40005,-0.00844102180560518,0.00636137259117867,-0.0209093120843154,0.00402726847310501,0.184554470610613
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GRK5,G protein-coupled receptor kinase 5,39581,-0.00652926318209183,0.00492447082917299,-0.0161812260072709,0.00312269964308722,0.184898322647762
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CNPY2,Protein canopy homolog 2,39581,0.00742369658576279,0.00559957833011971,-0.00355147694127184,0.0183988701127974,0.184938492020225
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CRYBB2,Beta-crystallin B2,37384,-0.00698397978053271,0.00526920413090708,-0.0173116198771106,0.00334366031604516,0.185049794988477
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ASRGL1,Isoaspartyl peptidase/L-asparaginase,37039,-0.0125979726983198,0.00950692716321298,-0.0312315499382172,0.00603560454157764,0.185148976713593
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MUC2,Mucin-2,37433,0.0110854169945777,0.00836929902900991,-0.00531840910228167,0.0274892430914372,0.185348223490848
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,37378,-0.0209124833990198,0.0157971269106596,-0.0518748521439126,0.010049885345873,0.185586671679064
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ENG,Endoglin,40048,0.00208409751352743,0.00157454219874434,-0.00100200519601147,0.00517020022306634,0.185647555908624
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FGF3,Fibroblast growth factor 3,37052,0.00377864676481261,0.00285680816831893,-0.00182069724509248,0.00937799077471771,0.185964310455903
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BHLHE40,Class E basic helix-loop-helix protein 40,36987,0.00877298640950799,0.00663527460712638,-0.00423215182045971,0.0217781246394757,0.186133312103647
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RBP7,Retinoid-binding protein 7,37378,-0.00739086485969131,0.00559292409188612,-0.0183529960797881,0.00357126636040549,0.186368049163331
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PBK,Lymphokine-activated killer T-cell-originated protein kinase,36958,0.00373153588614971,0.00282519226012014,-0.00180584094368576,0.00926891271598519,0.186588544257477
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CACYBP,Calcyclin-binding protein,37084,-0.012728308972055,0.00964329262723959,-0.0316291625214446,0.00617254457733455,0.18688685647559
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EPHA4,Ephrin type-A receptor 4,37120,-0.00345158846654069,0.00261596890657942,-0.00857888752343636,0.00167571059035498,0.187048100813328
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MEGF11,Multiple epidermal growth factor-like domains protein 11,37017,0.00385612163279444,0.00294458107706898,-0.00191525727826076,0.00962750054384965,0.190365750935025
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MYO6,Unconventional myosin-VI,37408,0.00463248830450412,0.00354260168311114,-0.00231101099439371,0.011575987603402,0.191013739234824
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL10RA,Interleukin-10 receptor subunit alpha,39583,0.00710348434824147,0.00543257920716369,-0.00354437089779937,0.0177513395942823,0.191037894897783
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL19,Interleukin-19,39415,-0.00832267500241624,0.00637860860091754,-0.0208247478602146,0.00417939785538214,0.191987390374743
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,STX4,Syntaxin-4,39784,-0.00717970308352967,0.00550756347290966,-0.0179745274904326,0.00361512132337326,0.192386162064035
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GAS2,Growth arrest-specific protein 2,37165,-0.00642364587021412,0.00493057385790437,-0.0160875706317067,0.00324027889127844,0.192659071036658
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NTF3,Neurotrophin-3,39862,0.00407144160412205,0.0031263114951532,-0.00205612892637821,0.0101990121346223,0.192827551608534
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GIMAP8,GTPase IMAP family member 8,36958,-0.00598048537845516,0.00459805249807988,-0.0149926682746917,0.00303169751778141,0.193399051918196
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TJP3,Tight junction protein ZO-3,36987,0.00525005817354915,0.00403981637750606,-0.00266798192636272,0.013168098273461,0.19376832230891
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PROC,Vitamin K-dependent protein C,39904,-0.00310393276620236,0.00239364028147989,-0.00779546771790294,0.00158760218549823,0.194738783016738
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RANBP1,Ran-specific GTPase-activating protein,37039,-0.00629408411222037,0.00485465416770172,-0.0158092062809157,0.00322103805647501,0.194824208888654
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LONP1,"Lon protease homolog, mitochondrial",37039,0.0105161031764319,0.00811138479770579,-0.00538221102707147,0.0264144173799352,0.194839020734527
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,THY1,Thy-1 membrane glycoprotein,40005,0.00324936399506126,0.00250676805047685,-0.00166390138387336,0.00816262937399589,0.194912580531806
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NBL1,Neuroblastoma suppressor of tumorigenicity 1,39909,-0.00306936269732985,0.00237156181818033,-0.0077176238609633,0.0015788984663036,0.195602244337836
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RBP1,Retinol-binding protein 1,37035,0.00846823116029624,0.00654799453563881,-0.00436583812955582,0.0213023004501483,0.195945316741853
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CNTF,Ciliary neurotrophic factor,36987,0.00407601150932952,0.00315493294142174,-0.00210765705585709,0.0102596800745161,0.196397655525845
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ATP2B4,Plasma membrane calcium-transporting ATPase 4,37017,0.00763581998689343,0.00592067659931208,-0.00396870614775825,0.0192403461215451,0.197182004084479
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EPHA10,Ephrin type-A receptor 10,39485,0.0076871768622849,0.00596916579495884,-0.00401238809583443,0.0193867418204042,0.19782969774398
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GLP1R,Glucagon-like peptide 1 receptor,36987,0.0045277951306771,0.00352351084717446,-0.00237828612978485,0.0114338763911391,0.198806656536189
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CYB5R2,NADH-cytochrome b5 reductase 2,37216,0.00664906172559473,0.00517469310940725,-0.00349333676884348,0.016791460220033,0.198842857942388
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FCN2,Ficolin-2,39806,-0.00483210313182512,0.00376568898927196,-0.0122128535507982,0.00254864728714792,0.199443360081901
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DUSP3,Dual specificity protein phosphatase 3,39485,0.0101230264573638,0.00789456445999156,-0.00535031988421966,0.0255963727989472,0.199764160439762
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DAB2,Disabled homolog 2,40026,-0.0132653119023406,0.0103579770226867,-0.0335669468668065,0.00703632306212529,0.200322496927105
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MNAT1,CDK-activating kinase assembly factor MAT1,37165,-0.00521771982736595,0.00407438031551091,-0.0132035052457673,0.00276806559103544,0.200350624167171
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TMEM25,Transmembrane protein 25,37408,-0.00531207756994865,0.00415450569716943,-0.0134549087364007,0.00283075359650343,0.201049117431605
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,UHRF2,E3 ubiquitin-protein ligase UHRF2,37017,0.00409939691427497,0.00321415748313649,-0.00220035175267256,0.0103991455812225,0.20218356294633
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,37433,0.00301482716270476,0.00236785250935795,-0.00162616375563681,0.00765581808104633,0.202957297901043
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,39243,-0.00728178072256722,0.00572042702496696,-0.0184938176915024,0.00393025624636801,0.203057308872942
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DCTPP1,dCTP pyrophosphatase 1,39864,0.00374349405155644,0.0029430668606653,-0.00202491699534755,0.00951190509846042,0.203402104114875
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,XRCC4,DNA repair protein XRCC4,39485,-0.00439593975754844,0.00345856374298086,-0.0111747246937909,0.00238284517869405,0.203736745335606
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DCUN1D1,DCN1-like protein 1,36987,0.00885356610441634,0.00697064388302742,-0.00480889590631741,0.0225160281151501,0.204063793072918
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DNAJB8,DnaJ homolog subfamily B member 8,39581,0.00671619238697226,0.00529370540788647,-0.00365947021248523,0.0170918549864298,0.204562261526639
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NGFR,Tumor necrosis factor receptor superfamily member 16,37433,-0.00351251137828718,0.00277269193494009,-0.00894698757076975,0.00192196481419539,0.205240134731247
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BTN2A1,Butyrophilin subfamily 2 member A1,39927,0.00293562484284348,0.00231865085926442,-0.00160893084131478,0.00748018052700173,0.20549857412882
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CFH,Complement factor H,36759,-0.00277352474592451,0.00219067385658819,-0.00706724550483736,0.00152019601298833,0.205514433220738
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SYAP1,Synapse-associated protein 1,37120,-0.00676562499921361,0.0053464359181165,-0.0172446393987219,0.00371338940029472,0.205733793028518
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GH2,Growth hormone variant,39473,0.0192905760708748,0.0152715965523621,-0.0106417531717548,0.0492229053135045,0.206548049602482
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KDM3A,Lysine-specific demethylase 3A,37052,0.0108882620515811,0.00864206399415374,-0.00605018337696019,0.0278267074801225,0.207722481970457
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GFRA3,GDNF family receptor alpha-3,39705,0.00322808761903131,0.00256512586129737,-0.00179955906911153,0.00825573430717415,0.208246899704088
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BRD3,Bromodomain-containing protein 3,37017,0.00542615653335642,0.00431457099038925,-0.00303040260780651,0.0138827156745194,0.208546022869827
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],39784,0.00672548022410233,0.00535076489154919,-0.00376201896333408,0.0172129794115388,0.208801256869851
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",37120,0.0104304852820552,0.00832344335173169,-0.00588346368733896,0.0267444342514493,0.21017486936408
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FOLH1,Glutamate carboxypeptidase 2,37052,0.0127243173480262,0.0101725349185429,-0.00721385109231792,0.0326624857883704,0.211011319247404
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,COL4A4,Collagen alpha-4(IV) chain,37143,0.00609283356050373,0.00487644172623376,-0.00346499222291444,0.0156506593439219,0.211525286135211
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RCC1,Regulator of chromosome condensation,37364,-0.00587529254715382,0.00470238821229236,-0.0150919734432468,0.00334138834893921,0.211530457157603
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FAM171B,Protein FAM171B,37364,0.00321438759976217,0.0025732368973222,-0.00182915671898935,0.00825793191851368,0.211627785025869
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ESR1,Estrogen receptor,37052,0.00686702635820239,0.00551745746286327,-0.00394719026900962,0.0176812429854144,0.213301010834208
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,37364,-0.00554638197383902,0.0044576357065596,-0.0142833479586958,0.00319058401101779,0.213431742012456
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EFNB2,Ephrin-B2,37035,0.00697453140085992,0.00561590814004448,-0.00403264855362725,0.0179817113553471,0.214286691597765
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EDDM3B,Epididymal secretory protein E3-beta,37364,0.00593518806649614,0.0047803485497648,-0.00343429509104286,0.0153046712240351,0.214412904215481
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PPM1B,Protein phosphatase 1B,37052,0.00733638483162228,0.0059171978723098,-0.00426132299810493,0.0189340926613495,0.215056244712458
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SV2A,Synaptic vesicle glycoprotein 2A,37035,-0.00709512995748702,0.00572589775092184,-0.0183178895492938,0.00412762963431979,0.215319543653413
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MEPE,Matrix extracellular phosphoglycoprotein,39858,0.00283574481698515,0.00229164024989435,-0.00165587007280777,0.00732735970677808,0.215945580282013
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",36987,-0.00532396061636506,0.00431015475859717,-0.0137718639432155,0.00312394271048539,0.216773225939211
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,WAS,Wiskott-Aldrich syndrome protein,39583,-0.00774407835729654,0.00627023535410177,-0.020033739651336,0.00454558293674293,0.216828916099375
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,39862,-0.0171035706737778,0.0138639334623152,-0.0442768802599157,0.01006973891236,0.217342621793114
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,37120,-0.00986825124451778,0.00800077061004023,-0.0255497616401966,0.00581325915116107,0.217443731317633
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,39928,-0.0128113717844989,0.0104227804716932,-0.0332400215090176,0.00761727794001979,0.219025976526649
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RILPL2,RILP-like protein 2,37433,0.0112779584434833,0.00917642959624701,-0.0067078435651609,0.0292637604521274,0.219087945284788
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EPHX2,Bifunctional epoxide hydrolase 2,39581,-0.0069987345280614,0.00570139405816607,-0.0181734668820669,0.0041759978259441,0.219635095375481
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,39745,-0.00685970760992864,0.00559086760567802,-0.0178178081170576,0.00409839289720028,0.219860065848272
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GPR101,Probable G-protein coupled receptor 101,36987,0.00714672791274065,0.00582603980555091,-0.00427231010613914,0.0185657659316204,0.219962216963521
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD164,Sialomucin core protein 24,39854,-0.00297532025044793,0.0024335080059098,-0.00774499594203113,0.00179435544113527,0.221481226257787
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,COLEC12,Collectin-12,39858,0.00281997697240467,0.00230682751510197,-0.00170140495719519,0.00734135890200453,0.221556218775488
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EFNA4,Ephrin-A4,39716,-0.00313617071827916,0.00256936849948081,-0.00817213297726156,0.00189979154070324,0.222255727279478
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EPN1,Epsin-1,37165,-0.00489161168083781,0.00400848351134636,-0.0127482393630767,0.00296501600140105,0.222367196268181
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PSCA,Prostate stem cell antigen,37378,0.0287108323161958,0.0235423272758356,-0.017432129144442,0.0748537937768337,0.22266021839926
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",37052,0.00569471265150391,0.00467343630012786,-0.00346522249674669,0.0148546477997545,0.223045208924062
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,37017,-0.00528321467917727,0.00434278208741523,-0.0137950675705111,0.00322863821215658,0.223797025081741
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,37364,-0.00762192971302982,0.00626857954226517,-0.0199083456158696,0.00466448618980992,0.224046469582949
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,37378,0.00947978751470415,0.00780160555167774,-0.00581135936658422,0.0247709343959925,0.224346408883654
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TSC1,Hamartin,37052,0.00859890779773565,0.00709286682395466,-0.00530311117721548,0.0225009267726868,0.225407118040459
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DNAJB6,DnaJ homolog subfamily B member 6,37009,-0.00964263095287518,0.0079574615847865,-0.0252392556590567,0.00595399375330636,0.22562135693614
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL7,Interleukin-7,39862,-0.00731165024579467,0.00605557774235524,-0.0191805826208109,0.00455728212922159,0.22728672158613
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SHPK,Sedoheptulokinase,37165,0.00469716916656263,0.00389621111509613,-0.00293940461902579,0.0123337429521511,0.228003392437822
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLSTN1,Calsyntenin-1,39485,-0.00563985302209447,0.00468553931850401,-0.0148235100863623,0.00354380404217338,0.228734569288913
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GP1BB,Platelet glycoprotein Ib beta chain,37017,-0.00757164729737472,0.00630189521407328,-0.0199233619169584,0.00478006732220891,0.229583842452457
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CHCHD6,MICOS complex subunit MIC25,37364,-0.00324140496085318,0.00269806472614408,-0.00852961182409557,0.00204680190238922,0.229624331181028
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCL26,C-C motif chemokine 26,39862,0.00948355442531828,0.00794659938594154,-0.00609178037112714,0.0250588892217637,0.232726373019394
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KIRREL2,Kin of IRRE-like protein 2,39485,0.00439718381321231,0.00368481301928582,-0.00282504970458791,0.0116194173310125,0.232759775177306
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SERPINB6,Serpin B6,39966,-0.00665275641205839,0.00558514646661275,-0.0175996434866194,0.0042941306625026,0.233611611143216
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL33,Interleukin-33,39583,0.0043299492306579,0.00363901330643434,-0.00280251684995341,0.0114624153112692,0.234115839285682
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ARHGAP45,Rho GTPase-activating protein 45,37120,-0.0091550153375552,0.00769472665175507,-0.0242366795749951,0.00592664889988474,0.234155019643863
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MYH7B,Myosin-7B,36958,0.00485448678978001,0.00408186037806923,-0.00314595955123568,0.0128549331307957,0.234349916927109
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ART5,Ecto-ADP-ribosyltransferase 5,36987,0.0067814350075675,0.00572674062109605,-0.00444297660978076,0.0180058466249158,0.236367176813053
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",37408,-0.00516454950555402,0.00436703987691337,-0.0137239476643042,0.00339484865319618,0.236980463075289
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PMS1,PMS1 protein homolog 1,37035,-0.00548181601777054,0.00463738875663458,-0.0145710979807743,0.00360746594523323,0.237190885908807
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRDX6,Peroxiredoxin-6,40026,0.00648547452476643,0.00549083893413094,-0.0042765697861302,0.0172475188356631,0.2375626778095
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",37039,0.0050253075363163,0.00425842395621948,-0.00332120341787389,0.0133718184905065,0.237987214424608
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LTO1,Protein LTO1 homolog,39583,0.00442074932371899,0.00375165911696808,-0.00293250254553845,0.0117740011929764,0.238676868113494
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NRTN,Neurturin,39583,-0.00543812700389192,0.00461596171908518,-0.0144854119732989,0.00360915796551503,0.238769174951378
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BAX,Apoptosis regulator BAX,39452,-0.0100296976258858,0.00851885205558929,-0.0267266476548408,0.00666725240306916,0.239072537058498
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,OTUD6B,Deubiquitinase OTUD6B,37378,-0.00637290450075074,0.0054130791549831,-0.0169825396445176,0.00423673064301614,0.239090145482445
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CHM,Rab proteins geranylgeranyltransferase component A 1,37035,-0.00671926988567945,0.00571402371475874,-0.0179187563666066,0.00448021659524767,0.239645637649767
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GOT1,"Aspartate aminotransferase, cytoplasmic",37433,-0.00457810847247206,0.00391103940019359,-0.0122437456968515,0.00308752875190737,0.24179600936404
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADRA2A,Alpha-2A adrenergic receptor,37017,0.00779407158769778,0.00666378562061616,-0.00526694822870989,0.0208550914041054,0.242176644305365
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ULBP2,UL16-binding protein 2,39745,-0.00395411294803532,0.00338909456120461,-0.0105967382879963,0.00268851239192571,0.24334234378045
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ARL13B,ADP-ribosylation factor-like protein 13B,37017,-0.00753265844328089,0.00646013286313036,-0.0201945188550164,0.00512920196845463,0.243626599146537
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,THTPA,Thiamine-triphosphatase,37341,-0.00954781429764754,0.00820130493137346,-0.0256223719631395,0.00652674336784444,0.244370731163781
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ACSL1,Long-chain-fatty-acid--CoA ligase 1,37017,0.00395661032395008,0.00339869542177282,-0.00270483270272464,0.0106180533506248,0.244382067208135
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SIRT2,NAD-dependent protein deacetylase sirtuin-2,39784,-0.00957705114862459,0.00824402218818142,-0.0257353346374602,0.00658123234021098,0.245376208114123
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PDAP1,28 kDa heat- and acid-stable phosphoprotein,37433,-0.0106367187535141,0.00917613248516746,-0.0286219384244424,0.00734850091741409,0.246406345329412
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCN3,CCN family member 3,40038,-0.003485885094405,0.00300774926411308,-0.00938107365206663,0.00240930346325663,0.246486342702801
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CIRBP,Cold-inducible RNA-binding protein,37378,0.0103630968525311,0.00894667041840058,-0.00717237716753402,0.0278985708725963,0.24675441110026
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PFDN6,Prefoldin subunit 6,37035,0.00710993590768939,0.00615257840089537,-0.00494911775806553,0.0191689895734443,0.247864679522139
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ABHD14B,Protein ABHD14B,39683,0.00616207419478797,0.00533626657132334,-0.00429700828500577,0.0166211566745817,0.248208692771034
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,COX6B1,Cytochrome c oxidase subunit 6B1,37433,-0.00343437162887525,0.00297414970743125,-0.0092637050554405,0.00239496179769,0.248216968521842
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BABAM1,BRISC and BRCA1-A complex member 1,37052,-0.00318218283626455,0.00275675817247125,-0.0085854288543082,0.00222106318177911,0.248389651162319
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,COL9A2,Collagen alpha-2(IX) chain,37165,0.00495447352134264,0.004294245471597,-0.00346224760298747,0.0133711946456727,0.248624567159003
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ZPR1,Zinc finger protein ZPR1,36987,0.0102861279690636,0.00892862162260874,-0.00721397041124958,0.0277862263493767,0.249325676008824
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PSMD9,26S proteasome non-ATPase regulatory subunit 9,39784,-0.00575345465655837,0.00500040243097361,-0.0155542434212666,0.0040473341081499,0.249914800328717
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SOD2,"Superoxide dismutase [Mn], mitochondrial",39854,0.00398307169498636,0.00346383263918122,-0.00280604027780884,0.0107721836677816,0.250201000514647
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TBL1X,F-box-like/WD repeat-containing protein TBL1X,39473,-0.00909005078504621,0.00790831508085853,-0.0245903483435289,0.00641024677343652,0.250396521613047
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TREML1,Trem-like transcript 1 protein,37441,0.0056505466950096,0.00492247590720707,-0.00399750608311625,0.0152985994731355,0.251026997788263
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTPRH,Receptor-type tyrosine-protein phosphatase H,37378,-0.00519593086005477,0.00452673276690494,-0.0140683270831885,0.00367646536307892,0.251058042166424
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD27,CD27 antigen,39909,0.00414548186644239,0.00361419959894213,-0.00293834934748418,0.011229313080369,0.251399300155508
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DEFB104A_DEFB104B,Beta-defensin 104,36987,0.00621584619894495,0.00542880690312709,-0.00442461533118414,0.016856307729074,0.252240539859009
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,37433,-0.00283967983138532,0.00248580867698386,-0.00771186483827369,0.00203250517550304,0.253325993734345
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,37035,0.00444935977796485,0.00390139178908849,-0.0031973681286486,0.0120960876845783,0.254117733954555
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LGALS3,Galectin-3,39897,0.00312126173322253,0.00273914368738417,-0.00224745989405044,0.0084899833604955,0.254510546112964
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,YWHAQ,14-3-3 protein theta,37120,-0.00786234403282424,0.00690115918911529,-0.0213886160434902,0.00566392797784173,0.25460748785918
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,37017,0.00500412479879939,0.00439964867213813,-0.00361918659859134,0.0136274361961901,0.255395201266402
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CGN,Cingulin,37035,-0.00411999369666252,0.00362305568017353,-0.0112211828298026,0.0029811954364776,0.255492120854247
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CTLA4,Cytotoxic T-lymphocyte protein 4,37433,0.00312298592540983,0.0027467150003613,-0.00226057547529831,0.00850654732611797,0.255562776015602
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,37165,0.00550927036399056,0.00484728772610615,-0.0039914135791775,0.0150099543071586,0.255739544919559
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EXOSC10,Exosome component 10,37017,0.00641537856373459,0.00566930386918049,-0.00469645701985917,0.0175272141473284,0.257823686910385
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ZCCHC8,Zinc finger CCHC domain-containing protein 8,37017,0.00618149637280161,0.0054732487567551,-0.00454607119043838,0.0169090639360416,0.258749012525706
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,37017,0.00424919722872023,0.00376343620103805,-0.00312713772531435,0.0116255321827548,0.258887286286402
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NPHS2,Podocin,37052,0.0106753692140413,0.00947103185261247,-0.00788785321707918,0.0292385916451617,0.259695297974241
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",39485,0.00316731497943203,0.00281915033729453,-0.00235821968166526,0.00869284964052932,0.261242525750012
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RLN2,Prorelaxin H2,37091,-0.0148069951656135,0.0131971944163079,-0.040673496221577,0.0110595058903501,0.261891079819554
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PON2,Serum paraoxonase/arylesterase 2,39581,-0.00358493117037428,0.00319834151228748,-0.00985368053445775,0.00268381819370918,0.262359509340122
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,INSL4,Early placenta insulin-like peptide,37364,-0.00555988775040705,0.00496336781937086,-0.0152880886763739,0.00416831317555983,0.262655065151305
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AIF1,Allograft inflammatory factor 1,39473,-0.00548570361803071,0.004900271698068,-0.015090236146244,0.00411882891018256,0.262957211852517
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DLL4,Delta-like protein 4,37039,-0.0089369628353171,0.00799181982680158,-0.0246009296958482,0.00672700402521399,0.263474724446175
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,40005,-0.00579267890772745,0.00519224363731988,-0.0159694764368744,0.00438411862141952,0.26459252008155
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD3D,T-cell surface glycoprotein CD3 delta chain,36987,0.00357106978829373,0.00321153311278767,-0.0027235351127701,0.00986567468935756,0.266179270557052
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ZBP1,Z-DNA-binding protein 1,37052,0.00425349490222464,0.00382637180167372,-0.00324619382905585,0.0117531836335051,0.26631918845719
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RNASE3,Eosinophil cationic protein,39787,0.0110823944945671,0.0099813547416507,-0.00848106079906829,0.0306458497882024,0.266882378281991
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DAPK2,Death-associated protein kinase 2,37052,-0.00548434754127499,0.0049440007345657,-0.0151745889810238,0.00420589389847377,0.267323838990122
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRDX5,"Peroxiredoxin-5, mitochondrial",40054,0.00713032963365364,0.00642802397134955,-0.00546859735019148,0.0197292566174988,0.267335865583189
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MAPRE3,Microtubule-associated protein RP/EB family member 3,36958,0.0148147568209234,0.0133577863111731,-0.0113665043489758,0.0409960179908226,0.267419161425547
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD101,Immunoglobulin superfamily member 2,37378,-0.00433641191088004,0.00391009684223255,-0.0120002017216558,0.00332737789989575,0.267437277718511
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ACTN2,Alpha-actinin-2,37017,-0.00608979897484918,0.00549326686429671,-0.0168566020288707,0.00467700407917237,0.267625923158327
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GSTT2B,Glutathione S-transferase theta-2B,37384,-0.0245594706398949,0.0221829472277818,-0.0680380472063472,0.0189191059265574,0.268256165387966
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BRD2,Bromodomain-containing protein 2,36987,0.00348336097125563,0.00314737168214986,-0.00268548752575809,0.00965220946826936,0.268421300330494
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HMOX2,Heme oxygenase 2,39485,0.00486084008500525,0.00440021083668491,-0.00376357315489718,0.0134852533249077,0.269313787894447
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLMP,CXADR-like membrane protein,40026,-0.0020976313403491,0.00190195219195384,-0.00582545763657862,0.00163019495588042,0.270094258073628
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL12RB1,Interleukin-12 receptor subunit beta-1,39583,0.00377956254889792,0.00342890859318863,-0.0029410982937518,0.0105002233915476,0.270363781232134
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LELP1,Late cornified envelope-like proline-rich protein 1,36987,0.00749009628867432,0.00681341435924225,-0.00586419585544049,0.0208443884327891,0.271650360786113
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TCOF1,Treacle protein,37433,-0.00310785526534907,0.00283039081693897,-0.00865542126654946,0.00243971073585131,0.272210676747884
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HYOU1,Hypoxia up-regulated protein 1,40048,-0.00219131872193279,0.0019964467980506,-0.00610435444611197,0.00172171700224639,0.272391423401522
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,37039,-0.0048071886803738,0.00438065301857401,-0.0133932685967789,0.00377889123603125,0.272500581774071
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CNTNAP4,Contactin-associated protein-like 4,37035,0.0105770540424061,0.0096420861825683,-0.00832143487542779,0.02947554296024,0.272675699877498
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VCPKMT,Protein-lysine methyltransferase METTL21D,36958,-0.00877521029900424,0.00802057257751428,-0.0244955325509322,0.00694511195292376,0.273936609143213
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DTX2,Probable E3 ubiquitin-protein ligase DTX2,37035,0.00639469851400134,0.00584965653790678,-0.00507062830029595,0.0178600253282986,0.274336941484692
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LACTB2,Endoribonuclease LACTB2,39864,-0.00675938758399957,0.00618382575175859,-0.0188796860574464,0.00536091088944727,0.274377164588882
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",36987,0.00569426228987363,0.00521900420649148,-0.00453498595484967,0.0159235105345969,0.27526519599762
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PADI2,Protein-arginine deiminase type-2,39583,-0.00577903307432089,0.00529964442136883,-0.0161663361402038,0.00460826999156203,0.27552870251903
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PLXDC1,Plexin domain-containing protein 1,39473,-0.00348317073941736,0.00319748309665045,-0.00975023760885225,0.00278389613001753,0.276017414931636
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MPRIP,Myosin phosphatase Rho-interacting protein,37334,0.00453387122554174,0.0041671705041515,-0.0036337829625952,0.0127015254136787,0.276615657576176
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",36958,-0.00511954255815554,0.0047087716842624,-0.0143487350593098,0.00410964994299876,0.276952862847547
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IGSF21,Immunoglobulin superfamily member 21,37039,-0.00397023266158113,0.00367342267435691,-0.0111701411033207,0.00322967578015841,0.279806176253126
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EIF4E,Eukaryotic translation initiation factor 4E,37052,-0.00914346387335781,0.00846362971363403,-0.0257321781120805,0.0074452503653649,0.280017593293298
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LZTFL1,Leucine zipper transcription factor-like protein 1,37120,-0.00724466896456653,0.00670607422366749,-0.0203885744429548,0.00589923651382175,0.280021820290739
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLIT2,Slit homolog 2 protein,39485,-0.00517863524409995,0.00480227798538768,-0.0145911000954598,0.00423382960725991,0.280885062697033
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VGF,Neurosecretory protein VGF,37408,0.00291518277817875,0.00271515510445811,-0.00240652122655914,0.00823688678291664,0.282989371417765
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DNAJA4,DnaJ homolog subfamily A member 4,37384,-0.00694107282628194,0.00646590445314076,-0.0196142455544378,0.00573209990187396,0.283071235566518
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TSLP,Thymic stromal lymphopoietin,39581,-0.00598450438760732,0.00557975867413131,-0.0169208313889047,0.00495182261369004,0.283494824056514
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NAGK,N-acetyl-D-glucosamine kinase,37022,-0.00572853003411607,0.00534390228732751,-0.016202578517278,0.00474551844904584,0.283750884003154
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,39581,-0.00304205728019873,0.00284379733599333,-0.00861590005874567,0.0025317854983482,0.284763305565619
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VSIG4,V-set and immunoglobulin domain-containing protein 4,39827,0.00377527954221254,0.00353540776113415,-0.00315411966961039,0.0107046787540355,0.285605043219647
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TMPRSS11B,Transmembrane protease serine 11B,36987,0.0076160498398132,0.00713515782940409,-0.00636885950581882,0.0216009591854452,0.285811992998687
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PPP3R1,Calcineurin subunit B type 1,39745,0.00411246372689171,0.00385464449295492,-0.00344263947929992,0.0116675669330833,0.286039826608857
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ANXA4,Annexin A4,39779,0.0071757203041762,0.00673013651899158,-0.00601534727304729,0.0203667878813997,0.286346138605902
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CTNNA1,Catenin alpha-1,36987,0.00347336278324732,0.0032655919332082,-0.00292719740584076,0.00987392297233539,0.287518515654993
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HEPACAM2,HEPACAM family member 2,37384,-0.00412985344508165,0.00388787686867218,-0.0117500921076791,0.00349038521751582,0.288146282421816
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,37165,0.00828347784923497,0.00780153278456984,-0.0070075264085219,0.0235744821069919,0.288356800814727
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DEFB118,Beta-defensin 118,36987,0.00572896337956235,0.00540101436142786,-0.00485702476883625,0.016314951527961,0.288836731569814
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IZUMO1,Izumo sperm-egg fusion protein 1,36958,0.00492349817243388,0.0046499822598114,-0.00419046705679645,0.0140374634016642,0.289700901559811
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MCTS1,Malignant T-cell-amplified sequence 1,37378,0.00244655264282505,0.00231445963754131,-0.0020897882467559,0.00698289353240601,0.290497191799567
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,C7orf50,Uncharacterized protein C7orf50,37384,-0.00215008415735581,0.00203458479419351,-0.00613787035397508,0.00183770203926347,0.290636346286238
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ATOX1,Copper transport protein ATOX1,39909,-0.0071324069623249,0.00676275055911243,-0.0203873980581853,0.00612258413353547,0.291596427156282
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",39485,-0.00536281556636995,0.00509075776182666,-0.0153407007795502,0.0046150696468103,0.292154975650931
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IGFBP6,Insulin-like growth factor-binding protein 6,39821,0.00269404681961854,0.00256445849933798,-0.00233229183908389,0.00772038547832098,0.293489294052842
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,39877,0.00475348104554929,0.00453295013353871,-0.00413110121618658,0.0136380633072852,0.294354763926506
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,WASF3,Wiskott-Aldrich syndrome protein family member 3,39485,-0.00816614188156714,0.00782581162532103,-0.0235047326671964,0.00717244890406209,0.296738399062078
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FAM171A2,Protein FAM171A2,37408,-0.0152188771764833,0.0145856231548142,-0.0438066985599191,0.0133689442069525,0.296774137691189
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,39473,0.00456281282919453,0.00437714463289768,-0.00401639065128492,0.013142016309674,0.297234226617763
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ACE,Angiotensin-converting enzyme,37441,-0.00246610608915597,0.00238063873855173,-0.00713215801671735,0.00219994583840541,0.300266767490191
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IGFL4,Insulin growth factor-like family member 4,37052,-0.00737077224323128,0.0071302498823552,-0.0213460620126475,0.00660451752618491,0.301280105654216
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PEPD,Xaa-Pro dipeptidase,37441,0.00246491696718408,0.00238567381028628,-0.00221100370097703,0.00714083763534519,0.301521104199872
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCDC50,Coiled-coil domain-containing protein 50,37408,0.00739526713701212,0.00717399821173759,-0.00666576935799356,0.0214563036320178,0.302632767014488
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PEBP1,Phosphatidylethanolamine-binding protein 1,39854,-0.00550233872593032,0.00535088790824816,-0.0159900790260967,0.00498540157423606,0.303822463307511
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ATF4,Cyclic AMP-dependent transcription factor ATF-4,36958,0.00320423018615429,0.00311642316768297,-0.00290395922250434,0.00931241959481292,0.303886231444696
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MSLNL,Mesothelin-like protein,37035,0.00347206408714778,0.00338268331726492,-0.00315799521469146,0.010102123388987,0.30471106756707
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SULT1A1,Sulfotransferase 1A1,40005,0.0122912090310523,0.011975451773281,-0.0111806764445785,0.0357630945066832,0.304733983249442
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SIRPB1,Signal-regulatory protein beta-1,39831,0.00421633785720604,0.00411284031659978,-0.00384482916332953,0.0122775048777416,0.305301105711564
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,37027,-0.00266232676732134,0.00259858967058834,-0.00775556252167448,0.0024309089870318,0.305604976086238
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,APOH,Beta-2-glycoprotein 1,39854,0.00337396598459074,0.00329590986053137,-0.00308601734205075,0.00983394931123223,0.306000640372234
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD7,T-cell antigen CD7,37033,0.00406329087545544,0.00397205468635526,-0.00372193630980086,0.0118485180607117,0.306341042679492
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KLRF1,Killer cell lectin-like receptor subfamily F member 1,37052,-0.00402355597165614,0.00394079837082834,-0.0117475207784797,0.00370040883516741,0.307273061226211
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCN3A,Sodium channel protein type 3 subunit alpha,37035,-0.00364307398452276,0.00357707302753591,-0.0106541371184931,0.00336798914944761,0.308482326306013
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SOD1,Superoxide dismutase [Cu-Zn],39483,-0.0045627555495154,0.00449697006213754,-0.013376816871305,0.00425130577227419,0.310298495806133
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VPS4B,Vacuolar protein sorting-associated protein 4B,37364,-0.0089131525115718,0.00879346086879946,-0.0261483358144187,0.00832203079127515,0.310786358237689
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AOC1,Amiloride-sensitive amine oxidase [copper-containing],39583,0.00515481934597842,0.00508595678513995,-0.00481365595289589,0.0151232946448527,0.310818017922416
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BAG3,BAG family molecular chaperone regulator 3,39716,-0.00370536428267399,0.00367064908382243,-0.0108998364869659,0.00348910792161798,0.312770673506868
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HDGF,Hepatoma-derived growth factor,40010,-0.00878126199206435,0.00871571179345448,-0.0258640571072351,0.00830153312310642,0.313699602915408
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CA11,Carbonic anhydrase-related protein 11,39473,0.00292759602919533,0.00291512703437692,-0.00278605295818343,0.0086412450165741,0.315260515782944
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RASA1,Ras GTPase-activating protein 1,39485,-0.00304733942505444,0.0030382638190328,-0.00900233651035874,0.00290765766024985,0.315882616175078
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SAP18,Histone deacetylase complex subunit SAP18,37165,0.0068108663089915,0.00679922037737013,-0.00651560563065396,0.020137338248637,0.316500523919355
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NUP50,Nuclear pore complex protein Nup50,37017,0.00307617523109472,0.00307502576579847,-0.00295087526987027,0.00910322573205971,0.317148038657352
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GART,Trifunctional purine biosynthetic protein adenosine-3,37408,0.00246741838052252,0.00248256733041518,-0.00239841358709123,0.00733325034813627,0.320290342330242
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PROCR,Endothelial protein C receptor,37017,0.00337550139123275,0.0033989579929018,-0.00328645627485478,0.0100374590573203,0.320680030882654
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GPR158,Probable G-protein coupled receptor 158,37408,0.00328760771761208,0.0033119225258956,-0.0032037604331433,0.00977897586836746,0.320894182305207
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",37384,-0.00233187477098413,0.00235239959494755,-0.00694257797708133,0.00227882843511308,0.321569080319557
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",39473,0.00745544855849377,0.00752155778409583,-0.00728680469833405,0.0221977018153216,0.321598067703735
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PCARE,Photoreceptor cilium actin regulator,36987,-0.00784570652619537,0.00792835635383805,-0.0233852849797179,0.0076938719273272,0.322399931338639
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TEX101,Testis-expressed protein 101,37035,0.00445597713749689,0.00453303578380704,-0.00442877299876492,0.0133407272737587,0.325625167819228
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PLA2G4A,Cytosolic phospholipase A2,39927,-0.00803770975733663,0.00819256962504848,-0.0240951462224317,0.00801972670775838,0.326559424937888
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MATN2,Matrilin-2,39881,-0.00270568379604974,0.00276445049745668,-0.00812400677106482,0.00271263917896535,0.327722255120472
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLASP1,CLIP-associating protein 1,36958,-0.0066419986379192,0.0067948848679004,-0.019959972979004,0.00667597570316559,0.328339827251687
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ATXN10,Ataxin-10,39485,-0.00665177950382857,0.00680700883417258,-0.0199935168188068,0.00668995781114969,0.328487424056393
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IFNAR1,Interferon alpha/beta receptor 1,37378,0.00231055113790192,0.00236679495287227,-0.00232836696972773,0.00694946924553157,0.328964849826378
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFSF11,Tumor necrosis factor ligand superfamily member 11,39862,0.00556028000978463,0.00571574878331435,-0.0056425876055115,0.0167631476250808,0.330667452433701
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FCAR,Immunoglobulin alpha Fc receptor,39862,-0.00422184253832514,0.0043444525755152,-0.0127369695863349,0.00429328450968465,0.331175794062892
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MYBPC2,"Myosin-binding protein C, fast-type",37039,-0.00767202700656891,0.00790374077276411,-0.0231633589211866,0.00781930490804875,0.331723961340156
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DCDC2C,Doublecortin domain-containing protein 2C,36958,0.00571430754179143,0.00588855795976695,-0.0058272660593518,0.0172558811429347,0.331860761084914
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,COPE,Coatomer subunit epsilon,39485,0.00427126275408239,0.00440234964482076,-0.00435734254976631,0.0128998680579311,0.331950154582192
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,37449,0.0017250570415116,0.00177839151492384,-0.00176059032773913,0.00521070441076232,0.332058915420437
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,37017,0.00441262749924234,0.00455458325728318,-0.00451435568503268,0.0133396106835174,0.332646663075493
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,36958,0.00390475759592079,0.00403681489191285,-0.0040073995922284,0.01181691478407,0.333418560528901
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRL,Prolactin,40005,0.00679181202830948,0.00703713820725139,-0.00700097885790326,0.0205846029145222,0.33448997167308
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TPMT,Thiopurine S-methyltransferase,39473,-0.00652176897232859,0.00676225336451938,-0.0197757855667866,0.00673224762212938,0.334841696499129
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BOLA1,BolA-like protein 1,36987,-0.00491766493351925,0.00510956038348176,-0.0149324032851435,0.00509707341810499,0.335844427211298
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MAPT,Microtubule-associated protein tau,39485,0.00469896646092935,0.00489961963421145,-0.00490428802212509,0.0143022209439838,0.33754981023557
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IMPA1,Inositol monophosphatase 1,39745,0.00543842978769407,0.00569300380456767,-0.00571985766925857,0.0165967172446467,0.339449135996794
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,36987,0.00546210578710104,0.00573677197051088,-0.00578196727510027,0.0167061788493024,0.341052732998337
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PARK7,Parkinson disease protein 7,39854,-0.00462848269302386,0.00487023008670559,-0.0141741336629668,0.00491716827691909,0.341942592348447
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CXCL14,C-X-C motif chemokine 14,39583,-0.00545735785896292,0.00574537657925546,-0.0167182959543036,0.00580358023637779,0.342193176579128
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NARS1,"Asparagine--tRNA ligase, cytoplasmic",37408,-0.00414755027413437,0.00437080507597646,-0.0127143282230482,0.00441922767477949,0.342677538568754
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MAGED1,Melanoma-associated antigen D1,39473,-0.00426066583397396,0.00449944781841715,-0.0130795835580716,0.00455825189012365,0.343688684469302
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FBN2,Fibrillin-2,37035,0.00529057768421091,0.00560327042854226,-0.00569183235573192,0.0162729877241537,0.345087528105247
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IGF1R,Insulin-like growth factor 1 receptor,39784,0.00190340637368914,0.00201723161790175,-0.00205036759739828,0.00585718034477657,0.345401935564259
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,36958,-0.00492746492788194,0.0052315122379359,-0.0151812289142363,0.00532629905847243,0.346270651130838
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IFNG,Interferon gamma,39583,-0.0100075353516272,0.010634364084126,-0.0308508889565142,0.0108358182532597,0.346690464439855
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,37017,0.00292617432868302,0.00311134548110486,-0.00317206281428251,0.00902441147164856,0.34698601186505
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PCDH1,Protocadherin-1,40014,0.00181533993788698,0.00193181739159833,-0.00197102214964576,0.00560170202541971,0.347382558339422
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NID1,Nidogen-1,39888,0.00327204309459281,0.00348963528496936,-0.00356764206394713,0.0101117282531327,0.348440413814801
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RPA2,Replication protein A 32 kDa subunit,37052,0.00277542497558305,0.00296396333552723,-0.00303394316205033,0.00858479311321642,0.349089679239925
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,40026,0.00258333829963572,0.00276187751184372,-0.00282994162357797,0.0079966182228494,0.349618910990485
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL1RL1,Interleukin-1 receptor-like 1,39998,-0.00405924663409177,0.00435239517629536,-0.0125899411796307,0.00447144791144713,0.351016408976106
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CBX2,Chromobox protein homolog 2,37017,0.0035083939268721,0.00376211016718418,-0.0038653420008089,0.0108821298545531,0.351064242070778
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,39784,-0.00388786687966123,0.00417494862977536,-0.0120707661940209,0.00429503243469847,0.351745070052189
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ID4,DNA-binding protein inhibitor ID-4,37165,0.00383743900485864,0.0041207993499592,-0.00423932772106139,0.0119142057307787,0.351748107336084
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL1A,Interleukin-1 alpha,39583,0.00461976316205076,0.00496493481759245,-0.00511150908043045,0.014351035404532,0.35213787886571
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GNPDA2,Glucosamine-6-phosphate isomerase 2,37120,-0.00319408209756141,0.0034383328650169,-0.00993321451299453,0.00354505031787171,0.352925460302101
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPRR3,Small proline-rich protein 3,37384,-0.00564078443527839,0.00608124402612823,-0.0175600227264897,0.00627845385593294,0.353646799505691
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ATF2,Cyclic AMP-dependent transcription factor ATF-2,39485,0.00594831214571266,0.00641874926307613,-0.00663243640991654,0.0185290607013419,0.354092002550375
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADGRE2,Adhesion G protein-coupled receptor E2,39927,0.0024122041949124,0.00260530948818219,-0.00269420240192469,0.00751861079174949,0.354522203427486
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,39473,-0.00496649129377364,0.00536534299763285,-0.015482563569134,0.00554958098158675,0.354636243760177
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PMM2,Phosphomannomutase 2,37017,0.00516409948918796,0.00559857997333879,-0.00580911725855607,0.016137316236932,0.356339740837731
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GHRL,Appetite-regulating hormone,39864,0.00656042262595945,0.00712339378529031,-0.00740142919320956,0.0205222744451285,0.357080657261388
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CENPJ,Centromere protein J,37165,-0.00622277236431079,0.00676044109790518,-0.019473236916205,0.00702769218758337,0.357344730157024
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NFIC,Nuclear factor 1 C-type,37408,0.00358108711833534,0.00389474951221246,-0.00405262192560109,0.0112147961622718,0.357868605432952
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,APRT,Adenine phosphoribosyltransferase,39734,-0.00410424531901649,0.00446631439384818,-0.0128582215309589,0.00464973089292593,0.358144389120591
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRKCQ,Protein kinase C theta type,39583,-0.00370371855743195,0.00403293098494382,-0.0116082632879218,0.00420082617305793,0.358439832934606
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLEC6A,C-type lectin domain family 6 member A,39473,0.00396432369876761,0.00431689234160782,-0.00449678529078372,0.0124254326883189,0.358461287266228
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRTN3,Myeloblastin,39417,0.00394395583667406,0.00429796515890766,-0.00448005587478495,0.0123679675481331,0.358825117700751
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD200R1,Cell surface glycoprotein CD200 receptor 1,39805,0.00294899612015235,0.00321407777459802,-0.00335059631805978,0.00924858855836447,0.358881572505064
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,37165,0.00579044747584762,0.00632419022094124,-0.00660496535719722,0.0181858603088925,0.35989175636483
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ATRAID,All-trans retinoic acid-induced differentiation factor,37378,-0.002300270997079,0.00251540483502858,-0.00723046447373501,0.00262992247957702,0.360484420853474
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD300A,CMRF35-like molecule 8,37120,0.00245565108190267,0.00268713525807528,-0.00281113402392488,0.00772243618773022,0.360809835681632
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FZD8,Frizzled-8,36987,0.00361310284893102,0.003957671545329,-0.00414393337991382,0.0113701390777759,0.361292700320911
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HDAC8,Histone deacetylase 8,37052,0.00534938055834619,0.00586505772757375,-0.00614613258769835,0.0168448937043907,0.361745183590667
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ARTN,Artemin,39583,0.00379501520294703,0.00416671877266282,-0.00437175359147209,0.0119617839973662,0.362418804663474
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BRD1,Bromodomain-containing protein 1,37165,-0.0026088660305645,0.00286460775976565,-0.00822349723970518,0.00300576517857618,0.362457499280942
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,XPNPEP2,Xaa-Pro aminopeptidase 2,39909,-0.00836937232506282,0.00919561454767404,-0.0263927768385039,0.00965403218837831,0.362758009500461
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,40005,0.00598505136600238,0.00658382784776906,-0.00691925121562497,0.0188893539476297,0.363335486556596
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HSD17B3,Testosterone 17-beta-dehydrogenase 3,37017,-0.00402392018782292,0.00443393112807593,-0.0127144251988517,0.0046665848232059,0.364143848904973
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL36G,Interleukin-36 gamma,37017,-0.00567087008089009,0.0062492418426619,-0.0179193840925074,0.00657764393072724,0.364185873172913
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HSPB1,Heat shock protein beta-1,39613,-0.00586993008016771,0.00647128026705955,-0.0185536394036044,0.00681377924326902,0.364381540622311
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LMOD1,Leiomodin-1,37408,0.00295879844677564,0.00327003629538282,-0.00345047269217469,0.00936806958572597,0.36557616236273
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,B2M,Beta-2-microglobulin,37449,0.00258490720393058,0.00285808051007896,-0.00301693059582419,0.00818674500368535,0.365788394029404
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GMFG,Glia maturation factor gamma,37433,-0.00604300091288137,0.00669418569044975,-0.0191636048661629,0.00707760304040015,0.36668850794916
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL2RG,Cytokine receptor common subunit gamma,37364,0.00314057211073755,0.00349912490047389,-0.00371771269419128,0.00999885691566638,0.36945178659
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GP6,Platelet glycoprotein VI,39832,-0.00738722809922023,0.00823272294636031,-0.0235233650740864,0.00874890887564598,0.369572005465025
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CXCL1,Growth-regulated alpha protein,39835,-0.00789446092520119,0.00880765530319801,-0.0251574653194693,0.00936854346906692,0.370096397432037
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,37017,0.0034243161694662,0.00382793280044431,-0.00407843211940464,0.0109270644583371,0.371038621982525
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GYS1,"Glycogen [starch] synthase, muscle",39581,-0.00775385032013894,0.00867333955617659,-0.0247535958502451,0.00924589520996717,0.371342685821248
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LSM8,U6 snRNA-associated Sm-like protein LSm8,37165,0.00718792955452676,0.00805466633691525,-0.00859921646582713,0.0229750755748807,0.372198347954826
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HLA_A,,37408,0.00266714995862292,0.0029971716785664,-0.00320730653136723,0.00854160644861306,0.373541318876695
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TMSB10,Thymosin beta-10,39854,0.00638160823612243,0.007173305520066,-0.00767807058320693,0.0204412870554518,0.373676441518766
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLAMF6,SLAM family member 6,39473,-0.00312079142966464,0.00350799727398946,-0.00999646608668397,0.0037548832273547,0.373682614481007
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BSND,Barttin,36958,0.00278237765272363,0.00312843357529828,-0.00334935215486101,0.00891410746030827,0.373813266102313
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,OLR1,Oxidized low-density lipoprotein receptor 1,39717,0.0048438986222639,0.00545092314376467,-0.00583991073951487,0.0155277079840427,0.37421102475916
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,37408,-0.0054560883633904,0.00614765030990963,-0.0175054829708133,0.00659330624403248,0.374821256913975
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,37165,0.00420317110201982,0.00473794965866173,-0.00508321022895717,0.0134895524329968,0.375025651288188
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GKN1,Gastrokine-1,39119,-0.00230915596518056,0.00261084958333558,-0.0074264211485183,0.00280810921815718,0.376469333859871
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VSTM1,V-set and transmembrane domain-containing protein 1,39485,-0.00396737129412612,0.00449264987395335,-0.0127729650470747,0.00483822245882245,0.37720638962181
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TK1,"Thymidine kinase, cytosolic",37165,-0.00377836326566586,0.00428932515343612,-0.0121854405664007,0.00462871403506893,0.378400890328309
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AGBL2,Cytosolic carboxypeptidase 2,36987,0.00748386956298874,0.00852078277839096,-0.00921686468265754,0.024184603808635,0.379792805827734
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FCRL6,Fc receptor-like protein 6,39862,-0.00535996878707134,0.00612564782794992,-0.0173662385298532,0.0066463009557105,0.381584645715565
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PI3,Elafin,39590,-0.00429813923200588,0.00492105075694737,-0.0139433987156227,0.00534712025161096,0.382448071585563
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCGB3A1,Secretoglobin family 3A member 1,37120,-0.00198580608078215,0.00227439621196284,-0.00644362265622932,0.00247201049466502,0.382617016397169
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,37017,-0.00532264220515789,0.00610205783152494,-0.0172826755549468,0.00663739114463099,0.383076997427799
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,C2CD2L,Phospholipid transfer protein C2CD2L,39449,-0.00339466411844773,0.0038927559306835,-0.0110244657425874,0.00423513750569193,0.383196450269942
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",37378,0.0082765304070788,0.00950720383650761,-0.0103575891124761,0.0269106499266337,0.384013406358178
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DUSP29,Dual specificity phosphatase 29,37035,-0.00537771920880847,0.00619520321485242,-0.0175203175099192,0.00676487909230228,0.385385152543118
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TPT1,Translationally-controlled tumor protein,39583,0.00525631746689798,0.00606617601297016,-0.00663338751852352,0.0171460224523195,0.386231421758345
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KLK12,Kallikrein-12,39473,0.0110826408989614,0.0127979008923858,-0.0140012448501147,0.0361665266480376,0.386518092119586
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NME1,Nucleoside diphosphate kinase A,37052,0.00175406480700143,0.00202619161709918,-0.00221727076251297,0.00572540037651582,0.386672954201392
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLNS1A,Methylosome subunit pICln,37035,-0.00271556750884802,0.00313956927815849,-0.00886912329403866,0.00343798827634263,0.387082494545648
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLEC14A,C-type lectin domain family 14 member A,39854,0.00241341057977775,0.00280521390378906,-0.00308480867164881,0.00791162983120431,0.3896198788795
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RNF4,E3 ubiquitin-protein ligase RNF4,37165,0.00525393111104684,0.00610799450844324,-0.00671773812550192,0.0172256003475956,0.389709261207917
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MTUS1,Microtubule-associated tumor suppressor 1,37165,-0.00447085800792001,0.00519963257386496,-0.0146621378526953,0.00572042183685531,0.389892109315529
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TMEM132A,Transmembrane protein 132A,37039,-0.00499479042912164,0.00582039459639611,-0.016402763838058,0.00641318297981474,0.390823463431131
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PGLYRP1,Peptidoglycan recognition protein 1,39958,0.00334294509284356,0.00389929455865004,-0.00429967224211052,0.0109855624277976,0.391280554329515
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL11,Interleukin-11,39583,-0.00494814438805855,0.00578586213798898,-0.016288434178517,0.00639214540239985,0.392446284239818
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CA8,Carbonic anhydrase-related protein,37052,0.00206887492235517,0.00242098621098205,-0.00267625805116965,0.00681400789588,0.392810996622396
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,WFDC2,WAP four-disulfide core domain protein 2,39013,0.00283520250589541,0.00332499515765841,-0.00368178800311508,0.0093521930149059,0.393842648853255
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",39784,-0.00256813230770796,0.00302826378200807,-0.00850352932044377,0.00336726470502785,0.39642044354159
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",39473,0.00403340798711584,0.00476158163681745,-0.00529929202104637,0.013366107995278,0.396967330078589
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CRX,Cone-rod homeobox protein,39581,0.0085050095526497,0.0100454844339052,-0.0111841399378044,0.0281941590431039,0.397203114492997
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IFNLR1,Interferon lambda receptor 1,39862,-0.00293311795368093,0.00347303084738475,-0.00974025841455504,0.00387402250719319,0.398379626154502
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SSH3,Protein phosphatase Slingshot homolog 3,36958,-0.00232226490437522,0.00275000852598727,-0.00771228161531027,0.00306775180655984,0.398429311694663
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BGLAP,Osteocalcin,37433,-0.0067679861758206,0.00802361530191273,-0.0224942721675696,0.00895829981592835,0.398959085642247
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MRPL46,"39S ribosomal protein L46, mitochondrial",39485,0.00213921211179898,0.00253660562354114,-0.00283253491034166,0.00711095913393963,0.399053183909529
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FOLR3,Folate receptor gamma,39854,0.0147836497478734,0.0175693473571234,-0.0196522710720885,0.0492195705678353,0.400110937962132
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL1B,Interleukin-1 beta,39474,0.00436489517833672,0.00519052795077272,-0.00580853960517781,0.0145383299618512,0.400397383059057
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ELAC1,Zinc phosphodiesterase ELAC protein 1,37408,-0.0066695398556348,0.00793822645839031,-0.0222284637140798,0.00888938400281021,0.400822243961388
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTGDS,Prostaglandin-H2 D-isomerase,39758,0.00220881991019606,0.00263418314422696,-0.00295417905248878,0.0073718188728809,0.401750333755086
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCRG1,Scrapie-responsive protein 1,37433,-0.00205958158506725,0.00245769685657635,-0.0068766674239569,0.0027575042538224,0.402038234344594
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CRYGD,Gamma-crystallin D,37384,-0.00748558666221647,0.00893896931972704,-0.0250059665288815,0.0100347932044485,0.402376670232103
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,37433,-0.00693026623376987,0.00827976438568695,-0.0231586044297163,0.00929807196217655,0.402600282111618
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FMR1,Synaptic functional regulator FMR1,39473,-0.00276037107561403,0.0033080961758079,-0.00924423958019752,0.00372349742896946,0.40405210030205
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,36987,0.00249843091237623,0.00299485546520894,-0.0033714857994333,0.00836834762418576,0.404160429581323
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GGA1,ADP-ribosylation factor-binding protein GGA1,39485,-0.0054368248307816,0.00651832694235519,-0.0182127456377978,0.00733909597623458,0.404247039415694
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HMMR,Hyaluronan mediated motility receptor,36938,0.00366098329224614,0.00440503856728075,-0.00497289229962413,0.0122948588841164,0.405937988207564
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VAMP8,Vesicle-associated membrane protein 8,37052,-0.00682629152746213,0.00821495508117964,-0.0229276034865742,0.00927502043164996,0.406011784426985
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NDRG1,Protein NDRG1,39485,0.0053523378619661,0.00644597813869118,-0.00728177928986861,0.0179864550138008,0.406360635223189
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FCRLB,Fc receptor-like B,39473,-0.00445569891889293,0.0053777484140898,-0.0149960858105089,0.00608468797272308,0.407375390880398
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,REG1A,Lithostathine-1-alpha,39800,-0.00356673944741988,0.00431609410916134,-0.0120262839013761,0.00489280500653635,0.408600198643104
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL4,Interleukin-4,39583,0.00692807141853901,0.00839386780622277,-0.00952390948165762,0.0233800523187356,0.409172410643487
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCRN1,Secernin-1,39862,0.00431078508953537,0.00522482352901117,-0.00592986902732652,0.0145514392063973,0.409350675118328
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,37408,-0.00182899968541276,0.00221723390717869,-0.006174778143483,0.00251677877265748,0.409442010031791
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CASP8,Caspase-8,39980,0.00471866215470646,0.00572684686088887,-0.00650595769263571,0.0159432820020486,0.40997751138362
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,39210,-0.00288788387210749,0.0035136457842665,-0.00977462960926983,0.00399886186505485,0.411143597862642
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDC123,Cell division cycle protein 123 homolog,36958,-0.00484486815527811,0.00590305050777979,-0.0164148471505265,0.00672511083997027,0.411809464640167
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SMARCA2,Probable global transcription activator SNF2L2,39485,-0.00562049312277962,0.00685501160758581,-0.0190563158736478,0.00781532962808856,0.412279876148695
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KLK11,Kallikrein-11,39775,-0.00221453596662736,0.00270270600454932,-0.00751183973554403,0.00308276780228931,0.412583448116599
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FCRL5,Fc receptor-like protein 5,39854,0.00424405704987761,0.00518646609934632,-0.00592141650484118,0.0144095306045964,0.413201196524322
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KRT14,"Keratin, type I cytoskeletal 14",39060,0.00220249966528037,0.00269876939849182,-0.0030870883557636,0.00749208768632433,0.414448536729105
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SIGLEC15,Sialic acid-binding Ig-like lectin 15,39485,-0.00603188480219913,0.0073982160431804,-0.0205323882468327,0.00846861864243445,0.414903811051555
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AKT2,RAC-beta serine/threonine-protein kinase,37408,-0.00960233842883305,0.0118044026640542,-0.0327389676503792,0.0135342907927131,0.415972111752775
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ACTA2,"Actin, aortic smooth muscle",39581,0.00324228330360299,0.00401364953667108,-0.00462446978827232,0.0111090363954783,0.419209741203692
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PHLDB1,Pleckstrin homology-like domain family B member 1,37378,-0.00398001740911113,0.00494270224057212,-0.0136677138006325,0.00570767898241023,0.420700513483184
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MST1,Hepatocyte growth factor-like protein,37267,-0.00470377265708554,0.00585559985224451,-0.0161807483674848,0.00677320305331369,0.421818628812285
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FH,"Fumarate hydratase, mitochondrial",36987,0.00617555035198593,0.00768941652356127,-0.00889570603419416,0.021246806738166,0.421917954272029
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ITGB6,Integrin beta-6,39583,-0.00220920183700529,0.00275855273439223,-0.00761596519641407,0.00319756152240349,0.423227467101702
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ZNF75D,Zinc finger protein 75D,37165,0.00440797607135205,0.00550417861178604,-0.00638021400774859,0.0151961661504527,0.42323756159099
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ZBTB17,Zinc finger and BTB domain-containing protein 17,39581,-0.00301723664059729,0.00376889829668447,-0.0104042773020988,0.00436980402090427,0.423397372797184
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LSM1,U6 snRNA-associated Sm-like protein LSm1,39473,0.00406138415082218,0.0050812768633319,-0.00589791850130834,0.0140206868029527,0.424137815963435
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MN1,Transcriptional activator MN1,37035,0.00440833646142106,0.00551745916148959,-0.00640588349509854,0.0152225564179407,0.424316733436276
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,STAM,Signal transducing adapter molecule 1,37364,0.00269940389036343,0.00338085320889905,-0.0039270683990787,0.00932587617980556,0.424630019806839
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CUZD1,CUB and zona pellucida-like domain-containing protein 1,37035,-0.00271397922702985,0.00339924229061991,-0.00937649411664488,0.00394853566258518,0.424648667411221
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MGMT,Methylated-DNA--protein-cysteine methyltransferase,39862,0.00907173234875737,0.0113822331998261,-0.0132374447229018,0.0313809094204165,0.42545813720387
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KRT6C,"Keratin, type II cytoskeletal 6C",37017,-0.00297792948830131,0.00374790522762617,-0.0103238237344486,0.00436796475784598,0.426884770986786
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MCFD2,Multiple coagulation factor deficiency protein 2,39784,0.00330300859017028,0.00416341994882496,-0.00485729450952665,0.0114633116898672,0.427591437343275
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CSH1,Chorionic somatomammotropin hormone 1,37441,0.00256171523606256,0.00323136399837275,-0.00377175820074802,0.00889518867287314,0.427928067059786
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDH3,Cadherin-3,40005,-0.00254905218035286,0.0032154797320002,-0.00885139245507326,0.00375328809436754,0.427938653248622
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MYOM1,Myomesin-1,36987,0.00348596974276289,0.00440619583165638,-0.00515017408728361,0.0121221135728094,0.428869711112603
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,39485,0.00360562658256125,0.00455909719190575,-0.00533020391357403,0.0125414570786965,0.429035266890014
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MRI1,Methylthioribose-1-phosphate isomerase,37035,-0.00495971303014735,0.00628547305339325,-0.0172792402147981,0.00735981415450342,0.430082057373953
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ARG1,Arginase-1,39750,-0.00378127978377995,0.00479535777562547,-0.0131801810240059,0.00561762145644598,0.430398970524873
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VNN2,Vascular non-inflammatory molecule 2,39784,-0.00338116142615928,0.00429631237337407,-0.0118019336779725,0.00503961082565391,0.431298539748297
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ANGPTL3,Angiopoietin-related protein 3,39888,-0.00257431814139571,0.00327158799924273,-0.00898663061991146,0.00383799433712005,0.431368944369616
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCL8,C-C motif chemokine 8,39999,-0.00440950705891645,0.00560412525666673,-0.0153935925619832,0.00657457844415035,0.431391565588318
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CSRP3,Cysteine and glycine-rich protein 3,37017,-0.0071248401117734,0.00905749115170038,-0.0248775227691061,0.0106278425455593,0.431516161077248
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LRP2,Low-density lipoprotein receptor-related protein 2,37035,0.00262572143110042,0.00333816194144391,-0.00391707597412963,0.00916851883633048,0.431543670673743
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EDNRB,Endothelin receptor type B,37052,0.00339911934813515,0.00432911564745332,-0.00508594732087335,0.0118841860171437,0.432364263219858
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",36987,0.00232887449872135,0.00296681877369224,-0.00348609029771544,0.00814383929515814,0.432483196627493
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,39854,-0.00200077389713112,0.00254974920628688,-0.00699828234145341,0.00299673454719118,0.432644395068399
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MKI67,Proliferation marker protein Ki-67,37052,0.00286144387693902,0.00364699573045089,-0.00428666775474472,0.0100095555086228,0.432700445464836
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CALB1,Calbindin,39784,0.00305567221921196,0.00389471266209383,-0.00457796459849194,0.0106893090369159,0.43271777175199
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DOC2B,Double C2-like domain-containing protein beta,37035,0.00265654400764291,0.00338786689739764,-0.00398367511125646,0.00929676312654227,0.432975171045279
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TRIAP1,TP53-regulated inhibitor of apoptosis 1,40026,0.00462816153300303,0.00591120173816722,-0.00695779387380472,0.0162141169398108,0.433669320996873
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EIF5,Eukaryotic translation initiation factor 5,37017,-0.00320766465625144,0.00410027417155101,-0.0112442020324914,0.00482887271998854,0.434049475047451
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TLR3,Toll-like receptor 3,40054,-0.00442406066254949,0.00566062472301895,-0.0155188851196666,0.00667076379456765,0.434490568272743
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ITGB1BP2,Integrin beta-1-binding protein 2,39581,-0.00815088615605475,0.0104435816574219,-0.0286203062046017,0.0123185338924922,0.435126932600327
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EPHB4,Ephrin type-B receptor 4,40048,-0.00169914372987526,0.00218333801237096,-0.00597848623412233,0.00258019877437182,0.436443569547136
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BPIFB2,BPI fold-containing family B member 2,37401,-0.00444278579879994,0.00570887993967516,-0.0156321904805632,0.00674661888296336,0.436450731555215
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,37035,0.00342186833360563,0.00440082279873006,-0.00520374435190529,0.0120474810191165,0.436847160685545
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CETN3,Centrin-3,37378,-0.00568486243899323,0.00733043327893043,-0.0200525116656969,0.00868278678771041,0.438048852846771
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GID8,Glucose-induced degradation protein 8 homolog,37408,0.00240233259579604,0.00310844225690977,-0.00369021422774711,0.00849487941933918,0.439629782692657
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CASP4,Caspase-4,37165,0.011840515987673,0.015346008905085,-0.0182376614662937,0.0419186934416397,0.440383009457284
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FZD10,Frizzled-10,37035,-0.00430719599427279,0.00558354448964581,-0.0152509431939786,0.006636551205433,0.440478427476051
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LYPLA2,Acyl-protein thioesterase 2,36987,0.00753767737285317,0.00977696729132992,-0.0116251785181535,0.0267005332638598,0.440742900372036
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LYAR,Cell growth-regulating nucleolar protein,39473,-0.00369301339457144,0.00479086909350483,-0.0130831168178409,0.00569709002869802,0.440810981511508
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GGCT,Gamma-glutamylcyclotransferase,37426,-0.00344625801676738,0.00447533294296115,-0.0122179105849712,0.00532539455143647,0.441279946831214
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,39347,0.00608105729988716,0.00791730984301921,-0.0094368699924305,0.0215989845922048,0.442456624622683
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CRYBB1,Beta-crystallin B1,37433,0.00474530467453893,0.00618614751705565,-0.00737954445889015,0.016870153807968,0.443043965854742
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLTA,Clathrin light chain A,39581,0.00331735214638724,0.00432593164034438,-0.00516147386868776,0.0117961781614622,0.44318064347658
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,39865,-0.0040976060371526,0.00535029334682089,-0.0145841809969216,0.00638896892261635,0.443767524590747
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,37378,-0.00631491642651443,0.00827052279862022,-0.0225251411118101,0.00989530825878119,0.445151754349635
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,37035,0.00713092266482281,0.00935128725472958,-0.0111976003544472,0.0254594456840928,0.445739176882226
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MED18,Mediator of RNA polymerase II transcription subunit 18,39473,-0.00543891473679191,0.00714562076432743,-0.0194443314348737,0.00856650196128985,0.446576843896295
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VAMP5,Vesicle-associated membrane protein 5,39581,0.00373170877722824,0.0049082641163121,-0.00588848889074348,0.0133519064452,0.447092093319386
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PDIA2,Protein disulfide-isomerase A2,36958,-0.00280009324791462,0.00368419257375995,-0.0100211106924841,0.00442092419665488,0.447250921922243
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SIRT1,NAD-dependent protein deacetylase sirtuin-1,37052,0.0063386276802848,0.0083430217022737,-0.0100136948561717,0.0226909502167413,0.447416397641128
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CRHR1,Corticotropin-releasing factor receptor 1,39581,-0.00437770039261871,0.00576507210667349,-0.0156772417216987,0.00692184093646132,0.447655338141915
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SAG,S-arrestin,36987,-0.00375003256421415,0.00494113387131713,-0.0134346549519957,0.00593458982356743,0.447901056499232
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NAP1L4,Nucleosome assembly protein 1-like 4,37358,-0.00283603321369553,0.003765812805679,-0.0102170263128264,0.00454495988543532,0.451403024366988
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MPO,Myeloperoxidase,39854,0.0031662129503113,0.00420736631306798,-0.00508022502330195,0.0114126509239245,0.451737244624217
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL18BP,Interleukin-18-binding protein,39927,0.00206249026605506,0.00274414087009642,-0.00331602583933392,0.00744100637144404,0.45230397016344
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CBLN4,Cerebellin-4,40026,-0.002160977554091,0.00287964099969033,-0.00780507391348405,0.00348311880530204,0.45300490076057
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ITGA6,Integrin alpha-6,39862,-0.00369035769550863,0.00492734837171385,-0.0133479605040678,0.00596724511305052,0.453895888229182
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADGRE5,Adhesion G protein-coupled receptor E5,39958,0.00206689690365253,0.00276460460887084,-0.00335172812973432,0.00748552193703938,0.454695253781112
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MAPK13,Mitogen-activated protein kinase 13,36958,-0.00295711898923855,0.00395724055675819,-0.0107133104804846,0.0047990725020075,0.454915256541943
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GAD1,Glutamate decarboxylase 1,36958,0.00179646964550921,0.00240613353624617,-0.00291955208553329,0.00651249137655171,0.455305814952342
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,39864,0.00337984893101166,0.00453470870767386,-0.0055081801360291,0.0122678779980524,0.456083929463432
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HLA_E,,39862,0.00189095996955242,0.00254309008285414,-0.00309349659284169,0.00687541653194653,0.457148889634278
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GZMH,Granzyme H,39581,0.00518048547482453,0.00699859171644787,-0.0085367542894133,0.0188977252390624,0.459178615663785
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MRPL28,"39S ribosomal protein L28, mitochondrial",37408,0.00247595967805899,0.00334680348160254,-0.00408377514588198,0.00903569450199997,0.459435181786563
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KCNH2,Potassium voltage-gated channel subfamily H member 2,37035,0.00537010078668755,0.00726495637841297,-0.00886921371500187,0.019609415288377,0.45981168048884
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ATP5F1D,"ATP synthase subunit delta, mitochondrial",37017,0.00348582887424929,0.00472500325458732,-0.00577517750474186,0.0127468352532404,0.460684977332474
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NFKB2,Nuclear factor NF-kappa-B p100 subunit,37165,0.00396556937414589,0.00543350200486627,-0.00668409455539201,0.0146152333036838,0.465502834661931
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MELTF,Melanotransferrin,37433,-0.00196900764110883,0.00269908295554674,-0.00725921023398043,0.00332119495176278,0.465702424506845
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ARNT,Aryl hydrocarbon receptor nuclear translocator,39583,-0.00255096273359024,0.00350775945367821,-0.00942617126279953,0.00432424579561905,0.4670933103759
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPRY2,Protein sprouty homolog 2,39583,-0.00626315071922692,0.00861638896367,-0.0231512730880201,0.0106249716495663,0.467305321148025
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ITGA5,Integrin alpha-5,39854,0.00167276315526286,0.00230187114271106,-0.00283890428445082,0.00618443059497653,0.467422146596437
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,37052,-0.00211289361881527,0.00290823867448103,-0.00781304142079808,0.00358725418316754,0.467532929747449
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PSMD5,26S proteasome non-ATPase regulatory subunit 5,37035,0.00372982639898663,0.0051645446507205,-0.00639268111642556,0.0138523339143988,0.470185263359442
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IFNL2,Interferon lambda-2,36987,-0.00415963026757383,0.00576069003162043,-0.0154505827295499,0.00713132219440222,0.470263362697794
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TPPP3,Tubulin polymerization-promoting protein family member 3,39485,0.00260699626584222,0.00361747144638048,-0.00448324776906352,0.00969724030074795,0.471124526406715
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRKG1,cGMP-dependent protein kinase 1,37120,0.00841308764836894,0.0117637993556355,-0.0146439590886766,0.0314701343854145,0.474518104698494
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HIP1,Huntingtin-interacting protein 1,37017,0.00221553956626662,0.00311953360915397,-0.00389874630767516,0.00832982544020839,0.47758340718499
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HMOX1,Heme oxygenase 1,39687,-0.00313807109507135,0.00442422742930685,-0.0118095568565128,0.00553341466637008,0.478153463371954
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RCOR1,REST corepressor 1,39581,-0.00295140653251059,0.00417681342341772,-0.0111379608424093,0.00523514777738815,0.479815118697802
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,L1CAM,Neural cell adhesion molecule L1,39909,0.00187654257039108,0.00265590073713401,-0.00332902287439159,0.00708210801517375,0.479852705022285
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SNX9,Sorting nexin-9,39864,-0.00454524822480642,0.00643697448553598,-0.0171617182164569,0.00807122176684411,0.480126517889699
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CWC15,Spliceosome-associated protein CWC15 homolog,37320,-0.00399369165218805,0.00568617295768198,-0.0151385906492447,0.00715120734486862,0.482472178683501
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CEP290,Centrosomal protein of 290 kDa,37165,-0.00338314811759595,0.00482966660846144,-0.0128492946701804,0.00608299843498847,0.483631663891784
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRC1,Protein regulator of cytokinesis 1,37364,0.00300075581896792,0.0042847651246106,-0.00539738382526886,0.0113988954632047,0.483732393755105
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GUCY2C,Heat-stable enterotoxin receptor,37165,0.00555714359651172,0.00797210090251217,-0.0100681741724121,0.0211824613654356,0.485768716052236
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CXCL10,C-X-C motif chemokine 10,39927,-0.00426664283500329,0.00612086471131609,-0.0162635376691828,0.00773025199917625,0.485771969333846
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ECE1,Endothelin-converting enzyme 1,39485,-0.00226644980698825,0.00325423334891486,-0.00864474717086138,0.00411184755688488,0.486149918599606
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,37165,-0.00418885104961059,0.00601484465165683,-0.015977946566858,0.00760024446763679,0.486178742452818
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CHEK2,Serine/threonine-protein kinase Chk2,39581,-0.0021603647416244,0.00311206665033392,-0.00826001537627888,0.00393928589303007,0.487573483159484
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RAB39B,Ras-related protein Rab-39B,37017,0.00571784404882222,0.00825169717018432,-0.010455482404739,0.0218911705023835,0.488366052470846
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CTAG1A_CTAG1B,Cancer/testis antigen 1,37131,0.00326339485628982,0.00471697070695663,-0.00598186772934518,0.0125086574419248,0.489049139120956
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KRT17,"Keratin, type I cytoskeletal 17",37017,-0.00250261463448417,0.00362679589130142,-0.00961113458143496,0.00460590531246662,0.490184602921662
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,36760,-0.0031713734483131,0.00460845951092022,-0.0122039540897167,0.00586120719309052,0.491362224642487
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD276,CD276 antigen,39858,0.00224146855931972,0.00326805598034224,-0.00416392116215107,0.00864685828079052,0.492803676990721
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MZB1,Marginal zone B- and B1-cell-specific protein,39904,-0.00312329410912143,0.004565571810586,-0.01207181485787,0.00582522663962712,0.493923778649705
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CSNK1D,Casein kinase I isoform delta,37052,-0.00409532526593221,0.00600381234185123,-0.0158627974559606,0.0076721469240962,0.495174546501737
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CORO6,Coronin-6,36987,-0.00240087886587434,0.00352390370709716,-0.00930773013178478,0.00450597240003609,0.495685933891488
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TPSAB1,Tryptase alpha/beta-1,40034,-0.00329020081467916,0.00485562971410798,-0.0128072350543308,0.00622683342497248,0.498031626796499
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL31RA,Interleukin-31 receptor subunit alpha,37011,0.00250709562709447,0.00370754268834577,-0.00475968804206322,0.00977387929625217,0.498916102304297
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,QSOX1,Sulfhydryl oxidase 1,37182,-0.00262117036304757,0.00390218919543965,-0.0102694611861093,0.00502712046001415,0.501774946317918
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CXCL16,C-X-C motif chemokine 16,40030,-0.00145040050390165,0.00215942413639359,-0.00568287181123308,0.00278207080342978,0.501809269065748
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,UBXN1,UBX domain-containing protein 1,37120,-0.00432839769808005,0.00645121740850139,-0.0169727838187428,0.00831598842258266,0.502268672850005
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RELT,Tumor necrosis factor receptor superfamily member 19L,39854,-0.00165291900123176,0.00246933533674928,-0.00649281626126036,0.00318697825879684,0.503263978991117
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL10,Interleukin-10,39583,0.0049069236339838,0.00736069953535926,-0.00952004745532035,0.0193338947232879,0.505013031694482
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FADD,FAS-associated death domain protein,39864,0.00475474735992911,0.00713812984399628,-0.00923598713430361,0.0187454818541618,0.505353287237766
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,39473,0.00215526978873874,0.00324160863574699,-0.00419828313732537,0.00850882271480285,0.506139231901927
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,37039,-0.00262917455303265,0.00396007293510053,-0.0103909175058297,0.0051325683997644,0.506752655601852
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ROBO4,Roundabout homolog 4,37039,-0.00109877682804574,0.00165577331003961,-0.00434409251572337,0.00214653885963189,0.506955776853351
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DBI,Acyl-CoA-binding protein,39789,-0.00492013005837859,0.00741839068744972,-0.01946017580578,0.00961991568902286,0.507190199241518
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CFB,Complement factor B,37216,0.0020321687914155,0.00306404907444988,-0.00397336739450627,0.00803770497733727,0.507194806502018
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AKR1B1,Aldo-keto reductase family 1 member B1,39473,0.00472777086199429,0.00714610351046351,-0.00927859201851418,0.0187341337425028,0.508245553968403
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ENAH,Protein enabled homolog,39583,-0.00294928689892744,0.00446318407320008,-0.0116971276823996,0.00579855388454471,0.508748128445742
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,39862,0.00735642079156834,0.0112230524255356,-0.0146407619624815,0.0293536035456182,0.512171944921904
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ENSA,Alpha-endosulfine,37364,0.00319259123967316,0.00487871656777808,-0.00636969323317188,0.0127548757125182,0.51287067619937
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RP2,Protein XRP2,39784,-0.00252438097846781,0.00388049617867344,-0.0101301534886678,0.00508139153173214,0.515359016007025
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LYPD1,Ly6/PLAUR domain-containing protein 1,39485,-0.00390215773328075,0.0060125876318508,-0.0156868294917083,0.00788251402514682,0.51634916624287
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,COL28A1,Collagen alpha-1(XXVIII) chain,37035,-0.00467929601716553,0.00723169204537472,-0.0188534124261,0.00949482039176893,0.517608200645635
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MB,Myoglobin,40048,-0.0031107800852271,0.00481865334452696,-0.0125553406404999,0.00633378047004574,0.518566746245647
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ITGA2,Integrin alpha-2,37120,-0.00200743445733472,0.00312531450824291,-0.00813305089349083,0.0041181819788214,0.520680182439775
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IST1,IST1 homolog,37283,0.00594191198623246,0.00926517740196227,-0.0122178357216136,0.0241016596940785,0.521327961773924
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DIABLO,"Diablo homolog, mitochondrial",39814,-0.00653967647273307,0.0101989567646321,-0.026529631731412,0.0134502787859458,0.521395247327995
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ECSCR,Endothelial cell-specific chemotaxis regulator,36987,0.00292880271941476,0.00456815089213536,-0.00602477302917054,0.0118823784680001,0.521445984569451
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADAMTSL5,ADAMTS-like protein 5,37433,-0.00232295676083247,0.00364381558275456,-0.00946483530303141,0.00481892178136647,0.523805616044487
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDHR5,Cadherin-related family member 5,39864,0.00229507217176133,0.00360026157114244,-0.00476144050767784,0.00935158485120051,0.523825435748178
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL9,Interleukin-9,37165,0.00339488071258395,0.00532808364862851,-0.00704816323872792,0.0138379246638958,0.52402683327542
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RAD51,DNA repair protein RAD51 homolog 1,37165,0.003126229118461,0.00490756440212221,-0.00649259710969853,0.0127450553466205,0.524121124963436
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL31,Interleukin-31,37052,0.00338615363466776,0.00533237935227892,-0.00706530989579892,0.0138376171651344,0.525428084705527
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AHSG,Alpha-2-HS-glycoprotein,37441,-0.00156624264489438,0.00247487785697643,-0.00641700324456819,0.00328451795477942,0.526837983892624
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SHISA5,Protein shisa-5,37433,-0.00133978359095937,0.00212667486168988,-0.00550806631987154,0.00282849913795279,0.528711825789162
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPRR1B,Cornifin-B,37165,0.0051172935513438,0.00816034851126244,-0.0108769895307306,0.0211115766334182,0.530609347182409
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CTSH,Pro-cathepsin H,39542,-0.00420363921203857,0.00672020655720655,-0.0173752440641634,0.00896796564008626,0.531637405077538
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,37364,0.00310370599561792,0.00496698121486877,-0.00663157718552487,0.0128389891767607,0.532068468277218
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",37364,-0.00211574669672348,0.00339780959667126,-0.00877545350619916,0.0045439601127522,0.533505610069388
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EPB41L5,Band 4.1-like protein 5,37035,-0.00372397086185141,0.00598711849402467,-0.0154587231101398,0.00801078138643694,0.533954480858996
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,37039,-0.00351091359566906,0.0056630931083109,-0.0146105760879584,0.0075887488966203,0.535292237441321
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BRSK2,Serine/threonine-protein kinase BRSK2,37408,-0.0022116743385212,0.00358026668030584,-0.00922899703192065,0.00480564835487826,0.536757049572832
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KCNIP4,Kv channel-interacting protein 4,39485,0.00300596001901223,0.00488143856069676,-0.00656165955995342,0.0125735795979779,0.538039533004281
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTPRM,Receptor-type tyrosine-protein phosphatase mu,39841,-0.00138621938520562,0.00225583163714688,-0.0058076493940135,0.00303521062360226,0.538890545783804
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,39854,0.00144640793331566,0.00235597275732012,-0.00317129867103177,0.0060641145376631,0.539268751882002
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FGFR4,Fibroblast growth factor receptor 4,37120,-0.00300146121792951,0.00490254541134148,-0.0126104502241588,0.00660752778829979,0.540399353295413
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BRDT,Bromodomain testis-specific protein,37017,0.00206691852039504,0.00340128530164966,-0.0045996006708383,0.00873343771162838,0.543405251347438
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KLRD1,Natural killer cells antigen CD94,40054,0.00256093429797186,0.00424336880409157,-0.00575606855804763,0.0108779371539913,0.546174972935198
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CABP2,Calcium-binding protein 2,37035,-0.00365511145850941,0.00613468862808064,-0.0156791011695475,0.00836887825252863,0.55131211128429
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AHNAK,Neuroblast differentiation-associated protein AHNAK,37039,0.0017300585572843,0.00290464346856165,-0.00396304264109655,0.00742315975566514,0.551440533465999
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PSAP,Prosaposin,37343,0.00153944404357803,0.0025954244289978,-0.00354758783725766,0.00662647592441372,0.553098959089988
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,37364,0.00459447128298489,0.00777342621964608,-0.0106414441075214,0.0198303866734912,0.554497871043041
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DDR1,Epithelial discoidin domain-containing receptor 1,40005,0.00127361680158295,0.00216191153066157,-0.00296372979851374,0.00551096340167963,0.555791663699521
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,36958,0.00143076819345209,0.0024347405130399,-0.00334132321210613,0.0062028595990103,0.556779322448571
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,37165,0.00353868232138362,0.006097846668518,-0.00841309714891167,0.0154904617916789,0.561710888099262
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KIF22,Kinesin-like protein KIF22,37017,-0.00651198847273102,0.0112811560101729,-0.0286230542526699,0.0155990773072078,0.563783984360503
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ACYP1,Acylphosphatase-1,37069,-0.00351171686348339,0.00610087994973605,-0.0154694415649661,0.00844600783799927,0.564889805371026
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,UBQLN3,Ubiquilin-3,37017,0.00251100600655218,0.00436984224100384,-0.00605388478581534,0.0110758967989197,0.565557023852927
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,39745,0.00184735033463473,0.00321542043392821,-0.00445487371586456,0.00814957438513403,0.565618428572595
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FAP,Prolyl endopeptidase FAP,40048,0.00145346168119941,0.00253588741348064,-0.00351687764922264,0.00642380101162147,0.566546341730808
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GIPR,Gastric inhibitory polypeptide receptor,37052,-0.00242266437571257,0.00424064122064553,-0.0107343211681778,0.00588899241675267,0.567808264245087
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NT5E,5'-nucleotidase,39909,-0.00293422152641221,0.00513762604083107,-0.0130039685664411,0.00713552551361667,0.567923589166803
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MINK1,Misshapen-like kinase 1,37384,-0.00492008175709611,0.00862532412673745,-0.0218257170455015,0.0119855535313093,0.568400428593031
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DDX58,Antiviral innate immune response receptor RIG-I,39473,-0.00302492543707974,0.00530867025032239,-0.0134299191277116,0.00738006825355214,0.568815787524396
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL13RA1,Interleukin-13 receptor subunit alpha-1,39593,-0.00119417494453952,0.0021005636043908,-0.00531127960914549,0.00292292972006645,0.569702154081811
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DENND2B,DENN domain-containing protein 2B,37017,-0.00272496436578085,0.00479541275407793,-0.0121239733637736,0.0066740446322119,0.569879018432259
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ECHS1,"Enoyl-CoA hydratase, mitochondrial",37039,-0.00512434587959351,0.00902790228265361,-0.0228190343535946,0.0125703425944076,0.570308110182183
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,37378,-0.00264432276200666,0.00466977093624925,-0.0117970737970552,0.00650842827304187,0.571223788600113
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",37165,0.00370047111299861,0.00654016708526537,-0.00911825637412152,0.0165191986001187,0.571534654475499
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDAN1,Codanin-1,37384,0.00118344800683432,0.00209163381871889,-0.00291615427785471,0.00528305029152335,0.57153861611819
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,39473,0.00391809779180558,0.00693477527030071,-0.00967406173798381,0.017510257321595,0.572086809088896
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GNPDA1,Glucosamine-6-phosphate isomerase 1,37039,-0.00171890865141159,0.00304713372326055,-0.00769129074900226,0.00425347344617908,0.572691095045609
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BTNL10,Butyrophilin-like protein 10,36958,0.00206251996133025,0.00366240993410326,-0.00511580350951213,0.00924084343217263,0.573336101410605
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CA13,Carbonic anhydrase 13,39653,0.00550009763616541,0.00980198632271797,-0.0137117955563618,0.0247119908286926,0.574723204230644
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD302,CD302 antigen,39784,0.00151412458371612,0.00269919629484657,-0.00377630015418316,0.0068045493216154,0.574836883764215
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PHACTR2,Phosphatase and actin regulator 2,37408,-0.00596060937512325,0.0106400513951777,-0.0268151101096715,0.0148938913594249,0.575348919198538
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLC28A1,Sodium/nucleoside cotransporter 1,36958,0.00309036721255908,0.00552954496717038,-0.00774754092309487,0.013928275348213,0.576251307920146
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DBN1,Drebrin,37052,-0.0027078911528703,0.00486683020432296,-0.0122468783533433,0.0068310960476027,0.577948726289943
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,APOL1,Apolipoprotein L1,37441,0.0031690741401328,0.00569746982136239,-0.00799796670973749,0.0143361149900031,0.578066336050122
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLEC5A,C-type lectin domain family 5 member A,39814,0.00146243664697032,0.00263314386397886,-0.00369852532642825,0.00662339862036889,0.578631854878257
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SNX5,Sorting nexin-5,37039,-0.00156937861385382,0.00282828847673843,-0.00711282402826114,0.0039740668005535,0.578981829442102
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GBP1,Guanylate-binding protein 1,37372,0.00326419079331743,0.00589996522407939,-0.00829974104587818,0.014828122632513,0.580097321663664
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GAGE2A,G antigen 2A,36958,0.00312639558276089,0.00565939279950833,-0.00796601430427543,0.0142188054697972,0.580665965030709
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GBP4,Guanylate-binding protein 4,39485,0.00251276881692726,0.00454862727427405,-0.00640254064064987,0.0114280782745044,0.580666102700481
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,37165,0.00324772434674006,0.00588632570384616,-0.00828947403279841,0.0147849227262785,0.581135417209206
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL17A,Interleukin-17A,39554,-0.00216043528834277,0.0039383695125652,-0.00987963953297055,0.00555876895628502,0.583314669317331
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,37449,0.000947535238709341,0.00172908089342618,-0.00244146331240596,0.00433653378982465,0.583701337275889
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ATP5PO,"ATP synthase subunit O, mitochondrial",39485,0.00222138598803388,0.00405366765400765,-0.00572380261382111,0.0101665745898889,0.583703777158671
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",37433,-0.00313724671149932,0.00572799430337591,-0.0143641155461161,0.00808962212311745,0.583904013120425
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRSS53,Serine protease 53,37384,0.00189200222320777,0.00346144145243068,-0.00489242302355636,0.00867642746997191,0.584666889526439
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCIN,Adseverin,36987,-0.00375143424605313,0.0068728732376087,-0.0172222657917662,0.00971939729965992,0.585190689634555
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRUNE2,Protein prune homolog 2,37165,0.00144813410945578,0.00265323279194831,-0.00375220216276291,0.00664847038167446,0.585212664076636
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,UGDH,UDP-glucose 6-dehydrogenase,37017,0.00508185378667923,0.00931429708761616,-0.0131741685050484,0.0233378760784069,0.585352145030736
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EFCAB2,Dynein regulatory complex protein 8,37165,-0.00177800949132669,0.00326076993051089,-0.00816911855512802,0.00461309957247465,0.585574976800155
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HRAS,GTPase Hras,37157,0.0049528626184727,0.00909943084996032,-0.0128820218474495,0.0227877470843949,0.586240967385802
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LRRC37A2,Leucine-rich repeat-containing protein 37A2,37378,-0.00212751118453613,0.00392748838659981,-0.00982538842227176,0.00557036605319949,0.588035744602919
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,39449,-0.00239045298072201,0.0044225036316561,-0.011058560098768,0.00627765413732396,0.588845988897883
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADGRF5,Adhesion G protein-coupled receptor F5,37433,-0.00143084386039759,0.00265295606244383,-0.0066306377427875,0.00376895002199232,0.589661500304133
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DNAJA1,DnaJ homolog subfamily A member 1,36958,0.00230540300038585,0.00428513621933461,-0.00609346398950998,0.0107042699902817,0.590586235792769
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CXCL9,C-X-C motif chemokine 9,39927,0.00324930591001958,0.00605268174595955,-0.00861395031206114,0.0151125621321003,0.591387370874516
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BCL7A,B-cell CLL/lymphoma 7 protein family member A,36958,0.0031711465567669,0.00590998055519039,-0.00841241533140627,0.0147547084449401,0.591570477102679
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MAG,Myelin-associated glycoprotein,37035,0.00230028054729047,0.00430161689583782,-0.00613088856855166,0.0107314496631326,0.592833227002671
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD164L2,CD164 sialomucin-like 2 protein,37035,-0.0018315454015975,0.00343309532736058,-0.00856041224322424,0.00489732144002923,0.593698719127865
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GRSF1,G-rich sequence factor 1,36870,0.00398932780950776,0.00749955106406868,-0.0107097922760669,0.0186884478950824,0.594775100564506
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FGF12,Fibroblast growth factor 12,37052,0.00230691399017103,0.00434941562184058,-0.0062179406286365,0.0108317686089786,0.595846112483229
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KLK3,Prostate-specific antigen,37433,0.00384528288327944,0.00730201988917523,-0.010466676099504,0.0181572418660629,0.598476267558008
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SHC1,SHC-transforming protein 1,36958,0.00563410670765629,0.0107238932970766,-0.0153847241546139,0.0266529375699265,0.599328747915165
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPON2,Spondin-2,39771,0.00163434551153794,0.00311440078106279,-0.00446988001934513,0.007738571042421,0.59975008452779
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NOP56,Nucleolar protein 56,37017,0.00538413322850587,0.0102625897580783,-0.0147305426973275,0.0254988091543392,0.59984447218906
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AMIGO1,Amphoterin-induced protein 1,37035,-0.00244192793176331,0.00465590813691941,-0.0115675078801254,0.00668365201659873,0.599953964074163
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MDM1,Nuclear protein MDM1,37035,-0.00152855816102009,0.00291737120766761,-0.00724660572804861,0.00418948940600843,0.600321768800239
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,STK4,Serine/threonine-protein kinase 4,39864,-0.00422674694615466,0.00809957413098974,-0.0201019122428945,0.0116484183505852,0.601783355026164
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CHIT1,Chitotriosidase-1,39902,0.00729892285684793,0.0139979235111207,-0.0201370072249487,0.0347348529386445,0.602075171935365
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL25,Interleukin-25,36899,0.00165821092321443,0.00318421985614868,-0.00458285999483697,0.00789928184126584,0.602543559884748
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HSBP1,Heat shock factor-binding protein 1,37039,0.00466501708224484,0.00896826327903566,-0.0129127789446651,0.0222428131091547,0.602954174365693
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CXCL3,C-X-C motif chemokine 3,39855,0.00454067336302582,0.00879966509341812,-0.0127066702200737,0.0217880169461253,0.605857876975123
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VSIG10,V-set and immunoglobulin domain-containing protein 10,37364,0.00172228533203408,0.00338017669269561,-0.00490286098564932,0.00834743164971748,0.610392439069985
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SERPINB5,Serpin B5,39581,-0.00229758084266406,0.00451956393462858,-0.0111559261545361,0.00656076446920795,0.611205655541092
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLITRK2,SLIT and NTRK-like protein 2,40026,-0.00181895472093943,0.00358499135506637,-0.00884553777686952,0.00520762833499066,0.611894783721112
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IGHMBP2,DNA-binding protein SMUBP-2,37017,-0.00265923212402532,0.00524185487065461,-0.0129332676705084,0.00761480342245772,0.611947602024241
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PALM3,Paralemmin-3,37017,0.00356558072060457,0.00703693267625338,-0.010226807324852,0.0173579687660612,0.612377119157903
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RNASE10,Inactive ribonuclease-like protein 10,37039,0.00218604826460946,0.00435092370549569,-0.00634176219816208,0.010713858727381,0.615371266348873
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FOLR1,Folate receptor alpha,39805,-0.00127914002824798,0.0025461139006175,-0.00626952327345827,0.00371124321696232,0.615400739306175
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CTSS,Cathepsin S,36540,0.00113805151152875,0.00226959173588536,-0.00331034829080656,0.00558645131386406,0.616074096335021
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,REPS1,RalBP1-associated Eps domain-containing protein 1,37052,0.00178250465641612,0.00356520814825528,-0.00520530331416423,0.00877031262699646,0.617103051945605
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BTC,Probetacellulin,39473,-0.00342099239889901,0.00687937626155072,-0.0169045698715384,0.0100625850737404,0.618996958585359
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,37017,0.0023381799871308,0.00470222220351399,-0.00687817553175663,0.0115545355060182,0.619021075870077
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CFHR2,Complement factor H-related protein 2,37360,0.00259617364769057,0.00523242166710178,-0.00765937281982892,0.0128517201152101,0.619782149953624
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BST2,Bone marrow stromal antigen 2,40005,0.00244931903295449,0.00494121806908796,-0.00723546838245791,0.0121341064483669,0.620118941085975
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,P4HB,Protein disulfide-isomerase,39772,-0.00178943190202349,0.00361488023126528,-0.00887459715530343,0.00529573335125645,0.62059403112532
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TIA1,Nucleolysin TIA-1 isoform p40,39370,-0.00565791933176028,0.0114331041992817,-0.0280668035623525,0.0167509648988319,0.620697721679959
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TCL1B,T-cell leukemia/lymphoma protein 1B,39581,0.00359936035210877,0.00728691301700479,-0.0106829891612206,0.0178817098654382,0.621349394039162
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CERT,Ceramide transfer protein,39485,-0.00282410880116338,0.00573403040595043,-0.0140628083968262,0.00841459079449946,0.622360661315372
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLC13A1,Solute carrier family 13 member 1,37364,0.00270456411371254,0.00555223369122101,-0.00817781392108063,0.0135869421485057,0.626186300727865
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NTproBNP,N-terminal prohormone of brain natriuretic peptide,39864,-0.00418363983099058,0.00860724026109877,-0.0210538307427442,0.012686551080763,0.626930899701077
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,THRAP3,Thyroid hormone receptor-associated protein 3,37017,-0.0052050552157018,0.0107740975809073,-0.0263222864742801,0.0159121760428765,0.629026929169106
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TMED1,Transmembrane emp24 domain-containing protein 1,37165,0.00242605494805595,0.00502857886540459,-0.00742995962813705,0.012282069524249,0.629491834685855
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TDGF1,Teratocarcinoma-derived growth factor 1,39485,-0.00634569021873026,0.0131618283079003,-0.0321428737022149,0.0194514932647543,0.629721543567765
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CRADD,Death domain-containing protein CRADD,39709,-0.00340766053685338,0.00708445154808767,-0.0172931855711052,0.0104778644973985,0.630519191895198
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CTF1,Cardiotrophin-1,39581,-0.0037843466171022,0.0078853953758113,-0.0192397215536923,0.0116710283194879,0.631292068174636
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PPT1,Palmitoyl-protein thioesterase 1,37035,-0.00349477166943622,0.00728444711557859,-0.0177722880159703,0.0107827446770978,0.631407455482105
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SNX2,Sorting nexin-2,37364,0.00359102850256142,0.00748656917618402,-0.0110826470827593,0.0182647040878821,0.631474973702581
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,39581,-0.00119686999377693,0.00249933119355459,-0.00609555913314393,0.00370181914559008,0.632033429229394
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DDX25,ATP-dependent RNA helicase DDX25,37035,-0.00167033965611131,0.00349471099515699,-0.00851997320661902,0.0051792938943964,0.632685059470094
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PXDNL,Peroxidasin-like protein,37364,-0.00263781816332193,0.00552582969668449,-0.0134684443688235,0.00819280804217967,0.63311247455626
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCDC134,Coiled-coil domain-containing protein 134,37364,-0.00215722593931131,0.00451917987724037,-0.0110148184987024,0.00670036662007981,0.633121358299402
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,39858,0.00167151149422601,0.00350313348428585,-0.00519463013497426,0.00853765312342627,0.633263588090522
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNPO1,Transportin-1,37165,0.00157155311291765,0.00329634740975369,-0.00488928781019958,0.00803239403603487,0.633543773881142
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MMP7,Matrilysin,39559,0.00218797102700763,0.00459643990020547,-0.00682105117739509,0.0111969932314104,0.634070828899291
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RGMA,Repulsive guidance molecule A,40005,0.00136712586947182,0.00287392392440861,-0.00426576502236906,0.0070000167613127,0.634294492963643
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TCL1A,T-cell leukemia/lymphoma protein 1A,39726,0.00417004332666425,0.008809570316649,-0.0130967144939678,0.0214368011472963,0.635967318373032
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FLT4,Vascular endothelial growth factor receptor 3,39909,0.00149132252205447,0.00315893482789292,-0.00470018974061565,0.00768283478472459,0.636864228455727
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AMBN,Ameloblastin,39583,0.00123550470403203,0.00265348578091776,-0.00396532742656678,0.00643633683463084,0.641497034824834
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PILRA,Paired immunoglobulin-like type 2 receptor alpha,39854,-0.00178482909569747,0.00385597418270853,-0.00934253849380619,0.00577288030241124,0.643461186579357
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CSTB,Cystatin-B,39615,-0.00181887660296789,0.00393882064563311,-0.00953896506840879,0.00590121186247301,0.644244012888022
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RRP15,RRP15-like protein,36987,0.00387194545368355,0.008404326833412,-0.012600535139804,0.0203444260471711,0.645015332824994
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,37408,-0.00423376836772177,0.00924496265379435,-0.0223538951691587,0.0138863584337151,0.646992776876825
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCN2A,Sodium channel protein type 2 subunit alpha,36987,0.00205403125525375,0.00451250403847404,-0.00679047666015538,0.0108985391706629,0.648982546446606
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RGS8,Regulator of G-protein signaling 8,39583,0.00278296244308946,0.0061160315617591,-0.00920445941795837,0.0147703843041373,0.649095750190846
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MDK,Midkine,39839,-0.00213759636628102,0.0046988669758447,-0.0113473756389366,0.00707218290637459,0.64917484184683
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TCP11,T-complex protein 11 homolog,37165,-0.00252182946646811,0.00554347299619043,-0.0133870365390013,0.00834337760606513,0.649175159633899
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLC34A3,Sodium-dependent phosphate transport protein 2C,36958,-0.00204877363486587,0.0045042093932713,-0.0108770240456776,0.00677947677594588,0.649219265028092
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,UBE2B,Ubiquitin-conjugating enzyme E2 B,37364,-0.00120050618790081,0.00263963472562643,-0.00637419025012861,0.00397317787432699,0.649260355350551
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ITGAX,Integrin alpha-X,37165,-0.00223419889529692,0.00492184873715922,-0.011881022420129,0.00741262462953516,0.649883090267761
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GAS6,Growth arrest-specific protein 6,39943,0.00107488811086383,0.00237172315106973,-0.00357368926523285,0.00572346548696051,0.650403809974957
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CHGA,Chromogranin-A,37433,0.00327511619216059,0.00727182045930371,-0.0109776519080747,0.0175278842923959,0.652440316705926
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BRME1,Break repair meiotic recombinase recruitment factor 1,36987,0.00169000207378763,0.00378514090712468,-0.00572887410417674,0.009108878251752,0.655255562831954
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PFDN4,Prefoldin subunit 4,36958,-0.00225180415049574,0.00504819874485418,-0.0121462736904099,0.00764266538941845,0.655560618234294
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL21R,Interleukin-21 receptor,37052,0.00224941049340828,0.00504562632460113,-0.00764001710280993,0.0121388380896265,0.655738976001732
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,37017,-0.00266670968165178,0.00599116168956435,-0.0144093865931979,0.00907596722989434,0.656249550828408
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",37017,0.0026718983770419,0.00600913875403445,-0.00910601358086562,0.0144498103349494,0.656587860511251
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ICOSLG,ICOS ligand,39784,-0.000778877522146561,0.00175187857070665,-0.00421255952073159,0.00265480447643847,0.656618062715779
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,OSBPL2,Oxysterol-binding protein-related protein 2,37384,0.00158759043370742,0.00357179370734643,-0.00541312523269158,0.00858830610010641,0.656702785679503
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FHIP2A,FHF complex subunit HOOK interacting protein 2A,37017,-0.00190449592017058,0.00430753795768509,-0.0103472703172334,0.00653827847689219,0.658401704410634
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLSTN2,Calsyntenin-2,40054,0.00161418407684477,0.00365942688662223,-0.0055582926209348,0.00878666077462435,0.65914434051497
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RGS10,Regulator of G-protein signaling 10,37408,0.00245361816873571,0.00556416757156349,-0.00845215027152874,0.0133593866090002,0.659243418181437
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LEFTY2,Left-right determination factor 2,40007,-0.00217757898400702,0.00495508098418619,-0.011889537713012,0.00753437974499792,0.660331348848837
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BATF,Basic leucine zipper transcriptional factor ATF-like,37035,0.0034387071259779,0.00782566382187092,-0.0118995939648891,0.0187770082168449,0.660368709117822
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HRG,Histidine-rich glycoprotein,37376,0.0012917550479301,0.00293981127867243,-0.00447027505826786,0.00705378515412805,0.660378265268942
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,37039,-0.0010645993533269,0.00246626521741417,-0.00589847917945867,0.00376928047280487,0.665992271368901
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",39784,0.00274451310770647,0.00650050134376244,-0.00999646952606791,0.0154854957414808,0.672884579777545
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL24,Interleukin-24,39583,-0.00185335587621038,0.00439033711938525,-0.0104584166302055,0.00675170487778471,0.6729254522372
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLC1A4,Neutral amino acid transporter A,37035,-0.00201598469039922,0.00478554764042691,-0.011395658065636,0.00736368868483752,0.673568309944906
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL12B,Interleukin-12 subunit beta,40054,-0.00204795278384702,0.00486145957501868,-0.0115764135508836,0.00748050798318959,0.673568675284363
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,OFD1,Oral-facial-digital syndrome 1 protein,37165,0.00266585989637405,0.00632868814482412,-0.00973836886748123,0.0150700886602293,0.673590876623288
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PNMA1,Paraneoplastic antigen Ma1,37039,-0.00221778594910566,0.00529441317382236,-0.0125948357697975,0.00815926387158617,0.67530208025
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLURP1,Secreted Ly-6/uPAR-related protein 1,37366,-0.00142682115508844,0.00341547807723393,-0.00812115818646694,0.00526751587629006,0.676135441407787
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ZP4,Zona pellucida sperm-binding protein 4,36958,0.00124753688950256,0.00298647771472205,-0.00460595943135266,0.00710103321035778,0.676152471591351
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNNI3,"Troponin I, cardiac muscle",39581,-0.00324618580416114,0.00781873757084124,-0.01857091144301,0.0120785398346877,0.678015585569539
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TRPV3,Transient receptor potential cation channel subfamily V member 3,37017,-0.00198555507424045,0.00481262787629347,-0.0114183057117757,0.00744719556329476,0.679927007635175
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SH3GL3,Endophilin-A3,37079,-0.00313483979086958,0.00768198010542161,-0.0181915207974959,0.0119218412157568,0.683223716664838
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,APOC1,Apolipoprotein C-I,37420,0.00141751191266073,0.0034769325594701,-0.00539727590390067,0.00823229972922213,0.683507446460558
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DIPK1C,Divergent protein kinase domain 1C,37035,0.00162569918520082,0.00398889508103838,-0.00619253517363441,0.00944393354403604,0.683606099515558
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DCC,Netrin receptor DCC,37035,-0.00085737950115499,0.00210840660105666,-0.00498985643922605,0.00327509743691607,0.684273082496357
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SIGLEC6,Sialic acid-binding Ig-like lectin 6,40026,-0.00123969104823894,0.00307233822515706,-0.00726147396954678,0.0047820918730689,0.686585155148387
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SHH,Sonic hedgehog protein,37052,-0.00162926948096075,0.00405043779339874,-0.00956812755602228,0.00630958859410079,0.68751003909438
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GUCA2A,Guanylin,39792,-0.00119334485218822,0.0029930814077144,-0.00705978441130844,0.00467309470693199,0.690118799864343
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,OSTN,Osteocrin,37035,-0.00155234607453078,0.00389916694152062,-0.00919471327991119,0.00609002113084963,0.690546343681237
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,C2orf69,UPF0565 protein C2orf69,37035,-0.00216406097823985,0.00544843988698905,-0.0128430031567384,0.00851488120025869,0.691234447664159
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SIGLEC9,Sialic acid-binding Ig-like lectin 9,39999,0.00110896329332835,0.00281024335219799,-0.00439911367697971,0.0066170402636364,0.693132489215545
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",37384,-0.00201601171367405,0.00513229265819086,-0.0120753053237281,0.00804328189638004,0.694466608769669
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SEPTIN3,Neuronal-specific septin-3,37408,0.00278097229571233,0.0070853241473934,-0.0111062630331787,0.0166682076246034,0.694696803498294
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PKD2,Polycystin-2,37017,-0.00217400867453245,0.00554416033429741,-0.0130405629297554,0.00869254558069048,0.694971567695457
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,THPO,Thrombopoietin,39581,0.00138517318660399,0.00354325041337754,-0.00555959762361599,0.00832994399682397,0.695852126512753
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BMP4,Bone morphogenetic protein 4,39716,-0.0016628103435696,0.00426537438771147,-0.0100229441434841,0.00669732345634488,0.696660655740214
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PPM1A,Protein phosphatase 1A,39473,0.00110434191268935,0.00283775487081011,-0.00445765763409847,0.00666634145947716,0.697162778570152
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NAA10,N-alpha-acetyltransferase 10,37017,-0.00182101324959203,0.00470449185704843,-0.011041817289407,0.00739979079022289,0.698703473573201
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,37433,-0.00262042091447745,0.00681771102290441,-0.0159831345193701,0.0107422926904152,0.700721413966589
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PFDN2,Prefoldin subunit 2,39485,-0.00198292571911019,0.00519418999095432,-0.0121635381013807,0.00819768666316028,0.702645760834107
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ARHGAP30,Rho GTPase-activating protein 30,37165,0.00139321862156271,0.00366192741543966,-0.00578415911269903,0.00857059635582445,0.703609709064102
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PGLYRP4,Peptidoglycan recognition protein 4,37017,0.00219149931884805,0.00580685992517822,-0.00918994613450125,0.0135729447721974,0.705883684683057
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,STOML2,"Stomatin-like protein 2, mitochondrial",36958,-0.00321694334227858,0.00860096727849504,-0.0200748392081289,0.0136409525235717,0.708394663603962
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,C1R,Complement C1r subcomponent,37449,0.000670017030880874,0.0017954684783568,-0.00284910118669845,0.0041891352484602,0.709026890004016
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,36987,0.00228924158770344,0.00613620913331992,-0.00973772831360361,0.0143162114890105,0.709101636439187
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,39583,0.00145905100236506,0.00392259804895824,-0.00622924117359308,0.0091473431783232,0.709927372206071
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PDIA4,Protein disulfide-isomerase A4,37433,0.00212017389842549,0.00570530522758699,-0.00906222434764502,0.013302572144496,0.71018572515082
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TAP1,Antigen peptide transporter 1,37165,-0.00202676051620752,0.005469785872655,-0.0127475408266113,0.00869401979419628,0.710987975759451
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ZNF174,Zinc finger protein 174,37052,0.00130803891222051,0.0035442119606496,-0.00563861653065271,0.00825469435509373,0.712086392708922
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SMC3,Structural maintenance of chromosomes protein 3,36958,0.00179148139407078,0.0049078462345544,-0.00782789722565584,0.0114108600137974,0.715099425769894
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SSB,Lupus La protein,39485,-0.00206128120888075,0.00564810828724736,-0.0131315734518856,0.00900901103412407,0.715153128821544
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TSPYL1,Testis-specific Y-encoded-like protein 1,37052,0.00137777094874948,0.00377585974837946,-0.00602291415807425,0.00877845605557321,0.715199865693447
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TXN,Thioredoxin,37285,0.00144583436508758,0.00401592358405115,-0.00642537585965266,0.00931704458982783,0.718833826564865
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,C3,Complement C3,36812,0.00154314588729094,0.0042887245748226,-0.00686275427936135,0.00994904605394324,0.718991621095538
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ACTN4,Alpha-actinin-4,39583,-0.00104699384501983,0.00291968245386858,-0.00676957145460225,0.00467558376456258,0.719900258969475
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NFYA,Nuclear transcription factor Y subunit alpha,37017,-0.00125891770033276,0.00352054296412688,-0.00815918191002145,0.00564134650935593,0.720654465539506
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CASQ2,Calsequestrin-2,37017,0.00161824083145655,0.00453538201575843,-0.00727110791942997,0.0105075895823431,0.7212445298399
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCL7,C-C motif chemokine 7,39862,-0.00192225325433122,0.00541284310081941,-0.0125314257319373,0.00868691922327482,0.722498227890414
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TMED10,Transmembrane emp24 domain-containing protein 10,37017,0.00166948357565326,0.00472507657226909,-0.00759166650599415,0.0109306336573007,0.723851117212105
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VASH1,Tubulinyl-Tyr carboxypeptidase 1,39862,-0.00268984166541294,0.00761376594784112,-0.0176128229231815,0.0122331395923557,0.723878226345787
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",37408,0.00212637346999992,0.00601915290791786,-0.00967116622951909,0.0139239131695189,0.723893109249938
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CYB5A,Cytochrome b5,36958,-0.00232515266463987,0.00664889966238501,-0.0153569960029145,0.0107066906736348,0.726565812677176
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DUOX2,Dual oxidase 2,39581,0.00231630823522187,0.00662430127008374,-0.0106673222541423,0.015299938724586,0.726592322252957
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MORF4L1,Mortality factor 4-like protein 1,37165,-0.00131275102551593,0.00375483687161521,-0.00867223129388173,0.00604672924284988,0.726632439432321
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ARFIP1,Arfaptin-1,37408,0.0022351823007014,0.00643264343150078,-0.0103727988250401,0.0148431634264429,0.728239950231302
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL5,Interleukin-5,39583,0.00463364532135271,0.0134162522928846,-0.0216622091727011,0.0309294998154065,0.729816687006415
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,STX7,Syntaxin-7,37052,-0.00158304399218588,0.00458379750613272,-0.010567287104206,0.00740119911983426,0.729831926473274
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RAB2B,Ras-related protein Rab-2B,37364,0.00200530409273186,0.00582551124317154,-0.00941269794388436,0.0134233061293481,0.730680185466952
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,METAP1,Methionine aminopeptidase 1,39485,-0.000962506680082302,0.00283654686196092,-0.00652213852952571,0.00459712516936111,0.734370688977423
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KLRK1,NKG2-D type II integral membrane protein,37384,-0.00138827016449474,0.00412076313377392,-0.00946496590669163,0.00668842557770215,0.736200245325656
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FRMD7,FERM domain-containing protein 7,37035,0.001052553049329,0.00313400518995358,-0.00509009712298001,0.00719520322163801,0.736989955418247
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ATP6V1D,V-type proton ATPase subunit D,39784,0.000809592071887164,0.00241960825006443,-0.00393284009823911,0.00555202424201344,0.737934010734407
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,POMC,Pro-opiomelanocortin,37039,0.00219997145681465,0.00658997253209105,-0.0107163747060838,0.0151163176197131,0.73850846891249
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EPHA2,Ephrin type-A receptor 2,39244,0.000909036535956789,0.00273452998822325,-0.00445064224096078,0.00626871531287436,0.739570020217716
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,40048,0.000699237552315548,0.00210876658610025,-0.00343394495644094,0.00483242006107204,0.740206158002438
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,37120,0.00186610401503659,0.00563753437412294,-0.00918346335824437,0.0129156713883176,0.740638978769736
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD2,T-cell surface antigen CD2,37017,0.00117771105647178,0.00356979672941732,-0.00581909053318616,0.00817451264612972,0.741473342844447
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TMEM106A,Transmembrane protein 106A,37364,-0.00218085612816633,0.00661668005688489,-0.0151495490396607,0.0107878367833281,0.741707519558737
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LMOD2,Leiomodin-2,36987,-0.00196528065279001,0.00596285951573757,-0.0136524853036356,0.00972192399805563,0.741717346794584
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MRPL24,"39S ribosomal protein L24, mitochondrial",37017,0.00120871105813067,0.00369202378864861,-0.0060276555676206,0.00844507768388195,0.743382359176979
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FDX1,"Adrenodoxin, mitochondrial",37017,-0.00192893509658212,0.00590445384342278,-0.0135016646296908,0.00964379443652653,0.743906399072646
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MUC16,Mucin-16,39784,-0.00561515807144102,0.0172868095620869,-0.0394973048131314,0.0282669886702493,0.745319096111976
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RBPMS,RNA-binding protein with multiple splicing,37052,-0.00195384732196316,0.00602606939001912,-0.0137649433264006,0.00985724868247431,0.74576718686321
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDH23,Cadherin-23,37384,0.000806801290810862,0.00249229696622309,-0.00407810076298639,0.00569170334460812,0.746156577637078
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,OGN,Mimecan,39854,0.00118455952843779,0.00366543713114474,-0.0059996972486059,0.00836881630548149,0.746570680782454
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,STXBP3,Syntaxin-binding protein 3,39473,-0.00132719576295283,0.00410771919061668,-0.00937832537656154,0.00672393385065587,0.746625368774709
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,36987,-0.00173107913596024,0.00536410788157614,-0.0122447305838495,0.008782572311929,0.746916081050107
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FXYD5,FXYD domain-containing ion transport regulator 5,39583,0.0019611612900796,0.00608436181324537,-0.00996418786388133,0.0138865104440405,0.7472083698601
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TRIM26,Tripartite motif-containing protein 26,36958,0.00166150970722273,0.00518155672710895,-0.0084943414779108,0.0118173608923563,0.748474388728086
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ZP3,Zona pellucida sperm-binding protein 3,37039,0.00767192483928907,0.0239668445806661,-0.0393030905388165,0.0546469402173946,0.748893239035309
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLAMF7,SLAM family member 7,39862,0.00170644971852694,0.00535924843922095,-0.00879767722234612,0.0122105766594,0.750176492637663
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",37433,-0.00218927225938026,0.00688622745000758,-0.0156862780613951,0.0113077335426346,0.750550200571034
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MRPS16,"28S ribosomal protein S16, mitochondrial",37052,0.000873338330010483,0.00275955850545463,-0.00453539634068059,0.00628207300070156,0.751645065927669
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SERPINB8,Serpin B8,40054,-0.00161395467255465,0.00511512135352148,-0.0116395925254568,0.00841168318034746,0.752366246817003
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,37039,-0.00118995824646816,0.00378677346454864,-0.0086120342369835,0.00623211774404717,0.753343226665385
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ISM2,Isthmin-2,37433,0.00129378475908903,0.00412802775673747,-0.0067971496441164,0.00938471916229447,0.753970400606365
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,S100A3,Protein S100-A3,37364,0.00130882004141792,0.00419038705146643,-0.00690433857945628,0.00952197866229212,0.754787954862427
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IDO1,"Indoleamine 2,3-dioxygenase 1",37039,0.00177769417189294,0.00589533111036631,-0.00977715480442503,0.0133325431482109,0.763005437625406
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLEC2L,C-type lectin domain family 2 member L,37035,0.0014236035770153,0.00476025008926628,-0.00790648659794662,0.0107536937519772,0.764898472158658
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CNPY4,Protein canopy homolog 4,39784,0.00209876785674196,0.00702990465475981,-0.0116798452665873,0.0158773809800712,0.765288420839582
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TOP1MT,"DNA topoisomerase I, mitochondrial",36958,-0.00135012827392981,0.0045264946483558,-0.0102220577847072,0.00752180123684756,0.765500024004161
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,39751,-0.000665219722600207,0.00223747722140645,-0.00505067507655684,0.00372023563135643,0.766235313633852
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FN1,Fibronectin,37449,-0.000734062640699507,0.00247250458905939,-0.00558017163525591,0.0041120463538569,0.766554796045229
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HNF1A,Hepatocyte nuclear factor 1-alpha,37035,-0.00196478813983878,0.00662149406073617,-0.0149429164988817,0.0110133402192041,0.766678227408967
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RAD23B,UV excision repair protein RAD23 homolog B,39473,0.00129717372540259,0.00438178207456168,-0.0072911191407383,0.00988546659154349,0.767205046920217
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,40054,-0.00094421547305812,0.00318969611928312,-0.00719601986685303,0.00530758892073679,0.767218213736213
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LAYN,Layilin,39709,-0.000884117225339272,0.00299336145377092,-0.00675110567473027,0.00498287122405172,0.767723269216167
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GDF2,Growth/differentiation factor 2,39864,0.000967404613597168,0.00327641161903383,-0.00545436215970914,0.00738917138690347,0.767796461832645
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PNLIPRP2,Pancreatic lipase-related protein 2,39858,-0.00800688842764436,0.0273093597593405,-0.0615332335559516,0.0455194567006629,0.769379128131105
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MILR1,Allergin-1,39583,-0.00134944380772702,0.00460279481669287,-0.010370921648445,0.00767203403299101,0.769389033563743
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KLK1,Kallikrein-1,39716,0.00340229564784287,0.0116680238795755,-0.0194670311561251,0.0262716224518109,0.770602851058698
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ERP29,Endoplasmic reticulum resident protein 29,37120,-0.00323009370968165,0.0111001818283097,-0.0249864500931686,0.0185262626738053,0.771059949823125
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ACP6,Lysophosphatidic acid phosphatase type 6,40007,0.00174046252485189,0.00606745798223503,-0.0101517551203288,0.0136326801700325,0.774229317021657
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LEO1,RNA polymerase-associated protein LEO1,37408,0.000741613261057563,0.00259729392056533,-0.00434908282325048,0.0058323093453656,0.775240150799067
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GJA8,Gap junction alpha-8 protein,36958,-0.00157693732294355,0.00554216573339794,-0.0124395821604035,0.00928570751451642,0.776005301640232
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DEFB116,Beta-defensin 116,36987,0.00204636432435806,0.00719559926567598,-0.0120570102363669,0.016149738885083,0.776115171557136
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GOLM2,Protein GOLM2,40005,0.000583863318701198,0.00205492962080152,-0.00344379873806979,0.00461152537547218,0.776315830896291
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,37378,-0.00101681956278555,0.00358675060904055,-0.00804685075650503,0.00601321163093393,0.776803101805838
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ITGB1BP1,Integrin beta-1-binding protein 1,39473,0.00106022502992469,0.00377146459908415,-0.00633184558428025,0.00845229564412962,0.778623937116811
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PDCL2,Phosducin-like protein 2,36958,0.00138135474640313,0.00492787749152829,-0.00827728513699232,0.0110399946297986,0.779240773770566
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DHODH,Dihydroorotate dehydrogenase,37017,0.00119752657565434,0.00431721785387045,-0.00726422041793173,0.00965927356924042,0.781489727343103
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,JAM2,Junctional adhesion molecule B,40005,0.000641717555686153,0.00232740472796991,-0.00391999571113488,0.00520343082250718,0.782764838706113
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,39784,-0.00243148702438616,0.00882056509013118,-0.0197197946010433,0.014856820552271,0.782811922543481
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FAM172A,Cotranscriptional regulator FAM172A,37039,0.00157717997396181,0.00574314389786103,-0.00967938206584581,0.0128337420137694,0.78361279842107
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BAP18,Chromatin complexes subunit BAP18,37384,-0.00163709650111278,0.00604384366792923,-0.0134830300902541,0.0102088370880285,0.786495080930857
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PDRG1,p53 and DNA damage-regulated protein 1,37035,-0.00134013682144375,0.00494885448551959,-0.0110398916130622,0.00835961797017464,0.786551118285793
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PPL,Periplakin,37052,0.000800125031680378,0.00297978701908805,-0.00504025752573221,0.00664050758909296,0.78830518670793
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL6ST,Interleukin-6 receptor subunit beta,39864,0.000437960939089484,0.00163191887894875,-0.00276060006365007,0.00363652194182903,0.788416634932279
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AFAP1,Actin filament-associated protein 1,37120,-0.00211577364618982,0.00788508429702809,-0.0175705388683649,0.0133389915759852,0.788452518227346
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MFAP3L,Microfibrillar-associated protein 3-like,37035,0.00159937957970132,0.00600869285659177,-0.0101776584192185,0.0133764175786212,0.790106581342875
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ARID3A,AT-rich interactive domain-containing protein 3A,36987,-0.000979011317793406,0.00370151142533244,-0.00823397371144498,0.00627595107585817,0.791406821281007
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DOCK9,Dedicator of cytokinesis protein 9,36987,0.00286005159463518,0.0108321632715104,-0.0183709884175251,0.0240910916067955,0.791758419662048
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GC,Vitamin D-binding protein,37449,-0.000628311482068494,0.0023990292814434,-0.00533040887369756,0.00407378590956058,0.793400673115707
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPESP1,Sperm equatorial segment protein 1,37433,-0.000701187904119831,0.00271115006120546,-0.00601504202408253,0.00461266621584286,0.795923755171624
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GGACT,Gamma-glutamylaminecyclotransferase,37433,0.00171446587213205,0.00663485553173958,-0.0112898509700775,0.0147187827143416,0.796099901214556
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RBM19,Probable RNA-binding protein 19,37017,0.00113596760586073,0.0044216341916952,-0.00753043540986187,0.00980237062158333,0.797251296260736
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NEK7,Serine/threonine-protein kinase Nek7,37165,-0.00176970119516217,0.00689186052706269,-0.015277747828205,0.0117383454378807,0.797351544588855
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RAB6A,Ras-related protein Rab-6A,39862,-0.00110202602004307,0.00429739157103403,-0.00952491349926978,0.00732086145918364,0.79761387566337
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ENO2,Gamma-enolase,40005,-0.00157254337940149,0.00614372941403145,-0.0136142530309031,0.0104691662721002,0.797985688947169
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KLK15,Kallikrein-15,37347,-0.00119397307278226,0.00467682625862144,-0.0103605525396803,0.00797260639411576,0.798498706322194
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MESD,LRP chaperone MESD,39854,-0.00288559927809551,0.0113368076204699,-0.0251057422142164,0.0193345436580254,0.799086565924116
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RNF31,E3 ubiquitin-protein ligase RNF31,37052,0.000882299545271235,0.00347882922741829,-0.00593620574046861,0.00770080483101108,0.799793345795486
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NECTIN1,Nectin-1,37052,0.000753948476325095,0.00297794638322022,-0.00508282643478653,0.00659072338743672,0.800135138865924
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MMP13,Collagenase 3,39485,0.000755275422756195,0.00298584179499382,-0.0050969744954317,0.00660752534094409,0.800308434173015
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MLLT1,Protein ENL,36958,0.00166511591707867,0.00662230115562773,-0.0113145943479517,0.014644826182109,0.801477362854033
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD274,Programmed cell death 1 ligand 1,39745,-0.000782392578603938,0.00311465388130243,-0.00688711418595669,0.00532232902874882,0.80166483772723
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PSMG4,Proteasome assembly chaperone 4,37052,-0.00128990825069499,0.00514508648928216,-0.011374277769688,0.00879446126829805,0.802044695126965
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ANXA11,Annexin A11,39825,-0.0015533887623014,0.00620478780364155,-0.0137147728574388,0.010607995332836,0.802317404857735
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,37364,0.00225973892158562,0.00906170578081674,-0.0155012044088152,0.0200206822519864,0.803076559182554
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,37408,-0.000687606362431917,0.00276307703460804,-0.00610323735026368,0.00472802462539984,0.803476485854173
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ACP5,Tartrate-resistant acid phosphatase type 5,39915,0.000764279967507913,0.0030829445711238,-0.00527829139189474,0.00680685132691057,0.80421043065047
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL5RA,Interleukin-5 receptor subunit alpha,39862,0.00124661804036708,0.00504052184855461,-0.00863280478279995,0.0111260408635341,0.804664341616355
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DCUN1D2,DCN1-like protein 2,36958,-0.00184148633158926,0.00746031576801454,-0.0164637052368978,0.0127807325737192,0.805037789703715
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BTN1A1,Butyrophilin subfamily 1 member A1,37344,0.000931993818682504,0.00380802872342007,-0.00653174247922084,0.00839573011658585,0.806658048113715
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TGFBI,Transforming growth factor-beta-induced protein ig-h3,39801,0.000606717198507399,0.00248844849585403,-0.0042706418533665,0.00548407625038129,0.80737844506272
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDSN,Corneodesmosin,39988,0.000954201776017622,0.00392974453610028,-0.00674809751473892,0.00865650106677416,0.80815163389823
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD3G,T-cell surface glycoprotein CD3 gamma chain,37052,-0.00204564926085469,0.00844401592829537,-0.0185959204803136,0.0145046219586042,0.808582291947676
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,COPB2,Coatomer subunit beta',37017,0.000963074001870804,0.00397708329415789,-0.00683200925467866,0.00875815725842027,0.808663174694717
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,S100A11,Protein S100-A11,39699,0.00101237165219808,0.0042190721678529,-0.0072570097967936,0.00928175310118977,0.810371152437604
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",39709,-0.00213456262226382,0.0089634426241774,-0.0197029101656515,0.0154337849211239,0.811774863590846
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,APPL2,DCC-interacting protein 13-beta,37120,-0.00247047615441061,0.0105074119226144,-0.0230650035227348,0.0181240512139136,0.814121186782427
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TIMP3,Metalloproteinase inhibitor 3,39927,-0.00279541064743774,0.0120346761799786,-0.0263833759601958,0.0207925546653204,0.816323757752933
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,37165,-0.000821159854969196,0.00353978812329541,-0.0077591445766282,0.0061168248666898,0.816557158055832
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ENPEP,Glutamyl aminopeptidase,37017,-0.000899348682829286,0.00389608482191102,-0.00853567493377488,0.00673697756811631,0.817447387524866
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ARHGAP1,Rho GTPase-activating protein 1,39473,0.000996897994608173,0.00436001039709217,-0.00754872238369248,0.00954251837290882,0.819147231254935
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",37052,0.0012690128889847,0.00555916149189569,-0.00962694363513085,0.0121649694131002,0.819436653993945
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ACRV1,Acrosomal protein SP-10,37052,-0.0015197058247485,0.00677273279246809,-0.014794262097986,0.011754850448489,0.822460506832095
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",37052,-0.000939913384778614,0.00423151453185336,-0.0092336818672112,0.00735385509765397,0.824222182378183
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GSAP,Gamma-secretase-activating protein,39473,-0.00179423056020726,0.00817601673741645,-0.0178192233655435,0.014230762245129,0.826302042239397
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IGFBP7,Insulin-like growth factor-binding protein 7,40048,0.000591171280775556,0.00272495064181708,-0.00474973197718593,0.00593207453873704,0.828251978633067
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TLR2,Toll-like receptor 2,37165,0.000456110692172134,0.00211261050582639,-0.00368460589924759,0.00459682728359186,0.829069713675473
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GRIK2,"Glutamate receptor ionotropic, kainate 2",37408,0.000789745417907476,0.003662738257772,-0.00638922156732564,0.0079687124031406,0.829290233891548
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CXCL11,C-X-C motif chemokine 11,40005,-0.00155595839382266,0.00722388416149491,-0.0157147713503527,0.0126028545627074,0.829465340814989
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,37408,0.00231121271306192,0.0107376678525881,-0.0187346162780107,0.0233570417041345,0.829580753620894
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,H2AP,Huntingtin-interacting protein M,36958,0.000999363411687438,0.00464802608857156,-0.00811076772191281,0.0101094945452877,0.82976432503794
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SNCA,Alpha-synuclein,37120,0.00229922198177162,0.0107853840620244,-0.0188401307797961,0.0234385747433394,0.831190292491136
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DCTD,Deoxycytidylate deaminase,37120,-0.00189672693325152,0.00889948169086525,-0.0193397110473474,0.0155462571808444,0.831230559726541
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NOS2,"Nitric oxide synthase, inducible",37017,0.000767348659748185,0.00368030467778532,-0.00644604850871104,0.00798074582820742,0.834840720955729
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ICAM5,Intercellular adhesion molecule 5,39864,-0.000850924035757075,0.00409626606003927,-0.00887960551343404,0.00717775744191989,0.835441160441862
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ERC2,ERC protein 2,37035,0.00144948805302042,0.0069889857908394,-0.0122489240970248,0.0151479002030656,0.835703771807841
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DLGAP5,Disks large-associated protein 5,37408,0.00100746998468525,0.00487074813241013,-0.00853919635483861,0.0105541363242091,0.83613721244611
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NRXN3,Neurexin-3,37035,-0.000668155543855496,0.00327011154524293,-0.00707757417253164,0.00574126308482065,0.838105079837766
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PREB,Prolactin regulatory element-binding protein,39583,-0.000543312185980358,0.00266067444288827,-0.00575823409404138,0.00467160972208066,0.838199130410265
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TET2,Methylcytosine dioxygenase TET2,37157,0.00187576191795884,0.00920667257394753,-0.0161693163269783,0.019920840162896,0.838560271348133
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DCTN6,Dynactin subunit 6,39485,0.00134154776859756,0.00660927455680895,-0.011612630362748,0.0142957258999431,0.839153636371342
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CAPG,Macrophage-capping protein,39735,0.00107402058105203,0.00538943586309181,-0.00948927371060791,0.011637314872712,0.842044272146329
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TMED4,Transmembrane emp24 domain-containing protein 4,37017,0.00103416554513733,0.00523509844392224,-0.00922662740495025,0.0112949584952249,0.843404417407747
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DNPEP,Aspartyl aminopeptidase,37384,0.00107752230135795,0.00548475441120392,-0.00967259634460173,0.0118276409473176,0.84425488067663
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CST6,Cystatin-M,39520,0.000852980287509444,0.00435402590984758,-0.00768091049579182,0.0093868710708107,0.844686195168976
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ACRBP,Acrosin-binding protein,37364,0.000695088088047757,0.0035660527888916,-0.00629437537817977,0.00768455155427529,0.845460028586074
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CPA4,Carboxypeptidase A4,36864,0.000786879886548992,0.00404806808019784,-0.00714733355063878,0.00872109332373676,0.845878210837713
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GHRHR,Growth hormone-releasing hormone receptor,39485,0.000971859213582562,0.00502279849616717,-0.00887282583890509,0.0108165442660702,0.846578074303255
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TBCA,Tubulin-specific chaperone A,37120,0.00154695294564341,0.00803412857739967,-0.01419993906606,0.0172938449573468,0.847316159615523
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,INPP1,Inositol polyphosphate 1-phosphatase,39784,-0.000959000460530018,0.00501490452216251,-0.0107882133239685,0.0088702124029085,0.848347796738881
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,37364,0.000785479740679929,0.00412157984548884,-0.0072928167564782,0.00886377623783805,0.848859606376631
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LPCAT2,Lysophosphatidylcholine acyltransferase 2,39784,0.000675562145760422,0.00355868439822633,-0.00629945927476318,0.00765058356628403,0.849441003843176
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DNAJC9,DnaJ homolog subfamily C member 9,37378,-0.00133546896626076,0.00704174603767029,-0.0151372912000945,0.012466353267573,0.849586047570613
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPRING1,SREBP regulating gene protein,36958,0.00104812413211056,0.00555550707299673,-0.00984066973096304,0.0119369179951842,0.850359099263133
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SAT1,Diamine acetyltransferase 1,37017,0.000861344688896835,0.0046200105971885,-0.00819387608159262,0.0099165654593863,0.852104313208934
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,39784,0.000763027085771017,0.00411756341647712,-0.00730739721052414,0.00883345138206617,0.852987986709356
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HYAL1,Hyaluronidase-1,39743,-0.000391282359919871,0.00211730967454194,-0.00454120932202208,0.00375864460218234,0.853386958865261
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD80,T-lymphocyte activation antigen CD80,37433,0.00057266958558782,0.00311770026420107,-0.00553802293224627,0.00668336210342191,0.85426462612856
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AIDA,"Axin interactor, dorsalization-associated protein",37035,-0.00141222351984511,0.00789379601180594,-0.0168840637029848,0.0140596166632945,0.858016644698301
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EPGN,Epigen,37364,0.000818968471936783,0.00463280406870916,-0.00826132750273317,0.00989926444660674,0.859687009370201
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MAGEA3,Melanoma-associated antigen 3,37165,-0.00136662404121447,0.00779794981603392,-0.0166506056806409,0.013917357598212,0.860882505780233
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CEP152,Centrosomal protein of 152 kDa,36958,0.000678351046744348,0.00387097240041049,-0.00690875485806021,0.00826545695154891,0.860893389766729
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NEB,Nebulin,37017,-0.000609591344338394,0.00349171767197283,-0.00745335798140513,0.00623417529272835,0.861410714278169
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CRTAP,Cartilage-associated protein,37035,-0.000800625284758595,0.00460722164967082,-0.00983077971811341,0.00822952914859622,0.862044050977613
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PMVK,Phosphomevalonate kinase,39476,-0.00179346583295799,0.0103361473919568,-0.0220523147211934,0.0184653830552774,0.862249707243964
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CEP112,Centrosomal protein of 112 kDa,37017,-0.000751332672751567,0.00433957433789721,-0.0092568983750301,0.00775423302952697,0.862547892563346
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CNGB3,Cyclic nucleotide-gated cation channel beta-3,36987,-0.000872970026054605,0.00508569533963733,-0.0108409328917438,0.00909499283963456,0.863713731338294
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CASP9,Caspase-9,37052,-0.00100361750172017,0.00587983489222964,-0.0125280938904903,0.0105208588870499,0.86447168405054
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,F2R,Proteinase-activated receptor 1,39904,0.000898435159906312,0.00542815892043526,-0.0097407563241468,0.0115376266439594,0.868541681444394
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NMRK2,Nicotinamide riboside kinase 2,36958,-0.00062570716929761,0.00378807761488598,-0.00805033929447412,0.0067989249558789,0.868806412303511
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IMPG1,Interphotoreceptor matrix proteoglycan 1,36987,0.000457445388278259,0.00279156580878637,-0.00501402359694303,0.00592891437349955,0.869838404409393
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FGF16,Fibroblast growth factor 16,37052,0.000713420018996047,0.00448254627614467,-0.0080723706822475,0.00949921072023959,0.873549128670637
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",36987,-0.000791231961063836,0.00501280059603602,-0.0106163211292944,0.00903385720716677,0.874583495917589
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RPE,Ribulose-phosphate 3-epimerase,37165,-0.00102285283767317,0.0066239599433682,-0.0140058143266748,0.0119601086513285,0.877283195479387
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MANF,Mesencephalic astrocyte-derived neurotrophic factor,39927,-0.00172178912508898,0.0112043584612237,-0.0236823317090875,0.0202387534589095,0.877870789238811
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NEO1,Neogenin,37408,0.000301746217721853,0.00200574380950725,-0.00362951164891236,0.00423300408435607,0.8804188910634
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,37035,0.000736802371700595,0.00490815242339747,-0.00888317637815844,0.0103567811215596,0.880673761275291
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,C1QA,Complement C1q subcomponent subunit A,39967,0.000309072567153968,0.00212943001901896,-0.00386461027012318,0.00448275540443112,0.884599523004933
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DTD1,D-aminoacyl-tRNA deacylase 1,37120,0.00118851446902718,0.00819988756765172,-0.0148832651635702,0.0172602941016246,0.884758255363892
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CA9,Carbonic anhydrase 9,40026,-0.000574163585317864,0.00401961680532652,-0.00845261252375784,0.00730428535312212,0.886418026912901
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FGF7,Fibroblast growth factor 7,36958,0.00105020883440684,0.00738393613639264,-0.0134223059929227,0.0155227236617364,0.886901422456893
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRAME,Melanoma antigen preferentially expressed in tumors,36958,-0.000333715437346629,0.00237768662227008,-0.00499398121699599,0.00432655034230273,0.88838325330229
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CYTH3,Cytohesin-3,36958,-0.000934237607110341,0.00670855726414944,-0.0140830098448432,0.0122145346306226,0.889246376240297
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTGES2,Prostaglandin E synthase 2,36957,-0.000717676546669691,0.00516327170389338,-0.0108376890863007,0.00940233599296133,0.889455074648926
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PSMD1,26S proteasome non-ATPase regulatory subunit 1,37408,-0.000622351982558304,0.00448074614307368,-0.00940461442298272,0.00815991045786611,0.889535407479052
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,37364,-0.000783146232252344,0.00568415595378932,-0.0119240919016794,0.0103577994371747,0.890418677915275
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ENDOU,Poly(U)-specific endoribonuclease,36426,0.000652284589210946,0.00479538005164828,-0.00874666031201969,0.0100512294904416,0.891804847465302
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LRP2BP,LRP2-binding protein,37035,-0.00100341444226893,0.00743456994066709,-0.0155751715259764,0.0135683426414386,0.89264078881176
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL6,Interleukin-6,39784,0.00085924124642094,0.00658079124726026,-0.0120391095982092,0.013757592091051,0.896118648084462
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GPR15L,Protein GPR15L,37378,0.0007414514900967,0.00569601485304704,-0.0104227376218755,0.0119056406020689,0.896433694201877
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PCDH9,Protocadherin-9,37378,0.00039957634481408,0.00308544101048196,-0.00564788803573056,0.00644704072535872,0.896960942688088
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,39473,-0.00143604762541644,0.0111811539296961,-0.0233511093276207,0.0204790140767879,0.897806663314724
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCL19,C-C motif chemokine 19,40005,-0.00137118612515494,0.0107369503130786,-0.022415608738789,0.0196732364884791,0.898382263025975
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PHLDB2,Pleckstrin homology-like domain family B member 2,36958,0.00107269155095768,0.00847908147522991,-0.0155463081404929,0.0176916912424083,0.899329899935695
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DXO,Decapping and exoribonuclease protein,37384,-0.000533657170169899,0.00422163289258508,-0.00880805763963666,0.00774074329929686,0.899409161686503
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,37023,-0.000426597896599822,0.00338404918234228,-0.00705933429399069,0.00620613850079104,0.899685266246522
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MFAP3,Microfibril-associated glycoprotein 3,39581,-0.000567196759838852,0.00455770555303175,-0.00950029964378109,0.00836590612410338,0.900962262189677
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AHNAK2,Protein AHNAK2,37039,-0.000336479793675973,0.00272401399039037,-0.00567554721484109,0.00500258762748915,0.901694435175996
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ODAM,Odontogenic ameloblast-associated protein,39452,-0.000581193225067913,0.0047643908207673,-0.00991939923377182,0.00875701278363599,0.902910972044859
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LGMN,Legumain,39927,0.000390746133262083,0.00333541665868428,-0.00614667051775911,0.00692816278428328,0.906742160305335
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CA12,Carbonic anhydrase 12,39784,0.000346465607876807,0.00296051972447356,-0.00545615305209138,0.00614908426784499,0.906838830957393
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AK2,"Adenylate kinase 2, mitochondrial",37384,0.00115007187894492,0.00989948045028429,-0.0182529098036123,0.0205530535615021,0.907515595630706
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VIPR1,Vasoactive intestinal polypeptide receptor 1,37039,-0.000274193082477712,0.00241307621796645,-0.00500382246969196,0.00445543630473654,0.909534402059435
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RUVBL1,RuvB-like 1,39473,0.00106939361288995,0.00943695707502461,-0.0174270422541583,0.0195658294799382,0.909778517125364
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL2,Interleukin-2,39583,0.000317945347121463,0.00289757493440012,-0.00536130152430278,0.00599719221854571,0.91262642709137
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,STX6,Syntaxin-6,39473,-0.000687526355512409,0.00633840751556065,-0.0131108050860113,0.0117357523749865,0.913624359051824
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,37081,-0.000387311444989197,0.0035850286953518,-0.00741396768787872,0.00663934479790032,0.913968933085949
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KIFBP,KIF-binding protein,39784,0.000829072184235638,0.00771452046163915,-0.0142913879205771,0.0159495322890484,0.914418231617303
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ATXN2,Ataxin-2,36987,-0.0011114650014258,0.0103496130044613,-0.02139670649017,0.0191737764873184,0.914479690994329
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DGKZ,Diacylglycerol kinase zeta,39583,0.000353945667502522,0.00334656305061507,-0.00620531791170302,0.00691320924670806,0.915771003405345
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,40005,0.000450117585676008,0.00431482203655542,-0.00800693360597261,0.00890716877732462,0.916917557653247
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RAC3,Ras-related C3 botulinum toxin substrate 3,37035,0.000653485470524738,0.00635142615730638,-0.0117953097977958,0.0131022807388452,0.918053435659112
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,37364,0.00072648948507807,0.00712047515145901,-0.0132296418117816,0.0146826207819377,0.918735781597498
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PPM1F,Protein phosphatase 1F,37433,-0.000503802536285721,0.00494948997914722,-0.0102048028954143,0.00919719782284283,0.918925836889049
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MORF4L2,Mortality factor 4-like protein 2,36958,-0.000349709445654852,0.00344616490556275,-0.00710419266055784,0.00640477376924814,0.919172683939621
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LUZP2,Leucine zipper protein 2,37364,0.000405872647619317,0.00405884221823635,-0.00754945810012394,0.00836120339536257,0.920348073748106
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",39583,-0.0011255278839009,0.0112671084725673,-0.0232090604901328,0.020958004722331,0.920428953659814
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,36987,0.000669319389613764,0.00671067044532677,-0.0124835946832267,0.0138222334624542,0.920552607309066
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TFAP2A,Transcription factor AP-2-alpha,36987,-0.000547203201345557,0.00551306507108783,-0.0113528107406777,0.0102584043379866,0.920936756668422
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TMPRSS11D,Transmembrane protease serine 11D,37353,0.000333295256594383,0.00335844252142967,-0.00624925208540777,0.00691584259859653,0.920948381757139
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EFHD1,EF-hand domain-containing protein D1,37408,-0.00031099911556345,0.0032039980351331,-0.00659083526442433,0.00596883703329743,0.922675456288856
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,37017,-0.000590734105981264,0.00628215334908634,-0.0129037546701905,0.011722286458228,0.925083820679848
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PCDH17,Protocadherin-17,39864,0.000304795653946148,0.00324625588085057,-0.00605786587252097,0.00666745718041327,0.925196565457977
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PLAUR,Urokinase plasminogen activator surface receptor,39753,0.000229114359692685,0.00248684042765242,-0.00464509287850605,0.00510332159789142,0.926595354997054
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,37035,0.000407975243069963,0.00450577270309763,-0.00842333925500139,0.00923928974114132,0.927855502925928
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LY96,Lymphocyte antigen 96,39745,-0.000293651874733983,0.00327879979013848,-0.0067200994634054,0.00613279571393743,0.928637379286677
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GIPC3,PDZ domain-containing protein GIPC3,37378,-0.000809032245678092,0.00918978139555607,-0.018821003780968,0.0172029392896118,0.929849311117796
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,37120,-0.000537962241926574,0.00621364624247684,-0.0127167088771812,0.011640784393328,0.931008621985268
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TPBGL,Trophoblast glycoprotein-like,37035,0.000325049090251922,0.00377958500403761,-0.00708293751766179,0.00773303569816563,0.931466718742057
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD177,CD177 antigen,39840,-0.000980710151730951,0.011583039026271,-0.023683466643222,0.0217220463397601,0.932526575737232
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TGFB2,Transforming growth factor beta-2 proprotein,37364,-0.000411525397310295,0.00488487396805924,-0.0099858783747064,0.00916282758008581,0.932863021142523
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HDAC9,Histone deacetylase 9,36987,0.000500273416983127,0.00597189899466581,-0.0112046486125619,0.0122051954465281,0.933239587753544
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RAB6B,Ras-related protein Rab-6B,39485,0.000351961095694601,0.00437658031193719,-0.00822613631570229,0.00893005850709149,0.935904885403881
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ZFYVE19,Abscission/NoCut checkpoint regulator,37378,-0.000675850407898274,0.0084372693654225,-0.0172128983641264,0.0158611975483298,0.936156539497063
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AKT3,RAC-gamma serine/threonine-protein kinase,39387,0.000427994104796439,0.00542323383482632,-0.0102015442114631,0.011057532421056,0.937098373517668
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,OMP,Olfactory marker protein,36987,-0.000343258945397371,0.00451996958450655,-0.0092023993310302,0.00851588144023546,0.939465798307127
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",37135,-0.000453521495763081,0.00599905642898315,-0.0122116720965701,0.0113046291050439,0.939739426577012
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TPD52L2,Tumor protein D54,37120,0.000725420874435409,0.0101475152695888,-0.0191637090539587,0.0206145508028295,0.943010821243316
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",37039,-0.000328164627703841,0.00466729218483423,-0.00947605730997893,0.00881972805457125,0.943946742880423
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RPGR,X-linked retinitis pigmentosa GTPase regulator,37035,0.000251229574344964,0.00380956285274488,-0.007215513617035,0.00771797276572493,0.947420952439598
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDC26,Anaphase-promoting complex subunit CDC26,37358,0.000427267645036833,0.00659649413217135,-0.012501860854019,0.0133563961440927,0.94835655164464
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD33,Myeloid cell surface antigen CD33,39909,-0.000464421426524038,0.00729147483441351,-0.0147557121019745,0.0138268692489264,0.949214869056862
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CPTP,Ceramide-1-phosphate transfer protein,37017,0.000234800195783187,0.00369345492421253,-0.00700437145567337,0.00747397184723974,0.949312019142983
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,UPK3BL1,Uroplakin-3b-like protein 1,37145,-0.000319855780157691,0.00505303022822524,-0.0102237950274792,0.00958408346716378,0.949528730918007
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CA3,Carbonic anhydrase 3,40013,0.000353258450529594,0.00559832280546521,-0.0106194542481822,0.0113259711492414,0.949687046068573
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PSMA1,Proteasome subunit alpha type-1,39473,-0.000271804349361722,0.00431857207249374,-0.00873620561144946,0.00819259691272602,0.949816300975465
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ACP1,Low molecular weight phosphotyrosine protein phosphatase,37052,0.00025042583304189,0.00402924756827554,-0.00764689940077817,0.00814775106686195,0.950442721025728
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ALMS1,Alstrom syndrome protein 1,37165,0.000255878202624171,0.00416921086736665,-0.00791577509741445,0.0084275315026628,0.95106284271784
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KLK7,Kallikrein-7,36814,0.000221356931278707,0.00363144450444337,-0.00689627429743029,0.00733898815998771,0.95139549813542
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FOS,Proto-oncogene c-Fos,36927,-0.000195743857184949,0.00327793236688843,-0.00662049129628626,0.00622900358191636,0.952383021425179
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RBM25,RNA-binding protein 25,36958,-0.000252637620646209,0.00423677369763092,-0.0085567140680028,0.00805143882671039,0.952451458676997
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ARHGEF5,Rho guanine nucleotide exchange factor 5,36987,0.000405688958339964,0.00694800714457911,-0.0132124050450351,0.014023782961715,0.953439462486319
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KIAA1549,UPF0606 protein KIAA1549,37165,-0.000368039939150284,0.00639872284022389,-0.0129095367059891,0.0121734568276885,0.954133655874475
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PYDC1,Pyrin domain-containing protein 1,37039,0.000219883480791982,0.00383256174577893,-0.00729193754093471,0.00773170450251868,0.954249373420618
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DDX53,Probable ATP-dependent RNA helicase DDX53,37035,0.000184905870037268,0.00328090469571032,-0.00624566733355496,0.0066154790736295,0.955057313334516
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NLGN1,Neuroligin-1,37035,0.000319465204245012,0.00627237947451298,-0.0119743985658004,0.0126133289742905,0.959380431020951
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PGM2,Phosphoglucomutase-2,37035,0.000286767918422984,0.00564498429778942,-0.0107774013052443,0.0113509371420902,0.959485277578865
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LGALS7_LGALS7B,Galectin-7,39818,-0.000189739913863196,0.00377362371356915,-0.00758604239245874,0.00720656256473234,0.959899444261456
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTK7,Inactive tyrosine-protein kinase 7,39485,-0.000178702831349192,0.00357945429924916,-0.00719443325787755,0.00683702759517917,0.960183110299459
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL12A_IL12B,Interleukin-12,39784,0.000331204248660454,0.0068439154490493,-0.0130828700314762,0.0137452785287971,0.961402870693642
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KHDC3L,KH domain-containing protein 3,36958,0.00029774948319834,0.00616847554926395,-0.011792462593359,0.0123879615597557,0.961502164988992
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDKL5,Cyclin-dependent kinase-like 5,36987,0.00023619362286777,0.00489871334737948,-0.00936528453799601,0.00983767178373155,0.961545278106924
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCARA5,Scavenger receptor class A member 5,40005,0.000129821639053151,0.00270945089438827,-0.00518070211394785,0.00544034539205415,0.96178507771253
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NACC1,Nucleus accumbens-associated protein 1,37364,-0.000235380420110437,0.00511047455480853,-0.0102519105475352,0.00978114970731428,0.963264362184281
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,37165,-0.000297983253712903,0.00668099234297644,-0.0133927282459467,0.0127967617385209,0.964425500185764
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TDO2,"Tryptophan 2,3-dioxygenase",37035,0.000156865704569339,0.00365149707013126,-0.00700006855288792,0.0073137999620266,0.965734640461697
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FES,Tyrosine-protein kinase Fes/Fps,39473,0.0001853461742866,0.00440140137058265,-0.00844140051205539,0.00881209286062859,0.966410974071513
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CINP,Cyclin-dependent kinase 2-interacting protein,37165,-0.000169603934055659,0.0040483341038397,-0.00810433877758147,0.00776513090947015,0.966583232451047
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,36958,0.000317234290817666,0.00774519126312131,-0.0148633405849001,0.0154978091665354,0.967329308696344
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AHCY,Adenosylhomocysteinase,39864,-0.000229719845611925,0.00629260276365747,-0.0125632212623806,0.0121037815711567,0.970879085181411
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,36987,-0.000188672820099332,0.00546215962186556,-0.0108945056789558,0.0105171600387572,0.972445636577189
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TPM3,Tropomyosin alpha-3 chain,37017,-0.000140632699434957,0.00412785573917747,-0.0082312299482228,0.00794996454935289,0.972822494239422
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ANGPTL2,Angiopoietin-related protein 2,39873,0.000121965751615072,0.00365444217995891,-0.00704074092110439,0.00728467242433453,0.973376235737721
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IGLC2,Immunoglobulin lambda constant 2,37418,7.5500630714166e-05,0.00226362145122393,-0.00436119741368474,0.00451219867511307,0.973392853065594
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TPPP2,Tubulin polymerization-promoting protein family member 2,37165,-0.00022300141686077,0.00729222249505375,-0.0145157575071661,0.0140697546734446,0.975604376571253
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SWAP70,Switch-associated protein 70,37378,9.74050819115575e-05,0.00333009866708592,-0.00642958830557684,0.00662439846939995,0.976665708661894
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SUGT1,Protein SGT1 homolog,39473,0.000218795623839093,0.00753463753250742,-0.0145490939398754,0.0149866851875536,0.976834144781938
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCDC80,Coiled-coil domain-containing protein 80,39864,-8.1665732126505e-05,0.00303217791852231,-0.00602473445243023,0.00586140298817722,0.978513486511436
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PPIB,Peptidyl-prolyl cis-trans isomerase B,39833,-0.000234779254307292,0.00893330768020481,-0.0177440623075087,0.0172745037988941,0.979033270370559
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCN2B,Sodium channel subunit beta-2,37035,6.94569468446341e-05,0.0026875795159157,-0.00519819890435013,0.0053371127980394,0.979382412720561
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MAX,Protein max,39485,0.000232435108011522,0.00981321203934469,-0.0190014604891041,0.0194663307051271,0.981103427116765
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,37035,0.000108577578256549,0.00507109910263912,-0.00983077666291612,0.0100479318194292,0.982918079767392
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HK2,Hexokinase-2,39581,-4.99876677689612e-05,0.00254013121654769,-0.00502864485220243,0.00492866951666451,0.984299559201266
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",37052,5.0510567929581e-05,0.00257827276657717,-0.00500290405456168,0.00510392519042084,0.984370055364501
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BCL7B,B-cell CLL/lymphoma 7 protein family member B,37364,-8.1565635356381e-05,0.0042078106707515,-0.00832887455002933,0.00816574327931657,0.984534788810504
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL17RA,Interleukin-17 receptor A,39854,7.87559439682656e-05,0.00409076513051472,-0.00793914371184059,0.00809665559977712,0.984640211350052
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EDAR,Tumor necrosis factor receptor superfamily member EDAR,39862,-0.000165358817209163,0.00860213402886578,-0.0170255415137861,0.0166948238793678,0.98466344979417
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCARB2,Lysosome membrane protein 2,39482,-5.0880856725167e-05,0.0026652207035725,-0.00527471343572727,0.00517295172227693,0.984769015806838
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TIMP2,Metalloproteinase inhibitor 2,37433,4.00787906103867e-05,0.00236927290278965,-0.00460369609885733,0.0046838536800781,0.98650381976963
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SHD,SH2 domain-containing adapter protein D,36998,0.000125520645335434,0.00773565093442961,-0.0150363551861466,0.0152873964768175,0.987054136077243
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD84,SLAM family member 5,39862,-4.47176504221953e-05,0.00289325305326212,-0.00571549363481594,0.00562605833397155,0.987668709152593
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TMOD4,Tropomodulin-4,36958,4.86642344925846e-05,0.00378445012919236,-0.00736885801872443,0.0074661864877096,0.989740483075198
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,37433,-6.32766773575803e-05,0.00579143979110427,-0.0114144986679219,0.0112879453132068,0.991282729114503
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LAP3,Cytosol aminopeptidase,39583,3.62673328264703e-05,0.00452415888371877,-0.00883108407926232,0.00890361874491526,0.993604032125436
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SDK2,Protein sidekick-2,37120,2.76546728568499e-05,0.00345245787721764,-0.00673916276648972,0.00679447211220342,0.993609021365862
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLSPN,Claspin,39449,-2.10174407824676e-05,0.00320410175834244,-0.00630105688713365,0.00625902200556871,0.994766363998445
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NAPRT,Nicotinate phosphoribosyltransferase,37384,-1.82347012809735e-05,0.00303386742655492,-0.00596461485732862,0.00592814545476668,0.995204526755196
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCARB1,Scavenger receptor class B member 1,39485,2.08011074698583e-05,0.00530307583196802,-0.0103732275231875,0.0104148297381272,0.996870387127277
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SAFB2,Scaffold attachment factor B2,37408,-9.40515987630174e-06,0.00254431190929417,-0.00499625650209288,0.00497744618234027,0.997050646084289
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL34,Interleukin-34,39452,-1.1097468969631e-05,0.00332921533610366,-0.0065363595277328,0.00651416458979354,0.997340412111553
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EXTL1,Exostosin-like 1,37017,1.39293505951164e-05,0.00444056461632497,-0.00868957729740183,0.00871743599859207,0.997497213679811
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDH4,Cadherin-4,36987,1.17998467761679e-05,0.00435164186250512,-0.00851741820373386,0.0085410178972862,0.997836512052422
